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ABSTRACT 
Helicobacter pylori (Hp) is a major cause of peptic ulcer disease (PUD) and 
gastric cancer, yet the infection remains asymptomatic in most people. One 
factor that influences the outcome of Hp infection is the host immune 
response. Expression ofthe immune-stimulating cytokine interleukin-17 (IL-
17) is increased in the human Hp-infected gastric mucosa, but its cellular 
source and role in pathology are unclear. 
In this study dendritic cell cytokine responses to Hp stimulation were studied, 
and relative IL-12p70 and IL-23 concentrations compared, to assess the 
potential of Hp to promote differentiation of IL-17-secreting T-helper cells 
(Th17). The effect of Hp virulence factors on cytokine secretion was assessed 
. and monocyte-derived DC (MoDCs) and CD1c+ myeloid DC (MyDC) responses 
compared. MoDCs produced high concentrations of IL-12p70 upon Hp 
stimulation. There was also a n ~ ~ IL-23 MoDCs response, but this was >10-fold 
lower than the IL-12p70 response. Both IL-12p70 and IL-23 responses were 
significantly reduced when Hp isogenic mutants for the virulence factor dupA 
were used, although the effect on MoDC IL-12p70 and IL-23 secretion was 
less marked than previously reported for monocytes. MyDCs produced lower 
concentrations of IL-23 than MoDCs, and no detectable IL-12p70. 
It is known that Hp infection can h a v ~ ~ systemic effects, so next peripheral 
blood mononuclear cells (PBMCs) from 21 Hp+ and 13 uninfected patients 
were stimulated with Hp or control antigen and Th17 and Th1 cell frequencies 
analyzed by flow cytometry. A systemic Hp-specific Th17 response was 
identified with higher Th17 cell frequencies in the Hp+ patients compared to 
the uninfected controls (2.0-fold, p=O.027). A variable proportion of these 
cells also secreted IFNy (median 33%, n=21), but there was no significant 
correlation between Th17 and Th1 cell frequencies. Peripheral blood Th1 cells 
were also increased in Hp+ patients (2.1-fold, p=O.018). No significant 
difference was found between peripheral blood Th17 and Th1 frequencies in 
the Hp+ patients. 
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The concentrations of Th17, Th1, Th2 and Treg cytokines in the gastric 
mucosa of Hp+ patients and uninfected controls were investigated using 
luminex and real-time PCR. High levels of Il-17 expression in the infected 
compared to uninfected gastric mucosa were confirmed at both the mRNA 
and protein level (mRNA: 42.6-fold, p<O.OOOl; protein 3.5-fold, p<O.OOOl). Il-
17 concentrations correlated with the levels of Il-17F (p=0.80, p<O.OOOl) and 
the chemokines CCl20 (p=0.59, p<O.OOOl) and Il-8 (p=0.49, p=0.0004). 
Concentrations of the Th17-differentiating cytokines I l - 1 ~ , , Il-6, Il-21 and Il-
23 were not increased in the Hp+ gastric biopsies, although Il-23 was present 
at high concentrations in all samples regardless of Hp infection status. Il-17 
was present at higher concentrations than IFNy (3.9-fold, p<O.OOOl), Il-4 (3.0-
fold, p<O.OOOl) and Il-10 (6.8-fold, p<O.OOOl) in Hp+ gastric biopsies. IFNG 
mRNA was also more highly expressed than 1L17 mRNA (3.3-fold, p=0.016). 
To identify the cellular source of the Il-17 mononuclear cells were extracted 
.-
from gastric biopsies, stimulated with PMA/ionomycin and analyzed by flow 
cytometry. Amongst biopsy C03+ T cells from 10 Hp+ patients, IL-17 was 
produced mainly by C04+ Th17 cells (68.5%), although CD8+/l-17+ (24.7%) and 
C04-C08- (18.2%) cells also made a significant contribution. 
High IL-17 concentrations were associated with increased inflammation (2.4-
fold, P=0.024) and neutrophil infiltration (2.4-fold, p=0.031). RORC2 mRNA 
.. 
expression was weakly associated with PUO (p=0.046, l.4-fold) but, 
surprisingly, no association was found between the IL-17 response and 
incidence of PUO or precancerous changes. 
In conclusion Hp can stimulate OCs to produce IL-23 in vitro, and high levels of 
this Th17-differentiating cytokine were found in gastric mucosal biopsies. 
Stimulation with dupA null Hp strains led to reduced IL-12p70 and IL-23 
secretion, suggesting a possible mechanism of action for this recently 
discovered virulence factor. Culturing Hp with MoDCs and MyDCs yielded 
quite different results, and it remains unknown whether either model closely 
reflects gastric mucosal DC responses. Hp-specific Th17 responses were 
iv 
identified in the peripheral blood of patients with active Hp infection for the 
first time. Th17 cells were identified as the main cellular source of IL-17 in the 
Hp-infected gastric mucosa but there were also significant numbers of CDS+IL-
17+ and CD4-CDS-IL-17+ T cells, which have not previously been described in 
this context. High mucosal concentrations of IL-17 and association of this 
cytokine with infiltration of immune cells indicate that it is an important 
component of the human immune response to Hp. However, no association 
between IL-17 and risk of disease was detected in this study, although RORC2 
expression was weakly associated with PUD. The role of I L-17/Th 17 in Hp-
related disease warrants further investigation. 
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1. INTRODUCTION 
1.1 HELICOBACTER PYLORI INFECTION AND DISEASE 
1.1.1 Helicobacter pylori: The Bacteria 
Helicobacter pylori (Hp) is a Gram negative spiral shaped bacterium. The 
bacterium and its link to peptic ulcer disease were discovered by Warren (a 
pathologist) and Marshall (a clinical fellow at the time) (Marshall and Warren, 
1984). Prior to Warren and Marshall's publication it was thought very unlikely 
that any infecting microorganisms could survive in the harsh acid 
environment of the stomach and peptic ulcer disease was thought to be 
largely due to stress and lifestyle factors. Marshall infected himself with Hp to 
demonstrate that it caused gastritis, which resolved with antibiotic treatment, 
thereby fulfilling Koch's postulates. Testing for Hp and, if found, eradicating 
with a triple drug therapy (consisting of two antibiotics and a proton pump 
inhibitor (PPI)) is now the most common first line treatment for peptic ulcer 
disease (Wolle and Malfertheiner, 2007). Marshall and Warren were awarded 
the Nobel Prize in 2005 for their seminal findings (Nobelprize.org, 2005). 
Evidence suggests that Hp has colonized the human stomach and co-evolved 
with its human host for at least 50,000 years (Atherton and Blaser, 2009). 
Point mutation and intragenomic and intergenomic recombination result in 
genetic diversity and enable Hp to adapt to its harsh acidic niche in the 
stomach (Atherton and Blaser, 2009). In order to survive Hp expresses large 
amounts of urease enzyme, which converts urea to ammonia and carbon 
dioxide, buffering the bacterium from the acid environment of the stomach 
(Dunn et aL, 1990). This reaction also forms the basis of some of the tests 
used to detect Hp infection including the urea breath test, and the biopsy 
urease test used in this study (Dunn et aL, 1990, Ricci et aL, 2007). Hp also has 
characteristic flagellae (2-6 per bacterium), which allow the bacteria to move 
through the mucus (Dunn et aI., 1997, Suerbaum et aL, 1993). Motility is 
essential for robust infection of the gastric mucosa (Ottemann and lowenthal, 
2002-;, presumably allowing the bacteria to rapidly swim from the acidic 
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stomach lumen into the thick mucus layer which protects the gastric 
epithelium. 
Following its isolation Hp was initially named Campylobaeter pyloridis. This 
was corrected to Campylobaeter pylori, prior to Helieobaeter becoming a 
separate genus in 1989 (Goodwin et aL, 1989). Virtually all mammals, 
including dolphins and whales, have been found to be colonized by 
Helicobacter species, most of which colonize the intestine rather than the 
stomach (Owen, 1998, Agency, 2011, Goodwin et aL, 1989). Hp is the main 
human pathogen but H. cinaedi, H. canis, H. pullorum and H. fenelliae have 
also been reported to cause human infection (Agency, 2011). Serum 
antibodies to non-gastric Helieobaeter species have been reported to be more 
prevalent in patient with autoimmune liver disease (Nilsson et aL, 2003). 
Other Helieobacter species that infect the gastric mucosa include H. felis, 
which can infect cats, dogs- and mice, H. mustelae which infects ferrets and H. 
suis which infects pigs (Owen, 1998). H. felis can cause the development of 
preneoplastic lesions in C57BL/6 mice and lymphoma in BALB/c mice 
(Sakagami et aL, 1996). Until recently Hp strains that can colonize mice and 
recapitulate pathology similar to that seen in Hp-infected humans have not 
been available" so the H. felis mouse infection model has been widely used 
(Pritchard and Przemeck, 2004, Sayi et aL, 2009, Roth et aL, 1999, Hitzler et 
aL, 2012a). The immune response to Helieobaeter hepatieus, a murine 
intestinal pathogen has also been well studied and is employed as a model for 
inflammatory bowel disease (Rao et aL, 2006, Kullberg et aL, 2006, Buonocore 
et aL, 2010, Mazmanian et aL, 2008). 
1.1.2 Epidemiology and Transmission 
Hp is one of the commonest bacterial infections in the world (Ezra J. Barzilay 
and Fagan, 2012). Its estimated prevalence is 70% in developing countries and 
30-40% in industrialized countries, though estimates vary widely depending 
on the study pop'ulation and methods used (Ezra J. Barzilay and Fagan, 2012, 
Bruc.@ and Maaroos, 2008, Goh et aL, 2011, Dunn et aL, 1997). The infection is 
usually acquired In early'childhood and persists life-long in the mucus layer of 
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the stomach unless treated (Bruce and Maaroos, 2008, Robinson et aL, 2007). 
Transmission requires close personal contact and is thought to be via the oral-
oral route (Goh et aL, 2011). Hp causes chronic gastritis, but this is 
asymptomatic in the vast majority of those infected, only causing disease in 
about 10-15% of cases (Robinson et aL, 2007, Atherton, 2006). A number of 
factors can influence the risk of disease including the host immune response, 
which is the focus of this study. Bacterial virulence factors and environmental 
factors, also contribute to disease risk, as discussed below. 
1.1.3 Helicobacter pylori-Related Disease 
1.1.3.1 Peptic ulcer disease 
Hp is the major cause of both gastric and duodenal ulcers. Peptic ulcer disease 
causes considerable morbidity and the complications of haemorrhage and 
perforation cause significant mortality, especially in the elderly and those 
with severe comorbidity (Alakkari et aI., 2011, Rockall et aL, 1995). Hp-
associated ulceration is associated with inflammation and causes 
characteristic epithelial damage (Chan et aL, 1991, Atherton, 2006). 
Eradication of the bacteria can heal ulcers and prevents their recurrence 
(Atherton, 2006). 
The pattern of colonization in the stomach can influence which disease 
develops (Figure 1.1). Antral-predominant colonization leads to increased 
gastrin secretion by G-cells, which stimulates acid production from the 
parietal cells in the oxyntic glands of the healthy corpus (Robinson and 
Atherton, 2009). This is mediated both by a direct effect and by stimulation of 
histamine release from enterochromaffin-like (ECl) cells (Zavros and 
Merchant, 2005). Antral inflammation also reduces somatostatin production 
by D-cells. Somatostatin provides negative feedback to G-cells, so reduction in 
somatostatin leads to hypergastrinaemia. The high stimulated gastric acid 
output can lead to gastric metaplasia of the duodenum, allowing Hp to 
colonize and potentially cause duodenal ulceration (Robinson and Atherton, 
2009). When Hp.coloniz,ation is corpus-predominant or pangastric there is 
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usually normal or reduced acid production, despite stimulation of G-cells 
{Atherton, 2006}. This is due to inhibition of acid secretion by pro-
inflammatory mediators such as IL-1P and TNFa. It has been suggested that 
Hp is not normally able to colonize the corpus unless acid secretion is reduced 
{Marshall and Warren, 1984}. Chronic hypergastrinaemia can lead to atrophy 
of the acid-secreting glands, causing further gastrin secretion and setting up a 
positive feedback loop. 
Duodenal ulcer patients have a reduced risk of gastric cancer compared to 
gastric ulcer patients {Hansson et aI., 1996}. Non-steroidal anti-inflammatory 
drugs are the other major cause of peptic ulcer disease. 
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Figure 1.1 Patterns of Hp colonization, their effects on acid production and associations with clinical disease. 
Adapted from (Robinson and Atherton, 2009). 6 
1.1.3.2 Gastric adenocarcinoma 
In 1994 Hp was the first bacterium to be classified as a carcinogen by the 
World Health Organization (WHO) (lARC, 1994). The incidence of gastric 
cancer is decreasing but it still accounts for approximately 10% of all cancer 
deaths worldwide (738,000 deaths per year) and is the 3rd most common 
cause of cancer mortality in men and the 5th in women (Jemal et aI., 2011). Hp 
is associated with distal (also known as non-cardia) gastric adenocarcinoma. 
Gastric adenocarcinoma is broadly divided into intestinal-type (well 
differentiated) and diffuse-type (undifferentiated), as proposed by Lauren in 
1965, though further subclassification and categorization of rare histological 
variants in an "interderminate" category were proposed by the WHO in 2010 
(Lauren, 1965, Hu et aI., 2012). The intestinal-type is the commonest and is 
most strongly associated with Hp infection (Hu et aI., 2012, Parsonnet et aI., 
1991). Correa observed t h ~ t t gastric cancer occurred more frequently in 
populations with high incidences of gastric atrophy and proposed a multistep 
model of carcinogenesis for the development of intestinal-type gastric cancer, 
with stepwise progression from superficial gastritis to atrophic gastritis (loss 
of acid-secreting glands), intestinal metaplasia, dysplasia and finally 
carcinoma (Figure 1.2) (Correa, 1988, Fox and Wang, 2007). Progression along 
this pathway usuaJly occurs over. decades, promoted by Hp-induced chronic 
inflammation which leads to accumulation of DNA damage and mutations. Hp 
also increases the risk of diffuse type gastric cancer but the histological 
development of this subtype is less well defined. 
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Figure 1.2 Correa multistep model of the development of intestinal-type 
gastric adenocarcinoma. {From Fox et 01. (Fox and Wang, 2007)). 
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Elegant studies using bone marrow transplants from transgenic mice into the 
H. felis/C57BL/6J mouse model of Hp have shown that gastric cancer may 
arise from bone marrow derived stem cells (Houghton and Wang, 2005). A 
model has been proposed whereby chronic inflammation leads to exhaustion 
of local stem cells and recruitment of bone marrow derived stem cells which 
fail to differentiate and become metaplastic, dysplastic then cancerous in the 
dysregulated, inflamed gastric tissue (Houghton and Wang, 2005). However, 
this has been controversial and is not supported by the lack of bone marrow-
derived cells found in the neoplastic epithelium of patients in a study of 
patients with bone marrow transplants who had developed solid organ 
tumours including gastric cancer (Worthley et aL, 2009). 
Hp is not the only chronic infection associated with development of cancer. 
Approximately 16% (2 million) cancers worldwide were attributable to 
infection in 2008 (de Martel et aL, 2012). The vast majority of these were 
accounted for by Hp-related gastric cancer, hepatitis B- and C-related liver 
cancer and papillomavirus-related cervical cancer (de Martel et aL, 2012, Ott 
et aI., 2010). A higher proportion of cancer deaths was due to infection in less 
developed/low-income countries (de Martel et aL, 2012, Ott et aL, 2010). The 
incidence of cancer is also increased in gastrointestinal conditions which 
cause non-infection related chronic inflammation such as reflux oesophagitis 
(Barrett's oesophagus), inflammatory bowel disease and coeliac disease 
(Cameron et aL, 1985, Itzkowitz and Vio, 2004, West et aL, 2004). 
IL-1f3, TNF-a. and IL-6 are key pro-inflammatory cytokines involved in the 
development of cancer (EI-Omar et aL, 2000, Chiba et aI., 2012). IL-1f3 and 
TNF-a. upregulate NF-KB expression in epithelial cells and IL-6 signals via 
STAT3: both oncogenic transcription factors (Ben-Neriah and Karin, 2011, 
Kuraishy et aL, 2011). STAT3 Signalling promotes Th17 differentiation (see 
section 1.3.2). NF-KB has a number of pro-tumorigenic effects including 
promotion of tumour cell growth and survival and stimulation of growth 
factors, cytokines,. cyclooxygenase-2 (COX-2) and reactive oxygen species 
(Ben-Neriah and Karin, 2011). Reactive oxygen species and mitogen-activated 
,-
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protein kinase (MAPK) cascades triggered by cytokines can activate proto-
oncogenes such as c-Fos, c-Jun and c-Myc (Hussain et aL, 2003). The Hp 
virulence factor cytotoxin associated gene A (CagA) can bind SRC- homology 2 
domain containing tyrosine phosphatase (SHP-2), thereby directly influencing 
receptor kinase signalling (Higashi et aL, 2002). Hp also upregulates epidermal 
growth factor expression in a CagA-dependent manner in vitro (Keates et aL, 
2007). 
Atrophy is a loss of acid-producing glands and I L - 1 ~ ~ and TNF-a also directly 
suppress acid production by parietal cells (Atherton, 2006). Some Hp antigens 
are similar in structure to the gastric proton pump ATPase which can lead to 
autoimmune destruction of the pump, further reducing acid secretion 
(Amedei et aL, 2003, Kiriya et aL, 2007). The increased gastric pH may allow 
other pathogens to infect the stomach, further adding to the inflammation. 
Gastrin is produced in order to stimulate acid production in the face of the 
increased pH. IL-8, I L - 1 ~ ~ and TNFa can also stimulate gastrin production 
which promotes epithelial cell proliferation, NF-KB activation and COX-2 
expression (Robinson et aL, 2007). Atrophy is associated with loss of the 
morphogen sonic hedgehog, which may have a role in early neoplastic 
transformation (Shiotani et aL, 2005). 
Hp can induce ap,optosis, however mediators such as COX-2, which catalyzes 
production of prostaglandin-E2, and nitric oxide that are upregulated during 
Hp infection are anti-apoptotic (Zhang et aL, 2007, Robinson et aL, 2007). 
Prolonged survival of damaged cells could allow mutations to accumulate. 
Houghton et al. used a mouse transplant model and found that bone marrow-
derived stem cells were recruited to in the context of chronic inflammation 
and could give rise to gastric cancer (Houghton and Wang, 2005). This is 
proposed to be due to local tissue stem cell failure following prolonged 
increased cell turnover, but the new stem cells themselves will, in turn, be 
subject to the local Hp-induced inflammation. 
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In addition to the increased reactive oxygen species mediated via Hp-induced 
cytokines, Hp can also directly stimulate generation of DNA-damaging 
reactive oxygen species (Obst et aL, 2000). Recruitment and activation of 
phagocytes and other pro-inflammatory cells, by IL-17 signalling and other 
mechanisms, will further boost levels of oxygen and nitrogen radicals and 
oxidative stress. IL-17 also increases inducible nitric oxide synthase expression 
(Miljkovic and Trajkovic, 2004). Expression of the RNA- and DNA-editing 
enzyme activation-induced cytidine deaminase (AID), which has a 
physiological role in generation of antibody diversity via somatic 
hypermutation and class switch recombination, is aberrant in Hp-infected 
gastric cell lines and in a number of malignancies (Matsumoto et aL, 2007, 
Chiba et aL, 2012). Hp also reduces levels of mismatch repair proteins, which 
is likely to increase the probability of mutations accumulating (Kim et aL, 
2002). 
Epigenetic changes can also influence expression of tumour suppressor and 
oncogenes. Hp causes aberrant DNA methylation, which has been linked to 
carcinogenesis (Maekita et aL, 2006, Nakajima et aL, 2009, Bae et al.). Recent 
studies have raised the possibility that methylation patterns in specific 
genes/DNA elements could act as prognostic markers (Bae et aL, Nakajima et 
aL, 2009). MicroRNAs are small, non-coding RNAs that can regulate gene 
expression post-transcriptionally. The effects of these on Hp-induced 
inflammation and gastric cancer have not been widely studied, but microRNA-
155 was upregulated in response to Hp and appeared to have a negative 
effect on Hp-induced inflammation (Xiao et aL, 2009). 
Following malignant transformation, new vessels are required to support the 
growing tumour. Cytokines induced by Hp infection including IL-8, IL-1B, IL-6 
and IL-17 are pro-angiogenic and reactive oxygen species and nitrogen oxide 
can also promote angiogenesis (Robinson et aL, 2007, Numasaki et aL, 2003). 
Metalloproteinases may facilitate tumour invasion and metastasis and a 
number ofthese can be upregulated by IL-17 receptor stimulation 
(MMP1,MMP3, MMP9, MMP13) (Gaffen, 2008) . 
. -
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Tregs, which are increased during Hp infection, may inhibit anti-tumour 
immunosurveillance. After malignant transformation cancerous cells can 
promote expansion of Tregs (Ghiringhelli et aI., 2006). Tregs can inhibit NK 
cells, C08+ T cells and C04+ T cells with anti-tumour activity (Ghiringhelli et aL, 
2006, Wang and Wang, 2005, Zhou and levitsky, 2007). 
. . 
1.1.3.3 
Lymphoma 
Gastric Mucosa-Associated Lymphoid Tissue (MALT) 
Hp is the main cause of B cell MALT lymphoma, which can transform to high-
grade diffuse large-cell B cell lymphoma. Ongoing antigenic stimulation 
appears to playa role in clonal expansion (Ou et aI., 1996). Like gastric 
adenocarcinoma, MALT lymphoma is associated with a pan-gastric pattern of 
inflammation (Miehlke et aL, 2001). Guidelines recommend Hp eradication, 
which leads to regression in over 70% patients when treated early, however 
relapse can occur so long-term follow up is recommended (Wotherspoon et 
aL, 1993, Zullo et aL, 2010). Mucosa-associated lymphoid tissue does not 
occur in the uninfected stomach. 
1.1.3.4 Other Hp-related disease 
Hp infection has also been associated with a number of extra-gastric diseases 
but, as it is common, studies need to be well designed to avoid making 
spurious connections. The best evidence is for idiopathic thrombocytopenic 
purpura (ITP) and unexplained iron ~ e f i c i e n c y y anaemia (Tan and Goh, 2012, 
Pellicano et aL, 2009). In a small randomized trial and systematic reviews Hp 
eradication led to increases in platelets in up to 50% Hp+ patients with ITP, 
especially those with mild disease (Suzuki et aL, 2005, Stasi et aL, 2009, 
Arnold et aI., 2009). Suzuki et 01. found higher titres of antibodies to the 
virulence factor CagA in the serum of those that responded to Hp eradication 
(Suzuki et aL, 2005). This is consistent with suggestions that ITP in Hp+ 
patients may be due to cross-reactivity between platelet-associated 
immunoglobulin G and anti-CagA antibodies (Takahashi et aL, 2004). 
International guidelines recommend Hp eradication in patients with ITP (Fock 
et aL, ~ 0 0 9 , , Malfertheiner et aI., 2012). 
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Unexplained iron deficiency anaemia {IDA} is more common in Hp+ patients, 
though it only affects a small proportion of Hp+ patients (Tan and Goh, 2012). 
The underlying mechanism is not clear but may relate to impaired iron 
absorption during Hp infection (Tan and Goh, 2012). A meta-analysis of 15 
. observati,onal studies confirmed an association between Hp infection and IDA 
{Qu et aL, 2010}. In five randomized controlled trials analyzed in the same 
study Hp eradication led to trends of increases in haemoglobin (Hb) and 
serum ferritin levels, but the changes did not reach statistical significance (Qu 
et aI., 2010). Larger meta-analyses found that Hp+ patients managed with Hp 
eradication and oral iron achieved greater increases in Hb and serum ferritin 
than those treated with oral iron only (Huang et aL, 2010, Yuan et aL, 2010). 
Guidelines recommend Hp eradication in infected patients with unexplained 
IDA (Fock et aL, 2009, Malfertheiner et aI., 2012). 
Other diseases that have been linked to Hp include ischaemic heart disease, 
ischaemic stroke, parkinson's.disease, alzheimer's disease, obesity (associated 
with changes in leptin and ghrelin levels) and chronic idiopathic urticaria. 
Evidence associating these diseases with Hp is not compelling with conflicting 
data for some and small or uncontrolled studies for others (Pellicano et aL, 
2009, Tan and Goh, 2012). 
1.1.3.5 Diseases where Hp may have a protective role 
Epidemiological studies show a n e g ~ t i v e e association between gastro-
oesophageal reflux disease (GORD) and Hp (O'Connor, 1999). The prevalence 
of GORD is increasing, whilst the prevalence of Hp infection is falling. GORD 
can lead to metaplasia, whereby the epithelium of the lower oesophagus 
which is normally squamous, becomes columnar (Barrett's oesophagus). This 
in turn predisposes to the development of adenocarcinoma. These sequelae 
of GORD are also less common in those with Hp infection (Rokkas et aI., 
2007). However, there is no evidence that eradicating Hp causes worsening of 
GORD symptoms (Malfertheiner et aI., 2012). A routine "test and treat" 
strategy is not recommended for patients with GORD, however it is 
recorn.mended that testing is considered in those on long-term proton pump 
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inhibitors (PPI), which are widely used to treat GORO (Fock et aI., 2009). This 
is because Hp+ patients treated with long-term PPls tend to develop corpus-
predominant inflammation with atrophy (Malfertheiner et aI., 2012). 
The incidence of allergic diseases in industrialized countries has been 
. increasing, while the prevalence of Hp infection has been falling (Chen and 
Blaser, 2007). The "hygiene hypothesis" was initially proposed by Strachan in 
1989, who found that hayfever was inversely related to the number of 
children in the household (Strachan, 1989). This hypothesis has been 
controversial. Initially it was suggested that infections early in childhood 
would cause a Thl bias, therefore shifting the Thl/Th2 balance away from 
Th2-allergy causing C04+ T cells. More recently it has been suggested that 
infections early in life are associated with increased Treg responses, which 
could provide an explanation for increases in autoimmune disease, in addition 
to allergy (Rook, 2007). 
Blaser et al. reviewed 12 cro;s-sectional and 4 case-control studies 
investigating the relationship of Hp with asthma and other allergic diseases. 
Most of the cross-sectional studies showed significant inverse association 
between Hp and allergy, whereas the case-control studies, which were 
generally smaller, did not. A larger study by Chen et al. found that Hp 
infection was inversely associated with "allergy symptoms"(Chen and Blaser, 
2007). Inverse associations betweer:t Hp and a number of other markers of 
allergy reached statistical significance for the younger subgroup and the 
group with CagA+ Hp (Chen and Blaser, 2007). A study of 3 year old Ethiopian 
children found a reduced risk of eczema in those with Hp infection (Amberbir 
et aI., 2011). 
There is now some experimental evidence from mouse models of allergy 
demonstrating a protective role for Hp. Arnold et al. showed that Hp 
protected against asthma, as measured by airway hyperreactivity, tissue 
inflammation and goblet cell hyperplasia, in airway inflammation induced by 
ovalbumin or house dust mite (Arnold et aI., 20lla). Protection was most 
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robust in mice infected with Hp neonatally and appeared to be Treg mediated 
(Arnold et aI., 2011a). My collegues have also investigated the effects of Hp 
infection on Der p 1 (immunodominant house dust mite allergen) 
sensitization and found that Hp-infected mice had lower levels of total and 
. Der p 1-specific IgE, and less macrophage and lymphocyte infiltration 
(Hussain, 2012). Hp-mediated protection from airway hyperresponsiveness 
and inflammation seems to depend on DC-derived Il-18, which drives Treg 
differentiation (Oertli et aI., 2012). 
Serology-based studies have found reduced rates of Hp infection amongst 
patients with mUltiple sclerosis. Preliminary experiments suggest that Hp 
protects against experimental autoimmune encephalomyelitis (EAE), a well 
studied mouse model of central nervous system inflammation (Hussain, 
2012). 
1.1.4 Diagnosis and Treatment of Hp 
1.1.4.1 Diagnostic tests for Hp 
Non-invasive tests for Hp include the urea breath test (based on Hp's urease 
activity) and stool antigen testing (Malfertheiner et aI., 2012). Both these 
tests indicate current infection. Serology testing is also widely available, but 
can stay positive for some time following Hp eradication. It is suggested that a 
positive serology result is followed up by one of the non-invasive tests above 
or endoscopy (Ezra J. Barzilay and F'agan, 2012). Upper gastrointestinal 
endoscopy allows inspection of the oesophagus, stomach and upper 
duodenum, and biopsies can be taken for urease test, culture and 
sensitivities, and histology. 
A "test and treat" strategy, using non-invasive testing, is advocated for 
younger patients with dyspepsia and no "alarm" symptoms (weight loss, 
dysphagia, gastrointestinal bleeding, abdominal mass and iron deficiency 
anaemia, which are associated with increased risk of gastric cancer) 
(Malfertheiner et aI., 2012, Fock et aI., 2009). Older patients and those with 
"alarm" ,symptoms should be referred for endoscopy. 
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The Updated Sydney Scoring System is the most widely used scheme for 
histopathological assessment of gastritis. Five variables (Hp density, 
neutrophil infiltration, lymphocyte infiltration, atrophy and intestinal 
metaplasia) are graded as normal (0), mild (1), moderate (2) or marked (3) 
. (Figure 1.3)(Dixon et aL, 1996). An experienced gastrointestinal 
histopathologist is required. 
Normal Mild Moderate Marked Norma' Mild Moderate Marked 
H. pylori Atrophy: Antrum 
Neutrophils Atrophy: qorpus 
• 
• 
• 
Mononuclear Cells Intestinal Metaplasia 
Figure 1.3 The Updated Sydney Scoring System. Schematic representation of 
variables to aid grading. Taken from (Dixon et aL, 1996). 
1.1.4.2 Treatment of Hp 
A 7 or 14 day course of triple therapy with a PPI, amoxicillin and 
clarithromycin or metronidazole have been standard treatment for Hp (Fock 
et aL, 2009, Malfertheiner et aL, 2007). However, increasing antibiotic 
resistance, particularly to clarithromycin, is resulting in higher rates of 
eradication failure (Malfertheiner et aL, 2012, Graham and Gisbert, 2013). A 
number of different strategies have been suggested, including bismuth 
quadruple therapy (PPI, bismuth, tetracycline and metronidazole). >95% 
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eradication rates have been achieved with sequential therapies, such as PPI 
and amoxicillin for 14 days with clarithromycin and metronidazole added for 
the final 7 days, and PPI and amoxicillin for 10 days with addition of rifabutin 
and ciprofloxacin on days 6-10, but these regimens are not yet recommended 
-for widespread use (Hsu et aLI 2011, Tay et aLI 2012, Graham and Gisbert, 
2013). Treatment should be guided by local antibiotic resistance patterns, and 
in resistant cases by antibiotic sensitivities of the Hp strain infecting the 
individuat if possible. A number of patient factors can influence success of 
eradication, including genetic polymorph isms that can influence 
bioavailability of PPI and gastric acidity. Smoking and obesity are associated 
with reduced eradication rates (Malfertheiner et aLI 2012). 
1.1.S HeIicobacter pylori Virulence Factors and Their 
Association with Disease 
1.1.5.1 Cytotoxin a s s o c i a ~ e d dgene A (CagA) and the cag 
pathogenicity island (cagPAI) 
CagA is a highly immunogenic protein encoded by one of approximately 30 
genes that make up the cag (cytotoxin-associated gene) pathogenicity island 
(cagPAI), and is often used as a marker for the island. cagA+ strains are 
strongly associated with increased risk of both peptic ulcer disease and gastric 
cancer (Atherton, 2006). 
The cagPAI encodes a type IV secretion system, which acts as a molecular 
syringe, injecting bacterial proteins, including CagA, into gastric epithelial 
cells. Once inside the host cell, CagA tyrosine phosphorylation motifs are 
phosphorylated by Src family kinases. CagA can activate transcription factors 
and oncogenes including SHP-2, c-fos, c-jun and c-met with effects on 
multiple cellular processes including migration, proliferation and apoptosis 
(Figure 1.4}{Blaser and Atherton, 2004, Atherton, 2006, Higashi et aLI 2002). 
CagA has phosphorylation sites which consist of the amino acid motif EPIYA. 
These motifs are classified as type A, B, Cor D, depending on the subsequent 
amino-acid sequence. The A and B motifs are found in strains from all over the 
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world, but the C motif is predominantly found in Hp strains from Western 
countries and the D motif in strains from East Asia (Argent et aL, 2008, Polk 
and Peek, 2010). The D motif interacts strongly with SHP-2, which may partly 
explain the high incidence of gastric carcinoma found in East Asia (Azuma et 
aL, 2004). The D motif is rarely duplicated but multiple C motifs can occur 
(Argent et aL, 2008). Strains with more tyrosine phosphorylation motifs 
induce more cytoskeletal changes and are more closely associated with 
gastric cancer (Argent et aL, 2004, Ferreira et aL, 2012). 
Some effects of CagA are independent of tyrosine phosphoylation. For 
example, it can bind tight junction proteins such as ZO-l, leading to loss of 
epithelial barrier polarity and integrity (Amieva et aL, 2003). The cagPAI type 
. IV secretion apparatus also allows delivery of peptidoglycan into host cells 
where it binds the intracellular pattern recognition receptor NODl which 
signals through NF-KB, activating pro-inflammatory genes, including IL-8 
(Figure 1.4)(Viala et aL, 2004). IL-8 is a chemokine and has a key role in 
attracting neutrophils to the Hp-infected stomach. Increased neutrophil 
infiltration induced by cagA+ strains may contribute to their increased 
pathogenicity (Yamaoka et aL, 1998). 
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Figure 1.4 Host signalling events induced by the cag pathogenicity island 
(taken from{Robinson and Atherton, 2009)). CagA translocated into gastric 
epithelial cells via type IV secretion apparatus encoded by the cagPAI is 
phosphorylated by Src kinase and activated SHP-2 and MAPK signalling 
cascades leading to effects on mUltiple cellular processes including 
proliferation, motility and apoptosis. The type IV secretion system also 
tral")slocates peptid'oglycan which binds NOD11eading to NF-KB stimulation 
and thereby upregulating expression of pro-inflammatory genes including 
IL-8. 
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1.1.5.2 Vacuolating cytotoxin A (VacA) 
vacA, which encodes Vacuolating cytotoxin A (VacA) is a polymorphic gene 
present in all Hp stains. Its expression and activity in different strains are 
largely determined by polymorph isms in the signal (s), intermediate (i) and 
.' . 
mid (m) regions. There are two main types of signal region: sl and s2, two 
types of intermediate region: i1 and i2, and two types of midregion: m1 and 
m2. Any combination of these ca n occur but only those shown in Figure 1.5 
~ c c u r r commonly (Atherton, 2006, Atherton et aI., 1995, Robinson and 
Atherton, 2009). vacA is init ially translated into a pre-protoxin, then the N-
terminus and (-terminus are cleaved during secretion. The sl type is a fully 
active toxin but the in the s2 type a short N-terminal extension is left 
. following cleavage which results in reduced vacuolating activity (Figure 1.5). 
Mature VacA toxin 
Signal p37 p58 
peLie VacA type s1/i1/m1 
Full In VI/ro adlvity. 
s1 ASSOCIated with Increased gastric adenocaranoma risk 
[I VacA type s1/i1/m2 Adive but binds to a narrow range of cells In VI/ro. 
s1 i1 m2 AssOCIated with Increased gastric adenocarcinoma risk 
-rt..J1 VacA type s1li2lm2 Does not vacuolate cells In vi/ro. 
s1 i2 m2 ASSOCIated with reduced gastric adenocarcinoma risk 
[] VacA type s2/i2lm2 Does not vacuolate cells In VI/ro, 
s2 i2 m2 Assocsated with reduced gastric adenocarcinoma risk 
Figure 1.5 Polymorph isms in VacA (from (Robinson and Atherton, 2009)). The 
main regions bf variation are signal (s) region, which determines vacuolating 
activity, the intermediate (i) region, which determines cytotoxic activity and 
the midregion (m), which determines t he range of cells the toxin is able to 
bind. 
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The intermediate region determines cytotoxic activity and strains with il 
alleles are strongly associated with gastric cancer (Rhead et aI., 2007). Indeed 
i-type was found to be an independent risk factor with a stronger influence on 
gastric carcinoma risk than s-type, m-type or cag status (Rhead et aL, 2007). 
The midregion determines the range of cells that the toxin binds, with ml 
allele conferring the ability to bind a wider range of cells (Blaser and Atherton, 
2004). sl/il/ml vacA strains are therefore the most pathogenic (Figure 1.5). 
VacA is named after its ability to cause vacuolation in gastric epithelial cell 
lines and classically forms hexameric pores in membranes. These pores allow 
leakage of cell contents, including urea, which acts as a substrate for urease, 
allowing Hp to buffer itself against the acid gastric environment (Atherton, 
-2006). VacA localizes to plasma and mitochondrial membranes where it can 
increase permeability (though pore formation) and activate apoptosis (Cover 
and Atherton, 2009, Galmiche et aL, 2000, Jain et aL, 2011). The toxin can 
also activate MAPK signalling cascades in gastric epithelial cells and reduce 
their barrier function (Cover and Atherton, 2009). 
The effects of VacA are not limited to gastric epithelial cells. The toxin also 
acts on a number of immune cells, including T cells, B cells, macrophages, 
mast cells, eosinophils and neutrophils (Cover and Atherton, 2009). The 
effects on T cells are best studied. VacA can enter T cells by binding (32 
integrin (C018) (Sewald et aL, 2008). Its effects include inhibition of nuclear 
factor of activated T cells (NFAT), possibly through calcineurin inhibition, 
which modulates IL-2 signalling pathways causing reduced IL-2 secretion and 
reduced IL-2R expression (Gebert et aL, 2003, Cover and Atherton, 2009). This 
leads to reduced T cell proliferation. VacA can also inhibit antigen processing 
and presentation (Molinari et aL, 1998). Though most of the effects of VacA 
are immunosuppressive, it can also increase transcription of some pro-
inflammatory genes, such as COX-2, and slml strains are more commonly 
associated with peptic ulcer disease and gastric cancer (Atherton et aL, 1995, 
Blaser and Atherton, 2004). Strains with VacA sl-type are often cagA+ 
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(Atherton et aL, 1995). It is possible that the immunosuppressive effects of 
VacA allow persistence of virulent cagA+ strains. 
1.1.5.3 Duodenal ulcer promoting gene A (DupA) 
The -duodenal -ulcer promoting gene A (dupA) virulence factor was only 
discovered relatively recently (Lu et aI., 2005). It has homology to virB4, 
suggesting that, like the cagPAl, it may be involved in translocating bacterial 
products into gastric epithelial cells. However its function has not yet been 
clarified. The initial study by Lu et 01. found dupA+ strains were associated 
with increased risk of duodenal ulcer but reduced risk of gastric atrophy and 
cancer (Lu et aL, 2005). It also reported that dupA+ strains caused increased 
IL-8 secretion from gastric epithelial lines, but others have been unable to 
replicate these findings, though higher IL8 mRNA level were found in the 
gastric mucosa of patients infected with dupA+ strains compared to those 
infected with dupA- strains (Lu et aL, 2005, Hussein et aL, 2010). My 
colleagues found that dupA+ strains increased IL-12p40, IL-12p70 and IL-23 
secretion by C014+ mononuclear cells, suggesting that dupA may exert its 
effects on immune cells rather than the gastric epithelium (Hussein et aL, 
2010)(see Chapter 3). 
There has been some ,controversy about clinical correlations with dupA status, 
as the initial findings have not been replicated in all subsequent study 
populations. This is likely to be at least in part due to uncertainty about what 
constitutes a functional dupA locus. Hussein et 01. described a truncated form 
(dupA2) with reduced activity compared to the longer (dupAl) form (Hussein 
et aL, 2010). A recent study by Jung et 01. the presence of dupA and 6 
adjacent vir gene homologues was used as a marker ("complete dupA 
cluster") (Jung et aL, 2012). The "complete dupA cluster" was associated with 
increased risk of duodenal ulcer and small increases in IL-8 and IL-12 in the 
gastric mucosa were also found, though the difference in IL-12 levels was not 
significant (Jung et aI., 2012). Surprisingly this study also found increased 
gastric atr?phy in the dupA+ group (Jung et aL, 2012). Previous work from the 
same group found dupA+ strains were associated with reduced atrophy in 
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patients from Japan and Colombia and suggested that dupA may help to 
protect the bacteria from gastric acidity (lu et aI., 2005). This could be 
beneficial for duodenal ulcer-causing bacteria as this pathology is often 
associated with antral inflammation and low pH (Figure 1.1). 
1.1.5.4 Other virulence factors 
Other Hp virulence factors include adhesins. Hp adhesins can bind to blood 
group antigens expressed on gastric epithelial cells: blood group antigen 
binding adhesin (BabA) binds the lewis b antigen and lewis x is a ligand for 
sialic-acid-binding adhesin (SabA). Higher expression of lewis antigens is 
associated with increased Hp density and active forms of BabA are associated 
with duodenal ulcer and gastric cancer (Atherton, 2006). 
Outer inflammatory protein A (OipA) is an outer membrane protein of Hp. 
Active forms are associated with increased mucosalll-8, neutrophil 
infiltration and duodenal ulceration (Yamaoka et aI., 2000, Atherton, 2006). 
A recent meta-analysis found that induced by contact with epithelium (iceA) 
polymorphisms had marginal effects on peptic ulcer risk and did not influence 
gastric cancer risk (Shiota et aL, 2012). 
Superoxide dismutase and catalase enzymes produced by Hp help protect the 
bacteria against phagocytosis and are also sometimes considered as virulence 
factors (Dunn et aL, 1997). The Hp-neutrophil activating protein (HP-NAP) 
may promote pro-inflammatory CD4+IFNy+ (Thl) responses in addition to 
activating neutrophils (Amedei et aL, 2006). 
1.1.6 Associations of Environmental and Host Factors with Hp-
related Disease 
1.1.6.1 Environmental factors 
Smoking is a recognized risk factor for gastric cancer and the risk increases 
with higher cigarette consumption (ladeiras-lopes et aL, 2008, Steevens et 
aL, 2010). ~ m o k i n g g had the greatest effect on increasing risk of progression 
from atrophy to dysplasia, suggesting that it may exert its influence when 
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progression along the Correa pathway (Figure 1.2) is already underway 
(Kneller et aL, 1992). 
Diet can also influence gastric cancer risk with high intake of nitrosamines, 
salt and red/processed meat increasing risk, whilst fresh fruit and vegetables, 
vitamin C and "Mediterranean diet" are protective (Liu and Russell, 2008, 
Buckland et aL, 2009, Gonzalez and Riboli, 2010, Peleteiro et aL, 2011). A 
large prospective study: European Prospective Investigation into Cancer and 
Nutrition (EPIC) has contributed significantly to contemporary knowledge 
about the influence of diet on gastric cancer risk. Antioxidants reduced risk in 
smokers, but not non-smokers (Serafini et aL, 2012). Though observational 
studies have shown that antioxidant vitamins are associated with reduced 
gastric cancer risk, supplementation with vitamin C and E has not protected 
against cancer in prospective randomized trials (Liu and Russell, 2008, Lin et 
aL, 2009). Hp infection leads to r e . ~ u c e d d vitamin C levels (Rokkas et aL, 1995). 
In addition to its antioxidant acitivity vitamin C can inhibit f o r m a ~ i o n n of N-
nitroso compounds, inhibit Hp growth (at pharmacological doses), enhance 
the immune response to infection, promote apopotosis and reduce gastric 
cell proliferation (Zhang and Farthing, 2005). 
Nitrosamines may be exogenous, as found in cured and smoked meat and 
fish, or may be formed by bacterial processing of dietary nitrate 
(endogenous). Epidemiological studies suggest a link between nitrosamines 
and gastric cancer but this has not always been borne out in large prospective 
studies (Keszei et aL, 2013, Liu and Russell, 2008, Cross et aL, 2010). One 
prospective study found a small increase in distal gastric cancer risk with high 
endogenous nitrosamines in those with reduced vitamin C levels or Hp 
infection (Jakszyn et aL, 2006), again demonstrating the importance of the 
combination of infection and other risk factors. 
1.1.6.2 Host genetic factors 
Host cytokine polymorphisms affect the immune response provoked by Hp 
infection and are known to influence risk of gastric cancer development, 
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though their effect on peptic ulcer disease is less clear. The best studied 
examples are polymorph isms in ILlB, which encodes I L - 1 ~ , , and ILlRN, the 
gene encoding the endogenous IL-1 receptor antagonist. I L - 1 ~ ~ is a potent 
suppressor of gastric acid production. Polymorph isms resulting in high I L - 1 ~ ~
production increase the risk of hypochlorrydia, atrophy and distal gastric 
adenocarcinoma (EI-Omar et aI., 2000). ILlB polymorph isms can also 
influence eradication rates, probably due to effects on gastric pH (Sugimoto 
et aI., 2009). More recently I L - 1 ~ ~ has been recognized to promote Th17 
differentiation, so it is possible that some of the pro-carcinogenic effects of 
these polymorphisms could be mediated by Th17 cells (Acosta-Rodriguez et 
aI., 2007a, Serelli-Lee et aI., 2012). Polymorphisms in IL-17 itself have also 
been reported to influence gastric cancer risk (Shibata et aI., 2009). 
Polymorph isms in the gene for TNF-a., another pro-inflammatory cytokine 
induced by Hp that can suppress acid production, can also increase distal 
gastric cancer risk (EI-Omar et aI., 2003). Certain polymorphisms.in ILl2A and 
1L12B, which encode the IL-12p35 and IL-12p40 (also common to IL-23) 
subunits were also reported to influence distal gastric cancer risk (Navaglia et 
aI., 2005). Polymorph isms in the IL-8 gene are linked with pre-cancerous 
changes but a positive, association with progression to cancer itself has not 
been found in all populations studied (Lochhead and EI-Omar, 2007). Pro-
inflammatory polymorphisms in the anti-inflammatory cytokine IL-10 also 
increase risk of distal gastric cancer (EI-Omar et aI., 2003). 
Polymorphisms in other genes involved in innate immunity can also modulate 
the risk of developing precancerous changes and cancer. Polymorph isms in 
the gene encoding Toll-like receptor 4 (TLR4) are associated with gastric 
cancer (Hold et aI., 2007, EI-Omar et aI., 2008). Genes linked to precancerous 
changes include the MPO gene encoding myeloperoxidase (intestinal 
metaplasia) and apoptosis-related genes FAS and FASL (intestinal metaplasia 
and atrophy) (Hsu et a l . ~ ~ 2008a, Hsu et aI., 2008b). 
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Combinations of multiple pro-inflammatory cytokine polymorph isms result in 
greater increases in gastric cancer risk, e.g. one study calculated an odds ratio 
of 27 (95% confidence interval 7-100) for combinations of 3 or 4 high-risk 
genotypes (EI-Omar et aI., 2003). The combination of virulent infecting Hp 
strain and pro-inflammatory host cytokine polymorph isms resulted in even 
greater odds of gastric cancer e.g. odds ratio 87 (95% confidence interval 11-
679) for Hp vacA 51-type and pro-inflammatory ILlB gene polymorphism 
(Figueiredo et aI., 2002). Pro-inflammatory cytokine polymorph isms, Hp 
infection and environmental factors can also combine to increase gastric 
cancer risk, as observed in a recent investigation of the effects of IL-10 gene 
polymorph isms, Hp infection status and smoking on gastric cancer risk (Kim et 
aI., 2012). 
C04+ T helper cells are important sources of many of these cytokines. The T 
helper cell subsets and their differentiation will be described next. 
1.2 CD4+ T HELPER CELL DIFFERENTIATION AND SUBSETS 
C04+ T helper cells have an important role in orchestrating immune 
responses. They differentiate into different lineages following activation of 
their T cell receptor (TCR). A number of factors including the local cytokine 
milieu, the strength of TCR-antigen interaction, the type of antigen presenting 
cell, strength of co-stimulation and other factors in the local environment 
determine which type of cell a naive T cell will differentiate into (Kapsenberg, 
2003, Shortman and Liu, 2002, Zhu and Paul, 2010). Each C04+ T cell lineage is 
characterized by a signature transcription factor and cytokine profile. 
Mosmann and Coffman proposed a dichotomy of C04+ T helper cells 
consisting of IFNy-secreting Th1 cells and IL-4-secreting Th2 cells which were 
mutually antagonistic in 1989 (Mosmann and Coffman, 1989). This was the 
accepted paradigm for over a decade but further C04+ T cell subsets have 
now been added to the model. 
Regulatory T cells (Tregs) were identified as a C04+C025+ population 
important for tolerance and protection against autoimmunity (Sakaguchi et 
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aL, 1995). Tregs can either originate directly from the thymus or be induced 
from differentiated T cells in the periphery. They may be characterized by 
expression of the transcription factor forkhead box protein 3 (FOXP3) (Hori et 
'aL, 2003,Khattri et aL, 2003, Fontenot et aL, 2003). 
Th17 cells were identified as a third effector C04+ T cell lineage following the 
discovery of Il-23 in 2000, and are described in detail below (section 1.3) 
(Oppmann et aL, 2000, Aggarwal et aL, 2003, Harrington et aL, 2005, Park et 
aL, 2005). Their lineage-defining transcription factor is retinoic acid receptor-
related orphan receptor (ROR)yt (RORC2 in humans) (Ivanov et aL, 2006). 
T G F - ~ ~ can differentiate Th2 cells into a proinflammatory Il-9-producing "Th9" 
population, involved in immunity to intestinal parasites (Oardalhon et aL, 
2008, Veldhoen et aL, 2008b). Il-22 and TNF-a producing clones isolated from 
psoriatic skin lesions led to the proposal of a "Th22" lineage (Eyerich et aL, 
2009). Lineage-specific transcription factors have not been identified for 
either Th9 or Th22. 
The most recent C04+ T cell lineage described are the T follicular helper cells 
(TFH ). The transcription factor B cell Cll lymphoma-6 (BCl6) has helped 
establish this as a bona fide distinct lineage. TFH cells are found in germinal 
centres, secrete high levels of Il-21, and provide help to B cells for antibody 
class-switching and somatic hypermutation (Spolski and leonard). 
A significant challenge for the study of C04+ T cell subsets is the realization 
that there is a considerable degree of plasticity between some of the subsets. 
For example, Th17-derived IFNy-producers have been widely described, and 
may express T-bet and lose Il-17-secreting capacity (lee et aI., 2009, Hirota et 
aL, Boniface et aL, 2010, Zielinski et aL, 2012, Shi et aL, 2008, Bending et aL, 
2009, Annunziato et aL, 2007, Cosmi et aL, 2011, Nistala et aL, 2010) and 
Tregs can convert to an Il-17-producing phenotype in proinflammatory 
environments (Xu et aL, 2007, Koenen et aL, 2008, Voo et aL, 2009). Some 
C04+ Tcell populations are more stable than others. TFH cells appear to be a 
particularly plastic population (Spolski and leonard, Nakayamada et aL). On 
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the other hand Thl seems to be a relatively stable phenotype (Shi et aI., 
2008). 
The main focus of this thesis is Th17 cells. These will be described in detail in 
the subsequent sections. 
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T helper subset 
Thl Th2 Th17 TFH iTreg 
Characteristic IFNy IL-4,IL-5, IL-17, IL-17F, IL-22 .. IL-21 IL-I0, TGF-/3, IL-35 
I 
cytokines IL-13 
Key transcription T-bet GATA-3 RORC2 BCL6 FOXP3 
factor 
Promotes Macrophage Antibody Neutrophil recruitment B cell help in germinal Inhibits effector Th 
activation production and antibacterial centres: Class-switching and proliferation and 
peptide expression somatic hypermutation cytokine secretion 
Necessary for Intracellular Extracellular Extracellular bacteria Antibody-mediated Damage from excess 
defence against pathogens parasites and fungi immunity to viruses and inflammation and 
extracellular bacteria cancer 
immunosurveillance 
Result of Autoimmunity Allergy Autoimmunity Autoimmunity 
overactivity 
-- ------ -------- -- -- --- - ---- - -- -------
Table 1.1 Key cytokines, transcription factors and activities of the major C04+ T cell subsets 
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1.3 TH17 CELLS 
1.3.1 Discovery of the Th17 Lineage 
IL-23 was discovered in 2000 (Oppmann et aL, 2000). It shares the p40 
subunit with IL-12 and the IL-12 and IL-23 receptors also have a common 
subunit ( l L - 1 2 R ~ 1 ) . . Some effects previously ascribed to IL-12 and Thl cells 
were found to be due to IL-23 and Th17 cells, as earlier experiments blocking 
p40 or I L - 1 2 R ~ 1 1 would have blocked IL-23 as well as IL-12. Experiments using 
the EAE mouse model of multiple sclerosis found that p40-1- mice were 
protected from disease but p3s-l - mice remained susceptible (Becher et aL, 
2002, Gran et aL, 2002). IL-23 was shown to promote IL-17 producing C04+ T 
cells (Aggarwal et aL, 2003). Th17 cells are now recognized as a distinct, C04+ 
T cell lineage, characterized by the transcription factor RORyt (Harrington et 
aL, 2005, Park et aL, 2005, Ivanov et aL, 2006). 
1.3.2 Th17 Differentiation 
Although IL-23 promotes Th17 cells and led to their discovery, IL-23R is not 
present on naIve T cells and other cytokines are required for the initial 
differentiation of Th17 cells (Figure 5.1). T G F - ~ ~ and IL-6 or IL-21 are required 
for Th17 differentiation in mice (Zhou et aL, 2007a, Bettelli et aL, 2006, 
Veldhoen et aL, 2006, Nurieva et aL, 2007). Pro-inflammatory cytokines, 
particularly I L - l ~ , , IL-6, and IL-21 favour human Th17 differentiation but the 
role of T G F - ~ ~ here has been controversial (Volpe et aL, 2008, Acosta-
Rodriguez et aL, 2007a, Manel et aL, 2008, Wilson et aL, 2007). 
Early studies reported development of human Th17 cells with I L - l ~ ~ and IL-6 
or I L - l ~ ~ and IL-23 (Acosta-Rodriguez et aL, 2007a, Wilson et aL, 2007). Manel 
et al. and Volpe et al. used serum-free medium and T G F - ~ ~ blocking antibody 
to exclude even low concentrations of T G F - ~ ~ from their T cell differentiation 
experiments and cord blood to ensure that the T cells were naIve. They 
reported that T G F - ~ ~ is required for human Th17 differentiation (Manel et aL, 
2008, Volpe et aL, 2008). Ghoreschi et al. demonstrated Th17 differentiation 
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in the absence of T G F - ~ ~ in mice, suggesting that maybe the differences in 
Th17 differentiation between mice and humans are not as great as previously 
thought (Ghoreschi et aL, 2010). In this study more IL-17 producing cells 
developed when T G F - ~ ~ was present and IL-23 absent. The cells differentiated 
in the presence of T G F - ~ ~ and absence of IL-23 produced IL-10 and were less 
pathogenic upon adoptive transfer in an EAE model than the Th17 cells 
differentiated in the absence of T G F - ~ . . Adoptive transfer of the latter led to a 
higher proportion of IL-17+IFNy+ cells in the central nervous system (Ghoreschi 
et aL, 2010). Tregs can promote murine Th17 differentiation in vitro and in 
vivo which may be at least partly due to their production of T G F - ~ ~ (Veldhoen 
et aL, 2006, Lohr et aL, 2006, Vokaer et aL, 2010). Tregs may also favour Th17 
differentiation by acting as an IL-2 sink (Chen et aL, 2011), as IL-2-deficient 
conditions promote Th17 cells (Laurence et aL, 2007, Lohr et aL, 2006). 
Recent studies indicate that Treg derived T G F - ~ ~ is not essential for Th17 
promotion and Th17 cells themselves are a source of T G F - ~ ~ which may act in 
an autocrine manner (Chen et aL, 2011, Gutcher et aL, 2011). IL-6 in the 
context of T G F - ~ ~ or IL-21 can upregulate IL23R expression on human C04+ T 
cells (Yang et aL, 2008a). 
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Figure 1.6 Summary of Th17 differentiation and phenotype. IFNy and GM-
(SF are examples of cytokines produced by a more pro-inflammatory subset 
of Th17 cells promoted by IL-23. 
Factors other than cytokines can also influence Th17 differentiation, for 
example halofuginone can inhibit Th17 differentiation in humans and mice by 
triggering the amino acid starvation pathway (Sundrud et aI., 2009). Digoxin 
and its synthetic derivatives inhibited Th17 differentiation by antagonizing 
RORyt activity (Huh et aI., 2011). TGF-f3 is involved in both Th17 and Treg 
differentiation and the balance of these pro- and anti-inflammatory cells is 
critical. This is particularly important in the gastrointestinal tract which is 
populated by millions of commensal bacteria and regularly exposed to foreign 
antigens in food, but must defend the body against pathogenic infection. 
During normal homeostasis Treg differentiation is favoured at the expense of 
Th17 differentiation by retinoic acid, IL-35 and IL-27 (Mucida et aI., 2007, 
Niedbala et aI., 2007, Pot et aI., 2011). However, if the innate immune system 
recognizes infected apoptotic cells or Pathogen Associated Molecular 
Patterns (PAMPs) are recognized by host cell Pattern Recognition Receptors 
(PRRs), a Th17 response will result (Torchinsky et aI., 2009, Nyirenda et aI., 
2011). Availability of suitable aryl hydrocarbon receptor (AhR) ligands can also 
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increase Th17 differentiation and was essential for IL-22 secretion in a mouse 
model (Veldhoen et aL, 2008a). Other AhR ligands favour Treg differentiation 
(Quintana et aL, 2008). Availability of AhR ligands in culture medium can 
influence the frequency of Th17 cells, which may have important implications 
for experiments where CD4+ T cells are cultured in vitro (Veldhoen et aL, 
2009). Intracellular osteopontin in DCs can suppress IL-27 secretion, favouring 
Th17 differentiation, but this pathway is inhibited by engagement of type 1 
interferon receptors (Cantor and Shinohara, 2009, Shinohara et aL, 2008). 
A number of transcription factors are involved in Th17 differentiation. RORyt 
was initially described as the lineage-specific transcription factor directing the 
Th17 programme (Ivanov et aL, 2006). Levels of RORa are also increased in 
murine Th17 cells, but lack of RORa has little effect on Th17 differentiation, 
suggesting that it has a minor role in comparison to RORyt (Yang et aL, 2008c, 
Zhou and Littman, 2009). Expression of RORA, the human homologue of 
murine RORa was marginally increased in Th17 and Treg cells compared to 
Thl and Th2 cells but levels were much lower and the differences much 
smaller than found for RORC2 (Burgler et aL, 2009). IL-6, IL-21 and IL-23 all 
signal via STAT3. These cytokines induce RORyt, which together with STAT3 
promote IL-17 expression (Zhou et aL, 2007a). The transcription factor IRF-4, 
which is involved in Th2 differentiation is also required for Th17 
differentiation in mice: IRF-4-1- did not develop EAE and had reduced RORyt 
but increased FOXP3 expression (Brustle et aL, 2007). A number of other 
transcription factors can fine tune Th17 differentiation. The transcription 
factor c-Maf is increased in murine Th17 cells and c-Maf/-mice had reduced 
IL-21 production and reduced numbers of Th17 cells, consistent with the 
autocrine role of IL-21 in Th17 differentiation (Bauquet et aL, 2009). c-Maf 
has also been implicated in promoting IL-lO production and suppressing IL-22 
production in Th17 cells, so it may favour a regulatory Th17 phenotype (Xu et 
aL, 2009, Rutz et aL, 2011). The AhR is also expressed in Th17 cells and seems 
to be particularly important for IL-22 production (Veldhoen et aL, 2008a). The 
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Ets-l transcription factor negatively regulates Th17 differentiation via effects 
on the IL-2 pathway (Moisan et aL, 2007). 
1.3.3 Th17 Phenotype and Plasticity 
Th17 cells typically produce IL-17, IL-17F, IL-21 and IL-22 (Acosta-Rodriguez et 
aL, 2007b, Wilson et aL, 2007, Volpe et aL, 2008), however the exact cytokine 
profile can vary depending on the conditions under which the cells 
differentiated and signals the cell receives from its local environment. Other 
cytokines reported to be produced by Th17 cells include IL-6, TNF-u, CCL20, 
and IL-26 (Volpe et al., 2008, Langrish et aI., 2005, Manel et aI., 2008, Wilson 
et aL, 2007). These cytokines are discussed in detail in Chapter 4, with the 
exception of IL-26. IL-26 is a member of the IL-l0 cytokine family. It has no 
murine homologue and has not been widely investigated but it is increased in 
inflamed colonic tissue from patients with Crohn's disease and upregulates 
TNF-u and IL-8 expression in colorectal cancer-derived epithelial cell lines in 
vitro (Dambacher et aL, 2009). 
GM-CSF production by murine Th17 cells was reported in an early study 
describing Th17 cells (Langrish et aL, 2005). There has been a recent 
resurgence of interest in GM-CSF as two studies have confirmed its 
production by murine Th17 cells and shown that it is required for the 
pathogenic effects of both Th17 and Thl cells in EAE (EI-Behi et aL, 2011, 
Codarri et aL, 2011). 
Th17 cells producing the regulatory cytokine IL-l0 and IFNy, classically a Thl 
cytokine have also been described (Volpe et aL, 2008, Peters et aL, 2011, 
Ghoreschi et aL, 2010, Zielinski et aI., 2012). It is now recognized that not all 
Th17 cells are the same and some may have more regulatory phenotypes 
while others are more pro-inflammatory (Peters et aL, 2011, Ghoreschi et aI., 
2010). As described above, Ghoreschi et al. found that the presence of T G F - ~ ~
and absence of IL-23 favoured differentiation of a more regulatory phenotype 
(Ghoreschi et aL, 2010). Zielinski et al. reported that I L - l ~ ~ favoured 
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differentiation of pro-inflammatory IL-17/IFNy double producers and inhibited 
Il-lO production (Zielinski et al., 2012). 
The finding of cells that produce classical Treg and Thl cytokines in addition 
to Il-17 is not unexpected as it is recognized that there is considerable 
plasticity in the Th17lineage. Murine Th17 cells can be converted to IFNy-
producers both in vitro and in vivo (Shi et aL, 2008, lee et aL, 2009, Bending 
et aL, 2009, Hirota et aL). Cells expressing both RORyt and T-bet transcription 
factors can occur (Zielinski et aL, 2012), though T-bet has been shown to 
inhibit RORyt by sequestering Runxl (Lazarevic et aL, 2011). Boniface et a/. 
studied human T cells differentiated under Th17-inducing conditions and 
identified a T-bet+IFNy+ll-lT population with a cytokine profile more similar 
to Th17 than Thl cells (Boniface et aL, 2010). This suggests that Th17-derived 
IFNy-producing T cells may not be classical Thl cells. There are no reports of 
Thl cells converting into Th17 cells (Shi et aL, 2008), suggesting that Thl cells 
are a more stable population. 
Treg cells can convert into Il-17-producing cells in pro-inflammatory 
environments (Xu et aL, 2007, Koenen et aL, 2008, Voo et aL, 2009). low 
frequencies of FOXP3+IL-17+ cells have been identified in human peripheral 
blood and tonsil tissue (Voo et aL, 2009). Despite producing IL-17 these cells 
have suppressive activity (Voo et aL, 2009). A further CD4+ subset, the T 
follicular helper cells, which secrete high levels of IL-2l and provide B cell help 
in germinal centres, have been shown to be a highly plastic population that 
can develop from Thl, Th2 and Th17 cells and vice versa (Lu et aL, 2011). 
Modifications in histone methylation patterns and microRNA expression can 
effect plasticity by causing epigenetic modification of gene transcription (Wei 
et aL, 2009, Rossi et aL, 2011). 
1.3.4 Th17 Cells and Host Defense 
Th17 cells are important for defense against extracellular bacteria and 
defense of mucosal surfaces and are also increased in many chronic 
inflammatory diseases and a number of cancers. Their methods of controlling 
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infection include recruiting inflammatory cells to the infected site, especially 
neutrophils, and promoting secretion of anti-bacterial peptides. Studies using 
cytokine knockout mice have shown that Th17 cytokines are involved in 
protection against bacterial and fungal infections of the lung and 
gastrointestinal tract (Ye et aL, 2001, Aujla et aL, 2008, Ishigame et aL, 2009, 
Conti et aL, 2009). IL-lO-/- mice infected with Helicobacter hepaticus and wild-
type mice infected with Hh develop IL-23-dependent colitis with Thl, Th17 
and C04+IL-17+IFNy+ mesenteric lymph node cell responses (Kullberg et aL, 
2006). Bacteroides fragilis polysaccharide A can reduce H. hepaticus-induced 
IL-17 production and colitis via C04+ T cell secreted IL-I0 (Mazmanian et aI., 
2008). Murine Th17 responses to pulmonary pathogens, such as 
Staphylococcus aureus, have also been demonstrated (Frank et aL, 2012). 
Human Th17 recall responses to antigens including Staphylococcus aureus and 
Candida albicans have been demonstrated (Zielinski et aL, 2012). Patients 
that have mutations in genes resulting in reduction in Th17 numbers or Th17 
function, including IL-17RA, IL-17F, STAT3, Oectin-l and CAR09 (pattern 
recognition receptor for C. albicans and its signaling molecule) and 
autoantibodies to IL-17A and IL-17F are prone to chronic mucocutaneous 
candidiasis with or without S. aureus infections (Ma et aI., 2008, Milner et aL, 
2008, Glocker et aL, 2009, Ferwerda et aL, 2009, Puel et aL, 2011). Patients 
with severe burns are susceptible to C. albicans infection and their PBMCs 
showed a markedly reduced Th17 response to C. albicans antigen stimulation 
in vitro (lnatsu et aL, 2011). This may be due to inhibition of the Th17 
response by IL-I0 (Inatsu et aL, 2011). 
In addition to their classical role in defense against extracellular bacteria and 
fungi, Th17 responses have also been described in a number of intracellular 
infections. There is a Th17 response to Mycobacterium tuberculosis (TB) and 
Mycobacterium bovis Bacille Calmette-Guerin (BCG) infection, though a 
significant proportion of the IL-17 response to these mycobacteria is 
produced by y8 T cells (Peng et aL, 2008, Umemura et aL, 2007). IL-17+IFNy+ 
double cytokine producing C04+ cells were increased in blood and pleural fluid 
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of patients with active TB and levels were higher in those with severe disease 
(Jurado et aL, 2012). IL-17-/- mice infected with BCG had reduced IFNy 
production and impaired granuloma formation compared to their wild-type 
counterparts (Umemura et aL, 2007), demonstrating a role for IL-17 in the 
pathogenesis of this infection. Human Th17 cells with specificity for HIV-l and 
CMV have also been demonstrated (Vue et aL, 2008). Th17 cell counts fall at 
an earlier stage in HIV infection than some other C04+ T cell subgroups 
(Prendergast et aL, 2010). In addition to direct anti-viral activity Th17 cells 
may also provide help to C08+ T cells and B cells (Khader et aL, 2009). Th17 
cells are also increased in chronic hepatitis Band C infection, where they 
correlate with liver inflammation and fibrosis, suggesting that with failure to 
clear the infecting organism the Th17 response may contribute to pathology 
(Sun et aL, 2012, Chang et aL, 2012, Ge et aL, 2009). Th17 cytokines IL-17 and 
IL-22 can promote hepatocellular cancer development in this chronic 
inflammatory context (Gu et aL, 2011, Jiang et aL, 2011). IL-17 also failed to 
clear the virus but contributed to pathology in models of murine HSV-l 
corneal infection and rhinovirus infection of human primary bronchial 
epithelial cells (Molesworth-Kenyon et aL, 2008, Wiehler and Proud, 2007). 
Where the host Th17 responses are not able to clear bacterial infection 
pathology may also result. Examples include chronic biofilm infection in cystic 
fibrosis and a mouse model of chronic granulomatous disease with defective 
NAOPH oxidase activity (Romani et aL, 2008, Dubin et aL, 2007). 
1.3.5 Th17 Cells and Chronic Inflammatory Disease 
Th17 cells have been shown to be increased in a number of chronic 
inflammatory conditions in humans (Pene et aL, 2008). Increased frequencies 
ofTh17 cells are found in intestinal biopsies from patients with Crohn's 
disease (Annunziato et aL, 2007, Kleinschek et aL, 2009). A significant 
proportion of these cells also secrete IFNy following stimulation with PMA and 
ionomycin (Annunziato et aL, 2007). Polymorphisms in the IL-23R gene and 
other Th17-related genes including stat3 and ccr6 affect risk of Crohn's 
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disease, further supporting a role for Th17 in its pathogenesis (Duerr et aL, 
2006, Dubinsky et aL, 2007, Barrett et aL, 2008). 
Patients with multiple sclerosis (MS) had high levels of Th17 cells in their 
cerebrospinal fluid (CSF), which increased during relapses (Brucklacher-
Waldert et aL, 2009b). Peripheral blood lymphocytes from relapsing MS 
patients had increased propensity to develop into CD4+IL-17+IFNl double-
producers upon expansion with IL-23 in vitro. T-bet and RORyt co-staining was 
also demonstrated in human central nervous system tissue using confocal 
microscopy (Kebir et aL, 2009). IFN-P, a widely used therapy for relapsing-
remitting MS, inhibits Th17 differentiation (Ramgolam et aL, 2009). 
IL-17+ and IL-22+ CD4+ T cells are also present at increased levels in the 
peripheral blood of patients with rheumatoid arthritis and ankylosing 
spondylitis (Shen et aL, 2009). Increased IL-17 concentrations in the synovial 
fluid of rheumatoid arthritis patients were demonstrated over a decade ago 
and IL-17 and IL-21 can stimulate osteoclastogenesis (Kotake et aL, 1999, 
Kwok et aL, 2012). However, it has been reported that Thl cells are more 
abundant than Th17 cells in the joints of patients with rheumatoid arthritis 
(Yamada et aL, 2011). Nistala et al. found that a significant proportion of Th17 
cells from joints of patients with juvenile idiopathic arthritis (JIA) secreted 
IFNy and expressed both Thl and Th17 transcription factors. A proportion of 
the CD4+IFNy+IL-IT cells from the joints of patients with JIA were CD161+ and 
had higher RORC2, CCR6 and IL-23R expression than the CD161" Thl 
population (Nistala et aL, 2010), suggesting that some CD4+IFNl cells in the 
inflamed joints may be derived from the Th17 lineage. Cosmi et al. also 
reported CD4+CD161+ "Thl/Th17" and "Th 1" cells in the synovial fluid of JIA 
patients, which correlated with inflammatory markers (Cosmi et aL, 2011). 
This could be consistent with a Th17-derived, IL-ITIFNy+ pathogenic cell 
population. 
Th17 cells are also increased in the skin lesions and peripheral blood of 
patients with psoriasis (Kagami et aL, 2010, Zhang et aL, 2010a). The Th17 
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cytokine IL-22 is increased in psoriatic lesions and in the plasma of patients 
with psoriasis, where it correlated with disease severity and reduced with 
treatment (Wolk et aLI 2006). A C04+IL-l TIL-22+ population was identified in 
the inflamed epidermis of patients with psoriasis and dubbed "Th22" (Eyerich 
et aLI 2009). However no lineage-specific transcription factor has yet been 
identified for this population. Res et al. found that skin-derived Th17 clones 
could lose IL-17 expression and become IL-22 single-producers (Res et aLI 
2010), suggesting that "Th22" cells may be a further manifestation of Th17 
instabil ity / plasticity. 
1.3.6 Th17 and Cancer 
Th17 cells have been found to be increased in gastric cancer (Zhang et aLI 
200Sa, lida et aLI 2011) and a number of other human tumours (Ye et aLI 
2010, Kryczek et aLI 2009a, Sfanos et aLI 200S, Kryczek et aLI 2007). Tumour 
microenvironments appear to favour recruitment and expansion of Th17 
populations (Su et aLI 2010). Tumour-infiltrating Th17 cell frequencies and 
Th17 cell numbers in malignant pleural effusions correlate with survival or 
slower progression of disease in a number of human cancers and, in mice, 
Th17 cells can completely eradicate large melanomas (Sfanos et aLI 200S, 
Muranski et aLI 200S, Kryczek et aLI 2009a, Ye et aLI 2010). However, in other 
malignancies Th17 levels did not affect disease outcome or conversely were 
associated with more rapid disease progression (Zhang et aLI 2010c, 
Oerhovanessian et aLI 2009). The role of IL-17 in neoplastic disease is 
discussed in Chapter 5. A significant proportion ofTh17 cells from tumour 
sites co-express TNF-u, IL-2 or IFNy (Kryczek et aLI 2009a). Studies in ovarian 
cancer suggest that Th17-derived IL-17 and IFNy can synergistically increase 
CXCL9 and CXCLlO expression, which in turn increase COS+ T cell recruitment 
(Kryczek et aLI 2009a). Th17 cells caused activation of COS+ T cells with anti-
tumour activity in murine lung melanoma (Martin-Orozco et aLI 2009). Other 
Th17 cytokines may also have important roles in cancer. IL-22 appears to have 
some pro-tumour effects as it can stimulate human pancreatic cancer cells to 
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produce vascular endothelial growth factor and anti-apoptotic factors (Curd 
et aL, 2012). 
1.3.7 Anti-Th17 Treatment in the Clinic 
The anti-p40 monoclonal antibody ustekinumab, which inhibits both Thl and 
Th17 differentiation has shown promise in randomized trials for Crohn's 
disease and psoriasis (Sandborn et aL, 2008, Krueger et aL, 2007, Leonardi et 
aL, 2008, Sandborn et aL, 2012). Anti-IL-17 monoclonal antibodies have 
shown some efficacy in clinical trials for psoriasis, rheumatoid arthritis and 
uveitis, but were disappointing in Crohn's disease, with a high incidence of 
infections in the anti-IL-17-treated group (Hueber et aL, 2012, Leonardi et aI., 
2012, Genovese et aL, 2010, Hueber et aL, 2010). An IL-17R antibody was also 
effective for the treatment of psoriasis (Papp et aL, 2012). IL-21 makes T cells 
resistant to Treg suppression and may be a further Th17 cytokine therapeutic 
target in Crohn's disease but this hypothesis has not yet been tested in clinical 
trials (Monteleone et aL, 2009). There is interest in inhibiting transcription 
factors involved in Th17 differentiation and drugs already in clinical use 
including simvastatin and digoxin have been shown to do this in vitro (Zhang 
et aL, 2008b, Huh et aL, 2011). Pioglitazone also inhibited EAE in mice (Klotz 
et aL, 2009). Intravenous immunoglobulin can also interfere with RORC2 and 
STAT3 expression and Th17 cytokine production, which may account for some 
of its immunomodulatory effects (Maddur et aL, 2011). 
1.3.8 Th17 Cell Markers 
The study of human Th17 cells has been hampered by the lack of specific cell 
markers to identify this population. Acosta-Rodriguez et 01. reported that 
CCR4 and CCR6 memory C04+ T cells have a Th17 phenotype (Acosta-
Rodriguez et aL, 2007b). However, CCR4 and CCR6 can also be expressed by 
Tregs (Lim et aL, 2008). CCR6 has been widely used in conjunction with other 
markers to help identify Th17 cells (Manel et aL, 2008, Boniface et aL, 2010, 
Annunziato et aL, 2007). 
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The IL-23R is upregulated on Th17 cells by IL-6 early in Th17 differentiation 
(Ivanov et aL, 2006, Zhou et aL, 2007a). Some investigators have used the IL-
23R, at the mRNA level or with polyclonal antibodies for flow cytometry, as a 
Th17 marker (Annunziato et aL, 2007, Wilson et aL, 2007). However, no 
monoclonal anti-IL-23R antibodies were available when this study was 
designed and the IL-23R is also expressed by other IL-17-secreting cells 
including C08+ T cells, yeS T cells and other innate lymphoid populations, 
including lymphoid tissue inducer-like cells (Billerbeck et aL, 2010, Huber et 
aL, 2009, Sutton et aL, 2009, Takatori et aL, 2009, Buonocore et aL, 2010). 
IL-22+Th17 cells originate from C0161+ precursors and maintain their C0161+ 
phenotype (Cosmi et aL, 2008). C0161 is also expressed on subsets of NK cells 
and C08+ T cells and can occur at low levels on Thl and Th2 clones (Lanier et 
aL, 1994, Cosmi et aL, 2008). C0161+ T cells may express IL-17 and/or IFNy 
(Cosmi et aL, 2008). A significant proportion of C0161 + T cells express the gut 
homing integrin u4P7 and high numbers of these cells have been found in 
inflamed colonic tissue from patients with Crohn's disease (Kleinschek et aL, 
2009). 
Even expression of the Th17 transcription factor RORC2 is not restricted to 
Th17 cells. RORC2 expression has been described in C08+T cells and NKT cells. 
Its murine orthologue RORyt is also expressed on innate IL-17 producing cells 
including yeS T cells and lymphoid tissue inducer-like cells (Burgler et aL, 2009, 
Sutton et aL, 2009, Takatori et aL, 2009). 
Flow cytometry with extracellular C04 staining and intracellular IL-17 staining 
may be the most reliable way of identifying C04+IL-17+ Th17 cells, but 
requires the cells to be permeabilized, precluding subsequent functional 
experiments. As the plasticity and complexity ofthe Th17 cells is becoming 
better understood, wider panels of markers are now becoming necessary to 
further characterize Th17 populations. 
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1.3.9 Non-Th17 Cell Sources ofIL-17 
IL-17-secreting C08+ T cells (Tc17s) develop in similar STAB-dependent 
conditions to those that promote Th17 development (Huber et aL, 2009). 
They have low perforin and granzyme expression but usually express IL-23R, 
C0161, CCR6 and RORC2 and often co-express other inflammatory cytokines 
such as IFNy, IL-21, IL-22 and TNF-a (Billerbeck et aL, 2010, Kondo et aL, 2009, 
Huber et aL, 2009, Ortega et al., 2009). They exhibit some plasticity with the 
potential to convert to IL-1TIFNy-producers (Hinrichs et aL, 2009, Yen et aL, 
2009). Tc17 cells are involved in anti-viral immunity (Billerbeck et aL, 2010, 
Intlekofer et aL, 2008, Grafmueller et aL, 2012, Hamada et aL, 2009). They 
have also been detected in a number of tumours and can mediate anti-
tumour immunity in mouse models (Kuang et aL, 2010, Hinrichs et aL, 2009, 
Garcia-Hernandez et aL, 2010). Tc17s are implicated in colitis and EAE mouse 
models (Tajima et aL, 2008, Huber et aL, 2009) and are increased in the skin 
of patients with psoriasis and in the blood of patients with relapsing multiple 
sclerosis and neuromyelitis optica (Ortega et aL, 2009, Res et aL, 2010, Wang 
et aL, 2011). 
T cells expressing the yo T cell receptor (TCR) are involved in innate immune 
responses. They can also express the IL-23R, RORyt, CCR6 and AhR and 
produce IL-17, IL-21 and IL-22 (Sutton et aL, 2009, Martin et aL, 2009). These 
cells express TLR1, TLR2 and dectin-1, allowing them to interact directly with 
some pathogens (Lochner et aL, 2008, Martin et aL, 2009). They contribute 
significantly to IL-17 secretion in murine bacterial infection and are expanded 
in the blood of patients with certain bacterial and viral infections (Lockhart et 
aL, 2006, Caccamo et aL, 2011, Fenoglio et aL, 2009, Shibata et aL, 2007). IL-
17+ yo T cells appear to contribute to pathology in mouse models of 
autoimmune disease, including EAE, collagen induced arthritis and colitis 
(Sutton et aL, 2009, Do et aL, 2011, Ito et aL, 2009). They are increased in the 
peripheral blood of patients with ankylosing spondylitis but their role in 
42 
human disease has not yet been fully elucidated (Kenna et aL, 2012, Ito et aL, 
2009). 
Invariant natural killer T (iNKT) cells are a further innate C03+ source of IL-17. 
They recognize glycolipid antigens, such as a-galactosylceramide, presented 
in the context of COld. A subset of iNKT cells in murine lymphoid tissue can 
express the IL-23R, RORyt, CCRG and C0103 and rapidly produce IL-17 in 
response to a-galactosylceramide or TCR or IL-23R ligation (Rachitskaya et aL, 
2008, Ooisne et aL, 2009). However, NKT cells are reported to account for 
<2% T cells in the gastric mucosa of patients without Hp infection, with no 
significant increase in gastric biopsies from Hp-infected patients (O'Keeffe et 
aL,2008). 
A number of non-T cell sources of IL-17 have also been described and recently 
it has been proposed that these IL-17- and/or IL-22-producing innate 
lymphoid cells (ILCs) should be termed group 3 ILCs, or ILC3s (Spits et aL, 
2013). This classification also encompasses ILC1s, including NK cells, that are 
defined by their production of IFNy, and ILC2s, which produce Th2-associated 
cytokines (Walker et aL, 2013, Spits et aL, 2013). An increased proportion of 
ILC2s was found in nasal polyps from patients with chronic rhinosinusitis 
(Mjosberg et aL, 2011). 
The ILC3 subset expresses RORyt and also depends on IL-7Ra (C0127) for its 
development. It may be further subdivided into lymphoid tissue-inducer (LTi) 
cells, natural cytotoxicity triggering receptor {NCRr and NCR- populations 
(Walker et aL, 2013, Spits et aL, 2013). LTi cells are required for the 
development of secondary lymphoid tissue (Eberl et aL, 2004). Some murine 
LTi cells express C04, but human LTi cells are C04- (Cupedo et aL, 2009). 
Takatori et al. were the first to report an IL-23R+CCRG+AhR+ lymphoid tissue 
inducer-like (LTi-like) population (NCR+ ILC3s, also previously referred to as 
NK22 cells) that produced IL-17 and IL-22 in response to zymosan stimulation 
in mice (Takatori et aL, 2009). A similar population has been identified in 
human fetal tissue and is thought to be the precursor to NKp4G+ cells {NCR+ 
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ILC3s) which produce IL-17 and IL-22 in humans, but IL-22 only in mice 
(Cupedo et aL, 2009, Satoh-Takayama et aL, 2008). Buonocore et a/. 
described yet another IL-23-responsive THY1+SCA1+CD3TD4'KIT innate IL-17-
producing population in the intestine of mice with infection-driven colitis 
(NCR- ILC3s), which also produces IFNy (Buonocore et aL, 2010). Depletion of 
this population ameliorated colitis in H. hepaticus Rag2-1- mice (Buonocore et 
aL, 2010). An equivalent NCR-ILC3 population has not yet been described in 
humans. 
The relationship between these populations and their plasticity is not yet fully 
understood, but interestingly, it seems that ILC3 cells may have the potential 
to convert into ILCls (Walker et aL, 2013). IL-7 and intestinal microbiota 
appear to stabilize the RORyt+ ILC3 phenotype (Vonarbourg et aL, 2010, Cella 
et aL, 2010). Vonarbourg et a/. fate-mapped LTi-like NCR-RORyt+ ILC3s from 
the lamina propria of the small intestine of R o r ~ f p / + + mice and found that they 
could develop into IL-22-producing NCR+ ILC3s. A proportion of these 
subsequently lost RORyt expression and acquired IFNy-secreting capacity, a 
phenomenon that was accelerated by IL-12 and IL-15 (Vonarbourg et aL, 
2010). Cella et a/. used NCR+ ILC3s isolated from human tonsils to 
demonstrate similar plasticity of human ILC3s. In this study deviation towards 
an IFNy-producing phenotype was favoured by IL-2 or IL-23 (Cella et aL, 2010). 
Additionally paneth cells in the murine intestine may act as a source of IL-17 
(Takahashi et aL, 2008). Neutrophils may also produce IL-17 under some 
circumstances (Werner et aL, 2011). 
1.4 THE IMMUNE RESPONSE TO HELICOBACTER PYLORI 
1.4.1 The Innate Immune Response to Helicobacter pylor; 
The innate immune response is the first line of defence. It can respond 
immediately but is not pathogen-specific and has no memory. Innate immune 
responses can help prime adaptive immune responses. This section will 
discuss how the innate immune system recognizes pathogens, and its effector 
proteins and cells. 
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1.4.1.1 The mucus layer and epithelial barrier 
The acid environment of the stomach forms a chemical barrier to infection 
with most organisms and the mucus layer and epithelium form additional 
physical barriers. Neither of these structures are inert barriers. Most Hp is 
found in the mucus layer which is made up of mucins (heavily glycosylated 
proteins). This is a dynamic structure that can transport trapped debris. The 
main mucins expressed in adult gastric mucosa are MUC5AC and MUCG which 
are secreted by the surface epithelium and glands respectively (De Bolos et 
aL, 1995, linden et aL, 201O). Mucin expression may be altered in 
precancerous conditions and gastric cancer (linden et al., 201O). Mucins can 
bind Hp, preventing it reaching the epithelium (linden et aL, 201O). Gastric 
mucins express Lewis antigens. Lewisb binds the Hp virulence factor BabA (see 
section 1.1.5.4). Gastric tissue lacking Lewisb expression did not bind Hp in 
vitro and a study of children with Hp infection found higher Hp density in 
Lewisb-negative children (Linden et aL, 2010, Boren et aL, 1993). The mucous 
layer acts as a matrix for antimicrobial peptides and MUCG itself has 
antimicrobial activity (Kawakubo et aL, 2004). Patients with Sjogren's 
syndrome, who have reduced mucous secretion, have increased prevalence 
and titres of anti-Hp antibodies, consistent with a protective role for the 
mucus (EI Miedany et aL, 2005). 
The gastric epithelium consists of a sheet of polarized cells bound together by 
tight junctions. The Hp virulence factor CagA is able to associate with the 
tight-junction scaffolding protein ZO-l to disrupt the apical-junctional 
complex allowing access to the gastric mucosa (Amieva et aL, 2003). Gastric 
epithelial cells secrete a number of cytokines including IL-lf3, IL-G and IL-8 
(lindholm et aL, 1998). They are also a key site for recognition of invading 
pathogens and express a number of pattern recognition receptors (PRRs) as 
described below. 
1.4.1.2 Pattern Recognition Receptors 
PRRs such as toll-like receptors (TLRs) and intracellular nucleotide 
oligomerization domain receptors (NODs) recognize conserved pathogen 
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associated molecular patterns (PAMPs), such as lipopolysaccharide, flagellin, 
muramyl dipeptide and CpG DNA motifs, not found in the human host 
(reviewed in (Kawai and Akira, 2010)). This allows the innate immune system 
to recognize invading pathogens as foreign early in infection. Recognition of 
PAMPs on apoptotic cells can trigger the combination of cytokines required 
for Th17 differentiation (Torchinsky et aL, 2009). 
The ligands for PRRs expressed by Hp are less potent that those expressed by 
many other bacteria, which may aid immune evasion, but are nonetheless 
important for triggering of the innate immune response (Gewirtz et aL, 2004, 
Lee and Josenhans, 2005). Gastric epithelium expresses TLR 4, 5 and 9 and 
immune cells that may be present in the gastric mucosa also express 
combinations of TLRs (Schmausser et aL, 2004, Kadowaki et aL, 2001, 
O'Mahony et aL, 2008). A subgroup of y'O T cells express TLR1, TLR2 and 
dectin-1 (which binds f3-glucan), and can produce IL-17 upon ligation of these 
receptors, without the need for T cell receptor binding (Martin et aL, 2009). 
MyD88 signalling pathways are triggered by all the TLRs with the exception of 
TLR3. DCs from MyD88-1- mice had impaired upregulation of activation 
markers and reduced cytokine secretion in response to Hp (Rad et aL, 2007). 
Using DCs from further knockout mice, the same group found that TLR2 was 
the major surface PRR for Hp, with TLR4 making a minor contribution, though 
TLR4 polymorph isms have been linked to gastric cancer and its precursors (EI-
Omar et aL, 2008, Rad et aL, 2009, Hold et aL, 2007). Intracellular TLR9 also 
contributed by binding Hp DNA (Rad et aL, 2009). TLR2 can trigger anti-
inflammatory responses in mice but activation of human TLR2 seems to have 
more pro-inflammatory effects (Rad et aL, 2009, Wang et aL, 2010, Zhang et 
aL, 20lOb, Nyirenda et aL, 2011, Amedei et aL, 2006, Sayi et aL, 2011). 
In addition to TLR9, as discussed above, NOD1 is an important intracellular 
PRR for recognition of peptidoglycan delivered to gastric epithelial cells via 
the type IV secretion system encoded by the cagPAI (Figure 1.4). NOD1 
binding triggers NF-KB activated pro inflammatory pathways. Van Beelen et 0/. 
found that a range of bacteria could stimulate IL-17 production in memory T 
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cells via N002 stimulation, particularly Gram negative bacteria, but Hp was 
not included in their panel (van Beelen et aL, 2007). 
1.4.1.3 Antimicrobial pep tides 
The antimicrobial peptides are cationic and can disrupt bacterial cell 
membranes (Zasloff, 2002). Some antimicrobial peptides also have 
chemotactic activity, for example p-defensin 2 (hP02) is a ligand for CCR6 
(Yang et aL, 1999). 
IL-17 and IL-22 can upregulate expression of a number of types of peptide 
with direct antibacterial activity, including defensins, calgranins and mucins 
(Gaffen, 2008, Liang et aL, 2006). The p-defensins are probably the best 
studied antimicrobial peptides in the context of Hp infection, particularly 
hp02. Expression of hP02 is inducible, and upregulated by Hp, whereas 
expression of hP01 is constitutive (Bauer et aL, 2013). In vitro studies suggest 
that cagPAI mediated activation of N001 is required for hP02 expression 
(Boughan et aL, 2006, Grubman et aL, 2010). IL-17 can upregulate hP02 via 
JAK and NF-kB pathways (Kao et aL, 2004). Upregulation of hP04 in gastritis, 
including Hp-related gastritis, has also been reported, with reduction in levels 
following eradication (Otte et aI., 2009). Conversely, hp03 expression appears 
to be reduced in chronic Hp infection via a cagPAI-mediated mechanism 
(Bauer et aL, 2012, Bauer et aL, 2013). My088-1- mice had reduced levels of 
the antibacterial peptide lipocalin 2 and increased H. /elis colonization density 
in addition to reduced IL-17 and IL-22 levels, indicating that TLR signalling is 
linked to expression of some antibacterial peptides (Obonyo et aL, 2011). 
Other antimicrobial peptides studied in Hp infection include the neutrophil-
derived a-defensins 1, 2 and 3, which were increased in the gastric juice of 
Hp-infected patients and fell after eradication, and the cathelicidin LL-37 (also 
known as human cationic antimicrobial peptide 18), which was increased in 
the epithelium and gastric secretions of Hp-infected patients (Isomoto et aL, 
2004, Hase et aL, 2003). 
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1.4.1.4 Cells o/the innate immune system 
Hp infection leads to infiltration of lymphocytes, granulocytes and monocytes 
(Robinson et aL, 2007, Kusugami et aL, 1999, Itoh et aL, 1999). Innate 
lymphocytes include NK cells, NKT cells, yo T cells and lymphoid tissue 
inducer-like (LTi-like) cells. Relatively little is known about these cells in the 
context of Hp infection. NK cell numbers in the gastric mucosa are low and 
studies have given mixed results regarding whether or not they increase in Hp 
infection (ltoh et aL, 1999, Fan et aL, 1994, Agnihotri et aL, 1998). 
O'Keefe et 01. found low numbers of NKT cells in the gastric mucosa with no 
increase in Hp infection (O'Keeffe et aL, 2008). Futagami et 01. found 
increased y<> T cells only in patients with severe gastritis or lymphoid follicles 
(Futagami et aL, 2006). However, Hatz et 01. found no increase in yo T cells in 
the lamina propria and Trejdosiewicz et 01. found no increase in y<> T cells in 
the gastric epithelium in Hp infection (Hatz et aL, 1996, Trejdosiewicz et aL, 
1991). 
Neutrophils and macrophages infiltrate the stomach within 2 days of Hp 
infection of mice (Algood et aL, 2007). Neutrophils may mediate protective 
responses in mouse vaccination models (DeLyria et aL, 2009). IL-8 is an 
important neutrophil chemokine and IL-17 upregulates genes involved in 
neutrophil recruitment and activation (Gaffen, 2008). Neutrophil infiltration is 
graded for the "activity" component of the updated Sydney score (Dixon et 
aL, 1996). 
Like neutrophils, macrophages are phagocytes. Phagocytosis and death due to 
reactive oxygen species (ROS) within the resultant phagosomes is an 
important bacterial killing mechanism, but Hp tries to evade this using its 
catalase activity (Ramarao et aL, 2000). 
Macrophages can be divided into M1 macrophages, which are 
proinflammatory and microbicidal, and M2 macrophages which are involved 
in resolution of inflammation and secrete IL-10. Markers of both M1 and M2 
macrophages are increased in the gastric mucosa of Hp-infected patients, but 
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levels of inducible nitric oxide synthase, which is associated with M1 
macrophages, were particularly high in Hp-infected patients with 
precancerous changes (Quiding-Jarbrink et aL, 2010). The macrophage-
derived chemokine MIP-1a is increased in Hp-infection (Kusugami et aL, 1999, 
Yamaoka et aL, 1998). Macrophages can also act as antigen-presenting cells. 
Dendritic cells, often described as professional antigen presenting cells, are 
specialized to take up and process antigen, then present it to T cells in the 
context of MHC. They are known to infiltrate the Hp-infected gastric mucosa 
and can take up Hp and its virulence products (Necchi et aL, 2009, Bimczok et 
aL, 2010, Khamri et aL, 2010). These cells and their responses to Hp are 
discussed in detail in Chapter 3. 
Mast cells are also increased in Hp-infected gastric mucosa (Bamba et aL, 
2002). They are able to recognize pathogens directly by receptors including 
TLR2 and TLR4 and have pleiotropic effects on immune and other cells 
involved in mucosal immunity (Abraham and St. John, 2010). Their role in Hp 
infection is not entirely clear but they were found to be essential for 
clearance of Hp in a mouse vaccination model (Velin et aL, 2005). 
1.4.2 The Adaptive Response to Helicobacter pylori 
The adaptive immune response consists of CD4+ (helper) and CD8+ (cytotoxic) 
T cell and B cell responses. B cells can develop into antibody-producing 
plasma cells. Specificity and memory are key features of the adaptive immune 
response. Clonal expansion allows rapid generation of a pool of lymphocytes 
specific for a pathogen to which the host has previously been exposed. 
Studies in mice indicate that Peyer's patches (PP) in the small intestine are an 
important site for induction of the adaptive immune response to Helicobacter 
species, with reduced gastritis, lymphocyte infiltration and antibody 
responses in PP-null mice (Nagai et aL, 2007, Kiriya et aL, 2007), but it is not 
known if this is also the case for human Hp infection. 
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1.4.2.1 Humoral immunity 
Mucosal and systemic IgG and IgA (particularly important for mucosal 
immunity) responses are mounted to Hp. There is some evidence that anti-Hp 
IgA antibodies in maternal milk can delay Hp colonisation of breastfed babies 
(Thomas et aL, 1998). However, B cell knockout mice were protected against 
Hp challenge as well as wild-type mice in a vaccination model (Ermak et aL, 
1998). Selective IgA deficiency is relatively common, but rates of Hp infection 
are not increased in these patients, despite a lack of compensatory increase in 
IgG (Bogstedt et aL, 1996). Levels of IgA specific for certain Hp antigens were 
found to correlate with grade of gastritis, suggesting that they act as a marker 
of infection rather than contributing to protective immunity (Hayashi et aL, 
1998). There is also interest in identifying antibody responses to components 
of Hp that may act as serological markers to help stratify for gastric cancer 
risk, perhaps as part of a multiplex panel (Gao et aL, 2009, Anderson et aL, 
2006). Sayi et 0/. reported that B cells stimulated by H. fe/is TLR2 ligands 
induced an IL-l0-secreting Trl population that could suppress the 
development of preneoplastic pathology (Sayi et aL, 2011). This suggests that 
B cells may have other immunoregulatory roles separate to their antibody 
production but it is not yet clear whether this is also the case in human Hp 
infection. 
Serology is often used in clinical practice as a screening test for Hp. Hp-
specific antibodies are still present in a significant proportion of patients up to 
24 months after successful eradication, so other tests are preferable if 
confirmation of successful eradication is required (Kato et aL, 1999). 
1.4.2.2 CD4+ T cell response to Hp 
T cells account for the largest component of the inflammatory cell infiltrate in 
Hp-associated gastritis (Itoh et aL, 1999). Studies with MHC II deficient mice 
found C04+ T cell responses to be crucial for protection in mouse vaccination 
models (Ermak et aL, 1998, Pappo et aI., 1999), with density of gastric T cells 
correlating with degree of protection (Ermak et aI., 1998). C04+ T cells are 
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required for development of gastric pathology in mouse Hp and H. felis 
infection models (Eaton et aL, 2001, Roth et aL, 1999). Nagai et 01. found that 
transfer of naiVe CD4+ T cells into Rag2-1- mice two months after Hp infection 
induced gastritis (Nagai et aL, 2007). A recent study by Hitzler et 01. confirmed 
that alp T cells are required to reduce H. felis colonization and for 
development of H. felis-induced precancerous changes (Hitzler et aL, 2012a). 
The type of Th response appears to have a large impact on disease 
development and severity of gastritis. 
1.4.2.3 Th1 response 
Strong evidence has now accumulated for both mucosal and peripheral blood 
CD4+IFNy+ (Th1) responses to Hp (D'Elios et aL, 1997, Pellicano et aL, 2007, 
Robinson et aL, 2008, Ren et aL, 2000, Quiding-Jarbrink et aL, 2001b, 
Kenefeck, 2008), though data from early experiments were not conclusive. 
Early studies isolated cells from the gastric mucosa and stimulated with 
PMA/ionomycin (Sommer et aL, 1998, D'Elios et aL, 1997, Bamford et aL, 
1998). However, over 70% CD4+ T cells from uninfected patients also secreted 
IFNy, suggesting that gastric T cells may be intrinsically Th1 polarized or 
PMA/ionomycin may disproportionately stimulate an IFNy response (ltoh et 
aL, 1999). ELiSPOT indicated that there were more IFNy secreting cells in Hp-
negative gastritis than Hp+ gastritis (Karttunen et aL, 1995) and lamina 
propria cells from uninfected patients secreted more IFNy than those from 
Hp+ patients, upon culture for 3 days with Hp stimulation, as measured by 
ELISA (Fan et aL, 1994). This could be due to suppression of the IFNy response 
by other factors induced by Hp e.g. Tregs/anti-inflammatory cytokines and 
suggests that an IFNy response may occur in gastric inflammation due to 
other causes. 
Antigen stimulation may be more physiological and less likely to skew the T 
helper cell distribution. Over 80% of CD4+ cells cloned from the gastric 
mucosa produced IFNy upon stimulation with Hp antigen (D'Elios et aL, 1997). 
My colleagues found an increase in CD4+IFNy+ lymphocyte frequencies with 
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antigenic stimulation in Hp+ but not uninfected patients (Robinson et aL, 
2008). Western blotting experiments indicate STAT4 (a signaling molecule 
involved in IFNy production) and T-bet (Th1 transcription factor) are increased 
in the Hp-infected gastric mucosa compared to uninfected tissue, with 
uninfected patients with gastritis having intermediate levels (Pellicano et aL, 
2007). Immunohistochemistry has also demonstrated upregulation of IFNy in 
the Hp-infected gastric mucosa (Lindholm et aL, 1998, Holck et aL, 2003). 
IFNy levels correlate with inflammation and pathology in humans (Lindholm 
et aL, 1998, Lehmann et aL, 2002, Holck et aL, 2003, Pellicano et aL, 2007) 
and animals (Yamaoka et aL, 2005, Sayi et aL, 2009) infected with 
Helicobacter species. Studies using IL-12-1-and IFNtl- indicate that protection 
against Hp in mouse vaccination models is Th1-dependent (Akhiani et aL, 
2002, Shi et aL, 2005). IFNy levels were higher in Mongolian gerbils with 
ulcers (Yamaoka et aL, 2005). T-bef/-and IFNtl - mice infected with H. felis 
were protected against the development of precancerous changes and cancer 
compared to wild-type mice (Stoicov et aL, 2009, Sayi et aL, 2009). However 
SCID mice did develop gastritis upon transfer of T-bef/-T cells, suggesting that 
Th1-independent mechanisms can contribute to Hp-induced gastric 
inflammation (Eaton et aL, 2006). Hitzler et al. found no difference in 
Helicobacter colonization densities between wild-type, p19-1-and p35-1- mice, 
suggesting that factors other than IL-23 and IL-12 can differentiate/expand 
Th17 and Th1 cell populations, or other lineages are involved in control of 
Helicobacter infections (Hitzler et aL, 2012a). Macrophage inhibitory factor 
(MIF) knockout mice had reduced inflammation, IFNy and T-bet expression, 
suggesting that MIF is a key factor in the Th1 response in this model (Wong et 
aL, 2009). The Hp neutrophil activating protein (NAP) promotes Th1 
responses (Amedei et aL, 2006). On the other hand cyclooxygenase-2, which 
is increased in the Hp-infected gastric mucosa, has an inhibitory effect on Th1 
differentiation (Pellicano et aL, 2007, Meyer et aL, 2003). 
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1.4.2.4 Th17 response 
IL-17/Th17 responses have been linked to protection in mouse vaccination 
models (DeLyria et aL, 2009, Velin et aL, 2009). IL-17 is increased in the 
human Hp-infected gastric mucosa (Luzza et aL, 2000, Serelli-Lee et aL, 2012). 
In a small study Caruso et al. reported increased Th17 cells in Hp-infected 
gastric mucosa but Serelli-Lee et al. reported that though Th17 cells were 
increased in those with previous Hp infection, there was no significant 
increase in Th17 levels in patients with active Hp infection compared to those 
that had never been infected (Serelli-Lee et aL, 2012). The current literature 
on Th17 cells in Hp infection is described in detail in Chapter 6. 
1.4.2.5 Regulatory T cell response 
Raghavan et al. demonstrated that athymic mice reconstituted with lymph 
node cells depleted of CD25+ T cells had lower density of Hp colonization and 
more severe gastritis than those reconstituted with undepleted lymph node 
cells (Raghavan et aL, 2003). A number of subsequent studies have shown 
increased numbers of FOXP3+Tregs in the Hp-infected gastric mucosa in both 
mice and humans (Robinson et aL, 2008, Lundgren et aL, 2005, Kandulski et 
aL, 2008, Hussain, 2012, Jang, 2010, Rad et aL, 2006). In keeping with 
Raghavan et aI's. findings depletion of Tregs in mice led to severe gastritis and 
reduced Hp colonization densities (Rad et aL, 2006, Kao et aL, 2010). Tregs 
have also been reported to be associated with higher Hp colonization 
densities in humans (Kandulski et aL, 2008). 
Studies in mice indicate that Hp-stimulated DCs favour Tregs differentiation as 
adoptive transfer of Hp-stimulated DCs reduced the IL-17/Foxp3 ratio (Kao et 
aL, 2010). However Mitchell et al. report that though Hp-stimulated DCs 
caused proliferation of Tregs, they also reduced their suppressive function, an 
effect that was IL-IB-mediated (Mitchell et aL, 2012). 
The influence of Hp on DCs and T cell differentiation is discussed in detail in 
Chapter 3. In addition to cytokines, tissue factors such as retinoic acid favour 
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Treg differentiation (Mucida et aL, 2007). Reduced retinoic acid is associated 
with increased inflammation, precancerous changes and cancer (Matsumoto 
et aL, 200Sa), which may be partly due to its pro-Treg properties. B7-Hl 
(ligand for programmed death 1 receptor on T cells) expression on gastric 
epithelial cells following exposure to Hp promotes Tregs (Beswick et aL, 
2007). 
In addition to Foxp3+ Tregs, IL-lO-secreting C04+C02S+Foxp3- cells, consistent 
with a Trl Treg phenotype have been reported in the H. felis mouse model 
(Sayi et aL, 2011). IL-l0-secreting Tregs are also present in the human Hp-
infected gastric mucosa (Robinson et aL, 2008, Hussain, 2012). IL-l0 appears 
to be an important anti-inflammatory mediator as IL-1O-1- mice had more 
severe gastritis (Matsumoto et aL, 200Sb, Chen et aL, 2001). This resulted in 
reduced Hp colonization densities, with complete eradication of the infection 
in some models (Matsumoto et aL, 200Sb, Chen et aL, 2001). The anti-
inflammatory mediator TGF-p is also increased in the Hp-infected gastric 
mucosa and correlated with FOXP3 expression (Li and Li, 2006, Robinson et 
aL, 2008, Kandulski et aL, 2008). 
The cell surface molecule CTLA-4 is also expressed on a proportion of Tregs in 
the human Hp-infected gastric mucosa (Hussain, 2012). Mice injected with 
anti-CTLA-4 prior to Hp challenge responded with increased inflammation and 
reduced bacterial loads, indicating that CTLA-4 is a further mechanism by 
which Tregs can exert suppressive effects in the context of Hp infection 
(Anderson et aL, 2006). 
Generation of adenosine catalyzed by C039 and C073 expressed on Foxp3+ 
Tregs has been described as another immunosuppressive mechanism (Oeaglio 
et aL, 2007). C073-1- mice infected with H. felis had increased inflammation 
and reduced bacterial colonization, indicating that they had reduced anti-
inflammatory responses compared to the wild-type control mice (Alam et aL, 
2009). Fletcher et 01. demonstrated that C039+FOXP3+ Tregs can suppress IL-
17 production by T effector cells (Fletcher et aL, 2009). 
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Helios is Treg marker that was initially thought to differentiate between 
thymus-derived and peripherally induced Tregs (Thornton et aL, 2010). It is 
found on Tregs in the Hp-infected gastric mucosa but has now shown to be 
induced in activated and proliferating T cells bringing into question its 
specificity for thymus-derived "natural" Tregs (Hussain, 2012, Akimova et aL, 
2011). 
Children mount stronger Treg responses to Hp infection than adults and it is 
thought that this may explain their lower incidence of Hp-related gastric 
pathology (Harris et aL, 2008, Freire de Melo et aLl. High gastric Treg levels 
are associated with reduced risk of peptic ulcer disease (Robinson et aL, 
2008). The role of Tregs in Hp-induced disease is discussed in detail in Chapter 
6, section 6.1.2. 
Increased levels of IL-lO-secreting FOXP3- Tregs, consistent with a Trl 
phenotype, have also been found in the peripheral blood of Hp-infected 
patients (Kenefeck, 2008, Greenaway et aL, 2011, Satoh et aLl. The systemic 
increase in Tregs during Hp infection could explain the increased risk of 
allergic disease found in the absence of Hp infection (Oertli et aL, 2012, Blaser 
et aL, 2008, Amberbir et aI., 2011). The peripheral blood Treg response to Hp 
infection is discussed in detail in Chapter 4. 
1.4.2.6 Th2 response 
Studies of unstimulated gastric cells and studies using PMA/ionomycin 
mitogenic stimulation found little or no IL-4/Th2 response to Hp infection 
(Sommer et aL, 1998, Bamford et aL, 1998, Itoh et aL, 1999, Lindholm et aL, 
1998, Luzza et aL, 2001, Shimizu et aI., 2004). However an IL-4/Th2 response 
was observed when gastric cells from Hp-infected patients were stimulated 
with Hp antigen in vitro (Robinson et aL, 2008, Marotti et aL, 2008). IL-4-1-
mice had more severe gastritis and higher levels of IFNy than wild-type mice 
(Smythies et aL, 2000), suggesting that IL-4 might have a protective role. Hp 
can induce the gastric epithelium to produce thymic stromallymphopoietin, 
which promotes Th2 responses (Kido et aL, 2010). Phase-variable expression 
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of lipopolysaccharide Lewis antigens in a single strain of Hp can alter the 
balance of the host Th1/Th2 response induced (Bergman et aL, 2004). IL-4 
findings in Hp-infected gastric mucosa are discussed further in section 5.1.3.3. 
1.4.2.7 CD8+ T cell response 
C08+ T cells recognize antigen-derived peptide presented on MHC class I and 
kill the antigen-bearing cells using granzyme and perforin. They are therefore 
suited to defense against intracellular pathogens, such as viruses. Most C08+ 
T cells secrete IFNy, TNF-a and Iymphotoxin, however some C08+ T cells have 
different cytokine profiles and may secrete cytokines including IL-4 or IL-17 
(Mosmann et aL, 1997, Huber et aL, 2009). 
Increased C08+ T cells have also been reported in the Hp-infected gastric 
mucosa (Nurgalieva et aL, 2005, Hatz et aL, 1996, Bamford et aL, 1998). In a 
small study (8 Hp+ and 8 uninfected patients) Fan et al. reported that lamina 
propria C08+ T cells were increased in the Hp-infected gastric mucosa but 
C04+ T cells were not (Fan et aL, 1994). Others have found that the C04:C08 T 
cell ratio is increased in Hp infection (Bamford et aL, 1998, Wu et aL, 2007). 
Bamford et al. found that C08+ T cells accounted for a higher proportion of 
the gastric T cells than C04+ T cells and formed a substantial proportion of the 
IFNy-secreting cells (Bamford et aL, 1998). Lundin et al. found reduced 
numbers of activated C08+ T cells and increased IL-lO levels in the gastric 
mucosa of patients with gastric cancer, which could be consistent with Hp-
induced IL-lO suppressing anti-tumour immunity (Lundin et aL, 2007). 
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1.5 HYPOTHESES AND AIMS 
1.5.1 Hypotheses 
The main hypotheses to be explored are as follows: 
• Dendritic cells produce IL-23 upon exposure to Hp, supporting Th17 
differentiation and expansion. 
• A Th17 response is present in the peripheral blood of Hp-infected 
patients. 
• IL-17/Th17 cells are an important component ofthe proinflammatory 
response to human Hp infection and lead to recruitment of 
proinflammatory cells, including neutrophils and CCR6+ lymphocytes 
to the Hp-infected stomach. 
• Th17-associated inflammation leads to increased risk of peptic ulcer 
disease and Th17 responses may also have a role in carcinogenesis in a 
subgroup of Hp-infected patients. 
1.5.2 Aims 
• To investigate IL-23 production by DCs in response to Hp, and IL-23 
levels relative to IL-12 levels (Chapter 3). 
• To investigate and characterize the Hp-specific peripheral blood Th17 
response (Chapter 4). 
• To compare IL-17 mRNA and protein levels in the gastric mucosa of 
Hp+ and uninfected patients and compare relative Th17 cytokine and 
Thl cytokine levels (Chapter 5). 
• To investigate frequencies ofTh17 cells and other IL-17 producing cells 
in the gastric mucosa of Hp+ and uninfected patients (Chapter 6). 
• To correlate IL-17/Th17 cell markers with gastric neutrophil and 
lymphocyte infiltration in Hp+ patients (Chapters 5 and 6). 
• To see if IL-17/Th17 responses and incidence of Hp-related peptic 
ulcer disease or precancerous pathology are associated (Chapters 5 
and 6). 
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CHAPTER 2 
MATERIALS AND METHODS 
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2. MATERIALS AND METHODS 
2.1 DENDRITIC CELL (DC) AND T CELL RESPONSES TO HP 
2.1.1 Isolation/Generation ofDCs and Naive CD4+ T Cells 
Monocyte-derived dendritic cells (MoDCs) were generated as previously 
described (Jackson et al,). Briefly, peripheral blood mononuclear cells (PBMCs) 
were obtained from donor buffy coats by density gradient centrifugation over 
Histopaque 1077 (Sigma), then washed in PBS. Monocytes were purified by 
positive selection of CD14+ cells using magnetic beads typically resulting in 
>95% purity. The monocytes were cultured in RPMI-1640 with 10% (v/v) FCS, 
1% (v/v) L-Glutamine, GM-CSF (lOOOU/ml) and IL-4 (800U/ml). Fresh media 
was added after 3 days and the immature MoDCs harvested after 5 or 6 days. 
lOOmis heparinised blood from each donor was used to obtain CDlc+ myeloid 
DCs (MyDCs) and CD4+CD45RA + T cells. First PBMCs were isolated, as above. 
MyDCs were isolated using Miltenyi COle MyDC kit, as per the manufacturer's 
instructions. CD19+ cells were depleted prior to positive selection of CDlc+ 
cells, as a subset of B cells express CDlc. Resulting CDlc+ populations were 
typically >95% pure. 
Naive CD4+ T cells for co-culture experiments were generated by CD4+, 
followed by CD45RA+ positive selection, again using magnetic beads. 
Flow cytometry was used to assess phenotype and activation marker status 
on the MoDCs after 24 hours of culture with Hp at multiplicities of infection of 
0,5, 10, 20 and 50. Antibodies were purchased from Beckman Coulter unless 
otherwise specified: CD14-FITC (AbO Serotec) and CD80-PE or CDllc-PE or 
CD86-PE and HLA-DR-ECD and CD83-PC5 were used for extracellular staining. 
The cells were fixed with 0.5% paraformaldehyde (Biolegend, London, UK) 
and data acquired on an FC500 Flow cytometer (Beckman Coulter). 
Appropriate isotype and minus one controls were used to confirm that 
staining was specific. The data was analyzed using Weasel 2.5 Flow Cytometry 
Software. 
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2.1.2 Co culture of DCs with Hp 
The AB21, AB31, Al0l and 93-67 wild-type Hp strains from our group's 
international strain collection and their isogenic fldupA mutants, previously 
described in Hussein et 01. (Hussein et aI., 2010) were used. Isogenic fleogE 
and fleogEfldupA double mutants were also available for the Hp AB21 strain. 
The Hp strains were grown on DENT Hp-selective plates (containing 
trimethoprim, vancomycin, cefsulodin and amphotericin B). The bacteria were 
suspended in DC culture media and the 00600 used to estimate their 
concentration based on an estimate that an 00 of 1.0 contains 5 X 108 H. 
pylori per mi. 1 x 104 DCs per well were plated in sterile flat-bottomed 96-well 
nunclon delta surface plates (Thermo Scientific). Hp was added at a 
multiplicity of infection (MOl) of 10, except where stated in the initial 
optimization experiments. A dilution series of each bacterial suspension was 
plated out to determine the number of colony forming units (CFUs). E. coli lPS 
(serotype 055:B50)(Sigma) 100ng/ml was used as a control. The DCs and Hp 
were co-cultured for 24 or 48 hours before harvesting supernatants. 
2.1.3 Cytokine ELiSAs to Assess DC Cytokine Secretion 
eBioscience Ready-SET-Go! ELISA kits were used to quantify I l - l ~ , , Il-6, Il-l0, 
Il-12p70 and Il-23 levels in the DC supernatants. Human Il-8 CytoSeeM from 
Biosource was used for Il-8 quantification and ELISA MAXTM HUman Il-12/ll-
23 (p40) (Biolegend) for Il-12p40 quantification. All kits were used as per 
manufacturer's instructions except half volumes of all reagents and samples 
were used. A standard curve (in duplicate), 6 "blank" wells with assay diluents 
instead of sample and wells without streptavidin-peroxidase and secondary 
antibody were included on each plate. Samples were run in duplicate and 
diluted 1:10 for I l - l ~ ~ and Il-23, 1:20 for Il-l0, 1:200 for Il-12p40, 1:400 for Il-
6 and Il-8 and 1:800 for Il-12p70. Plates were read on a microplate reader 
(labSystems iEMS reader MF) at 450 and 595nm and the cytokine 
concentrations calculated using the local standard curve. The limit of 
sensitivity was calculated from the mean + 3 standard deviations of the 
"blank" control wells. Typical sensitivities were I l - l ~ ~ 7.5 pg/ml, Il-6 7.2 pg/ml, 
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IL-8 7.8 pg/ml,IL-l0 3.1 pg/ml, IL-12p40 41.0 pg/ml, IL-12p70 3.7 pg/ml, IL-23 
10.6 pg/ml. Results were adjusted for the number of CFUs. 
2.1.4. Coculture ofT Cells with DC Supernatants and DCs 
DC supernatants were filtered to remove any bacterial debris and added to 
naive C04+ T cells (1 x 105 per well) with anti-C03/anti-C028 Oynabeads® 
(Invitrogen) in sterile 96 well tissue culture plates in RPMI-1640 with 10% 
foetal calf serum, 1% HEPES, 1% sodium pyruvate, 1% nonessential 
aminoacids, 1% L-glutamine + 20llM 2-mercaptoethanol. Supernatants were 
harvested after 5 days and frozen at -80°C until analysis. 
For co-culture of naive C04+ T cells a 1:10 DC to T cell ratio was used in 200 III 
media in sterile 96 well tissue culture plates, as above and supernatants were 
harvested after 5 days. eBioscience Ready-SET-Go! ELISA kits were used to 
quantify IFNy and IL-17 levels in the supernatants. These ELiSAs were run and 
analyzed in the same manner as the ELiSAs described above. Typical 
sensitivities were 45.7 pg/ml for IFNy, 9 pg/ml for IL-17. 
2.2 VOLUNTEERS AND CLINICAL MATERIALS 
The study was approved by Nottingham Research Ethics Committee 2. 
Samples were donated by patients undergoing upper gastrointestinal 
endoscopy at the Queen's Medical Centre Hospital, Nottingham, with 
informed consent. None of the patients had been taking proton pump 
inhibitors in the preceding two weeks, antibiotics in the preceding 4 weeks or 
regular non-steroidal anti-inflammatory drugs. 
Patients donated a blood sample and a series of gastric biopsies: One was 
placed in a rapid urease test (0.5 g urea + 100 III (w/v) phenol red made up to 
10 mls with distilled water) for an early indication of Hp status, one in iso-
sensitest broth (Oxoid, Cambridge, UK)/10% glycerol for isolation and culture 
of Hp, biopsies from the antrum and corpus were placed in formalin for 
histopathology, one biopsy from the antrum was placed in RNAlater (Qiagen, 
Crawley, UK) and 6 further antral biopsies in culture medium (RPMI-1640 with 
L-glutamine, 2% FCS and 1% Antibiotic Antimycotic Solution (Sigma) for 
61 
analysis by flow cytometry. The rapid urease test was considered positive if 
the colour changed within 10 minutes and after this time the biopsy was 
removed from the test solution and frozen in liquid nitrogen for protein 
analysis. Hp DNA was extracted from cultured isolates and peR genotyping 
carried out to ascertain cagA and dupA status, as previously described (Aviles-
Jimenez et aI., 2004, Hussein et aI., 2010). 
2.3 QUANTIFICATION OF GASTRIC CYTOKINE RESPONSES TO 
HP 
2.3.1 ELISA 
For IL-17 ELISA, biopsies were weighed, then homogenized in 250 III sterile 
PBS using a mini pellet pestle (Kimble Kontes, NJ, USA) and centrifuged. 
Supernatants were assayed with eBioscience human IL-17 ELISA Ready-Set-
Go! kit, as per the manufacturer's instructions, with an overnight incubation 
of the samples on the plate to maximize sensitivity. A standard curve and 
controls were included on each plate and plates were read at 450 and 595nm 
on a microplate reader, as above. The results were adjusted for biopsy 
weight. 
2.3.2 Luminex 
2.3.2.1 Kit comparison 
To assess accuracy and determine the lower limit of quantitation of IL-17 and 
IFNy for each kit, single biopsies from each patient were individually thawed 
and immediately disrupted in extraction buffer (A): RPMI-1640 (Sigma, Poole, 
UK) supplemented with 10% (v/v) fetal calf serum (Sigma, Poole, UK) and 
protease inhibitors (cOmplete mini [EDTA-freeJ, Roche, Germany) with a mini 
pellet pestle (Kimble Kontes, NJ, USA) for 2 minutes. After extraction, 
supernatants were obtained by centrifugation at 10,000 x g for 10 minutes at 
4°C. 
9 biopsies each from 3 patients were individually prepared. 50llL of each 
resulting supernatant were combined for each patient (to give a total volume 
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of 450IlL), split into three aliquots (to test with the 3 kits), and spiked with 
151lL of known concentrations of recombinant human IL-17 and IFNy 
(eBioscience) diluted in extraction buffer (A). Cytokine spikes were at final 
concentrations of 0, 0.75, 1.5, 6, 50, 100 and 1000pg/ml. 
Biopsies from a further 4 patients were used for repeatability studies and 
optimization of processing methods. Biopsies were processed using methods 
(1): manually with a mini pellet pestle (Kimble Kontes, NJ, USA) for 2 minutes, 
as above; (2): a proportion of those disrupted by pestle were further 
homogenised by 5-10 repeated passes through a 23G needle and ImL syringe, 
or (3): automatically with a bead-basher (TissueLyser LT, Qiagen), using a 
single 5mm stainless steel bead per sample at 50Hz for 3 minutes, in PBS-
based extraction buffer (B): Phosphate-buffered saline (PBS, pH 7.4, Dulbecco 
A, Oxoid, Cambridge, UK), or (C): PBS supplemented with 2mM Mg2+ (Sigma, 
Poole, UK) and Benzonase® nuclease (25U/mL, Novagen, Germany), each 
supplemented with protease inhibitors, as above. Biopsies from 3 patients 
were disrupted in 600 III extraction buffer and 4 identical aliquots prepared 
from each, which were included at different positions on the same plate, and 
a % coefficient of variation (%CV) calculated for each (mean/SO x 100). For 
tissue preparation comparisons 10 biopsies from 3 patients were spiked prior 
to biopsy disruption at 100pg/mL in the same total volume of extraction 
buffer as 10 paired, unspiked biopsies. Cytokine recovery was adjusted for 
background cytokine concentrations from the unspiked samples, and cytokine 
recovery using the different processing methods was compared. 
Assays were run according to each manufacturer's instructions, with the 
exception that MiIIiPLEX beads were vigorously vortexed rather than using an 
ultrasonic bath. The Versa MAP and BioPLEX kits had non-magnetic beads and 
the MilliPLEX kit magnetic beads. Filter plates and vacuum washing was used 
for all three kits. Standard curves were run in duplicate as provided and 
recommended by each manufacturer but extended down to SO.5 pg/ml to 
assess sensitivity. Data were acquired on a Bio-Plex 200 system and analyzed 
with Bio-Plex Manager 6.0 software (both Bio-Rad (Laboratories), CA, USA). 
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Standards curves were plated in duplicate. Wells with bead counts <37 were 
excluded and points with coefficient of variation >25% were excluded. Lower 
and upper limits of quantitation were automatically calculated by the 
software (using 5 parameter logistic non-linear regression model, after 
excluding points on the standard curve with recovery outside of 80-120% of 
expected). The linear dynamic range (LOR) was defined as the lowest and 
highest standards on the linear part of each standard curve on a log-log plot. 
2.3.2.2 Final Luminex Method 
Samples were individually thawed, and disrupted in 300 III PBS supplemented 
with 2mM Mg2+ (Sigma, Poole, UK), Benzonase® nuclease (25UjmL, Novagen, 
Germany), and protease inhibitors (cOmplete mini [EDTA-free], Roche, 
Germany) on ice, using pellet pestles with a cordless motor for 2 minutes, 
then homogenized by passing through a 200 III filter tip (diameter equivalent 
to 21-22G syringe) at least 20 times. Homogenized samples were left on ice 
for at least 5 minutes (to allow the benzonase to work), then centrifuged at 
10,OOOg for 10 minutes at 4°C, aliquoted into LoBind tubes (Eppendorf) and 
stored at -80°C until analysis. 
Samples were analyzed using MILUPLEX MAP Human Th17 Magnetic Bead 
Panel and MILLIPLEX MAP High Sensitivity Human Cytokine Magnetic Bead 
Panels, as per manufacturer's instructions, using a magnetic block for 
washing. 
Pierce bicinchoninic acid (BCA) (Thermoscientific) was used to assay total 
protein content of an aliquot from each sample and results were adjusted 
accordingly. 
2.4 IL-17 AND RORC2 RT-qPCR 
RNA was extracted using RNeasy Mini Kits (Qiagen, Crawley, UK), as per kit 
instructions. The RNA was treated with Ambion® TURBO™ DNase (Life 
Technologies, Paisley, UK) to remove any contaminating genomic DNA and 
reverse transcribed to cDNA using random primers (Invitrogen) and 
Superscript 1/ (Invitrogen). RT-qPCR was performed on a Rotor-Gene 3000 
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(Corbett Research, Cambridge, UK) using a DyNAmo HS SYBR Green Kit (New 
England BioLabs, Hitchin, UK). Amplification was carried out over 40 cycles of 
15 seconds at 95°C, 30 seconds at 62°C and 30 seconds at 72°e. Samples were 
run in triplicate and no template controls and samples produced without 
reverse transcriptase were included in each run as negative controls and 
melting curve analyses were performed. Results were analyzed according to 
the Pflaffl method (Pfaffl, 2001). Relative gene expression levels were 
determined by normalizing against GAPDH and comparing to a negative 
comparator generated by pooling Hp negative samples. Commercial human 
cDNA (Clontech) was included in all assays as a positive control. Efficiencies 
were as follows: RORC2 1.59, 1L17A 1.95, IFNG 1.95 (kindly analyzed by Dr R 
Ingram) and GAPDH 1.69. 
CommerciallL17A primers were used (Qiagen, Crawley, UK). RORC2 and 
GAPDH primer sequences are shown in Table 2.1 below. 
Gene Forward primer Reverse primer 
RORC2 CAGTCATGAGAACACAAATTG GGAAGAAGCCCTTGCACC 
AAGTG (Burgler et aI., 2009) 
GAPDH CCACATCGCCAGACACCACT GGCAACAATATCCACTTTACCA 
(Walker et GAGT 
aI., 2003) 
Table 2.1 RORC2 and GAPDH primer sequences 
2.5 FLOW CYTOMETRY 
2.5.2 Cell Isolation and Culture 
Blood samples were collected into vacutainer tubes containing EDTA. Blood 
was centrifuged to separate plasma, then layered over Histopaque 1077 
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(Sigma, Poole, UK) to isolate PBMCs, which were washed 3 times, then 
counted and placed in culture medium (RPMI-1640 with 10% FCS, 1% l-
glutamine or IMDM with 10% FCS, 1% l-glutamine) at a final concentration of 
1 x 106/ml for overnight culture. Cells were cultured with medium only 
(unstimulated control), 20 ng/ml phorbol myristate acetate (PMA) and 1 
j..lmol/I ionomycin (positive control), Hp whole cell sonicated antigen, final 
concentration 25 j..lg/ml (a mixture of 6 clinical strains isolated from 
Nottingham patients), tetanus toxoid (National Institute for Biological 
Standards and Control) at 5 lfu/ml or Candida albicans (kindly donated by 
Immunology Department, Nottingham University Hospitals), final 
concentration 1 x lOs/ml. 
Gastric biopsies were rubbed through sterile disposable 100 j..lm cell strainers 
(BD Biosciences, Oxford, UK), washed and resuspended in culture medium 
(IMDM with 10% FCS, 1% l-glutamine). In most cases this yielded <2 x 106 
cells. An unstimulated and a PMA/ionomycin (concentrations as above) 
stimulated sample was set up for each patient. 
PBMC and gastric biopsy samples were stimulated for 16 hours with the 
addition of Brefeldin A (10 j..lg/ml) after 1 hour. 
Some frozen PBMCs were used. They were prepared as above and placed in 
freezing medium (10% dimethyl sulphoxide (Sigma), 50% FCS, and 40% RPMI 
1640), after washing, packaged in polystyrene to slow the rate of temperature 
drop and frozen at -80°C. To use they were rapidly thawed with addition of 
warm cell culture media, taking care to avoid osmotic shock, washed and 
counted (viability 72-88%) then resuspended at 1 x 106/ml for overnight 
incubation as above (Disis et aI., 2006). 
2.5.3 Extracellular and Intracellular Staining 
PBMCs were stained with anti-CD4-PE-Texas red (ECD) (Beckman Coulter, 
High Wycombe, UK), fixed with 0.5% paraformaldehyde (Biolegend), washed, 
permeabilized and stained with anti-CD69-PC5 (Beckman Coulter) or anti-
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CD1s4-PCs (Biolegend), anti-IFNy-FITC (Beckman Coulter) and anti-IL-17-PE 
(eBioscience). 
Gastric biopsies were stained with anti-CD3-PCs, anti-CD4-PE-Texas red (ECD), 
anti-CDB-FITC (a" from Coulter), washed, permeabilized and stained with anti-
IL-17-PE (eBioscience). 
Data were acquired on an FCsOO Flow cytometer (Beckman Coulter). 
Appropriate isotype and minus one controls were used to confirm that 
staining was specific. The data was analyzed using Weasel 2.5 Flow Cytometry 
Software. 
2.6 STATISTICAL ANALYSIS 
Statistical analyses and box-and-whisker plots were prepared using GraphPad 
Prism 5 software. Boxes represent the 25th to 75th centiles, horizontal lines 
within the boxes represent the median and the whiskers depict the 5th and 
95th centiles. Bar charts in Chapter 3 and Figures 4.2 and 4.3 were prepared 
using Microsoft Office Excel 2007. Figure 4.4 was prepared using MINITAB 
release 14 software. 
The Mann-Whitney U-test was used for analysis of unpaired data and the 
Wilcoxon signed rank test for paired sets of data. Kruskal-Wa"is was used 
where there were 3 or more groups. Correlations were tested for using 
Spearman's rank correlation test. A significant difference was taken as p ~ O . O s . .
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3. INFLUENCE OF HP ON DENDRITIC CELLS AND T CELL 
DIFFERENTIATION 
3.1 INTRODUCTION 
3.1.1 Dendritic Cells Present Antigen to T Cells 
Dendritic cells (OCs) have a key role in determining what type ofT helper 
response the host will mount to a pathogen. In order for the adaptive 
immune system to respond to a pathogen, the pathogen must be taken up by 
antigen presenting cells and presented, with co-stimulation to T cells. OCs are 
professional antigen presenting cells adapted for this process. The name DC 
comes from the immature ~ C , , which has highly mobile processes known as 
dendrites and is phagocytic. Antigen is taken up at the site of infection. This 
causes the DC to mature, upregulating MHC class I and II (also known as HLA-
DR) on which it can present antigen to C08+ and C04+ T cells respectively, and 
a number of co-stimulatory surface molecules, such as C083, C080 and C086 
(also known as 87-1 and 87-2) (see Figure 3.1)(Kapsenberg, 2003, Sallusto and 
lanzavecchia, 2002). 
If antigen is presented to a T cell (signal 1) without costimulation (signal 2) the 
T cell may become anergic, leading to tolerance. Upregulation of the 
chemokine receptor CCR7 facilitates trafficking of the DC loaded with antigen 
from the invading pathogen towards its ligands, CCL19 (MIP-3J3) and CCl21 in 
organized lymphoid tissue (Hansson et aL, 2006) where the antigen is 
presented to T cells, along with co-stimulatory signals. Factors including the 
strength of the T cell receptor-antigen interaction, strength of costimulation, 
cytokines and other factors in the local environment and type of antigen 
presenting cell determine which type of cell the naiVe T cell will develop into 
(Kapsenberg, 2003, Shortman and Liu, 2002). 
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Figure 3.1 Naive C04+ T cell stimulation and polarization requires three 
signals from the dendritic cell, adapated from Kapsenberg (Kapsenberg, 
2003). Signal 1 is the presentation of pathogen derived antigen in the context 
of MHC class II. Signal 2 is the co-stimulatory signal, mainly delivered by 
stimulation of CD28 by CD80 and CD86 that are upregulated on the activated 
DC following recognition of pathogen associated molecular patterns (PAMPs) 
by pattern recognition receptors (PRRs). Signal 3 is the polarizing signal, which 
can include cytokines and local tissue factors. CD40 ligand (CD40L) may be 
upregulated on the T cell following signal 1 and 2 and can then interact with 
CD40 on the DC to amplify the signal. 
3.1.2 Uptake of Antigen for T Cell Priming in Hp Infection 
In the intestine antigen can be taken up by specialized epithelial cells, called 
M cells, present in organized lymphoid tissue, such as Peyer's patches. During 
Hp infection small areas of organized lymphoid tissue known as lymphoid 
follicles can develop in the stomach which may act as an inductive site for the 
mucosal immune response. Evidence from studies using mice lacking Peyer's 
patches, however, suggests that these areas in the small intestine are 
important for development of Hp-associated gastritis, lymphocyte 
development and homing (Nagai et aI., 2007, Kiriya et aI., 2007). The coccoid 
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form of Hp is reportedly taken up more efficiently by DCs in Peyer's patches 
and promotes more IL-12 secretion than the helical form of the bacteria 
(Nagai et aI., 2007). Though these studies suggest Peyer's patches may be the 
main inductive site for the immune response to Hp in mice it is not known if 
this is also the case in human Hp infection. 
Staining of mouse intestine demonstrated further villous M cells scattered at 
non-follicle-associated sites in the epithelium (Jang et aI., 2004). DCs can also 
extend their dendrites between epithelial cells to sample the gut lumen 
(Rescigno et aI., 2001). The epithelium maintains its integrity during this 
process, with no change in transepithelial electrical resistance. DCs express 
tight-junction proteins, leading the authors to propose that tight junction-like 
structures are temporarily formed between DCs and epithelial cells (Rescigno 
et aI., 2001). Dendrite extension is regulated by the fractalkine receptor 
(CX3CR1) (Niess et aI., 2005). One report on Hp-infected mice used 
immunohistochemistry and electron microscopy to visualize transepithelial 
DC dendrites in inflammed Hp-infected gastric mucosa (Necchi et aI., 2009). 
Bacterial toxins can damage the epithelial barrier, further facilitating 
interaction between host DCs and the invading bacteria, for example CagA 
can disrupt epithelial apical-junctional complexes (Amieva et aI., 2003). 
Uptake of IgG-bound antigen may occur in an FcRn (neonatal Fc receptor for 
IgG)-dependent manner in the intestine (Yoshida et aI., 2006), but this has not 
been reported for Hp antigens specifically. 
3.1.3 Different Types of Dendritic Cell 
Different types of DCs and their nomenclature can be confusing. Blood is the 
easiest compartment to study in humans but DCs do not become fully mature 
until they meet pathogen associated molecular patterns (PAMPs) and/or 
inflammatory cytokines in tissue when their phenotype radically changes 
(Huang et aI., 2001). DC precursors in blood may be divided into myeloid and 
plasmacytoid subsets. The plasmacytoid subgroup are CDllc-, express the IL-
3 receptor, respond to pathogens with I F N a / ~ ~ production and tend to 
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promote a Th2-biased response (Shortman and Liu, 2002). A consensus 
nomenclature document published in 2010 recommends subdividing the 
myeloid group into CDlc+ and CD141+, a minor, IFN/3 producing subset 
(Ziegler-Heitbrock et aL, 2010). The three groups of blood DCs can be 
differentiated by antibodies to CD303 (BDCA-2) (plasmacytoid), CDlc (BDCA-
1) and CD141 (BDCA-3) (Dzionek et aL, 2000, Ziegler-Heitbrock et aL, 2010) 
(Table 3.1). 
Surface Commercial Antibody Notes 
Type of DC 
markers antibody specificity 
CD11c-, BDCA-2 CD303 IFNa.//3 producers 
Plasmacytoid IL-3R+, Promote Th2 bias 
CD68+ 
CD11c+ BDCA-l CDlc CDlc also expressed 
CD 13+, on a proportion of B 
Myeloid CD33+ cells 
BDCA-3 CD141 Minor subset 
Produce IFN/3 
Table 3.1 Subsets of DC precursors in human blood. 
Tissue DCs phenotypes can vary depending on the organ. The first DC to be 
described was the Langerhans cell in skin with characteristic Birbeck granules. 
In the gastrointestinal tract DCs need to prime a protective response against 
pathogens yet tolerate commensal organisms and food. The intestine has 
been the focus of most gastrointestinal DC research and the vast majority of 
studies have been done in mice. There is a profound lack of data concerning 
human gastrointestinal DCs. A number of different types have been described 
but they can be broadly divided into those that express CDI03 (receptor for E-
cadherin) and those that do not. The CD103+ mesenteric lymph node and 
lamina propria DCs promote Treg differentiation in a TGF/3 and retinoic acid 
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dependent manner (Sun et aL, 2007, Coombes et aL, 2007). DCs express 
aldhla2, a retinal dehydrogenase that can convert retinal into retinoic acid 
(Coombes et aL, 2007). CD103+ intestinal DCs also have retinoic acid 
dependent roles in imprinting T and B cells with a4p7 (ligand MadCAM-l) and 
CCR9 (ligand TECK/CCl2S) to facilitate gut homing (Mora et aL, 2003, Iwata et 
aL, 2004, Johansson-Lindbom et aL, 2005) and in B cell class switching to IgA 
(Mora et aL, 2006). 
3.1.4 Stimulation of Dendritic Cells by Hp 
CS7Bl/6 mice recruited CDllc+ DCs to their gastric mucosa as soon as 6 hours 
after Hp infection and studies with DCs expressing yellow fluorescent protein 
indicate that they move nearer to the epithelial surface (Kao et aL, 2006b, 
Kao et aL, 2010). Dendritic cells (HLA-DR+CDllc+) have been demonstrated 
within the human gastric mucosa and are more numerous in subjects with Hp 
infection (Bimczok et aL, Oertli et aL, 2012). These cells have only been 
characterized in small numbers of patients and there is controversy as to 
whether Hp infection increases activation of DCs in vivo, with conflicting 
results from different groups (see discussion) (Bimczok et aL, Oertli et aL, 
2012). Insufficient co-stimulation may lead to an anergic T cell response and 
could help persistence of infection, but Hp is known to induce a CD4+ T cell 
response, although this is ineffective at clearing the infection. Myeloid (CDlc+) 
DCs were found in gastric mucosal biopsies from Hp-infected but not 
uninfected patients (Khamri et aL, 2010). 
Hp can interact with DCs in a number of different ways. Studies using Myd88-1-
mice indicate that toll-like receptors (TlRs) have a role in alerting DCs to the 
presence of the bacteria, though Hp TlR ligands are less potent than those of 
many other enteric bacteria (lee and Josenhans, 2005, Gewirtz et aL, 2004). 
DCs from Myd88-1- mice upregulated activation markers to a lesser extent and 
produced lower concentrations of Il-12 and Il-6 in response to Hp infection. 
Reduced gastritis and increased colonization densities were found in the 
Myd88-1-mice in vivo, in keeping with a reduced inflammatory response {Rad 
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et aL, 2007). In a study using the H. felis infection model MydSS-I- mice were 
found to have reduced IFNy, IL-17A, IL-22 responses to Hp and reduced 
expression of the antibacterial peptide lipocalin-2, but no significant 
reduction in inflammation scores was found in the null mice (Obonyo et aI., 
2011). Hafsi et al. found that polymyxin B did not significantly alter the IL-12 
response of MoDCs to Hp in vitro, suggesting interaction of Hp LPS with TLR4 
does not make a major contribution (Hafsi et aI., 2004). Conversely Kranzer et 
al. found addition of polymyxin B reduced IL-6 and IL-S secretion (Kranzer et 
aL, 2005). Rad et al. have subsequently identified a number of different 
pathways by which DCs can recognize Hp in a study using a range of TLR 
knockout mice. They report TLR2 to be the most important extracellular TLR, 
triggering an anti-inflammatory response, with DCs from TLR2-1- having an 
abrogated IL-I0 response (Rad et aL, 2009). A TLR2 dependent IL-I0 secretion 
pathway has also been described in murine bone marrow derived dendritic 
cells (BMDCs) (Wang et aL, 2010). Hp upregulated TLR2 expression in murine 
BMDCs more than exposure to E. coli or the gastric pathogen Acinetobacter 
Iwofti, and Hp-stimulated BMDCs were able to convert naiVe T cells into Tregs 
(Zhang et aL, 2010b). However a study using PBMCs suggests a more pro-
inflammatory role for TLR2 in humans as TLR2 stimulation was able to convert 
both na'ive and effector Tregs to Th17 cells (Nyirenda et aL, 2011). The Hp 
neutrophil-activating protein also mediates pro-inflammatory effects on 
human neutrophils and monocytes through TLR2 (Amedei et aL, 2006). 
Different types of DC and pre-DC express different TLRs. PCR studies showed 
that monocytes express TLR 1, 2,4,5, and S, and low level ofTLR6, whereas 
CDllc+ immature DCs expressed predominantly TLR 1, 2 and 3 and 
plasmacytoid pre-DCs showed strong expression of TLR 7 and 9 (Kadowaki et 
aL,2001). 
Gastric DCs internalize Hp (Bimczok et aL), therefore cytosolic Pattern 
Recognition Receptors (PRRs) such as intracellular TLRs and NOD receptors 
could also have a role. TLR9 can bind Hp DNA causing a proinflammatory IL-
12p40 and IL-6 response (Rad et aL, 2009). NODl is known to recognize 
74 
peptidoglycan delivered to gastric epithelial cells by the Hp type IV secretion 
system encoded by the cog pathogenicity island (Viala et aL, 2004) and work 
with gastric epithelial cells lines indicates NODl is an important sensor for 
expression of the antibacterial peptide human p-defensin-2 (Grubman et aL, 
2010, Boughan et aI., 2006). NOD2 stimulation is known to be able to 
promote Il-17 secretion by memory T cells (van Beelen et aI., 2007) but there 
is little in the literature on stimulation of NODl or NOD2 in DCs by Hp. A 
number of sma" studies have looked for associations between NOD2 
mutations and Hp-related disease, with particular interest in gastric 
lymphoma, but the results have been conflicting (Rosenstiel et aI., 2006, Ture-
Ozdemir et aI., 2008) 
A number of other components of Hp can interact with host immune cells to 
influence T cell differentiation. Hp urease upregulated HLA-DR and Il-2R on 
monocytes and increased their production of Il-1P, Il-6, Il-8 and TNFa (Harris 
et aI., 1996). Mice vaccinated with recombinant urease subunit B had an 
enhanced Th17 response (subcutaneous and intranasal routes) with reduced 
Hp colonization (intranasal route only) (Zhang et aI., 2011). The Hp neutrophil-
activating protein induces Il-12 and Il-23 expression and upregulates HLA-DR, 
CD80 and CD86 on monocytes and promotes IFNy producing T cells (Amedei 
et aI., 2006). lPS lewis antigens on Hp are able to bind DC-SIGN (Dendritic 
Cell-Specific Interce"ular adhesion molecule-3-Grabbing Non-integrin) on DCs 
(Appelmelk et aI., 2003), which increases DC Il-l0 production and reduces T 
cell IFNy production (Bergman et aL, 2004). Hp can switch lewis antigen 
expression on and off using translational frameshifting (phase-variable 
expressiont thereby altering the balance of Thl/Th2 cells it induces (Bergman 
et aI., 2004). The Hp plasticity region locusjhp0947-jhp0949, which is 
associated with duodenal ulcer disease, caused increased Il-12 secretion by 
the THP-l cell line (de Jonge et aI., 2004). 
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3.1.5 Dendritic Cell Cytokine Responses to Hp Stimulation 
A number of different models of human Des have been used in in vitro studies 
but the most commonly used in the Hp field, is isolation of CD14+ cells from 
peripheral blood and culture with IL-4 and GM-CSF for 5-6 days to obtain 
immature monocyte derived DCs (MoDCs) (Sallusto and Lanzavecchia, 1994). 
Other models have used CD34+ precursors from umbilical cord blood or bone 
marrow cultured with cytokines (Shortman and Liu, 2002). In an alternative 
strategy described by Randolph et al. blood monocytes are incubated with an 
endothelial cell layer (derived from umbilical vein) over a collagen matrix. The 
cells migrate into the matrix (analogous to cells migrating into tissue), then a 
proportion transmigrate back, said to represent trafficking from the tissue to 
lymph node. No cytokines are required and DCs are obtained in only 2 days 
(Randolph et aL, 1998) but this model has not been widely adopted. 
Leukaemia derived DC cell lines, such as THP-l are available but do not mimic 
DCs in all respects and may develop more macrophage-like features under 
some conditions (Santegoets et aL, 2008). BMDCs are commonly used in 
murine studies. 
The relative balance of IL-12 family cytokines produced by Hp-stimulated DCs 
could indicate whether Hp predominantly primes a Thl or Th17 response. IL-
12 is well established as a pro-Thl cytokine and IL-23 promotes Th17 
expansion and terminal differentiation (McGeachy et aL, 2009). The p40 
subunit, common to IL-12 and IL-23 was produced in much greater amounts 
than IL-12p70 or IL-23 by PBMCs stimulated by Hp. Stimulation using dupA-
deficient Hp mutant strains led to a reduction in secretion of p40, IL-12p70 
and IL-23 (Hussein et aL, 2010). The IL-12p70 response of MoDCs to Hp has 
been studied by a number of groups. Most authors found that Hp-stimulated 
MoDCs produced large amounts of IL-12p70 (Guiney et aL, 2003, Kranzer et 
aL, 2004, Hafsi et aL, 2004, Bimczok et aLl· However others including Khamri 
et al. have found a low IL-12p70 human DC response to Hp. Mitchell et al. 
found very little IL-12p70 production unless CD40L was added (Mitchell et aI., 
2007). In a study using murine BMDCs Hp-stimulated DCs secreted less IL-
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12p70 than DCs stimulated by Acinetobacter Iwolfi and Hp sonicate appeared 
to block IL-12 release by A. Iwoffi stimulated DCs (Kao et aI., 200Gb). Oertli et 
al. found low CD80 and CD8G on DCs from Hp-infected human gastric tissue 
suggesting that DCs in the Hp-infected mucosa may not fully mature and may 
therefore be inefficient at priming pro-inflammatory responses (Oertli et aI., 
2012). 
IL-23 has attracted less interest but was found at higher levels than IL-12p70 
in one study (Khamri et aI., 2010). Confocal microscopy demonstrated co-
localization of IL-23 with CDlc, suggesting it may be produced by myeloid DCs 
(Khamri et aI., 2010). 
IL-8 has been a key cytokine studied in Hp research for many years. It is 
produced in large amounts by epithelial cells upon Hp stimulation and has an 
important role in recruiting neutrophils to the infected mucosa. DCs can also 
produce large amounts of IL-8 in response to Hp (Bimczok et aI., Hafsi et aI., 
2004, Kranzer et aI., 2004, Kranzer et aI., 2005). There was a small but 
significant reduction in IL-8 when PBMCs were stimulated with fldupA 
mutants compared to wild type Hp strains (Hussein et aI., 2010). Hp strains 
with the cagPAI virulence factor are well recognized to induce more IL-8 
secretion by gastric epithelial cells (Sharma et aI., 1995). 
IL-1B and IL-G are both proinflammatory cytokines involved in human Th17 
differentiation (Acosta-Rodriguez et aI., 2007a). IL-G can be produced by Hp-
stimulated MoDCs (Kranzer et aI., 2004, Kranzer et aI., 2005) and gastric DCs 
(Bimczok et al.) but in one study IL-G was secreted by Salmonella-stimulated 
but not Hp-stimulated MoDCs (Guiney et aI., 2003). Other sources of IL-G 
include gastric epithelial cells and macrophages. MoDCs also secrete Il-
lB upon Hp stimulation (Kranzer et aI., 2005). Caspase-l is activated by Hp 
and processes pro-IL-1B to the active form in Hp infected BMDCs (Hitzler et 
aI., 2012b). However MoDCs and macrophages produce much less IL-1B than 
monocytes following stimulation with LPS, TlR2 ligand (Pam3Cys) or 
Staphylococcus epidermidis (Netea et aI., 2009). 
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IL-l0 is a key regulatory cytokine and DC-derived IL-l0 has a role in the 
differentiation ofTrl Tregs (Levings et aL, 2005). IL-lO is secreted by MoDCs 
(Kranzer et aL, 2004, Kranzer et aL, 2005, Mitchell et aL, 2007), BMDCs (Kao 
et aL, 200Gb) and gastric DCs (Bimczok et aL) upon Hp stimulation. Most 
authors have reported IL-l0 levels to be lower than IL-12p70 levels (Guiney et 
aL, 2003, Kranzer et aL, 2004, Kranzer et aL, 2005, Kao et aL, 200Gb) but 
Mitchell et al. found them to be higher (Mitchell et aL, 2007). 
3.1.6 Effect of Hp Virulence Factors on Dendritic Cell Responses 
Two of the best characterized virulence factors of Hp are CagA and VacA. As 
described in section 1.1.5.1, CagA is encoded by one of approximately 30 
genes that make up the cag (cytotoxin-associated gene) pathogenicity island 
(cagPAI). Genes in this region encode a type IV secretion system which 
transfers bacterial proteins, including CagA, into gastric epithelial cells. Here it 
has effects on mUltiple cellular processes including migration, proliferation 
and apoptosis (Blaser and Atherton, 2004). The cagE gene encodes an 
essential part of the type IV secretion system so without it CagA cannot 
mediate its effects. VacA is a polymorphic gene which classically causes 
vacuolation in gastric epithelial cell lines and forms hexameric pores in 
membranes in vitro. It also has some immunosuppressive effects including 
inhibition of antigen presentation (Molinari et aL, 1998) and reduction of T 
cell proliferation (Gebert et aL, 2003). VacA is discussed in detail in section 
1.1.5.2. 
Studies using isogenic cagE virulence factor mutants found that mutation of 
cagE reduced IL-12p70 (Guiney et aL, 2003) and IL-23 (Khamri et aL, 2010) 
secreted by Hp-stimulated MoDCs but a study using 8 wild type strains found 
no effect of cag pathogenicity island or VacA status on cytokine secretion 
(Kranzer et aL, 2005). Andres et al. did not find any significant difference in 
secretion of a panel of cytokines, including IL-12p70, in 20 clinical isolates of 
Hp analyzed by cagA, cagPAI or vacA status. However 
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BMOCs infected with Hp strains deficient in the virulence factors y-glutamyl 
transpeptidase or VacA had increased expression of C080 and increased 
secretion of IL-12p40 (Oertli et aL, 2013). Mice infected with the same Hp 
isogenic mutants had reduced Treg frequencies, lower Hp colonization 
densities and increased Thl and Th17 responses, suggesting that these 
virulence factors are involved in driving Treg responses and immune tolerance 
(Oertli et al., 2013). 
The virulence factor dupA (described in detail in section 1.1.5.3) was only 
described relatively recently (Lu et aL, 2005). It is a virB4 homologue, 
suggesting it may have a role translocating bacterial products into epithelial 
cells, analogous to cagE, but its function has not yet been clarified. 
Monocytes stimulated with dupA deficient mutant Hp strains produced less 
IL-12p40, IL-12p70 and IL-23 than the parental wild-type strain, with small but 
significant differences in IL-8 (Hussein et aL, 2010) suggesting that this 
virulence factor may act on immune cells rather than epithelial cells. No 
studies on the effect of dupA on the response of OCs to Hp have been 
published to date. 
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3.2 AIMS 
i. To establish the balance of Thl/Th17 differentiation promoted by Hp-
stimulated Des. 
ii. To determine the effects of mutation of virulence factors dupA and 
cagE on secretion of a range of cytokines by Hp-stimulated Des. 
iii. To compare responses to Hp using two models for human myeloid 
Des. 
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3.3 RESULTS 
3.3.1 Optimization of Conditions for Co-Culture of Monocyte-
Derived DCs with Hp 
Hp was co-cultured with MoDCs in 96 well plates at a range of multiplicities of 
infection (MOls) and for 2 different durations (24 and 48 hours) to select 
optimal conditions for further experiments. Other authors have used MOls of 
5-20 and 15-48 hour time points in similar studies (Guiney et aL, 2003, 
Kranzer et aL, 2004, Kranzer et aL, 2005, Hafsi et aL, 2004, Mitchell et aL, 
2007, Khamri et aL, 2010, Bimczok et aL, 2010). Concentrations of different 
cytokines may peak at different time points. It was necessary to select a 
suitable time point to assess IL-23 in view of its role in Th17 proliferation and 
maintenance. 
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Figure 3.2 Des produce IL-23 in a dose-dependent manner in response to Hp. 
MoDCs were co-cultured with a range of multiplicities of infection (Mal) of Hp 
or controls (LPS or medium only) and supernatants harvested after 24 and 48 
hours. IL-23 levels were measured by ELISA. Bars represent mean of duplicate 
results for 3 replicate wells and error bars represent standard deviations. 
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The AB31 strain was used as an isogenic dupA mutant of this Hp strain was 
available and the effects of this virulence factor on Hp-primed DC cytokine 
production were to be assessed later. The 26695 strain of Hp was included in 
initial optimization experiments (Figures 3.2 and 3.3), for comparison, as it 
was the strain used in a similar study by Khamri et 01. (Khamri et aI., 2010). 
AB31 and 26695 strains are both cog PAI+, AB31 is dupA+ but 26695 is dupA-. 
LPS from E. coli (serotype 055:B50), also used by Khamri et 01. was included as 
a positive control. 
IL-23 production by MoDCs increased in a dose-dependent manner in 
response to co-culture with Hp strain AB31 (Figure 3.2). Increasing the 
incubation time from 24 to 48 hours did not increase the concentrations of 
cytokine therefore a 24 hour period was used for all subsequent experiments. 
Levels of IL-12p40 and IL-12p70 were measured by ELISA in the same 
supernatants. These cytokines were also produced in a dose-dependent 
manner in response to co-culture with Hp, and in higher concentrations than 
IL-23. Concentrations of IL-12p40 were greatest, followed by IL-12p70, then 
IL-23 (Figure 3.3). 
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Figure 3.3 IL-12p40 and IL-12p70 were also produced in a dose-dependent 
manner in response to Hp, and in greater amounts than IL-23. MoDCs were 
co-cultured with Hp at a range of MOls or controls (lPS and medium only) and 
supernatants harvested at 24 hours. levels of p40, Il-12p70 and Il-23 in the 
supernatants were measured by ELISA. Bars represent mean of duplicate 
results for 3 replicate wells and error bars represent standard deviations. 
lPS provoked much less Il-23, Il-12p70 and p40 (all p<O.OOs) secretion than 
Hp AB31 MOllO. This has been noted previously for Il-12p70 and Il-1/3 by 
other authors using a panel of 8 different strains of Hp (Kranzer et aI., 2004). 
Single TlR agonists such as lPS may not activate DCs fully without additional T 
cell signals, such as CD28 and CD40l binding (Figure 3.1). Pathogens may 
stimulate multiple TlRs, which can act synergistically in the absence of T cells 
(Napolitani et aI., 2005). A further possibility is that the 24 hour t ime point 
was not optimal for lPS-stimulation of the cytokines measured. 
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The 26695 strain of Hp stimulated similar levels of cytokine secretion to the 
AB31 strain (Figures 3.2 and 3.3). 
Flow cytometry was used to assess expression of CD14, to ensure that this 
monocyte marker was no longer present on the Hp-stimulated DCs. The 
expression of activation markers HLA-DR and CD80 in response to co-culture 
with different doses of Hp was assessed to confirm that an MOl of 10 
activated the DCs appropriately (Figure 3.4). 
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Figure 3.4 DC activation markers C080 and HLA-OR increased as the Hp dose increased but there was little change above an MOl of 10. C014 
expression remained low. Immature MoOCs generated by culture of C014+ monocytes with IL-4 and GM-CSF were cultured with Hp for 24 
hours, as above. The cells were stained with fluorochrome conjugated antibodies specific for the surface markers C014, C080 and HLA-OR and 
analyzed by flow cytometry.Unstimulated cells are shown in red on the histograms for comparison, with the Hp-stimulated MoOCs in black. 
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Figure 3.5 DC markers COllc, C083 and C086 also increased following 
incubation with Hp strain AB31 at an MOl of 10. Immature MoOCs generated 
by culture of C014+ monocytes with IL-4 and GM-CSF were cultured with Hp 
for 24 hours, as above. The cells were stained with fluorochrome conjugated 
antibodies specific for the surface markers COllc, C083, C086 and HLA-OR 
and analyzed by f low cytometry. 
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Tube/conditions %C014+ %C080+ %HLA- %COllc %C083 %C086 
OR+ 
None 0.26 30 88.4 92.5 4.38 6.32 
Hp AB31 Mall 0.28 87.5 87.7 
Hp AB31 MOl5 0.29 95.8 93.8 
Hp AB31 MOllO 0.19 90.6 90.6 91 83.4 85.6 
Hp AB31 Mal 20 0.2 93.8 90.9 
Hp AB31 Mal 50 0.13 91 89.8 
Hp 26695 Mal 0.34 85.8 86.2 
10 
LPS 100ng/ml 0.15 89.2 90.1 
Table 3.2 Percentages of MoDe cell surface markers positive after 
stimulation with a range of MO.s of Hp. MoOCs were cultured with Hp (or 
medium only or LPS as controls) for 24 hours, then stained with fluorochrome 
conjugated antibodies. This data is shown in plots in Figures 3.4 and 3.5. 
C014 expression on the OCs was low, as expected, in all conditions (Figure 
3.4, Table 3.2). No significant further increase in HLA-OR or C080 expression 
was seen at MOls greater than 10 (Figure 3.4 and Table 3.2). COllc, C083 and 
C086 also increased following incubation with Hp strain AB31 at an Mal of 10 
(Figure 3.5 and Table 3.2). All subsequent experiments were done with a Mal 
of 10. 
Others in the research group have shown that PBMCs exposed to Hp strains 
deficient in the virulence factor dupA produced less IL-12p40, IL-12p70 and IL-
23. Small but significant differences in IL-8 were levels were also found 
(Hussein et aI., 2010). There are more marked differences between antrallL-8 
responses to dupA+ and dupA- strains in vivo (Lu et aI., 2005), however 
monocytes are not present in the gastric mucosa. Flow cytometry suggested 
88 
that the majority of cytokine producing PBMCs were CD14+ monocytes 
(Hussein et aI., 2010). We hypothesized that DCs could be the source of the 
dupA-induced differences in vivo and therefore cytokine production by 
MoDCs in response to Hp in vitro may be affected by dupA expression. 
3.3.2 Effects of Mutating Virulence Factor Genes dupA and cagE 
on Cytokine Secretion by Hp-Stimulated MoDCs 
Hp strain AB21 is dupA+ and cagPAI+. Isogenic dupA, cagE and a double dupA 
and cagE mutant were available for this strain. It has been reported by Khamri 
et al. that stimulation of MoDCs with an isogenic cagE mutant of Hp strain 84-
183 led to lower concentrations of IL-23 than stimulation with wild type Hp 
84-183. It was therefore desirable to include mutants of both these virulence 
factors in our study so that we could see which was having the greatest effect 
on cytokine secretion. The immature MoDCs were cultured with the different 
strains of Hp or controls in 96 well plates for 24 hours. The supernatants 
were then collected and cytokines analyzed by ELISA. 
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Figure 3.6 MoDes incubated with Hp 
AB21AdupA or AB21AcagE produced 
less IL-12p40, IL-6, IL-12p70, IL-23 and 
IL-IO than those incubated with Hp 
AB21wt. MoDCs from a single donor 
were incubated with Hp strain AB21 or 
its isogenic dupA and/or cagE mutants 
(or LPS or medium only as controls) for 
24 hours. Cytokine levels in 24 hour 
supernatants were measured by ELISA. 
(Graphs shown in order of prevalence of cytokines.) * indicates p<O.OS, ** 
p<O.OOS and *** p<O.OOOS. Bars represent mean of duplicate ELiSAs on 
supernatants from 3 wells, error bars depict standard deviations. 
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Figure 3.7 MoDes produced large amounts of IL-8 but there was no 
significant difference with the dupA mutant or cagE mutant compared to 
wild-type. MoDCs from a single donor were incubated with Hp strain AB21 or 
its isogenic dupA and/or cagE mutants (or LPS or medium only as controls) for 
24 hours. IL-8 levels in 24 hour supernatants were measured by ELISA. Bars 
represent mean of duplicate ELiSAs on supernatants from 3 wells, error bars 
depict standard deviations. 
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Figure 3.8 Low levels of IL-ll3 were produced. These were reduced with 
mutation of cagE compared to wild-type, but not with mutation of dupA. 
MoDCs from a single donor were incubated with Hp strain AB21 or its isogenic 
dupA and/or cagE mutants (or LPS or medium only as controls) for 24 hours. 
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IL-l/3 levels in 24 hour supernatants were measured by ELISA. Bars represent 
mean of duplicate ELiSAs on supernatants from 3 wells, error bars depict 
standard deviations. 
Production of the IL-12 family cytokines IL-12p40, IL-12p70 and IL-23 by 
MoDCs were all significantly reduced when fldupA and/or fleagE strains were 
used (Figure 3.6 a, c and d). The reduction compared to wild-type was more 
pronounced with the fleagE strain compared to the fldupA strain for all three 
cytokines: p40 fleagE 67% of wild-type, p<O.OOOl; fldupA 81%, p=O.OOOl, IL-
12p70 fleagE 26%, p<O.OOOl; fldupA 39%, p=O.0002, IL-23fleagE 48%, 
p=O.OOOl; fldupA 77%, p=O.0035. 
IL-6 and IL-l0 were also significantly reduced with the mutant strains 
compared to wild-type (Figure 3.6 b and e). Again absence of eagE resulted in 
a greater reduction of cytokine secretion than mutation of dupA: IL-6fleagE 
81% of wild-type, p<O.0024; fldupA 91%, p=O.018, IL-l0 fleagE 54%, 
p=O.0002, fldupA 81%, p=O.0038. 
MoDCs produced large amounts of IL-8 in response to HpJ but there was no 
significant reduction when dupA or eagE were mutated (Figure 3.7) 
Low levels of IL-l/3 were produced by MoDCs in response to Hp. The fleagE 
and fleagE fldupA strains caused reduced IL-l/3 secretion compared to the 
wild-type strain, but there was no significant reduction in IL-l/3 secretion with 
the fldupA strain (Figure 3.8). 
The cytokine levels were unexpectedly sometimes higher in the double, dupA 
and eagE mutant than in the single mutants. Cytokine levels were corrected 
for small differences in the colony forming units (CFUs) of the strains, so this 
is difficult to explain. 
To confirm these results the experiment was repeated using MoDCs from 
more donors and a range of Hp strains, including two with and two without 
active dupA types. AB21, AB31, Al0l and 93-67 Hp strains are all eag PAI+, 
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however AB21 and AB31 strains have active dupA secretion systems but A101 
and 93-67 strains do not (Hussein et aI., 2010). 
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Figure 3.9 Effect of dupA and cagE mutations on secretion of IL-12 family 
cytokines by Hp-stimulated MoDes. MoDCs from 6 donors were incubated 
with Hp wild-type strains AB21, AB31, 93-67 and A101 and isogenic dupA and 
cagE mutants for 24 hours. Cytokine levels in 24 hour supernatants were 
measured by ELISA. Bars represent mean of duplicate ELiSAs on supernatants 
from 3 wells, error bars depict standard deviations. Strains AB21 and AB31 
have an active dupA type, but strains 93-67 and AIDI do not. Results are 
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expressed as a percentage of the wild-type parental strain. A) Il-12p70, B) Il-
23, C) p40. * denotes p<O.OS, ** p<O.OOS. 
Mutation of dupA reduced Il-12p70 (l.4-fold, p=O.OlS) and Il-23 (l.4-fold, 
p=O.039) secretion by AB21 Hp-stimulated MoDes, but mutation of cagE had 
a still greater effect reducing Il-12p70 1.S-fold, p=O.013 and Il-23 1.9-fold, 
p=O.0016. Il-12p40 levels were only significantly reduced in the double 
mutant in the AB21 Hp strain background compared to wild-type (1.6 -fold, 
p=O.0023). Mutation of dupA in the AB31 strain background had no significant 
effect on Il-12 family cytokine levels but variation was wide (Figure 3.9). 
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Figure 3.10 Effect of dupA and cagE mutations on secretion of IL-6 and IL-10 
by Hp-stimufated MoDes. MoDCs from 6 donors were incubated with Hp wild 
type strains AB21, AB31, 93-67 and A10l and isogenic dupA and cagE mutants 
for 24 hours. Cytokine levels in 24 hour supernatants were measured by 
ELISA. Bars represent mean of duplicate ELlSAs on supernatants from 3 wells, 
error bars depict standard deviations. Strains AB21 and AB31 have an active 
dupA type, but strains 93-67 and A101 do not. Results are expressed as a 
percentage of the wild-type parental strain. A) IL-6, B) IL-10. 
There were trends towards reduced IL-6 in the AB21 Hp dupA mutant, cagE 
mutant and double mutant, but these did not reach statistical significance. 
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Mutation of dupA and cagE did not have any effect on IL-lO secretion by Hp-
stimulated MoDCs. 
Relative cytokine levels were compared using this data set of cytokine 
measurements in the supernatants of DCs from 6 different donors co-cultured 
for 24 hours with AB21 and AB31 Hp wild-type strains. IL-12p40 was found at 
the highest concentration followed by IL-12p70 (3.5-fold and 2.1-fold lower 
with AB21 and AB31 Hp strains respectively), IL-8, IL-6, IL-23, IL-10 and finally 
IL-1f3. Cytokines concentrations are listed in order of prevalence in Table 3.3 
with their fold difference compared to Il-12p40 in brackets. Il-23 was 11.8-
fold and 14.6-fold lower than IL-12p70 in the AB21 and AB31 Hp co-culture 
supernatants respectively. 
AB21 wt I AB31 wt 
Median cytokine level in pg/ml (fold difference less than 
p40) 
IL-12p40 431746 206401 
Il-12p70 124564 (3.5) 100668 (2.1) 
Il-8 91115 (4.7) 57400 (3.6) 
IL-6 27588 (16) 13471 (15) 
IL-23 10552 (41) 6900 (30) 
Il-lO 1306 (331) 1017 (203) 
IL-l(3 1072 (403) 702 (294) 
Table 3.3 Relative cytokine levels. MoDCs from 6 donors were incubated with 
Hp AB21 and AB31 wild-type strains for 24 hours. Cytokine levels in 24 hour 
supernatants were measured by ELISA. Mean cytokine concentrations for 
each donor were calculated based on duplicate EliSAs on supernatants from 
3 wells. The median of these values for the 6 donors has been included in the 
table with fold difference less than IL-12p40 shown in brackets. , 
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3.3.3 Effects of Hp-Stimulated DC Supernatants on the 
Differentiation of NaIve T Cells 
To determine how the Hp-stimulated MoDCs influenced naive T cell 
differentiation supernatants from MoDCs co-cultured with Hp were cultured 
with naive T cells for 5 days and IFNy and Il-17 were measured in the resulting 
supernatants. Naive T cells were isolated from PBMCs by CD4+ followed by 
CD45RA + positive selection using magnetic beads, as described in section 
2.1.1. The DC supernatants were filtered to remove any residual bacterial 
components. As no antigen presenting cells were present in this system anti-
CD3/CD28 beads were used to provide the appropriate signals to the T cells. 
Wells without T cells and anti-CD3/CD28 were included for each condition to 
exclude the possibility that any IFNy or Il-17 was being produced by the DCs 
themselves in response to the Hp. All of these wells had cytokine levels below 
the limit of sensitivity of the ElISAs used. 
The Hp-stimulated DC supernatants provoked a very strong IFNy response 
(Figure 3.11A) but Il-17 T cell secretion was only just above background levels 
(Figure 3.11B). High concentrations of Il-12, IFNy and Th1 cells could have 
inhibited Th17 differentiation and Il-17 secretion (see section 3.4.3 in 
discussion). 
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Figure 3.111FNy and IL-17 responses upon adding supernatants from Hp-
stimulated MoDes to naive T cells. Supernatants from Hp-stimulated MoDCs 
and anti-CD3/CD28 beads were added to naive T cells (89% CD4+CD45RA +) 
and cultured for 5 days. IFNy and IL-17 in the supernatants was measured by 
ELISA. Bars represent mean concentrations of 4 wells measured in duplicate. 
Error bars represent standard deviations. 
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3.3.4 Stimulation of CDlc+ Myeloid DCs (MyDCs) with Hp: 
Comparison with MoDCs and Effects of the Two DC Subtypes on 
Naive T Cell Differentiation 
MoDCs are convenient to work with and have been used in the majority of 
studies on DC responses to Hp but it is not clear how accurately they reflect 
gastric DCs. CDlc+ DCs have been identified in the Hp-infected gastric mucosa 
(Khamri et aI., 2010). CDlc+ cells can be isolated from peripheral blood and 
used as antigen presenting cells without any in vitro culture with cytokines or 
growth factors. MoDCs and MyDCs were isolated from 3 donors and their IL-
23 and IL-12p70 production after culture with Hp assessed. 
-E 
-en a. 
-(II) 
N 
I 
:::! 
10000 
100 
10 
+0 +4, 
AB31 
Figure 3.12 MyDCs produced less IL-23 than MoDCs. MyDCs isolated by 
positive selection from peripheral blood of 3 donors (typically >95% CDlc+) 
and MoDCs from the same donors were cultured with Hp for 24 hours. IL-23 
levels in the supernatants were determined by ELISA. Each point represents 
the mean IL-23 concentration for a single donor, calculated from duplicate 
ELiSAs performed on supernatants from 3 wells. 
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IL-23 levels were lower in the supernatants of MyDCs incubated with wild-
type Hp strains than MoDCs incubated with the same bacteria but the 
differences did not reach significance (median IL-23 levels in AB21 Hp strain 
MyDC supernatant 25pg/ml vs 2321pg/ml in MoDC supernatant, p=0.25; 
101pg/ml in MyDC supernatant vs 2146pg/ml in MoDC supernatant for AB31 
Hp strain, p=0.25 using Wilcoxon matched-pairs signed rank test). 
No reduction in IL-23 was seen with the dupA or cagE mutants in the MyDC 
supernatants of these 3 donors (data not shown). IL-23 concentrations were 
lower with LPS than with Hp stimulation, as noted previously. In most cases 
IL-23 was undetectable when the DCs were cultured with medium only but 
low levels were detected in the MoDC supernatant of one donor. 
An IL-12p70 ELISA with limit of sensitivity 4.0pg/ml was unable to detect 
cytokine in MyDC supernatants from any of the 3 donors. The MoDC 
supernatants in contrast contained median IL-12p70 levels of 19072pg/ml and 
41932pg/ml following stimulation with Hp AB21 and AB31 strains 
respectively. 
Having shown profound differences in the responses of MoDCs and MyDCs to 
Hp, the impact of this on naive T cell differentiation was examined. MoDCs 
and MyDCs from 3 donors that had been co-cultured with Hp for 24 hours 
were cultured with autologous naive T cells for 5 days and IFNy and IL-17 
levels in the supernatants were measured by ELISA. 
The very low IL-12p70 concentrations in supernatants of MyDC co-cultured 
with Hp led to the hypothesis that co-culture of Hp-primed MyDCs with naive 
T cells would result in reduced Th1 cell differentiation and much lower IFNy 
concentrations. 
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Figure 3.13 Relative cytokine levels produced by naive T cells incubated with 
Hp-stimulated MoDCs and MyDCs for 5 days. A) IFNy, B) Il-17. MoDCs and 
MyDCs from 3 donors that had been exposed to Hp for 24 hours were 
cultured with autologous naive T cells (95% CD4+CD45RA+) for 5 days and 
supernatants collected. IFNy and Il-17 levels were tested by ELISA. Points 
represent the mean cytokine concentration measured in supernatants from a 
single well in duplicate for each donor. Bars denote medians of the 3 donors. 
MyDC and T cell numbers were limiting, so the DCs stimulated with each Hp 
strain were only co-cultured with T cells in a single well for each donor. 
MoDCs tended to produce more IFNy than MyDCs, in keeping with their 
strong Il-12 response, but variation amongst the 3 donor samples was wide 
and the differences did not reach statistical significance (Figure 3.13A). 
However co-culture of Hp-stimulated MyDCs with naive T cells did result in 
substantiallFNy production, despite the lack of detectable Il-12p70 secreted 
by the Hp-stimulated MyDCs. 
low levels of Il-17 were produced by both types of DC. The median Il-17 
levels for Mo- and MyDCs were very similar. T cells from one of the 3 donors 
cultured with AB31 Hp-stimulated MyDC had a strong Il-17 response. (Figure 
3.13B). 
IFNy levels were higher than Il-17 levels for T cells stimulated by both types of 
Hp-primed DCs but the differences were not statistically significant. The 
difference was more marked in the MoDCs due to the strong IFNy response to 
AB31 Hp-stimulated MoDC supernatants. 
No consistent reduction in IFNy or Il-17 was found with T cells that had been 
stimulated by DCs previously exposed to Hp strains with mutated dupA or 
cagE (data not shown). 
Thank you to Qunwei Wang and Dr Hester Franks, Academic Unit of Clinical 
Oncology, University of Nottingham for their help with DC preparation and to 
Dr Chistian Marx, Helle Skjoldmose and Benoit Biousse who performed some 
of the cytokine ELlSAs from which data are presented in this chapter. 
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3.4 DISCUSSION 
3.4.1 Optimization of Conditions for Co-Culture of Monocyte-
Derived DCs with Hp 
The MoDC model was used initially as it is well recognized and has been the 
main published strategy used to study the human DC response to Hp. 
IL-23 levels were lower at 48 hours compared to 24 hours (Figure 3.2) in line 
with Khamri et al.'s findings that Hp-induced IL-23 secretion peaked at 24 
hours (Khamri et aL, 2010). There was no significant increase in IL-12p70, p40 
or IL-I0 at 48 hours compared to 24 hours either (data not shown). 24 hours 
was therefore selected as an appropriate duration for which to incubate Hp 
with the DCs for subsequent experiments. 
The dose-dependent production of cytokines by MoDCs in response to Hp 
was in keeping with the findings of others (Kranzer et aL, 2004, Bimczok et 
aLl. Cytokine production increased up to the maximum Mal of 50, however, 
an Mal of 10 was selected for subsequent experiments to provide a more 
physiologically relevant dose. Activation markers did not increase further with 
higher MOls (Figure 3.4 and Table 3.2). Cell death has been reported at MOls 
greater than 10 (Kranzer et aL, 2004). This Mal is thought to approximate 
levels of infection in viva and has been used by a number of authors in similar 
studies (Khamri et aL, 2010, Kranzer et aL, 2004, Kranzer et aL, 2005, Guiney 
et aL, 2003). 
Hp 26695 was included in the initial optimization experiments (Figures 3.2 
and 3.3), for comparison, as it was the strain used in a similar study by Khamri 
et al. It stimulated similar levels of cytokine secretion to the AB31 strain 
(Figures 3.2 and 3.3). Kranzer et al. measured levels of 6 different cytokines 
released by MoDCs from one donor stimulated by 8 different strains of Hp 
and found little strain to strain variation (Kranzer et aL, 2005). However, 
others have reported differences in activation marker expression and 
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cytokine production in response to different strains (Hansson et aL, 2006, 
Andres et aL, 2011). The levels of cytokines produced by Hp-stimulated DCs 
vary widely between different studies. This is likely to be due to a 
combination of factors including different Hp strains and MOls, different 
methods for isolating CD14+ cells, maturing them into DCs and concentrations 
for plating them and different time points. The purity of recombinant IL-4 and 
GM-CSF used may also be critical and can vary from batch to batch. 
The relative levels of IL-12 family members secreted by Hp-stimulated MoDCs 
are depicted in Figure 3.3. Concentrations of IL-12p40, IL-12p70 and IL-23 but 
not IL-12p35 were measured. Others have taken a similar approach (Fehlings 
et aL, 2012, Hussein et aL, 2010). However IL-12p35 ELiSAs are commercially 
available so direct measurement of IL-12p35 could be included in future 
studies. The p40 subunit was by far the most prevalent, to the extent that 
more of this was secreted than IL-12p70 and IL-23 combined. This is in 
keeping with previous findings that IL-12p40 is found in excess of p70 when 
monocytes are stimulated with E.coli LPS (Snijders et aL, 1996). Whereas IL-
12p35 is only secreted as part of IL-12p70, IL-12p40 can be secreted alone 
(Snijders et aL, 1996). The excess IL-12p40 may be present as monomers, 
homodimers, or with a subunit which has not yet been described. 
The role of IL-12p40 monomers and homodimers is not entirely clear. Levels 
of both IL-12p40 monomer and homodimer increased in the serum of 
C57BL/6 mice after injection of salmonella LPS. Mice treated with p40 
homodimer had reduced IFNy responses to endotoxin (Heinzel et aL, 1997), 
suggesting an inhibitory or blocking role for the homodimer. Studies using 
human cell lines also supported an antagonist role for IL-12p40 homodimers, 
which blocked IL-12 binding in vitro (Ling et aL, 1995). Homodimers of IL-
12p40 may have different effects on different cell populations as they were 
reported to reduce IFNy production by CD4+ splenocytes but increase IFNy 
production from the CD8+ splenocytes (Piccotti et aI., 1997). IL-12p40 levels 
are increased in the CNS of patients with multiple sclerosis (Fassbender et aI., 
1998) and mice with EAE (Bright et aL, 1998). The IL-12p40 homodimer has 
proinflammatory effects on microglia and macrophages including increasing 
induction of nitric oxide synthase (Pahan et aL, 2001, Jana et aL, 2009), TNFa 
(Jana et aL, 2003) and Iymphotoxin-a (Jana and Pahan, 2009) and increases 
NF-KB activation in the BV-2 cell line (Pahan et aL, 2001). The Il-12p40 
homodimer also has a role in macrophage chemotaxis (Russell et aL, 2003). 
Becker et 01. studied 1L128 (p40 gene) expression in various tissues using 
transgenic mice expressing firefly luciferase under control of the 1L128 
promoter and found constitutive 1L128 expression in CD11c+ lamina propria 
DCs in the terminal ileum (Becker et aL, 2003). Unfortunately stomach was 
not included in their panel of tissues. 
The predominance of Il-12p70 over Il-23 suggests that Hp-stimulated DCs are 
likely to be pro-Thl rather than pro-Th17. However, these findings are 
discrepant with the relative cytokine levels found in snap frozen human 
gastric biopsies (Figure 5.10). This might suggest that cells other than DCs 
present in the gastric mucosa produce Il-23, or that the in vitro MoDC model 
used here does not reflect gastric DCs (discussed further in chapter 5). 
Phenotyping of Hp-stimulated MoDCs demonstrated <0.5% CD14+ and >90% 
HLA-DR+ and CD11c+, consistent with a mature MoDC cell type. The activation 
markers CD80, CD83 and CD86 were present on >80% Hp-stimulated cells 
after 24 hours, confirming Hp as a strong inducer of DC activation/maturation. 
The percentage of CDllc+ cells in Table 3.2 do not increase with Hp 
stimulation, but this is misleading as the Mean Fluorescence Intensity (MFI) 
does increase but the cut-off has been chosen based on the two populations 
in the unstimulated sample {Figure 3.5}. 
Other authors have also noted increased activation of human MoDCs 
following stimulation with Hp in vitro. In keeping with the findings here 
Andres et 01. found increased CD80 and CD86 after 24 hours of stimulation 
with Hp MOllO (Andres et aL, 2011), but most investigators have used longer 
incubations with Hp. Kranzer et 01. found increased CD80, CD83, CD86 and 
HlA-DR expression on DCs at 72 hours {Kranzer et aL, 2004, Kranzer et aL, 
2005). Hansson et al. and Hafsi et al. found increased HLA-oR, C080 and C086 
and Hafsi et al. also reported increased C083 after 48 hours (Hansson et aL, 
2006, Hafsi et aL, 2004). Mitchell et al. also noted increased C040 and CCR7 
at 48 hours upon stimulation of Moocs with paraformaldehyde fixed Hp 
(Mitchell et aL, 2007). Some authors have reported MFls rather than 
percentages of cells positive for activation markers (Kranzer et aL, 2004, 
Mitchell et aL, 2007) but Bimczok et al.'s findings on oCs from human gastric 
tissue were similar to our own with HLA-oR+Collc+ MooCs having >80% 
C080, C083 and C086 after Hp stimulation, though they found very high C086 
expression in their unstimulated controls (Bimczok et aL). Studies using 
mouse BMocs have noted similar upregulation of C080, C086 in response to 
Hp stimulation (Rad et aL, 2007). 
As mentioned above, there is controversy as to whether Hp increases DC 
activation in vivo. Bimczok et al. found increased COlle, C083 and C086 on 
gastric oCs from infected patients compared to uninfected controls, although 
the percentages of these markers were much lower than those found on 
MooCs stimulated with Hp in vitro in the same study (Bimczok et aL). Oertli et 
al. found little or no C080, C083 or C086 on gastric oCs with no difference 
between the infected and uninfected groups. They argue that this may lead to 
tolerance and facilitate persistence of the infection but unfortunately no 
mechanistic experiments were carried out (Oertli et aL, 2012). Both studies 
were small with only 3-4 patients each in the infected and uninfected group. 
3.4.2 Effects of Mutating Virulence Factor Genes dupA and cagE 
on Cytokine Secretion by Hp-Stimulated MoDCs 
Guiney et al. found reduced IL-12p70 secretion by MooCs stimulated by Hp 
with mutated cagE (Guiney et aL, 2003). Galgani et al. were in agreement that 
IL-12 secretion by MooCs was reduced with an isogenic cagE mutant and also 
found reduced levels of IL-1 and TNFa (Galgani et aL, 2004). Khamri et al. 
found reduced IL-23 and a trend towards reduced I L - 1 ~ ~ secretion from 
MooCs stimulated with the isogenic cagE mutant and reduced IL-17 secretion 
by autologous CD4+ T cells stimulated co-cultured with DCs primed with the 
isogenic cagE mutant compared to the wild-type Hp strain (Khamri et aL, 
2010). However, Kranzer et al. did not find any effect of cag or vacA status on 
MoDC cytokine secretion or activation marker expression with their panel of 8 
different wild type strains of Hp with a range of different virulence factor 
genotypes (Kranzer et aL, 2005). Andres et al. did not find any significant 
difference in Il-12p70, TNF-a, Il-6 or I l - 1 ~ ~ secretion by MoDCs stimulated 
with 20 different clinical isolates of Hp analyzed according to cagA, cagPAI, 
vacA or babA status, though trends were observed for Il-12p70 and cagPAI 
(Andres et aL, 2011). Recent studies by Oertli et al. using Hp strains deficient 
in y-glutamyl transpeptidase and VacA expression to infect murine BMDCs in 
vitro and mice in vivo suggest that these virulence factors contribute to 
generating tolerogenic DCs that promote Treg generation (Oertli et aL, 2013). 
No data has yet been published on the effect of mutating dupA on the DC 
response to Hp. 
Production of a panel of 8 different cytokines in response to Hp strain AB21 
and its isogenic dupA, cagE and double mutants by MoDCs were initially 
studied in a single donor. The AB21 strain was used for this work as the full 
panel of isogenic mutants was available. Cytokine secretion was reduced in 
both the dupA and cagE mutants for Il-12p70, Il-23, p40, Il-6 and Il-10, but 
the effects were more marked with mutation of cagE. For I l - 1 ~ ~ only cagE 
mutation had a significant effect on cytokine levels. Neither mutation reduced 
levels of Il-8 secreted by MoDCs, though strains with the cagPAI are known to 
cause increased Il-8 secretion by gastric epithelial cells via NF-KB (Sharma et 
aL, 1998, Yamaoka et aL, 1998). To confirm these results MoDCs from 5 
further donors were tested and the panel of Hp strains expanded to include 
another strain with the more active form of dupA, dupAl (AB31) and 2 strains 
with the less active dupA2 (93-67 and A101). Wide variation was seen 
between absolute levels of cytokines produced by individual donors (Figures 
3.9 and 3.10), as has been noted by other authors (Kranzer et aL, 2004, 
Andres et aI., 2011). Il-12p70 and Il-23 secretion was reduced with all the 
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AB21 mutants, though the cagE mutant had a more marked effect than the 
dupA mutant, but mutation of dupA on the AB31 background did not have 
any effect on levels of cytokines secreted by the Hp-stimulated MoDCs (Figure 
3.9). This raises the question whether this is an AB21 strain-specific effect or 
whether the same phenomenon will occur in other Hp strains with active 
dupA secretion systems. However subsequent work has suggested that the 
IIAB31 dupA mutant" may not be a true isogenic mutant. The effect of 
mutating dupA in the AB31 strain should be reassessed with recently 
sequenced and confirmed strains. No reductions in cytokine secretion with 
mutation of dupA were seen in strains Hp 93-67 or Hp A10l, which was 
expected as these strains do not have a functional dupA genotype (Hussein et 
al.,2010). 
When results of the 6 donors were combined, mutation of dupA and/or cagE 
no longer had any significant effect on the levels of IL-6 and IL-10 produced in 
response to Hp. This highlights the technical difficulties of these experiments 
and the importance of ensuring that results are reproducible using cells from 
multiple donors. 
The Hp strains were grown on DENT Hp-selective plates (which contain 
trimethoprim, vancomycin, cefsulodin and amphotericin B) to minimize the 
chance of contamination and taken out of the freezer a few days before the 
experiment to try to encourage consistent growth and viability. Hp has 
modified PAMPs which are less potent stimuli than those of many other 
bacteria (Lee and Josenhans, 2005, Gewirtz et aI., 2004) and is known to 
stimulate less cytokine production from MoDCs than Salmonella enterica and 
E. coli (Guiney et aI., 2003, Hafsi et aI., 2004) and less cytokine production 
from murine BMDCs than Acinetobacter Iwo//i or E. coli (Kao et aI., 2006b). It 
is therefore likely that small numbers of contaminating bacteria could have a 
highly significant effect on the total cytokine levels in a well. 
The amount of Hp required for a particular MOl was calculated using the 
optical density method, which is widely used to determine bacterial 
concentration (Kranzer et aL, 2005, Mitchell et aL, 2007, Khamri et aL, 2010, 
Bimczok et aL, 2010). The Hp preparation was also plated out at a range of 
dilutions so that the actual number of CFUs could be determined. Results 
were adjusted for CFUs in order to allow fair comparison between different 
strains and mutants. 
Mutation of dupA appears to have a more marked effect on cytokine 
secretion by Hp-stimulated monocytes than on cytokine secretion by Hp-
stimulated DCs in vitro (Hussein et aL, 2010). This may be at least partly due 
to different expression of PRRs, such as TLRs by these different cell types. 
Monocytes express higher levels of TLR 2, 4, 5 and 8 mRNA than CDllc+ 
immature DCs (Kadowaki et aL, 2001). In keeping with these findings 
differentiation of monocytes into DCs leads to loss of their ability to secrete 
I L - l ~ ~ in response to TLR2 ligand (Pam3Cys), LPS and S. epidermidis (Netea et 
aL, 2009). However, monocytes are more susceptible to Hp-induced apoptosis 
than DCs (Galgani et aL, 2004). Macrophages, unlike monocytes, are present 
in the Hp infected stomach (Quiding-Jarbrink et aL, 2010). Monocyte-derived 
macrophages have similar TLR2 and 5 expression and higher TLR4 expression 
compared to monocytes (O'Mahony et aL, 2008). It is possible that they could 
be the dupA responsive link in vivo. 
Other cytokines may be relevant in addition to the the cytokines measured 
here. T G F - ~ ~ is important for both Th17 and Treg differentiation (Bettelli et aL, 
2006) and three isoforms are expressed in mammals: T G F - ~ l , , T G F - ~ 2 2 and 
T G F - ~ 3 3 (Massague, 1990, Bandyopadhyay and Raghavan, 2009, Ribeiro et aL, 
1999). However T G F - ~ ~ is synthesized and secreted in a pro-form in which it is 
covalently associated with latency associated peptide (LAP) (Massague, 1990, 
Bandyopadhyay and Raghavan, 2009), therefore though T G F - ~ ~ is very widely 
expressed at the mRNA level this may not reflect its biological activity. 
Activated circulating T G F - ~ ~ has a very short half-life (Massague, 1990). Acid 
activation is used to release active T G F - ~ ~ from its latent complex when T G F - ~ ~
is measured by ELISA but whether this reflect levels biological activity in vivo 
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is unclear. Concentrations of LAP may provide a surrogate measure of TGF-f3 
activity as release from the LAP-TGF-f3 complex is known to be a key point in 
regulation of TGF-f3 activity (Ribeiro et aL, 1999). IL-18 is increased in human 
Hp-infected gastric mucosa (Yamauchi et aL, 2008) and IL-18 from Hp-
stimulated DCs promotes Treg differentiation (Oertli et aL, 2012). IL-27 
induces Trl Tregs but inhibits Th17 differentiation (Awasthi et aL, 2007, 
Batten et aL, 2006). Though this study has focussed on measurement of DC 
cytokines and activation markers gene expression profiling of murine BMDCs 
showed induction of a wide range of cytokines and proinflammatory genes 
following Hp exposure, including enzymes involved in prostaglandin and nitric 
oxide synthesis and a number of chemokines, suggesting that DCs may have a 
role in recruiting immune cells to the site of infection as well as in their 
differentiation (Rad et aL, 2007). 
3.4.3 Effects of Hp-Stimulated DC Supernatants on Naive T Cell 
Differentiation 
Adding DC supernatants to naive T cells avoids the need to bleed the donor 
twice to obtain the naive T cells after the CD14+ cells have had 5-6 days to 
develop into immature MoDCs. Artificial CD3 and CD28 stimulation is required 
in the absence of antigen presenting cells. It was important to exclude IL-4 
(used with GM-CSF to generate immature MoDCs from CD14+ monocytes) 
from the medium when the DCs were co-cultured with Hp to avoid any 
skewing of T cell differentiation. There was a very strong IFNy response from 
the T cells (necessitating 1 in 8000 dilution to quantitate it by ELISA), with a 
weak IL-17 response, only just above background (Figure 3.11). During early 
experiments characterizing Th17 as a separate lineage it was noted that IL-12 
suppressed IL-17 production (Aggarwal et aL, 2003, Hoeve et aL, 2006, 
Annunziato et aL, 2007). IFNy was also shown to reduced Th17 differentiation 
and IL-17 secretion (Park et aL, 2005, Harrington et aL, 2005). More recently 
T-bet was found to inhibit Th17 differentiation via prevention of Runxl-
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mediated RORyt activity leading to reduced IL-17 production in the absence of 
T-bet (Lazarevic et aL, 2011). 
The naive T cells used were purified by positive CD4+ and CD45RA + selection 
but were only 89% pure, raising the possibility that a small fraction of 
contaminating cells (e.g. CD8+ T cells, CD4+CD45RA- or NK cells) could have 
contributed to the high levels of IFNy. Purer naive T cell populations (95% 
CD4+CD45RA+) were obtained for later DC:T cell co-culture experiments 
(Figure 3.13). 
Anti-CD3/CD28 T cell stimulating beads seemed to exaggerate the 
IFNy response, when compared with the response following co-culture with 
Hp-stimulated DCs directly, but the IL-17 response was of similar magnitude 
with the two different methods (Figures 3.11 and 3.13). However these were 
separate experiments with cells from different donors so it is difficult to draw 
any firm conclusions. 
Other authors have co-cultured autologous naive T cells of varying degrees of 
purity with Hp-pulsed MoDCs and measured IFNy production. Hafsi et a/. 
stimulated a more than 80% CD4+CD45RA+ T cell population with Hp-pulsed 
DCs and found IFNy secretion, which was increased with a membrane 
preparation of Hp compared to cytosolic preparation or whole bacteria (Hafsi 
et aL, 2004). There was an associated increase in TBX21 (gene encoding T-bet) 
expression and reciprocal decrease in GATA3 expression. NK cells incubated 
with Hp secreted larger amounts of IFNy than the T cell population, though 
there was no increase in their cytotoxic activity (Hafsi et aL, 2004). Mitchell et 
a/. found naive T cells (negatively selected, purity not stated) incubated with 
Hp-primed DCs for 48 hours produced less IFNy than those stimulated for 8 
hours. This was in keeping with their findings of reduced IL-12 production by 
MoDCs at the longer time point (Mitchell et aL, 2007). Bimczok et a/. pulsed 
MoDCs and gastric HLA-DR+ DCs with Hp for 2 hours, then cultured the DCs 
with autologous CD4+ T cells (total, not naive) for 3 days. ELiSAs on the 
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supernatants showed low levels of IL-lO and high levels of IFNy, which were 
similar for the MoDCs and gastric DCs (Bimczok et aL). 
Khamri et al. cultured Hp-stimulated MoDCs with autologous negatively 
selected naive CD4+ T cells for 5 days and found increased CD3+IL-17+ cells 
compared to co-culture with unstimulated MoDCs (Khamri et aL, 2010). 
CD4+IFNy+ cells were also found after culture of the naive CD4+ T cells with 
Hp-stimulated MoDCs but the relative levels of Th17 and Thl responses were 
not compared at cellular or cytokine level (Khamri et aL, 2010). 
DeLyria et al. cultured Hp-pulsed antigen presenting cells from Hp-infected 
mice with spleen-derived CD4+ T cells and found higher levels of IL-17 than 
IFNy in the supernatants by ELISA (DeLyria et aL, 2009). 
3.4.4 Stimulation of Myeloid DCs (MyDCs) with Hp: Comparison 
with MoDCs and Effects of the Two DC Subtypes on Naive T Cell 
Differentiation 
The CDlc+ MyDCs produced low levels of Il-23 in response to Hp compared to 
MoDCs (Figure 3.12) and no IL-12p70 was could be detected. Bimczok et al. 
reported a lack of IL-12p70 response by human gastric tissue DCs stimulated 
with Hp, and a corresponding lack of 1L12A and 1L128 mRNA by RT-qPCR 
(Bimczok et aL). In the same study MoDCs did secrete IL-12p70 in response to 
Hp. This suggests that MyDCs may be a better model for gastric DCs than 
MoDCs. Murine BMDCs also failed to produce IL-12p70 in response to Hp in 
one study (Wang et aL, 2010), though others have found that BMDCs do 
secrete IL-12p70 in response to Hp, although at lower levels than when 
stimulated with E.coli lPS (Rad et aL, 2007) or A. Iwof/i (Kao et aL, 200Gb). 
Autologous naive T cells stimulated by Hp-primed MoDCs tended to produce 
more IFNy than those stimulated by Hp-primed MyDCs, especially when the 
AB31 Hp strain was used (Figure 3.13A) but the differences were not 
statistically significant, probably due to low donor numbers. The median 
levels of Il-17 produced by T cells stimulated by the different types of DC 
were almost identical (Figure 3.13B). The T cells cultured with Hp-stimulated 
MyDCs made a substantiallFNy response despite the lack of IL-12p70 
production by the MyDCs. CD4+ T cells cultured with Hp-stimulated gastric 
DCs (which did not produce IL-12p70) also produced a large IFNy response 
(Bimczok et aL). In this paper total rather than naive CD4+ T cells were used, 
so it is likely some already Th1-differentiated CD4+ T cells were present. The 
authors postulate a role for DC-derived macrophage migration inhibitory 
factor (MIF) in Th1 differentiation (Bimczok et aL). MIF expression is increased 
in the gastric epithelium, T cells and macrophages in Hp infection and may 
have a role in the development of gastric cancer (He et aL, 2006). MIF 
knockout mice had reduced IFNy, reduced T-bet expression and reduced 
gastritis at 8 weeks (Wong et aL, 2009). However, MIF secretion from MoDCs 
was reported to decrease following Hp stimulation (Fehlings et aL, 2012). 
IL-23 levels measured in the gastric mucosa using Luminex were much higher 
than IL-12p70 levels (Chapter 5 section 5.3.4). Whole gastric biopsies are 
homogenized for this method so this suggests that there may be another 
source of IL-23 within the gastric mucosa. 
Other antigen presenting cells may also have a role. Macrophages are 
broadly divided into M1 macro phages, which are proinflammatory and 
microbicidal and M2 macrophages which have a role in resolution of 
inflammation and secrete IL-10 (Benoit et aL, 2008). Markers of both M1 and 
M2 macrophages are increased in the gastric mucosa of Hp-infected patients 
(Quiding-Jarbrink et aL, 2010). 
Fehlings et al. compared the response of human blood-derived monocytes, 
MoDCs and macrophages to Hp. Surprisingly they did not detect any IL-12p70 
secretion by monocytes in response to Hp, though they did find IL-12p40 and 
IL-23. IL-12p70 was secreted by MoDCs, but at lower levels than IL-23 
(Fehlings et aL, 2012) - opposite to my findings. This may reflect differences in 
the protocols used, for example Fehlings et al. pulsed the antigen presenting 
cells for only an hour whereas in this study Hp was co-cultured with DCs for 
24 hours. Levels of IL-12p40 secreted by monocytes were approximately 100-
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fold lower than those secreted by MoDCs, suggesting monocytes are not a 
major source of IL-12 family cytokines (Fehlings et aL, 2012, Hussein et aL, 
2010). M1 macrophages produced pro-inflammatory cytokines including IL-
12p40, IL-23, IL-12p70 Oust detectable), I L - 1 ~ , , IL-6 and low levels of IL-10. M2 
macrophages produced IL-10 and low levels of proinflammatory cytokines, as 
expected (Fehlings et aL, 2012). 
DeLyria et al. cultured Hp-pulsed bone marrow-derived antigen presenting 
cells from Hp-infected mice with CD4+ T cells and found that both IL-17 and 
IFNy production were approximately halved if macrophages were used 
compared to DCs (DeLyria et aL, 2009). Zhuang et al. also showed 
upregulation of T-bet and RORyt in murine splenic CD4+ T cells with increased 
IFNy and IL-17 secretion following incubation with Hp-infected macrophages 
(Zhuang et aLl. 
Other cells present in the stomach, but not present in our in vitro model, such 
as epithelial cells, may have important effects on DCs and T cell 
differentiation. Thymic Stromal Lymphopoietin (TSLP) secreted by epithelial 
cells can inhibit IL-12 secretion and promote Th2 responses (Rimoldi et aL, 
2005). Gastric epithelial cells secrete increased levels of TSLP, the chemokine 
CCL20 (MIP3a) and B cell activating factors (BAFF, also known as BLyS) upon 
exposure to Hp (Kido et aL, 2010). Somatostatin, a peptide hormone secreted 
in the stomach, inhibited Hp-induced IL-12 secretion when added to BMDCs 
(Kao et aL, 2006a). COX-2 and prostaglandin E2 are upregulated by Hp in 
human PBMCs and gastric biopsies (Meyer et aL, 2003, Pellicano et aL, 2007). 
Exogenous prostaglandin E2 suppressed PBMC IL-12 and IFNy responses and 
inhibition of COX-2 increased T-bet, IL-12 and IFNy protein (Meyer et aL, 
2003, Pellicano et aL, 2007). Bimczok et al. showed that gastric stromal 
factors could suppress DC-driven Th1 differentiation but this did not appear 
to be due to T G F ~ , , prostaglandin E2, IL-10 or TSLP (Bimczok et aL, 2011). 
In addition to its homing, imprinting and class-switching effects on DCs 
described in the introduction, the vitamin A metabolite retinoic acid favours 
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Treg differentiation at the expense of ThI7 differentiation (Mucida et aL, 
2007). Balance of Treg/Thl7 differentiation may also be affected by 
availability of AhR ligands (Quintana et aL, 2008). Endogenous ATP release by 
monocytes enables them to secrete IL-113 in response to TLR2 or TLR4 
whereas macrophages needed additional exogenous ATP to do so (Netea et 
aL, 2009). ATP produced by commensal bacteria can drive ThI7 
differentiation in the lamina propria (Atarashi et aL, 2008). Commensal 
bacteria may promote peripheral Treg development and shape the repertoire 
of Tregs in the gut as many colonic Tregs had T cell receptor specificities for 
antigens of commensal bacteria that were not found in other tissues (Lathrop 
et aL, 2011). Co-infection models have shown that Hp infection can modulate 
the immune response to intestinal infection and vice versa (Fox et aL, 2000). 
In addition to differentiation of naive CD4+T cells the gastric environment 
may also alter the phenotype of T helper cells recruited to the stomach, as T 
helper cells have some plasticity. For example mouse and human Tregs can be 
induced to become IL-17 producers in proinflammatory environments in vitro 
(Xu et aL, 2007, Koenen et aL, 2008, Nyirenda et aL, 2011) and ThI7 cells can 
take on Thl characteristics in vivo (Bending et aL, 2009, Shi et al., 2008). 
All this complexity makes it difficult to model DCs in the human stomach. 
Mouse models have the advantages of a complete in vivo system with 
multiple cell types present in the stomach. However there are differences in T 
cell differentiation between mice and humans (reviewed in (Laurence and 
O'Shea, 2007)) and even the commensal bacteria present may affect these 
processes, which may cause differences in mice from different animal houses, 
as well as between mice and humans. Gastric DCs are the ideal choice as the 
basis of an in vitro human model system, but are difficult to obtain as large 
surgical resections of gastric tissue are needed to extract sufficient numbers 
of cells. The results presented here suggest that CDIc+ MyDCs may be a 
better model of gastric DCs than the more commonly used MoDCs. CDIc+ DCs 
can be isolated from blood. Larger volumes of blood are required than for 
extraction of CD14+ cells for development of MoDCs but once extracted the 
CD1c+ DCs are ready to use. 
In this chapter human DCs produced IL-23 in response to Hp, with maximal 
responses when dupA+ and cage strains were used, and this in turn led to 
Th17 differentiation. Next PBMCs from Hp-infected patients and uninfected 
controls were stimulated with Hp or control antigen (tetanus) to assess 
whether Hp infection results in a systemic Hp-specific Th17 response in vivo, 
as described in the next chapter. 
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4. PERIPHERAL BLOOD TH17. TH1 AND TREG RESPONSES 
TOHP 
4.1 INTRODUCTION 
Though the site of Hp infection is the stomach, changes have also been 
demonstrated in the peripheral blood of Hp-infected patients. The most 
obvious of these is the systemic antibody response, both IgA and IgG, to Hp 
which is in widespread clinical use as a marker of current or previous 
infection. As peripheral blood is relatively easy to sample any disease-
associated or prognostic marker found here would be an attractive candidate 
to develop for clinical use. Although the anti-Hp antibody response is well 
characterized, it is unclear if it has any effect on Hp colonization density 
(Robinson et aL, 2007). However, in this chapter I will focus on the less well 
characterized Th17, Thl and Treg cells and their associated cytokines in the 
peripheral blood. 
4.1.1 PBMC Proliferative Responses to Hp 
Early investigators found that PBMCs from both individuals who were 
seropositive for Hp and those with negative Hp serology proliferated in 
response to Hp antigen, indeed several groups noted that proliferation in the 
Hp+ group was reduced compared the Hp- group (Karttunen et aL, 1990, 
Birkholz et aL, 1993, Fan et aL, 1994). The proliferative response to Hp in 
those seronegative to Hp suggests that either the seronegative subjects have 
previously been exposed to Hp and the cellular memory response outlasts the 
antibody response, or that there is cross-reactivity between epitopes, such as 
PAMPs recognized on Hp and other microorganisms. The theory that the 
immune responding cells are not restricted to a small number of Hp-specific 
memory clones is supported by evidence from Oi Tommaso et al. who cloned 
Hp-specific C04+T cells from the peripheral blood and found them to be 
polyclonal in terms of both TCR usage and MHC restriction (Oi Tommaso et 
aL, 1995). Furthermore Quiding-Jarbrink et al. found that the majority of 
IFNy+ cells following Hp stimulation were C045RA+ in both Hp+ and Hp-
subjects, implying that these responder cells were na·ive and had not 
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previously been stimulated (Quiding-Jarbrink et aL, 2001b). Malfitano et al. 
also found evidence of Hp stimulating naive T cells including a lower 
CD4SRO/RA ratio of response to Hp antigen than to tetanus toxoid and 
greater proliferation of cord blood mononuclear cells in response to Hp than 
to tetanus (Malfitano et aI., 2006). 
To investigate the unexpected lower proliferative response of PBMCs from 
Hp+ compared to Hp- patients Jakob et al. postulated the Hp infection lead to 
"downregulated immunoreactivity". They stimulated PBMCs from Hp-infected 
patients with both their own Hp (autologous strain) and Hp isolated from 
other patients (heterologous strains). Stimulation with autologous Hp lead to 
lower proliferation but higher IL-10 production compared to stimulation with 
heterologous strains (Jakob et aL, 2001). In support of this Kayhan et al. 
found higher IL-10 levels in the serum of Hp+ patients compared to 
uninfected healthy controls (Kayhan et aL, 2008). This study also found 
evidence of an innate response to Hp in the peripheral blood with neutrophils 
and yo T cells increased in Hp+ patients compared to uninfected controls 
(Kayhan et aL, 2008). 
4.1.2 Peripheral Blood Treg Response to Hp 
Work by others in the research group has shown increased levels of 
CD4+CD2ShiIL-10+ cells in peripheral blood of Hp+ compared to Hp- patients 
(Kenefeck et aL, 2007), indicating that Tregs are an important source of the 
suppressive cytokine IL-10. Lundgren et al. found that depleting CD2Shigh cells 
from CD4+ memory cells of Hp+ donors increased their proliferative response 
to Hp-pulsed DCs but did not affect their response to tetanus toxoid-pulsed 
DCs. Co-culture experiments confirmed that CD2Shigh cells reduced memory T 
cell proliferation and IFNy secretion in response to Hp-pulsed DCs (Lundgren 
et aI., 2003). 
In addition to CD4+CD2ShighIL-10+ cells others in the research group have 
shown increased proportions of CTLA-4+ Tregs in the peripheral blood of Hp-
infected patients compared to controls. Occurence of Hp-associated peptic 
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ulcer disease was associated with lower frequencies of CTLA-4+ and IL-10+ 
C04+C02Shigh Tregs (Greenaway et aL, 2011). 
Satoh et 01. also found increased C04+C02Shigh Tregs, but no change in 
C04+C02ShighFOXP3+ cell frequencies in the blood of Hp-infected patients 
(Satoh et aL). 
There is interest in the hypothesis that systemic Treg responses to Hp could 
lead to protection against allergy and autoimmunity (see section 1.1.3.S). 
4.1.3 Peripheral Blood Th1 and Th2 Responses to Hp 
Ren et 01. found an increased IFNy response to Hp antigen upon stimulation of 
whole blood from Hp+ patients compared to uninfected controls (Ren et aL, 
2000). Quiding-Jarbrink et 01. isolated peripheral blood T cells, stimulated with 
Hp antigen, and found increased IFNy secretion and increased frequencies of 
IFNy+ T cells in Hp+ subjects compared to uninfected controls, though some 
uninfected controls did have a low levellFNy response to Hp antigen 
stimulation. It was noted that there was wide individual variation in 
IFNy response. Separation of C04+ T cells and C08+ T cells indicated that there 
were higher levels of IFNy and increased frequencies of IFNy+ cells amongst 
the C08+ T cells compared to the C04+ T cells (Quiding-Jarbrink et aL, 2001b). 
However, an earlier study found that HLA-OR antibody blocked the 
proliferative response to HpJ indicating the importance of C04+ cells here 
(Birkholz et aL, 1993). C08+T cells are reduced in the blood of Hp-infected 
patients, leading to an increased C04:C08 T cell ratio (Satoh et aL), as noted 
in the Hp-infected gastric mucosa (Figure 6.3A). 
Ren et 01. investigated the blood of Hp-infected patients following Hp 
eradication and found that the levels of IL-4 increased, though IFNy levels 
were unchanged, suggesting a readjustment of the Thl/Th2 balance (Ren et 
aL, 2000). Quiding-Jarbrink found that Il-4 and Il-S could rarely be detected 
following 48 hours of Hp antigen stimulation (Quiding-Jarbrink et aL, 2001b). 
In contrast Satoh et 01. found no difference in CD4+IFNy+ cells in the blood of 
their Hp-infected patients and uninfected control group with increased 
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CD4+IL-4+ cells in the Hp-infected group (Satoh et aLl. Mitogen stimulation 
with PMA/ionomycin was used in this study whereas Hp antigen was used by 
Ren and Quiding-Jarbrink. 
4.1.4 Peripheral Blood IL-17/Th17 Responses to Hp 
Jafarzadeh et al. report increased serum IL-17 levels in Hp patients with 
duodenal ulcer compared to both healthy controls and asymptomatic Hp 
serology-positive participants. In this study those positive for anti-cagA 
antibodies in the Hp+ duodenal ulcer ulcer group had higher serum IL-17 
levels than Cag A seronegative Hp+ duodenal ulcer patients (Jafarzadeh et aI., 
2009). 
A recent study assessed Th17 cell frequencies in 3 groups of patients: those 
with current Hp infection, those with previous infection (no evidence of 
current infection but a history of Hp eradication or positive serology) and 
those that had never been infected with Hp. They found increased Th17 levels 
in the previous infection group compared to the Hp naive group, but the 
levels in the active Hp infection group were not significantly different to the 
other two groups (Serelli-Lee et aL, 2012). HLA-DR blocking antibody 
substantially reduced IL-17 secretion by blood-derived CD4+ T cells incubated 
with Hp-pulsed antigen presenting cells (Serelli-Lee et aL, 2012). 
I am not aware of any other studies of peripheral blood Th17 responses to Hp 
but there are reports of peripherallL-17 responses to other infections, 
including viral infections such as chronic hepatitis B (Ge et aL, 2009) where it 
positively correlated with viral load and histological activity index (Zhang et 
aL) and HIV where reduced Th17:Treg ratio was associated with disease 
progression (Chauhan et a/., 2009) and an expanded V811FNy and IL-17 
producing population was identified (Fenoglio et aL, 2009). Circulating CD4+IL-
17+ cells have also been identified in C. albicans infection (Zhou et aI., 2008b) 
and patients suffering with the condition chronic mucocutaneous candidiasis 
have been found to have defects in Th17 immunity including STAT3 
deficiency, IL-17 receptor A deficiency and IL-17F deficiency (Puel et al., 2011, 
Eyerich et aL, 2008). 
4.1.5 Modulation of Activation Markers on PBMCs by Hp 
The response of a number of activation markers to Hp infection has been 
reported in the literature. Studies that have compared activation marker 
levels in the blood of Hp-infected and uninfected subjects have generally not 
found a significant difference: Kayhan et 01. found no increase in HLA-OR on T 
cells in 32 Hp+ patients compared to 15 uninfected patients (Kayhan et aL, 
2008). Soares et 01. agreed that there was no difference in T cell HLA-OR 
between infected and uninfected patients but found increased C04+ T cells in 
infected patients and an increased percentage of the costimulatory molecule 
C028 on both C04+ and C08+ T cells (Soares et aL, 2005). In contrast studies 
where PBMCs have been stimulated with Hp antigen in vitro have found that 
activation markers rise. Jakob et 01. found increased C025, C071 and HLA-OR 
on both C04+ and C08+ T cells following 6 days of exposure to Hp antigen 
(Jakob et aL, 2001). Similarly Kartunnen et 01. reported increased C025 and 
HLA-OR expression on C04+ and C08+ T cells after 7 days of stimulation with a 
6 strain mix of Hp antigen (Karttunen, 1991). 
4.1.6 Markers for Antigen-Specific Peripheral Blood CD4+ T Cell 
Responses 
As there are circulating lymphocytes with a wide range of specificities in the 
peripheral blood, activation markers are sometimes used to select cells 
specific for the stimulus used. Cells gated for the activation marker can then 
be used for subsequent analysis. My colleagues have used the early activation 
marker C069 for this purpose (Robinson et aL, 2002). C0154, also known as 
C040 ligand, is another activation marker, specific for C04+ T cells. It interacts 
with C040 on antigen presenting cells forming a costimulatory pair. It is 
thought to be more specific than other activation markers, such as C025, 
C069 and C071 which can become activated in the absence of TCR 
engagement (Frentsch et aL, 2005). 
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There is no single marker that definitively identifies Tregs in humans. Tregs 
are heterogeneous. Many Treg markers, including C025, GITR and FOXP3 can 
also be transiently expressed on activated human T cells (Wang et aL, 2007a). 
The transcription factor Helios was proposed as a marker to differentiate 
between thymus-derived "natural" Tregs and peripheral induced Tregs 
(Thornton et aL, 2010) but more recently it has also been found on activated 
and proliferating C04+ and C08+ human T cells (Akimova et aL, 2011). Surface 
staining for C04+C025 highC0127'° has been widely used to identify human 
Tregs (Liu et aL, 2006) and this profile is also able to distinguish Tregs from 
activated T cells (Seddiki et aL, 2006). This combination of markers was used 
here along with FOXP3 staining. 
Th1 and Th17 cells were identified as C04+ cells staining for IFNy and IL-17 
respectively. An alternative strategy would have been to stain for the 
transcription factors T-bet and RORC2, but non-specific staining was found to 
be problematic using this approach. C04+ T cells responding to Hp antigen 
stimulation with cytokine secretion would be expected to reflect the 
functional T helper response to the pathogen. As IFNy and IL-17 were included 
in the same tubes it was also possible to identify C04+IL-17+IFNy+ "double-
positive" responders. This double-positive population is thought to be Th17-
derived, pro-inflammatory and pathogenic and is discussed in section 1.3.3 
and section 4.4.2 below (Peters et aL, 2011, Hirota et aL, Abromson-Leeman 
et aL, 2009, Nistala et aL, 2010). 
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4.2 AIMS 
i. To compare serum IL-17 levels in Hp infected patients and uninfected 
controls. 
ii. To optimize peripheral blood antigen-specific Th1 and Th17 staining and 
to measure and compare systemic Th1 and Th17 responses to Hp. 
iii. To characterize the peripheral blood Treg response to Hp infection. 
iv. To correlate peripheral blood Th1, Th17 and Treg responses with 
occurrence of Hp-associated disease. 
v. To correlate the peripheral blood Th1 and Th17 responses with patient 
age and gender. 
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4.3 RESULTS 
4.3.1 Serum IL-17 Measurement 
Attempts were made to measure IL-17 levels in serum from 14 Hp+ patients 
and 13 uninfected controls. IL-17 levels in all the sera were below the limit of 
sensitivity of the ELISA (calculated as 7.0pg/ml and 8.1pg/ml for the 2 plates). 
The lowest standard was 6.25pg/mIIL-17. For the first assay samples were 
incubated on the plate for 2 hours at room temperature, as per standard 
ELISA protocol. For the second assay the samples were incubated overnight 
on the plate at 4°C as the ELISA kit instructions recommended that this would 
maximize sensitivity, however IL-17 levels remained below the limit of 
detection. 
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4.3.2 Optimization of Peripheral Blood Antigen-Specific T 
Helper Staining 
As T cells in the blood have a wide range of specificities, staining for an 
activation marker such as C069 or C0154 upon antigen stimulation may be 
used to select antigen specific cells, either alone or in combination with 
cytokine staining (Grabowska et aL, 2001, Robinson et aL, 2002, Frentsch et 
aL, 2005, Morgan et aL). Tetramers staining is an alternative method for 
identifying antigen-specific cells (see discussion, section 4.4.1}.C069 and 
C0154 activation markers were first compared using PBMCs from a healthy 
donor with tetanus toxoid as an antigenic stimulus. 
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Figure 4.1 Example plots showing C069 and C0154 staining with antigen and 
mitogen stimulation. PBMCs were stimulated with medium only 
(unstimulated control), tetanus toxoid antigen or PMA and ionomycin for 16 
hours and labelled with the fluorescence-conjugated antibodies C04-ECO and 
C0154-PC5 or C069-PC5. 
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Antigen stimulation caused only a small amount of lymphocyte activation as 
measured by C069 and C0154. The lymphocyte population divided into two 
subpopulations when stimulated with PMA/ionomycin and stained with 
C0154, as C0154 is only present on activated C04+ T cells. This facilitated 
identification and gating of the C0154+ population. In contrast, the whole 
lymphocyte population increased its C069 expression when stimulated with 
PMA/ionomycin (Figure 4.1). 
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Figure 4.2 Activation of peripheral blood lymphocytes by tetanus assessed 
using C069 and C0154 and comparison of these two activation markers. 
PBMCs separated from blood from a healthy donor were stimulated with 
tetanus toxoid antigen for 4, 8, 16 and 24 hours and labelled with the 
fluorescence-conjugated antibodies C04-ECO and C0154-PC5 or C069-PC5. 
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Figure 4.3 The frequency of C04+Activation marker+IFNy+ events was similar 
whether C069 or C0154 was used and did not differ significantly from the 
frequency of C04+IFNy+ events. PBMCs separated from blood from a healthy 
donor were stimulated with tetanus toxoid antigen for 4,8, 16 and 24 hours 
and labelled with the fluorescence-conjugated antibodies C04-ECO, C0154-
PC5 or C069-PC5 and IFNy-F/TC. 
The percentage of C0154+ cells was consistently lower than the percentage of 
C069+ cells (Figure 4.2) as it is only expressed on C04+ T cells, but numbers of 
C04+cytokine+ events were very similar for the two activation markers. If no 
activation marker was used and C04+/FNy+ lymphocytes were analyzed the 
results also correlated well (Figure 4.3). 
Ideally for this comparison C069 and C0154 should have both been in the 
same tubes, but it was planned to use the same fluorochrome for whichever 
activation marker was decided upon so this was not feasible. C04+IFNy+ 
events were analyzed without activation marker gating in two tubes for each 
time point (the tube containing C069 and the tube containing C0154). The 
tubes were prepared from the same donor at the same time so theoretically 
they should give the same results but there is a little variation, most 
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noticeable at the 24 hour time point where there are more C04+IFNl and 
C04+C069+IFNy+ events in the C069 tube (Figure 4.3). 
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Figure 4.4 Activation of peripheral blood lymphocytes by Hp assessed using 
C069 and C0154. PBMCs were incubated with medium only or Hp whole cell 
sonicate isolated from 6 clinical strains for 16 hours, then labelled with the 
fluorescence-conjugated antibodies C04-ECO and C069-PC5 or C0154-PC5. 
Frequency of C04+activation marker+ events was then analyzed. A) C069 
activation marker. 20 Hp infected and 42 uninfected patients. B) C0154 
activation marker. 13 Hp infected and 7 uninfected patients. 
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The baseline levels of C0154 in the unstimulated samples were lower than 
the C069 levels (1.33% vs 4.88%) (Figure 4.4). As a result levels were 
significantly increased in cells stimulated with Hp whole cell sonicate 
(containing 6 clinical isolates) compared to unstimulated samples when 
C0154 was used as the activation marker for both the Hp+ and uninfected 
patients. Following Hp antigen stimulation the percentage of activation 
marker positive C04+ T cells was approximately double that found in the 
uninfected group in the Hp+ group with both activation markers. Median 
%C04+C069+ was significantly higher in the Hp+ patients (10.14%) than in the 
uninfected group (4.88%) (p=0.006). The %C04+C0154+ events were lower 
(1.33% uninfected and 3.28% Hp-infected patients) and the p value did not 
reach significance (p=O.l1). The smaller numbers of samples analyzed for 
%C04+C0154+ may also contribute to the higher p value. 
A total of 34 peripheral blood samples were processed with C0154 staining 
(21 Hp+ and 13Hp-): 21 fresh samples (14 Hp+ and 7 Hp-) and 13 frozen 
samples (7 Hp+ and 6 Hp-). Amongst the Hp- patients the frozen samples had 
higher %C04+C0154+ than the fresh samples (median 6.92 vs 1.33, p=0.038). 
This suggests that the process of freezing and thawing the samples caused 
some cell activation, despite precautions taken to minimize rapid changes in 
temperature (see Chapter 2 section 2.5.2), thereby increasing the background 
level of activation. This is likely to mask any increase in activation with Hp 
stimulation. There was no significant difference between %C04+C0154+ levels 
for the Hp+ fresh and frozen samples. There was no significant difference in 
frequencies of C04+ll-17+ or C04+IFNy+ events between the fresh and frozen 
samples in either the Hp+ or Hp- groups suggesting that C0154 is more 
susceptible to increase on freeze-thawing than the cytokines. 
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Figure 4.5 Example plots comparing analysis of C04+cytokine+ events with 
lymphocyte and C0154 gating or lymphocyte gating only. PBMCs were 
incubated overnight with medium only, Hp antigen or PMAjionomycin, then 
stained with CD4-ECD, CD154-PC5, IFNy-FITC and IL-17-PE. Data was analyzed 
using both gating strategies for A) CD4+IFNl and B) CD4+IL-17+ events. 
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Figure 4,6 Example plots showing isotype control and "minus one" control 
staining. PBMCs were incubated overnight with medium only or 
PMA/ionomycin, then stained with CD4-ECD, IFNy-FITC and Il-17-PE. In 
control tubes either IFNy or Il-17 antibodies were replaced with isotype 
control antibodies or omitted (minus one controls). lymphocytes were gated 
on forward scatter/side scatter plots. CD4+ cytokine + cells of interest are in the 
right upper quadrants of the plots. A) IFNy, B) Il-17. 
There was a much stronger CD4+ cytokine + cell response to PMA/ionomycin 
than to Hp antigen, as expected. The CD4+IFNy+ response to PMA/ionomycin 
was strongerthan the CD4+ll-17+ response. Use of an activation marker had 
little effect on the numbers of CD4+cytokine+ events detected, though it did 
reduce the diagonal artefact sometime found when cells were gated on 
lymphocytes only (Figure 4.5). Despite the relatively long (16 hour) 
stimulation with PMA/ionomycin cell death, as assessed on forward 
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scatter/side scatter plots, did not appear to be a significant issue. A specific 
stain to assess viability was not used in this study. Most of the diagonal 
artefact was in the C04- negative part of the plot and therefore excluded 
from the analysis. A "dump channel" strategy was used also used to reduce 
the diagona l artefact by excluding events showing fluorescence in the FLs 
channel when no relevant fluorochrome was in use (Figure 4.7). A dump 
channel is used to gate out events that are not of interest and is useful when 
analyzing small populations (Baumgarth and Roederer, 2000). No 
fluorochrome-conjugated antibody was added with the emission spectrum 
detected in the dump channel, so any positive events detected could be 
assumed to be due to autofluorescence and gated out. 
Analyzing C04+cytokine+ events without the use of an activation marker had 
the advantage that all the samples processed, both fresh and frozen, could be 
included in the analysis. This was the strategy adopted for subsequent 
analyses, in combination with "dump channel" gating. Isotype and "minus 
oneil contro ls for IFNy and IL-17 staining are shown in Figure 4.6. 
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Figure 4.7 Dump channel used to gate out autofluorescence to minimise 
artefactual double positive staining. PBMCs were incubated for 16 hours 
with Hp antigen, labelled with the fluorochrome-conjugated antibodies C04-
ECO, IFNy-FITC and IL-17-PE and analyzed by flow cytometry. 
A) Cells gated on lymphocytes, C04+ and dump channel ("NOT FLspos" ). 
B) Cells gated on lymphocytes and C04+ only. 
C) FLspos region determined on FLs vs side scatter plot. 
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Representative example from an Hp+ donor. 
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4.3.3 The Systemic Thl and Th17 Response to Hp 
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Figure 4.8 The systemic Thl and Th17 response to Hp and tetanus. PBMCs 
were incubated overnight with medium only, Hp antigen (21 Hp+ and 13Hp-) 
tetanus toxoid (16Hp+ and 12Hp-), then labelled with the fluorochrome-
conjugated antibodies CD4-ECD, IFNy-FITC and IL-17-PE. Cells were gated on 
lymphocytes and autofluorescent cells gated out using a dump channel. 
CD4+cytokine+events per 100,000 lymphocytes were analyzed . A) 
CD4+IFNy+j100,OOO events, B) CD4+IL-17+jlOO,OOO events. Boxes represent 
the 25th to 75th centiles, horizontal lines within the boxes represent the 
median and the whiskers depict the 5
th 
and 95
th 
centiles . 
136 
Although the absolute numbers of events were not very high there were 
significant differences in the CD4+cytokine+ events between Hp-infected and 
uninfected patients for both cytokines upon stimulation with Hp antigen 
(Figure 4.BA and B). This indicates the detection of Hp-specific CD4+IFNy+ and 
CD4+,L-17+ responses in PBMCs from infected donors. Tetanus was used as a 
control antigen. Others studying the antigenic response to Hp have used 
tetanus toxoid as a control antigen (Quiding-Jarbrink et aL, 2001a, Lundgren 
et aL, 2003, Malfitano et aL, 2006). Most donors will have been exposed to it 
via vaccination and it is known to provoke a Th1 response (Viana et aL, 
Frentsch et aL, 2005). No difference in CD4+IL-17+ frequencies was seen 
between the Hp-infected and uninfected control groups for the unstimulated 
or tetanus stimulated samples (Figure 4.BB). CD4+IFN/ events were more 
frequent in PBMCs from Hp-infected patients, even when the samples 
weren't stimulated, but this only just reached significance (Figure 4.BA). 
Consistent with this basal immune activation Hp infection was found to be 
associated with an increased risk of elevated CRP (>3 mg/L) when factors 
including age and smoking status were adjusted for (Jackson et aL, 2009). In 
keeping with this CD4+IFNy+ cell frequencies in tetanus stimulated samples 
were also just significantly higher in Hp-infected compared to uninfected 
patients (p=0.04B, 1.6-fold). 
For 2 patients (1 Hp+ and 1 with positive Hp serology but negative rapid, 
urease test, histology and culture) response to stimulation with C. albicans 
was also assessed by flow cytometry, as most donors are likely to have been 
exposed to C. albicans and it is known to provoke a Th17 response (Zhou et 
aL, 200Bb, Zielinski et aL, 2012). The Hp+ patient had 4.74 and 1.09 CD4+,L-
17+ cells/100,OOO lymphocytes following PBMC stimulation with Hp and 
Candida respectively. The other patient, with probable previous Hp infection, 
had 1.60 and 1.B1 CD4+IL-17+ cells/100,OOO lymphocytes following PBMC 
stimulation with Hp and candida respectively. Both absolute numbers of 
events of interest and number of patients studied here was low making it 
unjustified to draw any conclusions about the exact numbers found, but these 
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findings suggest that the IL-17 response of PBMCs to Hp is of a similar 
magnitude to their response to C. albicans. 
Mitogen stimulation with PMA and ionomycin resulted in much higher 
frequencies of CD4+cytokine+ events. CD4+IFNy+ cells were increased in Hp-
infected compared to uninfected patients upon PMA/ionomycin stimulation 
(p=0.0009, median CD4+IFNy+/100,OOO lymphocytes 8176 in Hp+ vs 3096 in 
Hp-). There was a trend for increased CD4+IL-17+ events in the Hp-infected 
group but this did not reach significance (p=0.15, median CD4+IL-17+/100,OOO 
lymphocytes 528 in Hp+ vs 266 in Hp-). 
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Figure 4.9 Correlation between CD4+IFNl and CD4+,l-17+ events. PBMCs 
from 21 Hp+ donors were incubated with Hp antigen for 16 hours, then 
stained with fluorochrome conjugated antibodies CD4-ECD, IFNy-FITC and Il-
17-PE. Cells were gated on lymphocytes and autofluorescent cells gated out 
using a dump channel. CD4+IFNy+events and CD4+,l-17+ events per 100,000 
lymphocytes were analyzed and correlated. 
There was no significant correlation between the numbers of CD4+Il-17+ and 
numbers of CD4+IFNy+ cells found in the peripheral blood (Figure 4.9). 
A proportion of CD4+,l-17+ cells also produced IFNy+. This ranged between 0 
and 100%, with a median of 33.3% for the 21 Hp+ samples. 
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4.3.4 The Peripheral Blood Treg Response to Hp 
Numerous markers have been used to identify Tregs. CD4+CD25high and the 
transcription factor FOXP3 are probably the most widely used and accepted 
but often further markers are used in combination with these. I elected to use 
CD12io in addition to CD4CD25high and FOXP3, as described by Liu et al. (Liu 
et aI., 2006). CD121'o inversely correlates with FOXP3 but has the advantage 
that it is a surface marker meaning that it is possible to do further functional 
experiments with Tregs isolated on the basis of CD4+CD25highCD121'o. CD127 
is also a convenient marker to analyze as the cells generally separate into 
CD127+ and CD121'o populations in contrast with some other markers such as 
CD25 which appears as a continuum in which a cut-off point must be 
established. A system of classifying human FOXP3+ Tregs based on CD45RA 
and CD25 expression, including CD25++ and CD25+++ populations has also been 
described (discussed further in section 4.4.3). An example of CD4+CD25high 
gating demonstrating the CD25 continuum is shown in Figure 4.1DA. Figure 
6.10B (already CD4+CD25high gated) shows an example of gating of the 
CD12ioFOXP3+ population, which is easier to distinguish. 
A) B) 
0.41 3.71 70.2 5.92 
CD4 
Figure 4.10 Example of Treg analysis gating strategy. PBMCs were cultured 
with Hp antigen for 16 hours and labelled with the fluorochrome-labelled 
antibodies CD4-ECD, CD25-PC5, CD127-PE and FOXP3-Alexa 488. 
A) CD4+CD25high gating, 
B) CD4+CD25high gated cells assessed for CD121'oW and CD121'owFOXP3+. 
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Figure 4.11 CD4+CD2Shigh Tregs are increased in peripheral blood of Hp-
infected patients. PBMCs donated by 14 Hp+ patients and 14 uninfected 
controls were incubated with Hp antigen for 16 hours, then labelled with the 
fluorochrome-conjugated antibodies CD4-ECD and CD2S-PCS. The 
%Iymphocytes CD4+CD2Shigh in the infected and uninfected groups were 
compared. 
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Hp-infected median Uninfected median P 
CD4+CD2shigh 8.62 4.70 0.0063 
CD4+CD2shignCD12710 2.89 2.41 0.22 
CD4+CD2s highFOXP3 2.85 2.15 0.26 
Table 4.1 CD4+CD2Shigh Tregs are increased in peripheral blood of Hp-
infected patients but there were no significant differences between the 
infected and uninfected groups for CD4+CD2ShighCD127'o or 
CD4+CD2ShighFOXP3+ Tregs. PBMCs donated by 14 Hp+ patients and 14 
uninfected controls were incubated with Hp antigen for 16 hours, then 
labelled with the fluorochrome-conjugated antibodies CD4-ECD, CD2S-PCS, 
CD127-PE and FOXP3-Alexa488 and analyzed by flow cytometry. Median 
%Iymphocytes positive for Treg markers for the Hp-infected and uninfected 
groups were calculated and compared. 
CD4+CD2Shigh Tregs were significantly increased in the blood of Hp+ compared 
to uninfected patients (Figure 4.11 and Table 4.1) but there was no significant 
difference in the levels of CD4+CD2ShighCD127'° or CD4+CD2ShighFOXP3+ Tregs 
(Table 4.1). 
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Figure 4.12 No correlation found between Treg and Th17 levels. PBMCs 
donated by 14 Hp+ patients were incubated with Hp antigen for 16 hours, 
then labelled with fluorochrome-conjugated antibodies to stain for Treg and 
+ h" h Th17 markers, as above. Treg (% lymphocytes CD4 CD2S Ig ) and Th17 
(CD4+/L-17+) frequencies were compared. 
No significant correlation was found between levels of blood CD4+CD2Shigh 
Tregs and Th17 levels in Hp-infected patients (Figure 4.12). 
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4.3.5 Is There a Correlation Between the Peripheral Blood Thl, 
Th17 or Treg Response and Presence of Peptic Ulcer Disease? 
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Figure 4.13 Correlation of Th1 and Th17 responses with occurrence of peptic 
ulcer disease. PBMCs from 21 Hp+ patients, 7 with peptic ulcer disease and 
.14 without, were incubated with Hp antigen for 16 hours, then stained with 
fluorochrome-conjugated antibodies CD4-ECD, IFNy-FITC and IL-17-PE and 
analyzed by flow cytometry. Frequencies of A) CD4+IFNy+ and B) CD4+IL-17+ 
events were compared in the peptic ulcer disease and ulcer-free groups. 
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The median peripheral blood Th1 (CD4+IFNy+/100,OOO lymphocytes) and Th17 
(CD4+IL-17+/100,OOO lymphocytes) responses both showed a trend of being 
higher in patients with peptic ulcer disease, but the differences were very 
small and did not reach significance. It is clear that there is a significant 
overlap of Th1 and Th17 systemic responses between the peptic ulcer disease 
and ulcer-free groups so it is unlikely that this type of data could give clinically 
useful data on risk of peptic ulcer disease. Neither did blood Treg levels 
correlate with peptic ulcer disease (Figure 4.14) though low gastric Treg levels 
are known to be associated with peptic ulcer disease (Robinson et aI., 2008). 
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Figure 4.14 levels of CD4+CD2Shigh Tregs did not correlate with peptic ulcer 
disease. PBMCs from 14 Hp+ donors, 5 with peptic ulcer disease and 9 
without were incubated with Hp antigen for 16 hours, then stained with the 
fluorochrome-conjugated antibodies CD4-ECD and CD25-PC5 and analyzed by 
flow cytometry. % lymphocytes CD4+CD25high in the peptic ulcer disease and 
ulcer-free groups were compared. 
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4.3.6 Correlation of Peripheral Blood Thl, Th17 and Treg 
Responses with Patient Age and Gender 
Patients for this study were not selected at random from the general 
population but from those attending hospital for upper GI endoscopy. It was 
not possible to age- and sex-match the participants. In older individuals there 
is involution of the thymus and narrowing of the T cell repertoire with a 
higher proportion of antigen-experienced T cells and less naive T cells {Naylor 
et aL, 2005, Arnold et aL, Karanfilov et aL, 1999}. Ageing also has effects on T 
cell Signalling, ONA repair and antioxidant mechanisms and leads to 
shortened telomeres {Arnold et aL}. Hoffman et al. reported a positive 
correlation between age and intracellular IFNy levels in C04+ T cells in 
children. In adults C04+IL10+ and C08+IFNy+ but not C04+IFNy+ cells correlated 
with age {Hoffmann et aL, 2005}. Karanfilov et al. found similar frequencies of 
C04+ and C08+ in their young and elderly groups though the variation was 
wider in the elderly group. T celllFNy and IL-4 production was reduced in the 
elderly in this study but did not correlate with naive/memory T cell 
frequencies {Karanfilov et aL, 1999}. 
Afshan et al. reported reduced Treg frequencies in females compared to 
males, which they suggest may contribute to the increased incidence of 
autoimmune disease in females {Afshan et aL}. Changes in Treg numbers 
during different phases of the menstrual cycle have also been reported 
{Arruvito et aL, 2007}. In view of these findings Th1, Th17 and Treg levels 
were plotted against Clge and gender to ensure that these were not 
confounding factors. 
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Figure 4.15 Th1 and Th17 cell frequencies did not correlate with age. PBMCs 
from 21 Hp+ donors were incubated with Hp antigen for 16 hours, then 
stained with fluorochrome-conjugated antibodies CD4-ECD, IFNy-FITC and IL-
17-PE. Cells were gated on lymphocytes and autofluorescent cells gated out 
using a dump channel. A) CD4+IFNy+events and B) CD4+,L-17+ events per 
100,000 lymphocytes were analyzed and correlated with patient age. 
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Figure 4.16 CD4+CD25high Tregs levels did not correlate with age. PBMCs 
from 14 Hp+ donors were incubated with Hp antigen for 16 hours, then 
stained with the fluorochrome-conjugated antibodies CD4-ECD and CD2S-PCS 
and analyzed by flow cytometry. Results were correlated with the ages of the 
donors. 
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Figure 4.17 Th1 and Th17 levels in the peripheral blood were not associated 
with gender. PBMCs from 21 Hp+ donors (9 male and 12 female) were 
incubated with Hp antigen for 16 hours, then stained with the fluorochrome-
conjugated antibodies CD4-ECD, IFNy-FITC and IL-17-PE and analyzed by flow 
cytometry. Results for male and female donors were compared. 
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Figure 4.18 Treg levels in the peripheral blood were not associated with 
gender. PBMCs from 14 Hp+ donors (6 male and 8 female) were incubated 
with Hp antigen for 16 hours, then stained with the fluorochrome-conjugated 
antibodies CD4-ECD and CD25-PC5 and analyzed by flow cytometry. Results 
for male and female donors were compared. 
There was no significant difference between the ages of the Hp+ and 
uninfected groups (median age of Hp+ group 60 years of age, median age of 
uninfected control group 59 years of age). Male:female ratios were similar 
with slightly more females in both groups (Hp+ group 9:12; Hp- group 5:8) 
No correlation with age (Figure 4.15 and Figure 4.16) or gender (Figure 4.17 
and Figure 4.18) was found for peripheral blood Th1, Th17 or Treg responses. 
Thank you to Dr Rupert Kenefeckfor additional C04+C069+ cell data. 
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4.4 DISCUSSION 
4.4.1 Optimization of Peripheral Blood Antigen-Specific T 
Helper Staining 
Initially C069 and C0154 activation markers were compared, as they have 
been used to help identify antigen-specific cells in previous studies on 
peripheral blood (Robinson et aL, 2002, Frentsch et aL, 2005, Morgan et aL, 
Grabowska et aL, 2001). C069 has been widely used as an early activation 
marker in the study of antigen-specific PBMC responses, including in a 
number of local studies (Robinson et aL, 2002, Morgan et aL, Grabowska et 
aL, 2001). C0154 is also an early activation marker, reported to plateau 4-6 
hours after stimulation in vitro (Frentsch et aL, 2005). Unlike C069 its 
expression is restricted to C04+ T cells. It is transiently expressed at the cell 
surface, then rapidly internalized, so intracellular staining is the method of 
choice for detection of low frequency antigen-specific C04+ T cells (Meier et 
aL, 2008). Extracellular C0154 staining or inclusion of anti-C0154 antibody in 
the culture medium during stimulation can be used to identify viable antigen-
specific C04+'T cells (Meier et aL, 2008, Cohen et aL, 2005, Chattopadhyay et 
aL, 2005). C0154 is more specific for T cell receptor engagement that C069 
and is reported to be a robust marker for activation of T cells stimulated with 
peptides or protein (Frentsch et aI., 2005, Meier et aI., 2008). In keeping with 
the literature no difference was found in these activation markers on 
unstimulated PBMCs from Hp-infected and uninfected donors, but when the 
PBMCs were stimulated with Hp in vitro C04+C069+ levels were higher in the 
Hp-infected group, with a similar but not statistically significant trend for 
C04+C0154+ lymphocytes (Figure 4.4). This indicates a Hp-specific peripheral 
blood C04+ T cell response in infected patients. 
Levels of C04+C069+IFNy+, C04+C0154+IFNl and C04+IFNy+ without the use of 
an activation marker were very similar. The vast majority of IFNy+ cells also 
expressed the activation markers (Figure 4.3). Cytokines may be considered a 
form of activation marker themselves, as they are usually only secreted when 
cells are stimulated. Others have studied the proportion of C0154+ cells 
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secreting particular cytokines (Frentsch et aL, 2005, Chattopadhyay et aL, 
2005). Not all C0154+ cell secreted any of the cytokines measured, suggesting 
that these activated cells are working via other cytokines, mechanisms not 
involving soluble mediators, or reflect staining of non-activated cells. C0154 
may be a good marker for a broad range of activated T cell functions but in 
this study IFNy-secreting and IL-17-secreting cells were the particular focus. 
MHC class II tetramers are an alternative technology that can be used to 
investigate antigen-specific C04+ T cell responses. This requires knowledge of 
the HLA-OR type of the donor and immunodominant peptide epitope(s) of the 
antigen of interest. Oue to the low frequency of antigen-specific C04+ T cells 
in the peripheral blood it is normally necessary to either enrich or expand 
these cells in vitro (Cecconi et aL, 2008). Bonvalet et 01. expanded allergen-
specific PBMC-derived C04+ T cells in vitro, then stained with tetramers and a 
panel of activation marker antibodies, including antibodies to C069 and 
C0154. They found little correlation between tetramer and activation marker 
staining, with both tetrame(/marker+ and marke(jtetramer+ populations 
identified (BoTlvalet et aL). The tetrame(jmarker+ population secreted IL-5 
and IL-I0, but not as much as the tetramer+/marker+ cells. These cells may 
have become activated by cytokines secreted by allergen-specific C04+ T cells 
in a "bystander effect". This phenomenon has been described following 
tetanus toxoid booster vaccination (Oi Genova et aL). The marke(jtetramer+ 
population is thought to represent an anergic or exhausted allergen-specific 
C04+ T cell subset (Bonvalet et aL). 
As Hp antigen stimulation was used, it might be expected that only cells 
specific for Hp should be activated, but it is possible that epitopes in Hp 
antigen could activate cross-reactive T cell receptors or induce innate 
immunity via stimulation of PAMPs, leading to cytokine secretion and possible 
bystander activation of T cells with other specificities, as discussed above. Hp-
specific memory T cells may be expected to account for a high proportion of 
the T cell recall response to Hp in Hp+ donors but evidence indicating that Hp 
can also activate naive T cells casts some doubt over this assumption 
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(Quiding-Jarbrink et aL, 2001b, Malfitano et aI., 2006). The expression of 
activation markers, but not cytokines was increased in frozen compared to 
fresh samples. Use of an activation marker was not felt to add anything and 
allowed combined analysis of fresh and frozen samples. This also allowed the 
possibility of analyzing all the samples stained with C04 and IFNy or Il-17 
together, as the activation markers could be disregarded. 
4.4.2 The Systemic Thl and Th17 Responses to Hp Infection 
Satoh et al. and Serelli-lee et al. previously reported that there was no 
difference in the percentage of Th1 cells in the blood of Hp-infected patients 
compared to controls. Short (4-5 hour) stimulations with PMA/ionomycin 
were used in these studies. There were 45 Hp+ patients and 21 uninfected 
controls in Satoh's study and 37 Hp+ and 40 uninfected in Serelli-lee's study, 
so it is surprising in view of the results presented here that no difference was 
found. The mitogen may have acted as such as strong stimulus on the blood 
of both groups that any differences were obscured. Studies by my colleagues 
using Hp antigen stimulation have previously shown increased blood 
C04+C069+IFNl cells and increased IFNy secretion by PBMCs from Hp+ 
donors compared to PBMCs from uninfected controls (Kenefeck, 2008). Ren 
et aJ. and Quiding-Jarbrink et aJ. also found increased IFNy secretion from 
whole blood and peripheral blood T cells of Hp+ donors upon Hp antigen 
stimulation, in keeping with the findings presented here (Ren et aL, 2000, 
Quiding-Jarbrink et aL, 2001b). 
This is the first study to demonstrate a systemic Th17 response to Hp in those 
with current infection. Serelli-lee et al. measured the percentage of C03+C08-
CCR6+,l-17+ cells as a function of C03+C08- PBMCs following 5 hours 
PMA/ionomycin stimulation to quantify Th17 cells in the blood. PMA causes 
down regulation of C04 expression (Pelchen-Matthews et aI., 1993) so it is 
easier to gate C03+C08- PBMCs than C04+ T cells directly following PMA 
stimulation. C03+C08- cells were assumed to be C04+ T cells. In this study 
median Th17 levels were significantly higher in the previously Hp-infected 
group (1.4%) compared to the Hp naive group (0.8%), suggesting that the 
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Th17 response to Hp persists after the infection is cleared. The median of the 
group with current Hp infection (1.1%) was not significantly different to either 
of the other two groups. As PMA/ionomycin is a non-specific stimulus it is 
possible that Th17 cells with other specificities were reactivated in this study. 
The level of Th17 response found here correlates with the ages of the patients 
in the different groups with mean patient age lowest in the Hp naive group 
(51), higher in the current Hp infection group (56) and highest in the previous 
infection group (59) (Serelli-Lee et aL, 2012). Older patients may have had 
more pathogen exposure in general and hence have more Th17 cells that can 
reactivate in response to PMA/ionomycin stimulation. However in the same 
study levels of IL-17 secreted by Hp-stimulated PBMCs from the three groups 
and levels of CD4+,L-17+ cells in snap frozen gastric biopsies by 
immunofluorescence microscopy showed similar patterns (Serelli-Lee et aL, 
2012). 
The Th17 response to Hp detected here was of similar magnitude to the Thl 
response. The absolute numbers of events was low but consistent with the 
low frequency of antigen-specific CD4+ T cells found in peripheral blood in 
other studies (Frentsch et aL, 2005, Zhou et al., 2008b). To try to maximize 
the number of events of interest 400,000 events were typically acquired. 
Other ways to increase the number of CD4+ T cells staining for cytokine would 
have been to expand the PBMCs with longer-term antigen stimulation in vitro 
or to use mitogen stimulation. This type of approach has been used to 
generate Hp-specific T cell clones from the gastric antrum (D'Elios et aL, 
2003). However CD4+ T cells are known to have some plasticity and culture 
conditions can affect their differentiation (Veldhoen et aL, 2009). Many more 
cytokine positive event are generated with PMA/ionomycin stimulation, as 
used by Satoh et al. and Serelli-Lee et al. (Satoh et aL, Sere IIi-Lee et aI., 2012) 
but in view of the wide variety of T cell specificities in the peripheral blood 
antigen stimulation was chosen for this study. 
Some CD4+IFNy+IL17+ cells were identified and there was a trend for these 
"double positive" cells to be more common in the Hp-infected group. Despite 
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this there was no significant correlation between C04+IFNy+ and C04+,l-17+ 
cells. There was a trend towards a correlation between 1L17 and IFNG 
expression in gastric tissue, as measured in independent RT-qPCR 
experiments (r=0.39, p=0.051) (Chapter 5). 
Il-17 and IFNy co-producing cells have been described, at sites of tissue 
inflammation (Annunziato et aL, 2007, Ivanov et aL, 2006, Kebir et al., 2009, 
Brucklacher-Waldert et aL, 2009b) and in blood (Kebir et aL, 2009, 
Brucklacher-Waldert et aL, 2009b). Th17 cells can switch their phenotype to 
produce IFNy in vitro (Shi et aL, 2008, lee et aI., 2009) and in vivo (Bending et 
aL, 2009, Shi et aL, 2008, lee et al., 2009). These double producers seem to 
be more like Th17 cells than Thl cells in terms of the range of cytokines they 
produce and can upregulate defensin expression in epidermal keratinocytes 
(Boniface et aI., 2010). They express the genes for both RORyt and T-bet 
transcription factors (Boniface et aI., 2010, Abromson-leeman et al., 2009, 
Zielinski et aL, 2012), though t-bet has been shown to be able to inhibit RORyt 
transcription by sequestering Runxl (lazarevic et aL, 2011). Fate mapping 
studies in mice engineered to express a yellow fluorescent protein in cells 
that had ever activated the Il-17 program indicate that C04+IFNlll-17+ cells 
are derived from Th17 cells and Il-23 is required for upregulation of T-bet and 
IFNy secretion by Th17 cells (Hirota et aL). Il-23 was required for terminal 
Th17 differentiation and for Th17 cells to have full pathogenic function in EAE 
and a model of skin inflammation (McGeachy et aI., 2007, McGeachy et aL, 
2009). When the Th17 cells start to produce IFNy they downregulate Il-23 
receptor and CCR6 expression but retain AhR and Il-1R1 expression (Hirota et 
al.). This type of cell is at the more pro-inflammatory end of the Th17 
spectrum (Peters et aI., 2011). 
Th17 cells may respond to different pathogens with different cytokines. 
Zielinkski et al. found that human naive C04+ T cells incubated with 
autologous monocytes pulsed with C. albicans developed a substantialll-
17+IFNy+ population, whereas naive C04+ T cells incubated with 
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Staphylococcus aureus pulsed monocytes developed very few IL-17+IFNl 
cells. After restimulation some S. aureus-specific, but not C. albicans-specific 
Th17 clones produced IL-I0 (Zielinski et aI., 2012). In this system IL-113 was 
crucial for development of C04+IFNy+IL-17+ cells (Zielinski et aI., 2012). In 
contrast, when mice were cutaneously infected with C. albicans hardly any of 
the IFNy produced by C04+ T cells originated from Th17 cells (Hirota et aL). 
T-bet expressing C04+IL-IT1FNl populations differentiated under Th17 
inducing (lL-II3, IL-23, and PGE2) conditions in vitro (Boniface et aI., 2010) or 
derived from Th17 cells (Hirota et aI., Lee et aI., 2009) have been described , 
which have characteristics more like the Th17 than Thl subset, suggesting 
additional phenotyping may be required to confirm the identity ofThl cells. 
4.4.3 The Peripheral Blood Treg Response to Hp 
In this study only the C04+C025high Tregs were shown to be significantly 
increased in peripheral blood of Hp-infected patients compared to uninfected 
controls, although there were trends for increased C04+C025highCOI2?'0 and 
C 0 4 + C 0 2 5 h i ~ h F O X P 3 + T r e g s . . This is consistent with the findings of other groups 
(Satoh et aL) and FOXP3 real-time qPCR data from the research group 
(Greenaway et aI., 2011). Lundgren et al. found increased C04+C025high Tregs 
in the stomach but not the blood of Hp-infected patients (Lundgren et aI., 
2005) but the numbers in their study were small. It might be expected that 
difference would be more marked at the site of infection itself compared to 
the blood. As C025 is also a marker of activation it could be argued that these 
results simply reflect more activated C04+ T cells in the peripheral blood of 
Hp-infected patients upon stimulation with Hp antigen, as shown earlier in 
this chapter with the activation marker C069. However, C025
high 
has been 
shown to be a specific feature of Tregs (Baecher-Allan et aI., 2005) and as 
discussed in section 1.4.2.5 there are different subgroups of Tregs that do not 
all express FOXP3, such as IL-I0 secreting Trl cells. This was a relatively small 
study with only 14 patients each in the Hp-infected and uninfected groups 
and doesn't exclude the possibility that increases in FOXP3 and COI27'° might 
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be found in the peripheral blood of Hp+ patients in a larger study. These 
results in combination with others from my colleagues demonstrating 
increased C04+C02Shigh IL-10+ and C04+C02ShighCTLA-4+ T cells and increased 
IL-lO by real-time qPCR in peripheral blood (Greenaway et aI., 2011) make a 
compelling case that the increase in Tregs in the peripheral blood of Hp-
infected patients is real. 
Miyara et 01. describe three subpopulations of human FOXP3+ C04+ T cells. 
"Fraction r' is FOXP31°C045RA +C02S++ and thought to represent resting Treg 
(rTreg) cells. "Fraction II" is FOXP3+C04SRA-C02S+++, has the highest CTLA-4 
expression and highest proliferation index, and is thought to represent 
activated Tregs (aTregs). Both these populations were suppressive in vitro. In 
vivo experiments indicate that rTregs can convert to aTregs. Microarray 
analysis found more IL-10 transcription in aTregs but more TGF-p expression 
in rTregs. The third population with a FOXP31°C04SRA-C02S++ phenotype 
(fraction III) was the greatest producer of IL-17 and did not exhibit 
Suppressive function (Miyara et aI., 2009). The increased C04+C02ShighIL-10+ 
and C04+CO'2S highCTLA-4+ T cells reported in the peripheral blood of Hp-
infected patients could fit with a "fraction II" aTreg phenotype though no 
increase in C04+FOXP3+ cells in the peripheral blood of Hp-infected patients 
has been detected to date. 
Whether the peripheral blood response reflects a "spill over" of the local 
immune response or reflects separate populations of cells, which might 
perhaps home to or from the stomach is unclear. Strong gastric Treg 
responses to Hp are associated with protection from peptic ulcer disease 
(Robinson et aI., 2008). This study did not find an association between 
peripheral blood C04+C02S high Tregs and peptic ulcer disease but my 
colleagues have shown associations between peptic ulcer disease and lower 
frequencies of CTLA-4+ and IL-10+ C04+C02Shigh peripheral blood Tregs 
(Greenaway et al., 2011), reflecting the findings in the stomach. It is possible 
that the C04+C02Shigh cell population contains some other activated cells in 
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addition to the Tregs and more specific markers for Tregs induced by Hp are 
required. 
In a large study by Wang et al. peripheral blood parameters in patients with 
cag+ or cag- Hp and uninfected controls with pathology at different stages 
along the Correa pathway were measured. As the pathology progressed the 
Th1/Th2 ratio reduced and the Treg levels increased in those infected with 
cag+ Hp strains, suggesting gastric pathology is reflected at some level in the 
blood (Wang et aL, 2007b). 
On the other hand although there was no significant difference in frequencies 
of FOXP3 or CD127'° CD4+CD2Shigh events between Hp-infected and 
uninfected patients in blood, FOXP3 expression is increased in Hp-infected 
stomach and correlates with TGF-pl expression (Kandulski et aL, 2008, 
Hussain, 2012). This suggests that gastric and peripheral blood Tregs may 
have distinct phenotypes. 
The increase in Tregs in peripheral blood of Hp-infected patients raises the 
possibility that Hp could have wider effects on the host immune response, 
distant to the stomach. Epidemiological studies have shown an inverse 
association between Hp infection and asthma and allergy, particularly 
infection with cag+ Hp strains (Chen and Blaser, 2007, Amberbir et aL, 2011), 
reviewed by Blaser et al. (Blaser et aL, 2008). Hp infection protects against 
asthma and allergy in mouse models (Arnold et aL, 2011a). DC-derived Il-18 
induced Treg development following exposure to Hp in this model (Oertli et 
aL, 2012). 
Epidemiological studies also show inverse associations between Hp infection 
and autoimmune conditions such as mUltiple sclerosis (li et aI., 2007). 
Conversely Hp eradication is advocated as a treatment for the autoimmune 
disease immune thrombocytopaenic purpura (Malfertheiner et al., 2012, Stasi 
et aI., 2009, Fock et aL, 2009). 
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Hp infection is common, especially in those with lower socioeconomic status, 
so epidemiological studies need to be carefully controlled to account for 
possible confounding factors, including other infections. 
Having demonstrated an Hp-specific Th17 response in the peripheral blood of 
infected patients the rest of this thesis will focus on the local immune 
response to Hp in the stomach. Data on cytokine levels in the Hp-infected 
gastric mucosa are presented in Chapter 5. 
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5. IL-17 AND OTHER TH17-RELATED CYTOKINES IN THE 
GASTRIC MUCOSA 
5.1 INTRODUCTION 
As Th17 is a relatively newly recognized T helper cell population, relatively 
little is known about IL-17 and other Thl7-related cytokines in the context of 
Hp infection in humans. Human research has mainly focused on Thl and 
regulatory T cell responses to Hp. Relative levels of Thl-related and Th17-
related cytokines in human Hp infection have not previously been studied , 
and many investigators have measured cytokines after in vitro stimulation of 
gastric biopsies or cells, which can alter their cytokine profile, depending on 
culture conditions (Veldhoen et aI., 2009). The importance of IL-17 in Hp-
induced disease is also unclear. These questions will be addressed in this 
chapter by using Luminex to analyze cytokine concentrations in snap frozen 
biopsies, which should more accurately reflect the in vivo cytokine 
concentrations. First the existing knowledge about Thl7-related cytokines, 
Thl-related cytokines and other cytokines known to have roles in Hp gastritis 
including IL-8, TNF-a, regulatory cytokines and Th2 cytokines are reviewed. 
5.1.1 Cytokines Produced by Th17 Cells and Cytokines Involved 
in Th17 Differentiation. 
5.1.1.1IL-23, a key cytokine for terminal Th17 differentiation is 
found at increased concentrations in Hp infection 
The discovery of IL-23 in 2000 (Oppmann et aI., 2000) led to the discovery of 
Th17 cells (Aggarwal et aI., 2003, Harrington et aI., 2005, Park et aI., 2005), as 
described in section 1.3.1. IL-23 was known to promote Th17 cells but was 
found not to be critical for the initial differentiation of human Th17 cells from 
na'ive CD4+ T cells (Bettelli et aI., 2006, Veldhoen et aI., 2006, Mangan et aI., 
2006). Levels of IL-23 receptor (IL-23R) are low on na'ive CD4+ T cells but are 
upregulated upon activation of these cells in the presence of T G F - ~ ~ and 
proinflammatory cytokines (Mangan et aI., 2006, McGeachy et aI., 2009). 
Studies using bone marrow chimeric mice with some IL-23R deficient and 
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some normal cells indicate that IL-23 is required for terminal differentiation 
and Th17 effector function in vivo (McGeachy et aL, 2009). This is consistent 
with the protection of IL-23p19 subunit deficient mice from models of 
autoimmune disease (Cua et aL, 2003, Murphy et aL, 2003) and the finding 
that IL-23R polymorph isms are associated with inflammatory bowel disease 
and psoriasis (Duerr et aL, 2006, Dubinsky et aL, 2007, Cargill et aL, 2007). 
Hp can induce DCs to secrete IL-23 (Chapter 3, (Khamri et aL, 2010)). Caruso 
et 01. found increased IL-23 in Hp+ human gastric biopsies by ELISA and 
increased IL-23p19 in the biopsies by RT-qPCR (Caruso et aL, 2008). Gastric 
lamina propria mononuclear cells produced IL-17 in response to IL-23 in vitro 
and this could be abrogated by anti-IL-23 antibody or a STAB inhibitor 
(Caruso et aI., 2008). Serelli-Lee et 01. also found increased IL-23p19 in Hp+ 
gastric biopsies, though the differences between the groups were small 
(Serelli-Lee et aL, 2012). It has been reported that serum Il-23 levels are 
elevated in Hp-infected patients (Jafarzadeh et aL, 2009). IL-23 can also drive 
Il-17 productipn by innate lymphoid cells (Buonocore et aL, 2010). 
5.1.1.2 IL-17: Effects and concentrations in the Up- infected 
gastric mucosa 
Il-17 itself is recognized by a heterodimeric receptor made up of IL-17RA and 
Il-l7RC. This receptor can also recognize IL-17F and IL-17A/F heterodimers 
and is present on epithelial, endothelial and stromal cells. 
IL-17 
Gastric epithelial cells 
Neutrophil 
maturation and 
chemotaxis 
Chemokine 
attracts Th17 and 
Tregs via CCR6 
ligand 
3. Anti-bacterial p e P t t ~ ~
Figure 4.1 Effects of IL-17 mediated via gastric epithelial cells include 
induction of Il-8, G-CSF, CCl20 and anti-bacterial peptide genes. 
Genes that Il-17 induces in these cells include anti-microbial proteins 
(including p-defensins, calgranins, cathelicidin and Iipocalin-2), chemokines 
and neutrophil-activating factors (including G-CSF, GM-CSF, CXCll, CXClS, Il-
8 and CCl20), acute phase proteins (including Il-6 and SAA) and matrix 
metalloproteinases (MMPs) (Gaffen, 2008, Gaffen, 2011) (Figure 4.1). CCR6, 
the CCl20 ligand is present on Th17 cells and Tregs. CCl20 is increased in the 
Hp-infected stomach and falls following Hp eradication (Yoshida et a/., 2009, 
Serelli-lee et a/., 2012, Wu et a/., 2007). 
Extracellular Signal-regulated protein kinase 1/2 (ERK1/2), AP-l, NF-KB and Il-
8 synthesis were induced bV Il-17 treatment of the MKN28 gastric epithelial 
cell line and gastric epithelial cells from Hp-infected patients had higher 
ERK1/2 activation and Il-8 levels, particularly the CagA seropositive subset 
(luzza et aL, 2000). Actl is the key signaling molecule bound by the Il-17 
receptor to trigger downstream signaling pathways including MAPK and NF-
KB (Chang et aL, 2006, Qian et aL, 2007, Ho et a/.) . The Il-17 receptor has a 
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cytoplasmic SEFIR domain, which has homology to the TIR domains found in 
Toll and IL-1 receptors which can bind Actl (Novatchkova et al., 2003). Actl-
deficient mice were protected from the IL-17-mediated disease models EAE 
and dextran sodium sulfate -induced colitis (Qian et aL, 2007). 
Luzza et 01. first demonstrated increased IL-17 in the Hp-infected gastric 
mucosa using semi-quantitative PCR and western blotting in 2000. IL-17 levels 
fell following Hp eradication (Luzza et aL, 2000). Several other studies have 
confirmed increased IL-17 in the Hp-infected stomach in humans (Kimang'a et 
aL, Serelli-Lee et aI., 2012, Caruso et al., 2008) and mice (Algood et aL, 2007, 
Shiomi et aL, 2008, Shi et aL, 2010). IL-17 mRNA was also higher in Hp 
infected children (Luzza et al., 2001). Mizuno et 01. cultured gastric biopsies in 
media with phytohaemagluttinin for 48 hours and measured IL-17 and IL-8 
levels by ELISA in the supernatants. Both IL-17 and IL-8 were increased in the 
Supernatants of Hp-infected compared to uninfected biopsies and IL-17 levels 
correlated with IL-8 levels and neutrophil infiltration. No difference was found 
in cytokine I:vels between Hp+ patients with or without peptic ulcer disease, 
though supernatants from ulcer sites contained more IL-17 than those from 
the antrum of the same patient (Mizuno et aL, 2005). 
5.1.1.3 Concentrations of lL-17 target chemokines in Hp infection 
CCL20 and p-defensin-2 gene expression are increased in gastric biopsies from 
Hp+ patients compared to those from uninfected patients but correlations 
with IL-17 levels have not been investigated (Wu et aL, 2007, Sere iii-Lee et aL, 
2012, Yoshida et aL, 2009). IL-8 and GROa (also known as CXCL1 and KC) 
chemokines, also IL-17 targets, were increased in Hp infected gastric biopsies 
and correlated with Hp density and neutrophil and lymphocyte infiltration 
(Yamaoka et aL, 1998). A number of studies have shown IL-8 secretion in 
response to IL-17 in human gastric epithelial cells lines (Luzza et aL, 2000, 
Mizuno et aL, 2005, Sebkova et al., 2004). Mouse gastric epithelial cells and 
fibroblasts produced the chemokines KC (CXCL1) and LlX (CXCL5) in response 
torecombinant IL-17 (DeLyria et al., 2009). IL-17 increased expression of 
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MMP-2, MMP- 3, MMP-7, MMP- 9, CCl2, CClS, CCl20, CCl2S, CXCLl in a 
mouse gastric cell line (Shi et aI., 2010). Il-17RA knockout mice expressed 
lower levels of KC, L1X and GM-CSF and in keeping with this had lower 
neutrophil infiltration and higher Hp colonization than their wild-type 
counterparts (Algood et aI., 2009). Gastric Il-17 and Il-21 mRNA levels and 
lymphocyte infiltration were increased in the Il-17RA knockout animals and 
they also had increased gastric B cells, lymphoid follicles and Hp-specific 
antibody responses, leading the authors to propose that Il-17 signaling has a 
role in regulation of B cell recruitment (Algood et aI., 2009). 
5.1.1.4IL-17 responses in mouse models of Up infection 
Il-17 responses are associated with protection against Hp infection in mouse 
vaccination models. Delyria et 01. found increased gastric Il-17 mRNA in 
immunized compared to unimmunized mice by day 3 post-challenge. 
Protection was abrogated in neutrophil-depleted immunized mice (Delyria et 
aI., 2009). Velin et 01. found increased gastric Il-17 mRNA and protein on day 
10 after H. '-elis challenge in another mouse vaccination model. Vaccine-
induced protection against Helicobacter was abrogated by anti-ll-17 antibody 
treatment (Velin et aI., 2009, Flach et al.). Kao et 01. adoptively transferred 
Hp-pulsed BMDCs, then infected the mice with Hp in a study to investigate 
the balance of Treg and Th17 differentiation. In this study the Il-17 was 
inversely correlated with Hp colonization density at 2 weeks, but this 
correlation did not persist to the 6 week time point (Kao et al., 2010). 
However in a further study by Delyria et 01., immunized Il-17 and Il-17RA 
knockout mice were not compromised in their ability to reduce Hp load, even 
when anti-IFNy was also given, suggesting substantial redundancy in the 
immune response to Hp vaccination (Delyria et aI., 2011). 
Studies with Il-17 knockout mice have shown reduced neutrophil infiltration 
and reduced Hp colonization compared to wild-type (Shiomi et aI., 2008, Shi 
et aI., 2010, Delyria et aI., 2011). This suggests that Il-17 is not protective in 
these models. However Il-17RA knockout mice had increased levels of 
colonization in addition to reduced neutrophil infiltration, suggesting that Il-
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17 signalling can mediate protection (Algood et aI., 2009). Shi et 01. found IL-
17 increased before IFNy in response to Hp infection and IL-17 knockout mice 
also had reduced Thl responses (Shi et aI., 2010). These findings suggest that 
neutralizing IL-17 may be a good therapeutic strategy to reduce colonization 
levels and Hp-associated pathology. 
A study in which C57BL/6J mice were treated with anti-IL-17A 6 months after 
Hp infection suggested that IL-17 may have an anti-inflammatory role in Hp-
induced gastritis. Levels of gastric IFNy and TNFa. mRNA were increased in the 
mice treated with anti-IL-17A, though IL-12 levels were unchanged (Otani et 
al.,2009). 
5.1.1.5 Th17 effector cytokines in Hp infection 
C04+ Th17 cells are a major source of IL-17 in chronic inflammation and 
infection (sections 1.3.4 and 1.3.5) but are not the only source of this 
cytokine. Other sources include COS+ T cells, yO T cells, NKT cells, 
macrophages, LTis and other ILC3s, paneth cells, and under some 
circumstances neutrophils (see section 1.3.9)(Gaffen, 2011, Cua and Tato, 
Takatori et aI., 2009, Takahashi et al., 200S, Buonocore et aI., 2010). 
IL-17F can also be produced by Th17 cells and signal through the IL-17RA/C 
receptor. IL-17F was less potent than IL-17 at inducing IL-S expression in 
gastric epithelial cell lines (Zhou et aI., 2007b). In a study using gene knockout 
mice Ishigame et 01. showed that IL-17F had little role in mouse models of 
autoimmune disea'se but worked together with IL-17 in defence against 
mucosal infections, particularly by activating epithelial cell innate immunity 
(Ishigame et aI., 2009). Data on this cytokine in the context of Hp infection is 
limited. Kimang'a et 01. studied cytokine expression in gastric biopsies of 
subjects from Kenya and Germany by RT-PCR and found increased IL-17F 
expression in Hp infection. This correlated with IL-17 expression (Kimang'a et 
al.). 
IL-22 is also produced by Th17 cells. It is a member of the IL-l0 family and 
mediates its effects through the IL-22R which is expressed on epithelial cells 
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and pairs with IL-l0R2. Like IL-17, IL-22 can induce expression of 
proinflammmatory cytokines, chemokines and acute phase proteins and also 
induces expression of antimicrobial peptides including l3-defensins and 5100-
family proteins (Ouyang et aL, 2008). It can work with IL-17, for example to 
increase defensin expression in keratinocytes (Liang et aL, 2006). It has a 
crucial role in defence against K. pneumonia and C. rodentium in mice (Aujla 
et aL, 2008, 5atoh-Takayama et aL, 2008). In addition to its roles in 
inflammation and host defense IL-22 affords some protection against tissue 
damage (Zenewicz et aL, 2007) and induces genes involved in wound healing 
and tissue repair (Sa et aL, 2007). IL-22 is increased in inflamed skin and 
Eyerich et al. derived T cell clones that secrete IL-22 but not IL-17 from skin 
biopsies, leading to the proposal of a Th22 lineage (Eyerich et aL, 2009). 
Though it has probably been best studied in the skin IL-22 is also increased in 
inflammation associated with rheumatoid arthritis and inflammatory bowel 
disease (Wolk et aLl. 
Data on IL-?2 in Hp infection are limited. Obonyo found that wild-type mice 
had higher IL-22 expression than MyD88-deficient mice following infection 
with H. /elis (Obonyo et al., 2011). Serelli-Lee et al. found no significant 
difference in IL-22 expression in gastric biopsies from uninfected patients and 
those with current or previous Hp infection by immunofluorescence 
microscopy or ELISA (Serelli-Lee et aL, 2012). 
T cells are a major,source of IL-22 but it can also be produced by ILC3s 
including LTi and NCR+ cells in the intestine (Cupedo et aL, 2009, Wolk et aL, 
Satoh-Takayama et aL, 2008). Murine intestinal p46+ NK cells (NCR+ ILC3s) 
differ from conventional NK cells in that they have low expression of genes for 
cytotoxic molecules and IFNy (Satoh-Takayama et aL, 2008). They express 
RORyt but not IL-17 (Satoh-Takayama et al., 2008). Using lymph nodes from 
human fetal tissue Cupedo et al. showed that CD4- LTi cells could differentiate 
into CD56+CD127+RORC+ NK cells that produced IL-17 and IL-22 but not IFNy 
(Cupedo et al., 2009). 
166 
5.1.1.6IL-21 in Hp infection 
IL-21 can be produced by Th17 cells and can also act in an autocrine manner 
to promote their differentiation (Nurieva et aL, 2007, Zhou et aL, 2007a, Korn 
et aL, 2007). Like IL-6, IL-21 can act via STAT3 to promote Th17 development 
at the expense of Treg development in pro-inflammatory environments 
(Nurieva et al., 2007, Zhou et aI., 2007a). IL-21R forms a receptor complex 
with the common gamma chain and is expressed on T cells, B cells, NK cells, 
dendritic cells, macrophages, fibroblasts and epithelial cells, including gastric 
epithelial cells (Ouyang et aL, 2008, Caruso et aL, 2007a, Monteleone et aI., 
2006) so IL-21 can have a broad range of effects. IL-21 promotes IgG and 
SUppresses IgE synthesis by B cells. Germinal centre T follicular helper cells 
produce abundant IL-21 which is crucial for germinal centre formation 
(Spolski and Leonard). IL-21 also has roles in maturation and stimulation of 
IFNy secretion from Th1, C08+ T cell and NK cells (Ouyang et aL, 2008). Brandt 
et a/found that IL-21 inhibited the activation and maturation of murine 
BMOCs (Brandt et al., 2003) 
IL-21 is produced by activated T cells and increased levels have been shown in 
biopsies from Hp infected patients (Caruso et aL, 2007a), as well as biopsies 
from patients with other gastrointestinal inflammatory diseases including 
Crohn's disease ulcerative colitis and coeliac disease (Monteleone et aL, , 
2005, Fantini et aL, 2008, Fina et aL, 2008). IL-21 increased secretion of the 
chemokine CCL20 by a colon epithelial cell line (Caruso et aL, 2007b). It also 
promotes tissue damage by increasing expression of matrix 
metalloproteinases (MMPs), as demonstrated using gastric epithelial cells 
lines and fibroblast cell lines derived from the colons of patients with Crohn's 
disease (Caruso et aI., 2007a, Monteleone et aL, 2006). 
Algood et a/ infected IL-17RA knockout and wild-type mice with Hp and 
measured Th17 cytokine production by RT-qPCR at 3 and 6 months. Levels of 
IL-21 were increased at both time points in the IL-17RA knockout mice, as 
were IL-17 levels. The authors suggest that this could be due to lack of a 
negative feedback loop (Algood et al., 2009). 
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S.1.1.7 Other Th17-differentiating cytokines in Hp infection: IL-lft 
and IL-6 
I l - 1 ~ ~ is involved in differentiation of human Th17 cells {Acosta-Rodriguez et 
aL, 2007a, Volpe et aL, 2008} but was of interest in Hp research before the 
discovery ofTh17 cells. It stimulates secretion of the hormone gastrin {levi et 
aL, 1989, Robinson et aL, 2007, Takashima et aL, 2001}, which in turn 
stimulates gastric acid secretion. However, I l - 1 ~ ~ itself inhibits gastric acid 
secretion in animal models {Takashima et aL, 2001, Uehara et aL, 1989, 
Waghray et aL}. I l - 1 ~ ~ polymorphisms are associated with gastric cancer risk 
{EI-Omar et aL, 2000}. Sonic hedgehog, a morphogen initially identified in 
Drosophila, may contribute to the link between I l - l ~ ~ and cancer as I l - l ~ ~
inhibited sonic hedgehog expression {Waghray et aL} and reduced sonic 
hedgehog expression is associated with precancerous changes {Shiotani et aL, 
2005}. Gastric I l - l ~ ~ is upregulated in infection by cagA+ Hp strains {Yamaoka 
et aL, 1997}. I l - l ~ ~ increases Il-8 and MMP-3 expression in gastric epithelial 
cell lines {Gooz et aL, 2003}. Eradication of Hp does not always prevent the 
development of gastric cancer, particularly if precancerous changes have 
begun to develop (Wong et al., 2004). Serelli-Lee et al. found that gastric I L - l ~ ~
levels remained elevated in patients who had previously been infected with 
Hp. They hypothesize that this may drive the persistent Th17 response they 
identify following Hp eradication and that chronic Th17 gene activation may 
lead to carcinogenesis {Serelli-Lee et al., 2012}. Active I L - l ~ ~ is cleaved from 
p r o - / l - 1 ~ ~ precursor by caspase-l. IL-IR-1- mice failed to develop vaccine-
induced immunity to Hp but were protected against gastric inflammation and 
precancerous changes {Hitzler et al., 2012b}. I L - l ~ ~ is produced by antigen 
presenting cells including macrophages and dendritic cells {Chapter 3} and 
also by gastric epithelial cells {Lindholm et aL, 1998}. 
like I l - l ~ , , the proinflammatory cytokine IL-6 is involved in Th17 
differentiation {Bettelli et aL, 2006, Acosta-Rodriguez et aL, 2007a, Manel et 
aL, 2008, Zhou et aL, 2007a}. Increased levels of IL-6 are present in Hp-
infected gastric mucosa {Crabtree et al., 1991}. Hp induces IL-6 production by 
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the gastric epithelium (Lindholm et aI., 1998) as well as strongly upregulating 
IL-6 secretion by antigen presenting cells (Chapter 3), (Odenbreit et aI., 2006, 
Gobert et aI., 2004). IL-6 is increased in gastric cancer but, unlike IL-8, fell with 
Hp eradication (Yamaoka et aI., 2001). 
5.1.2 Cytokines Produced by Th1 Cells and Cytokines Involved 
in Th1 Differentiation 
5.1.2.1IFNy response to Hp infection in humans 
Early studies found increased IFNy+ in the Hp-infected stomach that correlated 
with inflammation using immunohistochemistry (Lindholm et aI., 1998, 
Lehmann et aI., 2002, Holck et aI., 2003). Flow cytometry studies in the late 
1990s found increased IFNy+ lymphocytes in Hp-infected human gastric 
biopsies following in vitro stimulation with PMA and ionomycin (Bamford et 
aL, 1998, Sommer et aI., 1998) but gastric T cells from uninfected patients can 
also secrete IFNy following mitogen stimulation (Sommer et al., 1998, Itoh et 
aL, 1999). ~ o r e e recent flow cytometry data and studies looking at cytokine 
production by cells cloned from Hp-infected gastric mucosa are discussed in 
section 1.4.2.3. Lehmann et 01. found increased IFNy and TNF-a staining in 
gastric biopsies from Hp-infected patients which positively correlated with 
activity and grade of gastritis, local density of Hp and apoptosis of stromal 
cells (Lehmann et aI., 2002). Bontems et 01. found increased IFNy in Hp-
infected biopsies compared to uninfected biopsies from both adults and 
children with approximately 10-fold lower concentration in children 
compared to adults using cytokine bead array, adjusted for biopsy weight and 
ELiSPOT (Bontems et al., 2003). Shimuzu et 01. also studied gastric biopsies 
from children but homogenized in PBS with ultrasound homogenizer and 
adjusted ELISA results for total protein. They confirmed higher IFNy levels in 
antral biopsies of Hp-infected compared to uninfected children but did not 
find any correlation with neutrophil or lymphocyte infiltration (Shimizu et aL, 
2004). 
Pellicano et 01. disrupted biopsies using a lysis buffer and found increased 
IFNy and Il-12 in Hp-infected compared to un infected biopsies by ELISA 
(adjusted for total protein). Those with higher mononuclear cell infiltrates had 
higher Il-12 and IFNy levels (Pellicano et al., 2007). 
Case-control studies indicate that a polymorphism in the interferon gamma 
receptor 1 is associated with increased risk of early onset gastric cancer 
(Canedo et aI., 2008). 
5.1.2.2 IFNy response to Hp in mice and Mongolian gerbils 
Mice also mount an IFNy response to Hp infection (Sawai et aI., 1999, 
Smythies et aI., 2000, Algood et aI., 2007, Akhiani et al., 2002). IFNy knockout 
mice were protected from gastric inflammation (Smythies et aI., 2000, Akhiani 
et aI., 2002, Sawai et al., 1999) and were not able to upregulate the 
inflammatory mediators inducible nitric oxide synthase (iNOS) and 
macrophage inflammatory protein-2 or clear H. /e/is infection like their wild-
type counterr.arts (Obonyo et aI., 2002, Hitzler et aI., 2012b). Addition of IFNy 
with Hp increased iNOS expression in gastric epithelial cells compared to 
treatment of the cells with Hp alone (Perfetto et al., 2004). A study using Hp-
infected Mongolian gerbils found that IFNy levels correlated with activity and 
inflammation and were higher in the gerbils with ulcers (Yamaoka et aI., 
2005). Sayi et 01. found that in addition to correlating with chronic 
inflammation IFNy levels correlated with the pre neoplastic changes of 
atrophy and epithelial hyperplasia (Sayi et al., 2009). Even in the absence of 
Hp infection mice infused with IFNy developed atrophy and intestinal 
metaplasia (Cui et aI., 2003). 
A number of studies report a protective role for IFNy in mouse vaccination 
models (Akhiani et aI., 2002, Sayi et aI., 2009, Shi et aI., 2005) but others 
found a small or no protective effect associated with IFNy (Sawai et aI., 1999, 
Garhart et al., 2003). In some vaccination studies IFNy levels correlated with 
reduced colonization levels but there was no reduction in protection when 
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IFNy was neutralized with antibody or IFNy knockout mice were used (Flach et 
aI., Garhart et al., 2003). 
A recent study comparing wild type, p35 and p19 knockout mice infected with 
H. felis or H. pylori found no difference in colonization density between the 
three groups, suggesting that neither Il-12 nor Il-23 is essential for a 
protective response. The p19 knockout group did have some reduction in 
gastritis and preneoplasia in the Hp infection model (Hitzler et aI., 2012a). 
IFNy is sometimes thought of as a T cell cytokine but can also be produced by 
NK cells in response to Hp (Lindgren et al.). THYlhiSCAl+ IlC3s also produce 
IFNy and Il-17 in response to Il-23 (Buonocore et aL, 2010). 
5.1.2.3 IL-18 in Hp infection 
Il-18 was identified as an IFNy-inducing factor (Okamura et al., 1995) and is 
often described as a Thl cytokine. Like I l - l ~ ~ it is processed to its mature form 
by caspase-l. Tomita et 01. found increased Il-18 expression in the antrum of 
Hp-infected patients compared to uninfected controls with normal mucosa 
using semi-quantitative PCR (Tomita et aL, 2001). Yamauchi et 01. also found 
increased Il-18 in the Hp-infected gastric antrum at both the mRNA and 
protein level and demonstrated Il-18 secretion by primary gastric epithelial 
cells in response to Hp. In contrast, Kimang'a et 01. found that Il-18 mRNA 
levels did not differ between Hp+ and Hp- patients from Germany and Kenya 
(Kimang'a et aL). Some of the uninfected patients in this group did have a 
degree of inflammat'ion on histopathology scoring whereas the Hp-infected 
patients were compared to uninfected patients with normal mucosa in the 
other two studies. It is not clear which part of the stomach the biopSies used 
for the RT-qPCR studies were taken from in Kimang'a et 01. 's study. More 
recently Il-18 has been shown to drive differentiation of Tregs which can 
prevent the development of asthma in a mouse model (Oertli et aI., 2012). In 
keeping with this regulatory role for Il-18, Il-18-1-mice had increased 
inflammation and precancerous changes one month after Hp infection 
compared to their wild-type littermates (Hitzler et al., 2012b). 
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5.1.3 Other Cytokines Investigated in the Hp-Infected Gastric 
Mucosa 
5.1.3.1 Other pro-inflammatory cytokines: IL-8 and TNF-a 
Il-8 is a neutrophil chemoattractant. Increased Il-8levels are found in the Hp-
infected gastric mucosa and are associated with Hp density and inflammation 
scores (Yamaoka et aI., 1998, Yamaoka et aI., 1997, Holck et aI., 2003, 
Kimang'a et al., Shimizu et aI., 2004, Yamaoka et aI., 1995). Il-8 is expressed 
by gastric epithelial cells via an NF-KB-dependent pathway (Sharma et aI., 
1998). Gastric epithelial cell lines express more Il-8 when exposed to cag+ Hp 
strains than cag- strains (Sharma et aI., 1995). Increased Il-8 is also found in 
gastric biopSies of patients infected with cag+ strains (Yamaoka et al., 1998, 
Yamaoka et al., 1997). In vitro studies using cell lines suggest that CagA is 
necessary for epithelial TlR2 and TlR5 upregulation which allows Il-8 and 
TNF-a expression (Kumar Pachathundikandi et al.). Usually Il-8 falls following 
Hp eradication (Moss et al., 1994, Sere iii-lee et al., 2012), but levels are 
increased in gastric cancer, especially advanced stage, where they appear to 
be independent of Hp infection (Yamaoka et aI., 2001). As mentioned above, 
Il-8 is now known to be an Il-17 target gene. 
Increased TNF-a has been found in Hp-infected gastric mucosa using a range 
of methods (Crabtree et al., 1991, lindholm et aI., 1998, D'Elios et al., 1997, 
B'odger et al., 1997). It was higher in Hp-infected patients with active gastritis 
(Crabtree et al., 1991) and correlated with Hp density and inflammation 
SCores (Lehmann et aI., 2002). However, Bontems et 01. reported that there 
Was no difference in numbers of TNF-a secreting cells between Hp-infected 
and un infected adults or children (Bontems et aI., 2003). This was a relatively 
small study. EIiSPOT was used to investigate the number of cytokine-secreting 
cells whereas the total amount of cytokine secreted or mRNA levels were 
measured in the other studies. Yamaoka et 01. did not detect any TNF-a 
mRNA at all in Hp-infected or uninfected patients (Yamaoka et al., 1995), but 
later reported increased TNF-a in Hp-infected antral biopSies at the protein 
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level (Yamaoka et aI., 1997). TNF-a and IL-113 upregulate Fas in vitro 
(Houghton et al., 2000), and Fas-induced apoptosis is thought to contribute to 
breakdown of the epithelial barrier in Hp infection (Suerbaum and Michetti , 
2002). Proinflammatory polymorphisms in TNF-a increase gastric cancer risk 
(EI-Omar et aI., 2003). Two proteins produced by Hp that can induce TNF-a 
secretion and translocate into host cells have been identified: HP0596 gene 
produces a protein known as TNF-a-inducing protein (Tipa) (Suganuma et aL, 
2005) and the JHP940 locus produces a kinase (Rizwan et al., 2008, Kim et al.). 
Hp strains isolated from gastric cancer patients produced more Tipa than 
those from Hp patients with chronic gastritis (Suganuma et aL, 2008). 
5.1.3.2 Anti-inflammatory cytokines: lL-10 and TGF-p 
Anti-inflammatory cytokines found in the gastric mucosa include IL-10 and 
TGF-I3. Expression of both these cytokines is increased in the Hp-infected 
gastric mucosa (Li and Li, 2006, Robinson et aL, 2008, Holck et aL, 2003, 
Lindholm et aL, 1998). Those with peptic ulcer disease had less gastric IL-10-
secreting Tregs'(Robinson et al., 2008). IL-27 can induce IL-10-secreting type 1 
regulatory T (Tr1) cells at the expense of pro-inflammatory Th17 cells (Pot et 
aI., 2011) and has been shown to induce aryl hydrocarbon receptor which can 
interact with c-maf, to promote T cell IL-10 secretion in the intestine (Apetoh 
et aL, 2010). However, its expression in the Hp-infected stomach has not yet 
been studied. Bodger et 01. found that IL-10 secretion of gastric biopsies from 
HP-infected patients \Vas significantly higher than that from gastric biopsies 
from uninfected patients with chronic gastritis (Bodger et al., 1997). Hp-
infected gastric cancer patients produced more IL-10 upon Hp stimulation of 
their peripheral blood T cells and had higher gastric IL-10 mRNA levels than 
asymptomatic Hp+ patients (Lundin et aL, 2007). Proinflammatory IL-10 . 
Polymorph isms are associated with an increased risk of non-cardia gastric 
cancer (EI-Omar et al., 2003). 
Hp increases TGF-13 expression by the gastric epithelium and upregulates TGF-
13 receptor on C04+ T cells (Beswick et aL, 2007). Li et 01. found increased 
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mucosal TGF-f3 in Hp infection which correlated positively with the severity of 
gastritis (Li and Li, 2006). Similarly Kandulski found TGF-f3 correlated with 
FOXP3 expression, which also correlated positively with inflammation 
(Kandulski et aL, 2008). Tregs are likely to be recruited to limit the pro-
inflammatory response and may sustain inflammation by reducing anti-
bacterial immunity. Robinson et aI's. findings of low Treg frequencies in peptic 
ulcer disease (Robinson et aL, 2008) suggests that the Tregs may protect from 
ulceration by reducing inflammation. Harris et 01. found increased Tregs, IL-lO 
and TGF-f3 in Hp-infected children compared to adults, which could fit with 
the anti-inflammatory response protecting from Hp-induced disease (Harris et 
aL,2008). 
5.1.3.3IL-4 
Hp-infected IL-4-1- mice had more severe gastritis than their wild-type 
counterparts, suggesting that IL-4 could also have an anti-inflammatory role 
(Smythies et al., 2000). This could be at least in part due to the mutual 
antagonism between IFNy-producing Th1 cells and IL-4-producing Th2 cells. 
Studies investigating IL-4 expression at both the mRNA (in children) and 
protein level by immunohistochemistry reported no difference between Hp-
infected and uninfected patients (Lindholm et aL, 1998, Shimizu et al., 2004). 
Marotti et 01. isolated mononuclear cells from gastric biopsies and counted 
the number of IL-4- secreting cells using EJiSPOT. In keeping with the 
previously mentioned studies they found no difference between mononuclear 
cells from Hp-infected and uninfected patients when the cells were 
unstimulated, however, mononuclear cells isolated from gastric mucosa of 
Hp-infected patients showed increased numbers of IL-4-secreting cells upon 
Hp antigen stimulation whereas those from uninfected patients did not 
(Marotti et aL, 2008). Robinson et 01. also found a strong CD4S+CD4+/L-4+ 
response in Hp-stimulated mononuclear cells derived from Hp-infected 
biopsies compared to biopsies from uninfected patients using flow cytometry 
(Robinson et aJ., 2008). This study also found increased IL-4 mRNA in gastric 
biopsies from Hp-infected adults compared to uninfected controls {Robinson 
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et aI., 2008). As discussed in Chapter 3, Hp promotes thymic stromal 
Iymphopoietin production by gastric epithelial cells (Kido et aI., 2010) which 
favours a Th2 bias (Rimoldi et al., 2005). 
175 
5.2 AIMS 
i. To confirm that Il-17 levels are increased in the Hp-infected gastric 
mucosa. 
ii. To determine the most sensitive method for quantifying Il-17 protein 
and other cytokines of interest in gastric biopsies and optimize this 
method. 
iii. To compare relative levels of Th1 and Th17 cytokines. 
iv. To correlate Il-17 levels with cag and dupA virulence factors. 
v. To correlate Il-17 with histopathological findings and Hp-related 
disease. 
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5.3 RESULTS 
5.3.1 IL-17 Levels are Increased in the Hp-Infected Gastric 
Mucosa 
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Figure 5.2IL-17A mRNA levels increased in the Hp-infected gastric mucosa 
(RT-qPCR). mRNA was extracted from gastric tissue biopsies from 41 Hp-
infected and 14 uninfected patients. Relative IL-17A levels were calculated by 
normalizing against GAPDH and expressing levels relative to a negative 
comparator reference sample prepared from 14 uninfected biopsies. Boxes 
.. 
represent the 25 th to 75 th centiles, horizontal lines within the boxes represent 
the median and the whiskers depict the 5th and 95 th centiles. The Mann-
Whitney U-test was used for Statistical analysis. 
Il-17mRNA and protein expression was first investigated by RT-qPCR and 
ELISA to confirm increased IL-17 expression in the Hp-infected gastric mucosa. 
Il-17 mRNA expression was 42.6-fold higher in biopsies from Hp-infected 
compared to 'uninfected patients (p<0.0001)(Figure 5.2). 
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To confirm these results at the protein level gastric biopsies were initially 
homogenized in 250 III PBS and IL-17A ELISA performed on the supernatants. 
Results were adjusted for the total weight of gastric tissue. 
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Figure 5.3 IL-17 levels are increased in the Hp-infected gastric mucosa. 
Gastric biopSies from 7 Hp-infected and 7 uninfected patients were 
homogenized in PBS and IL-17 measured by ELISA in the supernatants. 
Multiple gastric biopsies were required for many of the samples from 
yninfected patients in order for IL-17 levels to reach sufficient concentration 
to be measured by ELISA. 
Luminex technology enables measurement of mUltiple cytokines in a single 
sample of small volume (usually 25-50 III compared to 100-200 III per ELISA). 
This has the potential to allow quantitation of multiple cytokines in small 
gastric biopsies, without in vitro culture or stimulation, which may affect 
cytokine concentrations. Luminex kits from 3 different manufacturers were 
therefore compared and methods optimized. 
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5.3.2 Luminex Kit Comparison and Optimization 
luminex kits from 3 different manufacturers (R&D Versa MAP, BioRad BioPlEX 
and Millipore M/lliPlEX) were compared for accuracy, sensitivity and 
precision of Il-17 and IFNy cytokine measurement. Biopsies were processed in 
RPM I-based media, as described in Material and Methods (Chapter 2) and 
spiked with a range of known concentrations of cytokine (0.75, 1.5, 6, 50, 100 
and 1000 pg/m/). 
Observed Il-17 values were closest to expected with the VersaMAP kit at 50 
pg/ml and over, where the BioPlEX and M/lliPlEX kit gave lower than 
expected readings. The M/lliPlEX kit performed best at lower spiked 
concentrations (Figure 5.4A). Il-17 background levels in unspiked samples 
were 0, 0 and 1.78 pg/ml for the BioPlEX kit and a little higher at 0, 2.49 and 
2.37 pg/ml for M/lliPlEX and 3.45, 0 and 7.19 pg/ml for the VersaMAP kits. 
Accuracy was poor below 6 pg/m/. For the 6, 50, 100 and 1000 pg/mlll-17 
spikes the percentage recovery ranged between 85-123% for VersaMAP, 31-
47% for BioPlEX and 27-69% for M/lliPlEX. However, it could be argued that 
linearity and consistency are more important than the absolute values 
obtained. 
The IFNy spikes were recovered with the highest degree of accuracy in the 
M/lliPlEX kit. In general the VersaMAP kit gave lower than expected readings 
and the BioPlEX kit higher than expected readings for IFNy (Figure 5.4B). High 
levels of background were detected in the wells containing supernatant from 
biopsies disrupted in RPMI/l0%FCS/protease inhibitor with no cytokine spike 
with the BioPlEX kit when analyzing for IFNy (49.19, 263.99 and 1193.72 
pg/m/). Background levels with Versa MAP (2.25, 0.42 and 0 pg/m/) and 
M/lllPlEX (0.3, 6.73 and 4.54 pg/m/) kits were much lower. A well with 
RPMl/lO% FCS/Protease inhibitor only yielded an IFNy reading of 1177.74 
pg/ml with the BioPlEX kit compared to 0 pg/ml for PBS/Protease inhibitor, 
suggesting that the IFNy detection antibody in this kit may react with a 
component of the RPMI/l0% FCS medium. Percentage recovery ranges for 
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IFNy were 2.7-7.2% for VersaMAP, 57.5-476.0 for BioPLEX and 22.2-103.7 for 
MILLIPLEX. 
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Figure 5.4 Recovery of spiked IL-17 (A) and IFNy (8) with Luminex kits from 3 
different manufacturers. Single biopsies were processed in RPM/-based 
media and the supernatants from 3 biopsies from the same donor combined. 
This supernatant was spiked with known concentrations of cytokine, then 
divided into 3 aliquots to test with the 3 different kits. Key for both shown at 
top left of A). 
Next the sensitivity and operative range of each kit was compared by 
assessing the lower limit of quantitation (LLOQ), upper limit of quantitation 
(ULOQ) and linear dynamic range based on the standard curves extended 
down to SO.5 pg/ml. 
LLOQ ULOQ LOR Standard curve 
(pg/mL) (pg/mL) (pg/mL) (pg/mL) 
VersaMAP 5.9 4,643 5.9 4,643 0.2 4,616 (19.0) (4616) 
IL-17 BioPLEX 1.3 23,036 1.3 5,120 0.3 21,505 (1.3) (21,505) 
MILLIPLEX 3.4 8,938 3.4 8,938 
0.2 9,000 
(3.2) (10,000) 
VersaMAP 0.3 5,754 1.0 2,398 
0.3 6,620 
(27.2) (6620) 
IFNy BioPLEX 8.1 30,660 26.5 7,661 
0.5 30,646 
(1.9) (30,646) 
MILLIPLEX 2.8 9,144 2.8 9,144 
0.2 9,000 
-
(3.2) (10,000) 
Table 5.1 Lower Limit of Quantitation (LLOQ) and Upper Limit of 
QUantitation (ULOQ), Linear Dynamic Range (LOR) and Standard Curve 
Ranges for the three kits tested for IFNy and IL-17. Standard curves shown 
are based on extended dilution series with figures in brackets showing lower 
arid upper limits suggested by each manufacturer. Lower and upper limits of 
quantitation were automatically calculated by the BioPLEX manager 6.0 
software (using 5 parameter logistic non-linear regression model, after 
excluding points on the standard curve with recovery outside of 80-120% of 
expected). The linear dynamic range (LOR) was defined as the lowest and 
highest standards on the linear part of each standard curve on a log-log plot. 
For IFNy the VersaMAP kit had the lowest LLOQ but for IL-17 BioPLEX had the 
lowest LLOQ. The ULOQ was highest with the BioPLEX kit for both IFNy and IL-
17, however wider linear dynamic ranges were obtained using the MILLIPLEX 
kit (Table 5.1). 
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Wells with bead counts <37 were excluded as at least this number is required 
to minimize the potential impact of outlier beads on median fluorescence 
intensity (MFI). Low bead counts were more common with the VersaMAP kit 
(>90% of samples on some runs and up to 1 in 3 standard/control wells). In 
contrast, low bead counts were not observed in any standard/control wells 
and in 11% and 1% of samples respectively for the BioPLEX and MILLIPLEX 
kits. This may have been a result of greater median bead aggregation 
observed for the VersaMAP kit than for the BioPLEX and MILLIPLEX kits (29% 
vs 11% and 12% respectively). 
Repeatability (precision) was investigated for the BioPLEX and MILLIPLEX kits 
only. 
CV% 
Sample 1 Sample 2 Sample 3 Mean 
IFNy BioPLEX 33.56 33.56 168.17 87.54 
MILLIPLEX 30.45 63.28 35.83 43.19 
IL- BioPLEX 16.52 6.81 22.66 15.33 
17 
MILLIPLEX 25.65 10.79 23.84 20.09 
Table 5.2 Precision of IFNy and IL-17 measurement by BioPLEX and 
MILLIPLEX kits. 3 sets of 4 identical spiked supernatants from biopsies 
disrupted in PBS-based media were included at different positions on the 
same plate and the % Coefficient of Variation (%CV) calculated for each 
(mean/SO x 100). 
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Repeatability was better for IL-17 than for IFNy. In this analysis the 
repeatability was better with the MILLIPLEX kit for IFNy but with the BioPLEX 
kit for IL-17 {Table 5.2}. 
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Manufacturers have validated Luminex kits for use with serum, plasma and 
tissue culture supernatants but there are no standard protocols for 
preparation of tissue samples for Luminex assays. We therefore compared 
processing methods and extraction buffers using paired biopsies from 4 
further patients. Within each pair one biopsy was spiked at 100 pg/ml and the 
other Ifunspiked" biopsy with buffer only. The biopsies were then processed, 
split into aliquots to test using different kits, and frozen at -80°C until analysis. 
Manual sample disruption using a mini pellet pestle with or without 
homogenization using a needle and syringe, and automated processing using 
a TissueLyser LT bead-basher (QIAGEN) were compared. Cytokine spikes were 
recovered more accurately from samples processed manually (Table 5.3). 
p value for 
Median cytokine recovered manual vs 
(pg/ml) automated 
Manual processing Automated processing 
processing 
Pestle + + + TissueLyser 
Needle/syringe + + 
Benzonase + 
IL-17 BioPLEX 56 51 68 30 0.033 
MILLIPLEX 52 42 62 37 0.12 
IFNy BioPLEX 143 164 182 9 0.056 
MILLIPLEX 55 41 70 4 0.017 
Table 5.3 Comparison of manual and automated processing methods and 
effect of adding benzonase to the extraction buffer. Gastric mucosal biopsies 
were spiked with 100pg/ml of IL-17 and IFNV prior to manual biopsy 
processing. Data were adjusted for background using paired unspiked 
biopsies from the same patient, and are equivalent to percentage spiked 
cytokine recovery. 
184 
Additional homogenization using a needle and syringe following disruption 
with a pestle did not improve cytokine recovery (Table 5.3). Homogenization 
with a needle and syringe lead to loss of sample volume, which was retained 
in equipment dead space. Addition of the endonuclease benzonase was also 
evaluated. Digestion of nucleic acids by benzonase may reduce sample 
viscosity. There was a trend for increased cytokine recovery when benzonase 
was included in the extraction buffer but this did not reach statistical 
significance (Table 5.3). 
MILLIPLEX kits were used for subsequent analyses as they had demonstrated 
good accuracy and reasonable sensitivity and precision. They had the 
advantage of only requiring 25 ~ I I sample, compared to 50 ~ I I for the other 
kits. MILLIPLEX also have a Th17 panel and other panels available, covering 
most of the cytokines of interest. 
When comparing cytokine concentrations in different gastric biopsies it is 
necessary to control for biopsy size. This can be done by adjusting for biopsy 
weight as for the ELISA data in Figure 5.2 and by Serelli-Lee et 01. (Serelli-Lee 
et aL, 2012). Another approach is to adjust for total protein concentrations 
measured by either modified Lowry, Bradford or BCA assays (Crabtree et al., 
1991, Yamaoka et aL, 1997, Yamaoka et aL, 2001, Hwang et al., 2002, Shimizu 
et aL, 2004, Yamauchi et aL, 2008). Similar to previous studies (Kusugami et 
aL, 1999), the gastric biopsies were small with mean (± SO) weight of 4.3 ± 2.9 
mg (n=18). Snap frozen samples are associated with variable amounts of 
water and mucus during thawing, so weight was a less reliable measure of 
biopsy tissue content for these samples. 
The final processing method selected after optimization comprised: 
disruption in 300 ~ L L of PBS-based buffer, with benzonase and protease 
inhibitors, with a pellet pestle on ice, homogenization by repeated aspiration 
into a 200 ~ L L filter pipette tip to minimize volume loss, incubation on ice, 
centrifugation and division of the supernatant into aliquots for storage. 
(further details are given in section 2.3.2.2). 
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5.3.3 Cytokine Levels in The Gastric Antrum of Patients with Hp 
Infection and Uninfected Controls 
Snap frozen gastric biopsies from 62 Hp+ and 34 uninfected patients were 
processed as above and IL-17 concentrations in the supernatants measured 
by Luminex. 
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Figure 5.5 IL-17 is increased in the Hp-infected stomach and correlates with 
IL-17 mRNA levels. A) Snap frozen gastric biopsies from 62 Hp-infected 
patients and 34 uninfected controls were processed in PBS-based media and 
the supernatants assayed for IL-17 by Luminex. B) IL-17 mRNA levels were 
available for 26 of the Hp-infected patients and were correlated with the 
Luminex results. 
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In keeping with the RT-qPCR and ELISA results, there was a highly significant 
increase in Il-17 in the Hp-infected stomach (Figure 5.5A). The luminex and 
RT-qPCR results correlated positively (Figure 5.5B). 
Concentrations of Il-17F, which is also produced by Th17 cells were also 
measured. 
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Figure 5.6 IL-!7F is increased in the Hp-infected stomach and is correlated 
with IL-!7. A) Snap frozen gastric biopsies from 45 Hp-infected patients and 
23 uninfected controls were processed in PBS-based media and the 
supernatants assayed for Il-17F by luminex. B) IL-17 and Il-17F results were 
correlated for 45 Hp+ patients. 
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IL-17F was significantly increased in the Hp-infected stomach and correlated 
tightly with IL-17 levels (Figure 5.GA and B). 
IL-17 can upregulate expression of a number of chemokines including CCL20 
and IL-8 by epithelial cells and other cells upon IL-17 receptor binding (Gaffen, 
2008). CCL20 is a ligand for CCRG which is found on Tregs and Th17 cells. IL-8 
is chemotactic for neutrophils. Mizuno et 01. previously reported that IL-8 
concentrations correlated with IL-17 concentrations in the supernatants of 
Hp+ gastric biopsies cultured in vitro with phytohaemagluttinin for 48 hours. 
Concentrations of these chemokines in snap frozen gastric biopsies and 
correlations with IL-17 were investigated next. 
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Figure 5.7 The IL-!7 target chemokines CCL20 and IL-8 are increased in the 
Hp-infected stomach and correlate with IL-!7. Snap frozen gastric biopsies 
were processed in PBS-based media and A) supernatants from 60 Hp-infected 
patients and 34 uninfected controls assayed for CCL20 and B) supernatants 
from 47 Hp-infected patients and 27 uninfected controls assayed for IL-8 by 
Luminex. C) IL-17 and CCL20 results were correlated for 58 Hp+ patients. 0) IL-
17 and IL-8 results were correlated for 47 Hp+ patients. 
There was a highly significant increase in CCL20 and IL-8 in the Hp-infected 
gastric mucosa (Figure 5.7 A and B). CCL20 and IL-8levels correlated strongly 
with IL-17 levels (Figure 5.7 C and 0). 
Levels of IL-22 (often produced by Th17 cells) were not significantly different 
between Hp-infected and uninfected patients (data not shown). 
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Next concentrations of the Th17-differentiating cytokines IL-21 and IL-23 
were quantitated. 
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Figure 5.8 IL-23 and IL-21 levels are reduced in the Hp-infected stomach. 
Snap frozen gastric biopsies were processed in PBS-based media and A) 
supernatants from 58 Hp-infected patients and 33 uninfected controls 
assayed for IL-23 and B) supernatants from 64 Hp-infected patients and 34 
uninfected controls assayed for IL-8 by Luminex. 
There were relatively high levels of IL-23 in all the gastric biopsies. These were 
unexpectedly slightly higher in the uninfected controls compared to the Hp-
infect ed patient biopsies (Figure 5.8A). IL-21 can be produced by Th17 cells 
and can be involved in their differentiation. IL-21 levels were also significant ly 
higher in the uninfected control biopsies compared to the Hp-infected 
biopsies (Figure 5.8B). There was no significa nt positive or negative 
correlation with IL-17 for IL-23 or IL-21 (data not shown). 
IL-1P and IL-6 are also involved in human Th17 differentiation but there was 
no significant difference between either of these cytokines in the Hp-infect ed 
and uninfected control groups (data not shown). 
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There was no significant difference in levels of the Thl-related cytokines IL-
12p70 and IFNy between the Hp-infected and uninfected groups, t hough 
there was a trend towards higher IL-12p70 in the uninfected group (p=0.087). 
Nor were any significant differences found between the Hp-infected and 
uninfected groups in the pro-inflammatory cytokines TNF-a or GM-CSF or the 
Th2 cytokine IL-4 (data not shown). 
As discussed in section 5.1.3.2., increased levels of the regulatory cytokine IL-
10 in the human Hp-infected gastric mucosa have been well documented 
(Bodger et aL, 1997, Holck et aL, 2003, Robinson et aL, 2008). Sources of IL-l0 
include Trl Tregs, which can be induced by IL-27, which also inhibits Th17 
differentiation (Pot et aL, 2011). IL-27 concentrations in Hp-infected gastric 
mucosa have not previously been investigated. 
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Figure 5.9 IL-I0 and IL-27 are increased in the Hp-infected stomach. Snap 
frozen gastric biopsies were processed in PBS-based media and A) 
supernatants from 59 Hp-infected patients and 33 uninfected controls 
assayed for IL-l0 and B) supernatants from 59 Hp-infected patients and 32 
uninfected controls assayed for IL-27 by Luminex. 
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Il-l0 concentrations were very significantly increased in the Hp-infected 
stomach (Figure 5.9A), consistent with the known increase in Tregs in the Hp-
infected gastric mucosa. Il-27 was also significantly upregulated in the Hp-
infected stomach (Figure 5.9B). There was a positive correlation between Il-
10 and Il-27 levels (Spearman's rank correlation p=0.51, p=0.009, n=25). 
Tregs express CCR6 and can be recruited by CCL20, however no significant 
correlation was found between CCl20 and Il-l0 concentrations (data not 
shown). 
Il-2 can promote Tregs at the expense of Th17 cells via STAT5 signalling 
(laurence et aI., 2007) but no significant difference in Il-2 levels between the 
biopsies from Hp-infected and uninfected patients was found (data not 
shown). T G F - ~ ~ levels were not measured in this study. 
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5.3.4 Relative Levels ofThl and Th17 Cytokines in the Hp-
Infected Gastric Mucosa 
Hp infection in humans is known to cause a Th1 response (section 1.4.2.3) 
(Robinson et aL, 2008, Pellicano et aL, 2007) and more recently Th17 
responses have been demonstrated in this study (Chapter 6) and by others 
(Caruso et aL, 2008, Serelli-Lee et aL, 2012). However, the relative importance 
of these two types of pro-inflammatory T cell responses is not known. 
Relative levels of IL-23 and IL-12, which are pro-Th17 and Th1-differentiating 
factors respectively, and the signature Th17 and Th1 cytokines, IL-17 and IFNy 
respectively, in the Hp-infected gastric mucosa were therefore compared. 
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Figure 5.10 Pro-Th17'cytokine Il-23 and Th17 signature cytokine Il-17 are 
more prevalent than Thl-differentiating cytokine Il-12 and Thl signature 
cytokine IFNy. IL-23 and IL-12p70 levels were measured in supernatants of 
gastric biopsy supernatants by Luminex as above and relative levels were 
compared (Mann-Whitney U-test). 
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IL-23 protein levels were much higher than IL-12p70 protein levels in gastric 
tissue (Figure s.lO). This was also the case in Hp-negative biopsies where 
there was also 179-fold more IL-23 than IL-12p70 (p<O.OOO1). 
In biopsies from Hp-infected patients there were 3.9-fold higher levels of IL-
17 than the Thl signature cytokine IFNy (Figure s.10). However in biopsies 
from uninfected patients there was no significant difference in IFNy and IL-17 
levels. 
Samples were spiked with known concentrations of IFNy and IL-12 to confirm 
that the Luminex assay was able to detect these cytokines satisfactorily. 
IL-17 and IFNy mRNA expression was also compared in 22 Hp-infected 
patients. There was significantly more upregulation of IL-17 mRNA than IFNy 
mRNA (p=0.016, 3.3-fold) (Figure s.l1). 
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Figure S.11IL-17 mRNA expression is higher than IFNy mRNA expression in 
the Hp-infected gastric mucosa. mRNA was extracted from gastric tissue 
biopsies from 22 Hp-infected patients. Relative expression of the 1L17 and 
IFNG genes was normalized to against GAPDH and expressed relative to a 
comparator reference sample prepared from 14 uninfected biopsies. Relative 
expression of the two genes was compared. 
The RT-qPCR data was analyzed using the Pfaffl method which takes account 
of the RT-qPCR efficiency for each gene of interest and the GAPDH used to 
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normalize (Pfaffl, 2001). RT-qPCR efficiencies for each gene are given in 
section 2.4. 
No correlation was found between IL-17 and IFNy concentrations at the 
protein level. This may reflect difficulty accurately measuring low 
concentrations of IFNy. There was a strong trend towards a weak positive 
correlation of 1L17 and IFNG mRNA expression, n=25, Spearman's p=0.40, 
p=0.051 (data not shown). 
5.3.5 Correlation of IL-17 Levels and Hp Virulence Factor Status 
Hp strains that are cagPAI+ are associated with increased risk of both peptic 
ulcer disease and gastric cancer. MoDCs secreted lower concentrations of IL-
12 family cytokines, including IL-23, when stimulated with Hp strains with 
mutated cagE (Figure 3.9). This suggests that infection with cagPAI+ strains 
could lead to increased gastric IL-17 levels. Gastric Il-8levels are known to be 
increased in cagA+ compared to cagA- gastritis (Yamaoka et aI., 1999). This 
has been ascribed to stimulation of NOD1 by peptidoglycan delivered to 
gastric epithelial cells through the cagPAI-encoded type IV secretion system 
activating NF-KB and hence upregulating IL-8 expression (Figure 1.4) (Viala et 
aI., 2004). If IL-17 concentrations were found to be higher upon infection with 
cagPAI+ strains this could be a further mechanism for IL-8 upregulation. 
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The cagA gene was used as a marker for the cagPAI. Biopsies from patients 
infected with cag+ strains of Hp did not have higher Il-17 levels than those 
from patients infected with cag- Hp strains (Figure 5.12A). Il-8 levels were 
higher in cag+ biopsies, as expected (Figure 5.12B). 
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Figure 5.12 IL-17 and'IL-8levels stratified by Hp and cag status. Biopsies 
from Hp infected patients were homogenized in PBS-based media and A} Il-17 
and B} Il-8 levels in the supernatants measured by luminex. Results were 
stratified by cag status. 
The virulence factor dupA has been associated with increased risk of 
duodenal ulceration and higher gastric Il-8 levels in vivo (lu et aI., 2005, 
Hussein et aI., 2010). Hussein et al. found that monocytes produced less Il-
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12p40, IL-12p70 and IL-23 when stimulated by dupA-deficient Hp strains, 
suggesting that this virulence factor could work with stimulation of immune 
cells rather than the gastric epithelium (Hussein et aI., 2010). Stimulation of 
MoDes with isogenic dupA mutants also reduced IL-12p70 and IL-23 secretion 
(Figure 3.9). IL-17 levels were therefore stratified by dupA status to see if this 
virulence factor is associated with higher gastric IL-17 levels in vivo. Patients 
found to have dupA2 were included in the dupA- group as this truncated form 
of dupA is not thought to be fully functional (Hussein et aI., 2010). No 
significant difference was found between IL-17 concentrations in biopsy 
supernatants from 10 patients infected with dupA- and 5 patients infected 
with dupA+ Hp strains (data not shown), however data on both gastric IL-17 
concentration and dupA status was only available for a small number of 
patients, so this finding needs to be interpreted with some caution. 
There were not sufficient numbers of Hp+ patients with IL-8 concentration 
measurements where dupA status was known to assess for an association 
between these variables. 
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5.3.6 Association of IL-17 Levels with Histopathological 
Parameters and Peptic Ulcer Disease 
As IL-17 is known to upregulate chemokines which recruit lymphocytes and 
neutrophils correlations of gastric mucosallL-17 concentrations with immune 
cell infiltration were investigated. 
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Figure 5.13 Association of Il-17 levels with inflammation and activity scores. 
Biopsies were taken from 43 Hp+ patients. One biopsy from each patient was 
snap frozen, then homogenized in PBS-based media and IL-17 levels in the 
supernatant measured by Luminex. Further biopsies were scored by an 
experienced gastrointestinal histopathologist for A) Inflammation score 
(lymphocyte infiltration) and B) Activity score (neutrophil infiltration). IL-17 
levels were stratified by the histopathological parameters. 
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There were trends for increasing IL-17 with increasing inflammation score 
(p=0.082) and activity score (p=0.059)(Figure 5.13A and B). As numbers with 
very high inflammation and activity scores were low (n=3), IL-17 levels in 
those with low (1) and high (2 or 3) inflammation scores were also compared 
using the Mann-Whitney U test. Using this method those in the group with 
high inflammation scores had significantly higher IL-17 concentrations 
(p=0.024). Similarly, a comparison of those with substantial neutrophil 
infiltration (activity score 2 or 3) had significantly higher IL-17 levels than 
those with no or minor neutrophil infiltration (activity score 0 or 1) 
(p=0.031).This is in keeping with the role of IL-17 in recruitment of neutrophils 
and lymphocytes. 
Gastric IL-8 concentrations were less closely associated with immune cell 
infiltration than IL-17 concentrations (data not shown). Kruskal-Wallis analysis 
of IL-8 concentrations stratified by inflammation score resulted in a p value of 
0.44 and a similar analysis for IL-8 and activity scores gave a p value of 0.40. 
The p values for association of IL-8 with neither the inflammation nor activity 
activity scores approached significance when the Mann-Whitney U-test was 
used for grouped analysis. 
Th17 cells have been shown to be increased in a number of cancers, including 
g a ~ t r i c c cancer (section 1.3.6). It is not clear if the IL-17 response to Hp 
infection contributes to carcinogenesis, or if gastric tumours promote Th17 
responses following malignant transformation. To address this question IL-17 
levels were stratified by the presence or absence of precancerous changes 
(atrophy and/or intestinal metaplasia). 
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Figure 5.14 IL-17 levels stratified by absence of presence of intestinal 
metaplasia and/or atrophy and Hp density score. Biopsies were taken from 
43 Hp+ patients. One biopsy from each patient was snap frozen, then 
homogenized in PBS-based media and IL-17 levels in the supernatant 
measured by Luminex. Further biopsies were scored by an experienced 
gastrointestinal histopathologist for A) Atrophy and intestinal metaplasia and 
B) Hp density. IL-17 levels were stratified by the histopathological parameters. 
No association was found between IL-17 levels and the presence of 
precancerous changes (atrophy and/or intestinal metaplasia)(Figure 5.14A), 
nor was there an association between IL-17 levels and Hp density score 
(Figure 5.14B). 
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To investigate the hypothesis that Th17-related inflammation contributes to 
PUD IL-17 mRNA and protein concentrations were stratified by the presence 
or absence of PUD. 
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Figure 5.15 IL-17 levels are not increased in peptic ulcer disease. A) mRNA 
was extracted from gastric tissue biopsies from 41 Hp+ patients (20 with and 
21 without peptic ulcer disease) and relative IL-17A levels calculated by 
normalizing against GAPDH and expressing levels relative to a negative 
comparator reference sample. B) IL-17 levels were measured in supernatants 
of gastric biopsy supernatants from 61 Hp+ patients (32 with and 29 without 
peptic ulcer disease) by Luminex as above. IL-17 levels in the presence and 
absence of peptic ulcer disease were compared. 
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No significant difference in IL-17 at the mRNA or protein level was found 
between Hp-infected patients with and without peptic ulcer disease (Figure 
5.15A and B). 
Thankyou to Dr Richard Ingram for RT-qPCR IFNG data and help with Luminex 
assays. 
202 
5.4 DISCUSSION 
5.4.1 IL-1' Levels are Increased in the Hp-Infected Gastric 
Mucosa 
Increases in IL-17 at the mRNA (Figure 5.2) and protein level (Figure 5.3 and 
Figure 5.5A) in the Hp-infected gastric mucosa have been confirmed using RT-
qPCR, ELISA and Luminex techniques. Other studies that have investigated IL-
17 mRNA levels in the Hp-infected gastric mucosa have not quoted fold 
differences compared to uninfected controls (Luzza et aI., 2000, Caruso et aI., 
2008, Kimang'a et al.). Here the fold difference in IL-17 mRNA between gastric 
biopsies from Hp-infected patients and uninfected controls (42.6-fold) was 
much greater than the fold difference in protein levels (6.1-fold and 3.5-fold 
for ELISA and Luminex respectively). It is possible that not a1i1L-17 mRNA is 
translated into protein, or that the protein is degraded more rapidly than the 
mRNA. 
Initially IL-17 protein levels were studied by ELISA, adjusting for the total 
weight of the biopsies. Serelli-Lee et 01. measured IL-17 supernatants from a 
similar number of biopsy culture supernatants using ELISA, adjusted for 
biopsy weight and also found approximately 6-fold more IL-17 in patients with 
active Hp infection compared to those that had never been infected (Serelli-
Lee et aI., 2012). Mizuno et 01. found a similar fold increase in IL-17 
concentrations (adjusted for total protein rather than weight) in the 
supernatants of Hp+ gastric biopsies following 48 hours of in vitro culture, 
with higher levels in the gastric ulcer compared to non-ulcer patient biopsies 
(Mizuno et aI., 2005). Subsequently Luminex was used in the current study to 
maximize data from the gastric biopsies. 
5.4.2 Luminex Kit Comparison and Optimization 
Gastric biopsies have a variable amount of mucus and water associated with 
them, so we found that weight did not provide a very reliable measure of the 
tissue content of the biopsy. Total protein content of biopsies was therefore 
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measured, using BCA assay and IL-17 results adjusted for total protein levels. 
Several authors investigating cytokine levels in gastric mucosa have taken the 
approach of adjusting for total protein levels measured by either modified 
Lowry, Bradford or BCA assays (Crabtree et aI., 1991, Yamaoka et aI., 1997, 
Yamaoka et aI., 2001, Yamauchi et aI., 2008). 
Analyzing cytokine levels in the supernatants of snap frozen homogenized 
gastric biopsies should reflect the inflammatory state of the gastric mucosa at 
the time of biopsy. This would be expected to more directly reflect the actual 
cytokine levels present than studying their mRNA levels or measuring 
cytokines after in vitro culture. Many cytokines are only present at low 
concentration in the gastric mucosa, so measuring their levels in small 
mucosal biopsies presents a technical challenge. ELISA usually requires at 
least 100 III sample for each cytokine to be measured. Often it was necessary 
to use more than one gastric biopsy to obtain IL-17 levels within the range of 
the assay, especially for uninfected patients. 
Luminex allows multiplexing so that many cytokines can be measured in 25-
50 III sample in a single assay. In addition to allowing data on many more 
cytokines to be obtained from valuable gastric biopsies this allows direct 
comparison of levels of different cytokines in the same sample. Sensitivity is 
similar to ELISA but biopsies can be homogenized in a small volume of 
extraction buffer, thereby increasing cytokine concentrations. 
All Luminex methods have in built replicates in the sense that the 
quantification reaction occurs on the surface of multiple beads for each 
analyte in each well, which are analyzed independently. 
RPM I-based extraction buffer gave some very high background IFNy readings 
with the BioPLEX kit. PBS-based extraction buffer was therefore used for the 
main study. 
The BioPLEX kit was the fastest assay to run with the longest incubation time 
only 30 minutes. Both the VersaMAP and MILLIPLEX kits had incubations of 2 
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hours after adding the samples, then 1 hour after adding the biotinylated 
antibody. 
The MILLIPLEX kit had the advantage of only requiring 25 ul sample, whereas 
the VersaMAP and BioPLEX kits required 50 ul sample. It was also relatively 
accurate and reasonably sensitive and precise. Most of the analytes of 
interest were available for MILLIPLEX so this was used for further analysis. 
5.4.3 Cytoldne Levels in Gastric Antral Biopsies from Patients 
with Hp Infection and Uninfected Controls 
IL-17 levels were measured in 62 Hp-infected patients and 34 uninfected 
patients and were found to be 3.5-fold higher in those with Hp infection. This 
is the largest study of IL-17 protein levels in Hp infection to date. IL-17 levels 
were not measured by Luminex in the biopsy supernatants used for ELISA, so 
a direct comparison of IL-17 ELISA and Luminex results was not possible. 
IL-17F protein was shown to be increased in Hp-infected gastric biopsies for 
the first time. IL-17F correlated strongly with IL-17 levels. This correlation has 
been shown previously at the mRNA level (Kimang'a et al.), and might be 
expected as IL-17 and IL-17F are both produced by Th17 cells. 
The chemokine CCL20 is important for attracting CCR6+ Th17 cells and Tregs. 
Its expression by epithelial cells is upregulated by IL-17, I l - ~ , , TNFo. and IL-21 
(KiJO et aL, 2005, Caruso et aL, 2007b, Wu et aL, 2007). Murine peritoneal 
macrophages cultured with Hp also upregulated CCL20 (Zhuang et al.). T cells 
in the gastric mucosa of Hp-infected patients express high levels of CCR6 
compared to peripheral blood T cells from the same patients (Duerr et aL, 
2006), suggesting that CCR6+ cells are preferentially recruited to the inflamed 
stomach. Others have previously demonstrated increased CCl20 in the Hp-
infected human gastric mucosa (Yoshida et aL, 2009, Serelli-lee et al., 2012, 
Duerr et aL, 2006) but this is the first time that it has been shown to correlate 
with IL-17 levels. CCL20 has anti-microbial effects against organisms including 
Escherichia coli, Pseudomonas aeruginosa, Moraxella catarrhalis, 
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Streptococcus pyogenes, Enterococcus /aecium, Staphylococcus aureus and 
Candida albicans (Yang et aL, 2003). However it is associated with chronic 
gastritis in Hp infection (Yoshida et aL, 2009). 
IL-8 is thought to have a key role in Hp-induced pathology due to its 
neutrophil-attracting properties and is probably the most extensively studied 
cytokine in Hp research. It was therefore helpful to include it in this study to 
validate the methods used against previously published data as well as to 
confirm the association between IL-8 and IL-17. Numerous other studies have 
found highly significant increases in IL-8 protein during Hp infection, but most 
have used semi-quantitative immunohistochemistry (Holck et aL, 2003) or 
ELISA which found median IL-8 concentrations in uninfected controls to be 0 
pg/ml (Yamaoka et aL, 1997, Yamaoka et aL, 1998), making it impossible to 
calculate a fold difference, or values were not given (Shimizu et al., 2004). A 
recent study by Serelli-Lee et al. used Luminex and found that IL-8 was 46-fold 
increased in biopsies from Hp-infected gastric biopsies compared to those 
from uninfected controls. This study found a smaller, 20-fold difference, but 
Sere iii-Lee et al. adjusted for biopsy size using weight whereas total protein 
levels were used here so the results are not directly comparable. 
Mizuno et al. previously reported a strong correlation between IL-8 and IL-17 
levels in supernatants of gastric biopsies cultured with phytohaemagluttinin 
for 48 hours. Strong correlation between these cytokines was evident again 
here in snap frozen gastric biopsies. 
Given the marked increase in IL-17 concentrations in the Hp-infected gastric 
mucosa levels of other Th17 effector cytokines were also investigated. No 
significant difference was found in IL-22 levels between Hp-infected biopsies 
and those from uninfected controls. This is consistent with recent 
immunohistochemistry and ELISA findings by Sere iii-Lee et al. (Serelli-Lee et 
aI., 2012). Th17 cells are not all the same. The cytokines they produce may 
vary depending on the stimulating pathogen and local factors such as 
availability of AhR ligands (Zielinski et aI., 2012, Veldhoen et aI., 2008a, 
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Quintana et aL, 2008, Veldhoen et aL, 2009). Mouse studies indicate that Il-
22 present in mucosal tissue may have roles in homeostasis and tissue repair 
(Zenewicz et aL, 2008, Sugimoto et aL, 2008, Pickert et aL, 2009). It is possible 
that even in the absence of an additional Hp-induced Il-22 response, this 
baseline Il-22 can synergize with Il-17 to promote anti-bacterial immunity 
(liang et aL, 2006). 
High levels of Il-23 were found in the gastric mucosa, as previously reported 
(Caruso et aL, 2008). However, in contrast to the findings of Caruso et 0/., no 
increase in Il-23 was found in the gastric mucosa of Hp-infected patients in 
this study, in fact their Il-23 levels were slightly lower than those found in 
uninfected controls. Increased Il-23p19 mRNA has also been reported in the 
Hp-infected gastric mucosa (Caruso et aL, 2008, Serelli-lee et aL, 2012). No 
mention of exclusion of patients taking PPls or antibiotics was made in the 
study by Caruso et 0/./ which could have led to failure of detection of Hp 
infection in some of the patients classified as Hp negative. As gastric Il-23 
levels are so high in both infected and uninfected patients it is unlikely that 
this cytokine will be a limiting factor restraining T cell differentiation. 
Caruso et 0/. previously reported increased Il-21 in Hp-infected gastric 
biopsies by RT-qPCR and western blotting. This might be expected, as Il-21 is 
often produced by Th17 cells and can promote their differentiation, but 
contrasts with the findings of this study which detected a highly significant 
reduction in Il-21 protein levels in gastric biopsies of Hp-infected patients 
compared to un infected controls. As in the other study by Caruso et 0/. 
discussed above, patients taking proton pump inhibitors or antibiotics were 
not excluded, which could have led to some misclassification of Hp status. 
Raw Il-21 data from Hp+ and uninfected biopsies were compared to exclude 
the possibility that high total protein levels in the Hp+ biopSies were causing 
spuriously low adjusted Il-21 levels. Raw Il-21 levels were also significantly 
lower in the Hp+ biopsies (there was a non-statististically significant trend 
towards higher total protein levels in the Hp+ biopsies). Il-21 can also be 
produced by the Trl group of regulatory T cells (Apetoh et aL, 2010, Pot et al., 
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2011) and may have an anti-inflammatory role. However, IL-10 secreting 
Tregs are increased in the Hp-infected human stomach (Robinson et aI., 
2008), so this does not explain the reduced IL-21 levels found in the Hp-
infected gastric biopsies here. 
In keeping with published immunohistochemistry, flow cytometry and PCR 
data (lindholm et aI., 1998, Holck et aI., 2003, Robinson et aI., 2008), there 
was a highly significant increase in IL-10 levels in the Hp-infected compared to 
uninfected biopsies. Much of this IL-10 is likely to be derived from 
CD4+CD2Shlgh Tregs (Amberbir et aI., 2011, Robinson et al., 2008). IL-27 was 
also shown to be increased in the Hp-infected stomach for the first time. This 
is consistent with its role in inducing IL-10 secreting regulatory T cells 
(Fitzgerald et aI., 2007, Stumhofer et aI., 2007, Awasthi et al., 2007, Pot et al., 
2011). IL-2 has the potential to shift the balance between Th17 cell and Tregs 
but there was no significant difference in IL-2 between the Hp-infected and 
uninfected groups. 
5.4.4 Relative Levels ofThl and Th17 Cytokines in the Hp-
Infected Gastric Mucosa 
Though the presence ofTh1 and Th17 cytokine responses in the human Hp-
infected gastric mucosa have been reported previously (lindholm et aI., 1998, 
Pellicano et aI., 2007, Luzza et aI., 2000) little has been published about their 
relative magnitudes. IL-17 levels were 3.9-fold higher than IFNy levels in 
gastric biopsies from Hp-infected patients (unpaired analysis), suggesting that 
the Th17 response predominates. Samples were spiked with known 
concentrations of IFNy and IL-12 to confirm that the Luminex assay was able 
to detect these cytokines satisfactorily. The gastric IFNy concentrations 
detected were of a similar order of magnitude to those found in a study of Hp 
infected children by Shimizu et 01. (Shimizu et aI., 2004). 
Greater upregulation of IL-17, compared to IFNy, was also confirmed at the 
mRNA level by RT-qPCR. Pro-Th17 cytokine IL-23 was 179-fold more prevalent 
than the Th1-differentiating cytokine IL-12 in the Hp+ gastric biopsies. This 
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again suggests a Th17 bias, although other cytokines are also involved in Th17 
and Th1 differentiation (Manel et aL, 200S, Wong et aL, 2009, Acosta-
Rodriguez et aL, 2007a, Volpe et aL, 200S). IL-23 levels were also significantly 
higher than IL-12 levels in the uninfected gastric mucosa. 
In a recent study Serelli-Lee et 0/. used ELlSAs to measure IL-17 and IFNy. 
Lamina propria mononuclear cells were cultured with phytohaemagglutinin 
and IL-2 and culture supernatants assayed. Biopsy weight rather than total 
protein was used to adjust for biopsy size, so the results are not directly 
comparable. In contrast to findings of the current study Sere iii-Lee et 0/. 
reported median IL-17 concentrations S9 pg/ml/g tissue and 
IFNy concentrations 173 pg/ml/g tissue. The in vitro culture or other 
methodological differences with the current study could account for the 
discrepant findings. It is also possible that differences in the study populations 
could have contributed to the differences. 
Relative levels of IL-12(p70) and IL-23 produced by DCs co-cultured with Hp in 
vitro were investigated in Chapter 3. MoDCs produced much more IL-12(p70) 
than IL-23, and naiVe CD4+ T cells co-cultured with the Hp-primed MoDCs had 
corresponding high IFNy responses. MyDCs co-cultured with Hp produced 
low levels of IL-23 but undetectable IL-12(p70), yet naive CD4+ T cells co-
cultured with the Hp-primed MyDCs produced more IFNy than IL-17 (Chapter 
3). This strong in vitro IFNy response is at variance with the Luminex findings 
from snap frozen gastric biopsies and RT-qPCR findings. This raises questions 
as to how well the in vitro DC models reflect the gastric mucosa in vivo. In 
contrast to the in vitro situation where only DCs and nai·ve CD4+ T cells were 
present, supernatants of snap frozen gastric biopsy homogenates will contain 
cytokines derived from additional cell types, including epithelial cells and 
innate immune cells. IL-17 and IFNy can be produced by CDS+ T cells, NK cells, 
NKT cells, yo T cells and other innate-like cells such as ILCs including LTis, 
which could be present in the gastric mucosa, in addition to conventional 
CD4+ T cells. Simple in vitro models cannot entirely mimic the complexity of 
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the gastric mucosa where multiple cell types interact and tissue factors may 
also influence C04+ T cell differentiation. The source of Il-17 in the Hp-
infected gastric mucosa is investigated in Chapter 6. 
5.4.5 Correlation of IL-17 Levels and Hp Virulence Factor Status 
Neither cagA nor dupA status correlated with gastric Il-17 levels, though 
numbers studied were low, particularly for dupA status so an association 
cannot be completely excluded. Il-8 concentrations were higher in biopsies 
infected with cagA+ Hp strains, as expected, validating the methods used. The 
lack of Il-17 correlation with virulence factor status is in keeping with the lack 
of direct association found between Il-17 and peptic ulcer disease or 
precancerous changes. It is possible that localized, rather than total biopsy, Il-
17 concentrations are important for the development of disease, or that Il-17 
has a role at a particular stage of disease (see below). It is now recognized 
that Th17 cells are heterogeneous. Some may co-secrete Il-10 and have a 
regulatory phenotype, whilst others may co-express IFNy and/or GM-CSF and 
be more pro-inflammatory (Peters et aI., 2011). This may cloud the picture 
regarding the role of Il-17. 
5.4.6 Association of IL-17 Levels with Histopathological 
Parameters and PeptiC Ulcer Disease 
5.4.6.1 Association of1L-17 concentrations with Inflammation 
and activity scores 
As Il-17 protein levels were measured in gastric biopsies from a large number 
of Hp+ patients in this study it was possible to assess for associations between 
gastric Il-17 levels and histopathological scores and clinical features. High 
inflammation scores (measure of mononuclear cell infiltration) and high 
activity scores (measure of neutrophil infiltration) were associated with 
higher Il-17 levels upon grouped analysis, though the trends did not quite 
reach significance when analyzed using Kruskal-Wallis (Figure 5.13A and B). 
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Given the role of Th17 cells in the recruitment of these types of immune cell 
to sites of inflammation this association might be expected. IL-8 
concentrations did not correlate with inflammation or activity scores. Mizuno 
et 01. previously showed that IL-17 levels in gastric biopsy culture 
supernatants correlated more strongly with mononuclear cell infiltration and 
neutrophil infiltration than IL-8levels (Mizuno et aI., 2005). In this study 
neutrophils and monocytes were quantified, whereas here the category-
based Sydney scoring system was used. 
5.4.6.2 Association o/IL-17 concentrations with precancerous 
changes 
Zhang et 01. found increased Th17 cells in the peripheral blood of gastric 
cancer patients, with higher levels in those with advanced stage cancer. They 
also detected increased Th17 cells in the tumour draining lymph nodes and 
increased serum IL-17 in patients with advanced gastric cancer (Zhang et al., 
2008a).lida et 01. found higher IL-17 mRNA levels in gastric cancer tissue 
compared to normal adjacent tissue, which were higher in tumours of 
patients with more advanced stage disease (Iida et al., 2011). This study also 
reported that most C04+ cells in gastric tumours co-stained for IL-17 using 
immunohistochemistry (Iida et aI., 2011). Increased IL-17 has also been 
reported in a number of other types of malignancy including ovarian, breast, 
hepatoce"ular, renal, pancreatic and prostate cancers (Kato et al., 2001, Zhu 
et aI., 2008, Zhang et aI., 2009, Kryczek et aI., 2007, Steiner et aI., 2003). 
The findings of increasing IL-17 and Th17 cells in tumour draining lymph 
nodes in gastric cancer suggest that Th17 ce"s/IL-17 might have a role in 
carcinogenesis, but it is also possible that the tumour microenvironment 
promotes IL-17 production following neoplastic transformation. Su et 01. 
studied the effect of tumour cell lines and tumour-derived fibroblast cell lines 
on na'ive C04+ T cells to help address this issue. Both cell lines increased the 
number of Th17 cells when na'ive C04+ T cells from peripheral blood were 
used, though the increase was more marked with the tumour-derived 
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fibroblasts (Su et aI., 2010). However, the same cell lines did not increase 
Th17 cells when na'ive C04+ T cells from cord blood were used, suggesting the 
Th17 cells in cancer may be from recruitment and expansion of existing Th17 
cells rather than de novo differentiation of completely na'ive T cells. In the 
same study attraction of Th17 cells by supernatants from tumour cell and 
tumour-derived fibroblast cell lines was reduced by antibodies against MCP-l 
and RANTES. Expression of these chemokines by tumour cell lines was 
increased upon stimulation with TLR ligands and the N002ligand muramyl 
dipeptide (Su et aI., 2010). 
The literature on the role of IL-17 in cancer is mixed. IL-17-I - mice have been 
reported to have more rapid tumour growth (Kryczek et al., 2009b, Martin-
Orozco et aI., 2009), but other studies have reported slower tumour growth in 
IL-lT1- and IL-17R-1- mice (Wang et aI., 2009, He et al., 2010). IL-17 can 
promote angiogenesis (Numasaki et al., 2003) and studies have found that 
high levels of IL-17-producing cells in hepatocellular carcinoma and non-small 
cell lung patients (measured by immunohistochemistry) are associated with 
increased tumour microvessels and reduced survival (Zhang et aI., 2009, Chen 
et aI., 2009). On the other hand ovarian cancer patients with higher ascitic 
fluid IL-17levels had increased survival (Kryczek et aI., 2009b). Mouse 
melanoma IFNy-secreting Th17 cells and C08+ IL-17-secreting "Tc17" cells can 
mediate anti-tumour immunity (Garcia-Hernandez et aI., 2010, Muranski et 
aI., 2008, Hinrichs et al., 2009). The Th17 and Treg lineages are closely related. 
As Tregs can down regulate anti-tumour immunity, the balance between Tregs 
and Th17 cells in the tumour microenvironment may be critical. Gnerlich et 0/. 
demonstrated that adding IL-6 to murine pancreatic cancer skewed the 
balance, increasing Th17 cells numbers, reducing tumour growth and 
increasing survival (Gnerlich et aI., 2010). 
IL-17 may be produced by cells other than Th17 cells in the tumour 
microenvironment, including C08+ T cells and macrophages (Kryczek et aI., 
2007, Zhu et aI., 2008). Th17 cells in tumours produce other cytokines in 
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addition to Il-17. The phenotype and function of tumour infiltrating Th17 cells 
is discussed further in section 1.3.6. 
Studying gastric biopsies from patients with precancerous changes may help 
to elucidate whether Il-17 has a role in carcinogenesis. As patients with the 
precancerous changes of atrophy and intestinal metaplasia were uncommon 
in our cohort, patients with either or both of these histopathological changes 
were combined. No significant difference was found between gastric mucosal 
Il-17 levels in those with and without precancerous changes (Figure 5.14A). 
Similarly, Mizuno et 01. did not find any association between Il-17 levels 
secreted in their gastric biopsy culture system and degree of atrophy or 
intestinal metaplasia (Mizuno et aI., 2005). Though numbers are relatively 
small, this suggests that Il-17 may not have a significant role in initiation of 
gastric carcinogenesis but may modulate tumour growth once neoplastic 
transformation has occurred. 
5.4.6.3 lL-17 concentrations and Up density scores 
No association was found between Il-17 levels and Hp density (Figure 5.14B). 
An earlier study by luzza et 01. positively correlated Il-17 mRNA, as well as 
IFNy, Il-12 and Il-8 mRNA levels with Hp density in children (luzza et al., 
2001). This study did not find any correlation between inflammation or 
activity scores and Il-17 levels in the Hp-infected children but numbers were 
quite low (n=13). It is clear that the human host mounts an Il-17 response to 
Hp infection but Il-17 promotes a range of anti-bacterial responses, including 
anti-bacterial peptide expression, recruitment of lymphocytes, neutrophils 
and other phagocytes (liang et aI., 2006, Gaffen, 2008). Presumably in chronic 
Hp infection in the adult human stomach a balance is reached between the 
bacteria provoking an Il-17 response and the Il-17 limiting bacterial numbers. 
5.4.6.4 Association of lL-17 concentration and peptic ulcer 
disease 
Neither Il-17 mRNA levels nor Il-17 protein were associated with peptic ulcer 
disease (Figure 4.15A and B). Nor was an association found between GM-CSF 
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or TNF-a, which can be produced by Th17 cells, and occurrence of peptic 
disease in this study. Previous data on IL-17 and peptic ulcer disease is 
limited. Mizuno et al. measured IL-17 levels in gastric biopsy culture 
supernatants and also found no significant difference in levels between their 
Hp-infected peptic ulcer and ulcer-free groups (Mizuno et aI., 2005). 
However, in the same study IL-17 levels in the supernatants of biopsies taken 
from the gastric ulcer site were higher than those in the supernatants of 
biopsies taken from the antrum of the same patients, suggesting that IL-17 
may contribute locally to mucosal inflammation and breakdown. Jafarzadeh 
et al. found higher serum IL-17 levels in Hp-infected patients with duodenal 
ulcers compared those with asymptomatic infection (Jafarzadeh et aI., 2009). 
The relationship between Th17 cells and peptic ulcer disease and the cellular 
sources of gastric IL-17 will be investigated in Chapter 6. 
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CHAPTER 6 
THt7 AND OTHER IL-t7-
PRODUCING CELLS IN THE 
GASTRIC MUCOSA 
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6. TH17 AND OTHER IL-17-PRODUCING CELLS IN THE 
GASTRIC MUCOSA 
6.1 INTRODUCTION 
6.1.1 Gastric Th17 Response to Hp 
As shown previously by others (Luzza et aI., 2000, Caruso et aI., 200S, Serelli-
Lee et aI., 2012) and confirmed in Chapter 5 (Figures 5.2, 5.3 and 5.5), IL-17 is 
significantly increased in the human Hp-infected gastric mucosa. However, 
there is little published data on which cells produce the IL-17. Caruso et al. 
found increased numbers of both C04+ and COS+ IL-17-producing T cells in the 
Hp-infected mucosa by flow cytometry, though this was a small study with 
only 5 Hp+ subjects and COS+ T cells were not positively identified (Caruso et 
aI., 200S). Serelli-Lee et al. found that C04+,L-17+ cells identified by 
immunofluorescence microscopy were increased in those with previous Hp 
infection compared to those who had never been infected, but the difference 
between those with active infection and those who had never been infected 
was not significant (Serelli-Lee et aI., 2012). 
Th17 responses to Hp have been better studied in mice. Hp urease subunit B 
promoted Th17 responses in vitro and when used to immunize mice (Zhang et 
aI., 2011). There is evidence that Th17 cells are protective in mouse 
vaccination models (Velin et al., 2009, OeLyria et aI., 2009), though it has also 
been reported that vaccinated mice can be immune to Hp challenge in the 
absence of IL-17 (OeLyria et aI., 2011). IL-17/Th17 responses precede 
IFNy/Th1 responses in mice (Algood et aI., 2007, Shi et aI., 2010). IL-23-1- mice 
had increased levels of Hp but reduced IL-17, IFNy and inflammation (Horvath 
et aI., 2012). Th1 responses were also reduced in IL-17-I - mice, suggesting that 
Th17 and Th1 responses to Hp may act synergistically (Shi et aI., 2010). 
Th17 cells are the best characterized producers of IL-17, but as discussed in 
Section 1.3.9, a number of other cell types can act as sources of IL-17. These 
include other types of T cells, such as COS+ T cells, yo T cells and NKT cells and 
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non-T cell innate lymphoid sources including LTi-like cells and other members 
of the recently designated ILC3 group (Billerbeck et aI., 2010, Huber et al., 
2009, Kondo et aI., 2009, Ortega et aL, 2009, Sutton et aL, 2009, Martin et al., 
2009, Rachitskaya et aL, 200S, Ooisne et aL, 2009, Takatori et al., 2009, 
Buonocore et aL, 2010). 
Here cells from Hp+ and uninfected gastric biopsies were stained with C03, 
C04, COS and IL-17 and analyzed by flow cytometry, allowing identification of 
Th17, Tc17 and C04-COS-'L-17+T cells. 
6.1.2 The Role ofTh17 and Other CD4+ Tcell Subsets in Hp-
induced Disease 
The few studies of the human Th17 response to Hp have not investigated 
associations with disease, although Th17 responses are known to contribute 
to pathology in Hp-infected mice (Shi et aL, 2010, Horvath et aL, 2012). In this 
chapter the Th17 marker RORC2 is correlated with histopathological findings 
and disease giving novel insights into the role of Th17 cells in Hp-induced 
disease in humans. 
C04+ T cells are required for development of gastric pathology in mouse Hp 
and H. felis infection models (Eaton et aL, 2001, Roth et al., 1999). Nagai et 01. 
found that transfer of naive C04+ T cells into Rag2-1- mice two months after Hp 
infection induced gastritis (Nagai et aL, 2007). A recent study by Hitzler et 01. 
confirmed that a J ~ ~ T cells are required to reduce H. felis colonization and for 
development of H. felis-induced precancerous changes (Hitzler et al., 2012a). 
Thl responses to Hp have been associated with pathology, as described 
below, but the relative importance of Th 1 and Th 17 responses for the 
development of disease is not clear. Current knowledge of the roles of these 
populations in peptic ulcer disease and gastric cancer is reviewed below. 
6.1.2.1 CD4+ T cell response to Hp and peptic ulcer disease 
As discussed in Chapter 5, IFNy responses to Hp are associated with gastritis 
in the infected human gastric mucosa and gastritis and peptic ulcer disease in 
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Hp-infected mice and Mongolian gerbils (Sawai et aI., 1999, Lindholm et aI., 
1998, Lehmann et aI., 2002, Holck et aI., 2003, Pellicano et aI., 2007, Smythies 
et aI., 2000, Akhiani et aI., 2002, Yamaoka et aI., 2005). D'Elios et al. found 
that T cell clones derived from gastric tissue of Hp+ patients with peptic ulcer 
disease had a predominantly Th1 response to Hp antigen stimulation, 
whereas in those from Hp+ patients with gastritis only a ThO (lL-4 and/or IL-s 
with IFNy) response predominated (lL-17 responses were not assessed) 
(D'Elios et aI., 2003). Higher numbers of CD4+FOXP3+ T cells were found in 
areas of gastric metaplasia in the duodenum (Kind lund et al., 2009), which 
could contribute to persistence of Hp at high colonizations and risk of 
ulceration. Robinson et al. found that patients with peptic ulcers had 
increased levels of Th1 (and Th2) cells in their gastric mucosa compared to 
those without ulcers (Robinson et aI., 2008). Again Th17 cells were not 
investigated in this study. As might be expected, Tregs showed the inverse, 
with strong Treg responses being associated with reduced risk of peptic ulcer 
disease (Robinson et aI., 2008, Hussain, 2012). 
6.1.2.2 CD4+ T cell response to Hp and neoplastic disease 
Hp was listed as a grade I carcinogen by the World Health Organization in 
1994 and is a major cause of gastric adenocarcinoma and gastric lymphoma 
(IARC, 1994). Recent studies using T C R - a . ~ ~ knock-out mice indicate that 
classical T cells are required for the development of preneoplasia, however 
preneoplastic lesions could develop in p3s-l- and p19-1- mice (Hitzler et al., 
2012a). T-bef/- mice were protected against the development of cancer in the 
H. felis murine infection model, suggesting a key role for Th1 cells in gastric 
carcinogenesis (Stoicov et aI., 2009). Interestingly the T-bef/- mice still had 
substantial levels of IFNy, albeit lower than the wild-type controls in this study 
and other cytokines including I L - l ~ , , TNF-a. and IL-10 were also reduced in the 
T-bef/- mice (Stoicov et al., 2009). IFNy expressed by Thl cells appears to have 
the dual role of reducing Hp burden and promoting carcinogenesis (Sayi et al., 
2009, Mueller et aI., 2009). 
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Th17 cells are increased in the peripheral blood of patients with gastric 
cancer, and levels increase with clinical stage of disease (Zhang et aL, 2008a). 
However, their role in initial transformation to Hp-induced gastric cancer is 
not clear. lida et 01. found increased IL-17 mRNA in tumour tissue compared 
to adjacent normal tissue, and high IL-17 levels were associated with markers 
of progression, but all the patients in this study had established gastric cancer 
(Iida et al., 2011). Hitzler et 01. used two different mouse infection models and 
found that precancerous changes were reduced in p19-1- mice infected with 
Hp (PMSSl strain) but there was no difference in precancerous changes 
between the two groups of mice following H. felis infection (Hitzler et al., 
2012a). 
It is well established that I L - l ~ ~ polymorph isms are associated with increased 
risk of gastric cancer (EI-Omar et aL, 2000). I L - l ~ ~ promotes Th17 
differentiation, so some of the pro-carcinogenic effects of I L - l ~ ~ could be 
mediated via Th17 cells. Serelli-Lee et 01. found that Th17 cells were elevated 
in patients who had previously had Hp infection and IL-17 and I L - l ~ ~ levels 
remained elevated despite Hp eradication (Serelli-Lee et aL, 2012). When IL-
l ~ ~ was neutralized the C04+ T ce1l1L-17 response to Hp antigen stimulation 
was reduced, leading the authors to suggest that I L - l ~ ~ may drive a persistent 
Th17 response, which could account for the ongoing risk of gastric cancer 
following Hp eradication (Serelli-Lee et aL, 2012). IL-IR-1- mice were protected 
against Hp-induced pre neoplastic changes (Hitzler et aL, 2012b). 
Polymorphisms in ILl 7 itself and the Thl-related genes TNFA and IFNGR2 
have also been associated with increased gastric cancer risk (Hou et aL, 2007, 
Shibata et aL, 2009). 
Increased numbers of C04+FOXP3+ were found in gastric cancer compared to 
adjacent normal mucosa (Enarsson et al., 2006, Jang, 2010). These Tregs could 
be suppressing anti-Hp and anti-tumour immunity, but studies in gastric 
cancer patients cannot elucidate whether Tregs are involved in carcinogenesis 
or favoured by the tumour microenvironment. Tregs can suppress anti-
tumour immunity. High Treg frequencies and high FOXP3:C08 ratios occur in 
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advanced stage gastric cancer and are associated with poor prognosis (Shen 
et aL, 2010, Mizukami et aL, 2008). The distribution of the Tregs can also 
affect prognosis (Mizukami et aL, 2008). My colleagues found increased 
CD4+CD25hlgh,L-lO+ Tregs in Hp+ patients with atrophy compared to those 
without, but no significant difference in Treg levels between patients with and 
without intestinal metaplasia (Hussain, 2012). In mouse models Tregs seem to 
protect from preneoplasia. TLR2 activated B cells suppressed Hp-induced 
preneoplastic changes by inducing IL-lO secreting Trl Tregs in the H. felis 
model (Sayi et aL, 2011). Mice infected with Hp during the neonatal period 
were protected from preneoplasia compared to mice infected at 5-6 weeks of 
age and this protection was lost in TGF-Wl - mice (Arnold et aL, 2011b). 
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6.2 AIMS 
i. To compare T cell frequencies in Hp-infected and uninfected gastric 
mucosa. 
ii. To determine which of these cell types are Il-17 producers. 
iii. To correlate Th17 levels with virulence factor status of patients' Hp 
isolates. 
iv. To correlate Th17 levels with histopathological findings and incidence 
of peptic ulcer disease and precancerous changes. 
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6.3 RESULTS 
6.3.1 Relative Frequencies ofCD4+, CDS+ and CD4-CDS· T Cells 
in the Hp-Infected Gastric Mucosa Compared to Uninfected 
Donors 
Hp infection leads to a marked T cell infiltration of both the gastric epithelium 
and lamina propria (Bamford et aI., 1998, Itoh et aI., 1999). In keeping with 
this absolute T cell numbers, calculated using the microscopy mononuclear 
cell count, were higher in the biopsies from Hp-infected patients, though this 
did not reach significance (p=O.13)(Figure 6.2) 
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Figure 6.1 Example plots showing A) C03 gating and B) C04+ and C08+ cell 
staining of gastric biopsy cells from uninfected and Hp-infected donors. 6 
gastric biopsies from each patient were collected into culture medium, 
rubbed through a disposable cell strainer, washed, resuspended in culture 
medium, incubated overnight, then stained with the fluorochrome-labelled 
antibodies CD3-PCS CD4-ECD and CD8-FITC and analyzed on a flow , 
cytometer. Plots A) are ungated, plots B) are CD3 gated. 
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Figure 6.2 Trend towards increased T cells in Hp-infected gastric biopsies. 
Gastric biopsies from 8 Hp-infected and 11 uninfected patients were stained 
with fluorochrome-labelled anti-C03 and analyzed by flow cytometry. 
Microscopy mononuclear cell counts were used to calculate absolute T cell 
numbers and the Hp-infected and uninfected groups compared. 
The majority of research on T cells in the Hp-infected stomach has focused on 
C04+ T cells . However, Bamford et al. found the majority of gastric lamina 
propria T cells to be C08+, though the percentage of C04+ T cells was 
increased in gastric tissue from patients with Hp infection (Bamford et aI., 
1998, Wu et aI., 2007). 
Peripheral blood C08+ '; cells from Hp-infected patients were reported to 
have a greater IFNy response to Hp stimulation than C04+ T cells from the 
same patients, so C08+ T cells may contribute significantly to T cell cytokine 
production (Quiding-Jarbrink et aI., 2001b). 
Proportions of C04+ and C08+ T cells in unstimulated gastric biopsies from Hp-
infected and uninfected patients were compared. Examples of the T cell 
gating strategy are shown in Figure 6.1A. 
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Figure 6.3 CD4 infiltration leads to an increased CD4:CD8 T cell ratio in the 
. Hp-infected gastric mucosa. Gastric biopsies from 10 Hp-infected and 11 
uninfected patients were stained with fluorochrome-labelled antibodies and 
analyzed by flow cytometry. Absolute C04+ and COB+ T cell counts were 
calculated using microscopy mononuclear cell counts and C04+ T cell, COB+ T 
cells and C04:COB ratios in the infected and uninfected groups were 
compared. 
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There was marked C04+ T cell infiltration in the Hp-infected biopsies (Figure 
6.3B) with no significant increase in C08+ T cells (Figure 6.3C). This resulted in 
an increase in C04:C08 ratio in Hp infection, consistent with previous reports 
(Bamford et aI., 1998, Wu et aI., 2007). However, the median C04:C08 ratio 
remained less than one in the majority (7/1O) of the Hp+ samples, median 
0.63 (range 0.19-2.89) (Figure 6.1B and Figure 6.3A). 
C04-C08- y8 T cells are an innate T cell source of IL-17. Kayhan et al. reported 
increased proportions of y8 T cells in peripheral blood of Hp-infected 
compared to uninfected donors (Kayhan et aI., 2008), but Hatz et al. reported 
no increase in y8 T cells in the Hp-infected gastric mucosa. 
There were increased numbers of C04"C08- T cells in Hp-infected gastric 
biopsies (Figure 6.4B). There was a strong trend towards an increased 
proportion of C04-C08- T cells in the gastric mucosa in Hp infection, although 
this did not reach statistical significance (median % C04-C08- of C03+ cells was 
11.3% in the Hp-infected group compared to 4.1% in the uninfected controls) 
(Figure 6.4A). This raises the possibility that these cells could be contributing 
to the increased gastric IL-17 levels during Hp infection. 
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Figure 6.4 Increased C04-C08- T cells in the Hp-infected gastric mucosa. 
Gastric biopsies from 10 Hp-infected and 11 un infected patients were stained 
with fluorochrome-labelled antibodies and analyzed by flow cytometry. 
A) The percentage of C03+ cells that were C04-and COS- and B) Absolute C04-
COS-T cell counts calculated using microscopy mononuclear cell counts in the 
infected and uninfected groupS were compared. 
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6.3.2 IL-17 Production by Total T Cells, C04+, C08+ and C04-C08-
T Cells in the Hp-Infected Gastric Mucosa 
Having demonstrated increased IL-17levels in the Hp-infected gastric mucosa 
by RT-qPCR, ELISA and Luminex (Figures 5.2, 5.3 and 5.5) flow cytometry was 
used to identify which cells produce the IL-17. In a small study with 5 Hp+ and 
5 uninfected patients Caruso et al. found that the vast majority of IL-17 in the 
gastric mucosa was produced by T cells and the percentage of IL-17-producing 
T cells was increased in Hp infection (Caruso et aI., 2008). 
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Figure 6.5 IL-17+ T cells were increased in the Hp-infected gastric mucosa. 
Gastric biopsies from 10 Hp-infected and 11 uninfected patients were stained 
with fluorochrome-labelled antibodies and analyzed by flow cytometry. A) 
The frequency of C03+IL-17+ events among the total C03+ population and B) 
C03+IL-17+ cell counts calculated using microscopy mononuclear cell counts 
were compared between infected and uninfected patients. 
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This study confirmed an increase in both the percentage of IL-17+ T cells and 
absolute numbers of IL-17+ T cells in the Hp-infected stomach (Figure 6.5A 
and B). Staining with antibodies against C04 and C08 was used to further 
characterize the IL-17-producing T cells. 
Hp- Hp+ 
0.04 '0' 0 o 0.04 
, ~ ~
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~ 1 t 1 1
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p . . . . . ~ ~ ~ ~ _ ~ ~ PMA/ionomycin 
stimulated 
C08 
Figure 6.6 Example plots showing IL-17 staining of T cells in gastric C03+ cells 
from one uninfected and one Hp-infected donor. Cells extracted from gastric 
biopsies of..one uninfe.cted and one Hp-infected donor were incubated over 
night with PMA/ionomycin or cell culture medium only (unstimulated) and 
brefeldin A to block cytokine secretion, then stained with the fluorochrome-
labelled antibodies C03-PCS, C08-FITC and IL-17-PE and analyzed by flow 
cytometry. 
Examples of intracellular IL-17 staining are shown in Figure 6.6. Both C04+ and 
C08+ T cells were positively identified in this study. An unstimulated as well as 
a PMA/iononiycin-stimulated sample was analyzed for each patient. 
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Figure 6.7 C04+/L-17+ (Th17) cells (A and B) and COS+/L-17+ (Tc17) cells (C and 
0) were increased in the Hp-infected gastric mucosa. Gastric biopsies from 
10 Hp-infected and 11 uninfected patients were stained with fluorochrome-
labelled antibodies and analyzed by flow cytometry. Proportions and absolute 
numbers of CD4+fl-17+ (A and B) and CD8+fl-17+ (C and D) events in the 
infected and uninfected groups were compared. 
The percentages of fl-17 + CD4+ T cells (Th17 cells) and CD8+ T cells (Tc17 cells) 
were both increased in the Hp-infected group (Figure 6.7 A and C and Table 
6.1). Absolute numbers of Th17 and Tc17 cells were also increased, with 
greater fold differences (Figure 6.7B and D). 
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There were also significantly higher percentages and absolute numbers of 
C04-C08-T cells producing IL-17 upon stimulation in the Hp-infected 
compared to the uninfected biopsies (Figure 6.8A and B}(Table 6.1). 
1-. p=O.015 
.... 
...J 8 p=O.027 8.4-fold i;O 2.9-fold ~ ~c 
0 6 1i :.,. 
c ~ ~
0 t... 
!!! 4 
... 
...:. 
Qj r-oo CJ C 
~ ~ 2 !-' 
+ oot M C 
C u 
0 0 ~ ~ Negative Positive 
Hpstatus 
Figure 6.S CD4-CDS-IL-17+ T cells are increased in Hp-infected gastric mucosa. 
Gastric biopsies from 10 Hp-infected and 11 uninfected patients were stained 
with fluorochrome-labelled antibodies and analyzed by flow cytometry. A) 
Proportions of CD4-C08-IL-17+ T cells and B) Absolute numbers of C04-C08-IL-
17+ T cells in the infected and uninfected groups were compared. 
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The C04-C08- T cells were a minority of the Il-17-secreting T cell population. 
C04+ T cells accounted for 68.5%, C08+ T cells 24.7% and C04-C08- 18.2% of Il-
17 producing T cells in the Hp+ biopsies (median percentages). However, 
relatively high proportions of the C04-C08-T cells present in Hp-infected 
gastric biopsies secreted Il-17: 13.1%, compared to 8.0% of C04+ T cells and 
3.5% of C08+ T cells (Table 6.1). 
Median C03+ cells in Median C03+,l-17+ cells in 
unstimulated samples PMA/ionomycin samples 
Hp status C04+ C08+ C04- C04+ C08+ C04-
C08- C08-
of 
patients 
Negative 4134 40997 1471 314 240 141 
Positive 43193 60279 9016 3434 2101 1181 
P value p=0.004 Ns p=0.035 p=0.015 p=0.043 p=0.015 
Table 6.1 Summary of median numbers of the T cell subsets in unstimulated 
samples, and in IL-17 secreting T cell populations in PMA/ionomycin 
stimulated samples, in 8 Hp+ and 11 uninfected patients. Mann-Whitney-U 
test was used to compare Hp-infected and uninfected groups and the 
resulting p values are given. 
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6.3.3 Expression ofTh17 Transcription Factor RORC2 in Hp 
Infection and Correlation ofTh17 Markers 
RORyt was identified as the transcription factor that directs Th17 
differentiation in mice by Ivanov et al. in 2006 (Ivanov et aL, 2006). The 
human orthologue, RORC2, is generally accepted as the Th17 lineage-defining 
transcription factor and one of the most specific Th17 markers (Crome et aL, 
2009): However, it may also be expressed in CDS+T cells and innate cells such 
as NKT cells (Burgler et aL, 2009). RORyt expression has been reported in IL-
17-producing y8 T cells, lymphoid tissue inducer-like cells and other IL-17-
producing innate lymphoid cells (ILC3s) in mice (Sutton et aL, 2009, Takatori 
et aL, 2009, Buonocore et aL, 2010). 
RORC2 expression in gastric biopsies from Hp-infected and uninfected 
patients was quantified in this study as a measure of IL-17-producing cells. 
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Figure 6.8 The Th17 transcription factor, RORC2 is increased in the Hp-
infected gastric mucosa. mRNA was extracted from gastric tissue biopsies 
from 41 Hp+ and 15 uninfected patients and relative RORC21eveis calculated 
by normalizing against GAPDH and expressing levels relative to a negative 
comparator reference sample. 
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As demonstrated in the previous section, the majority of Il-17-producing T 
cells in the Hp-infected gastric mucosa are Th17 cells, though Tc17 and C04-
C08- T cells also make a contribution. 
RORC2 expression was increased in Hp-infected gastric mucosal tissue (Figure 
6.8). This is in keeping with the highly significant increased in III 7 expression 
found in Hp-infected gastric tissue (Figure 5.2), though the fold difference in 
III 7 expression was much greater than that found for RORC2 expression 
(42.6-fold vs 2.7-fold). There was a trend towards correlation of RORC2 with 
IL17 mRNA levels but this did not reach statistical significance (Figure 6.9). 
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Figure 6.9 RORC2 and ILl7 mRNA expression were not significantly 
Correlated. mRNA was extracted from gastric tissue biopsies from 41 Hp+ 
patients and relative III 7 and RORC21eveis calculated. Values for the two 
genes were correlated. 
Although III 7 mRNA and Il-17 protein levels correlated (Figure 5.58), no 
correlation was found between RORC2 mRNA expression and Il-17levels 
measured by luminex (data not shown). RORC2 was not measured at the 
protein level in this study. 
There were insufficient Hp+ patients with both Th17 frequencies by flow 
cytometry and RORC2 mRNA expression,lLll mRNA or IL-17 Luminex 
measurements to correlate these variables. 
6.3.4 Correlation of RORC2 Expression with Virulence Factor 
Status 
The Hp virulence factors cagA (marker for the cagPAJ) and dupA are 
associated with increased risk of disease (sections 1.1.5.1 and 1.1.5.3). 
Mutation of both these virulence factors leads to lower production of IL-23 by 
MoDes stimulated with AB21 Hp (Figure 3.9A). This raises the possibility that 
these virulence factors could be associated with higher levels of the Th 17-
differentiating cytokine, IL-23, in vivo. 
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Figure 6.10 Association of RORC2 expression with expression of the 
virulence factor cagA and dupA genes. RORC2 mRNA expression in Hp+ 
biopsies (normalized against GAPDH and expressed relative to a negative 
comparator reference sample) was stratified by A) cagA status and B) dupA 
status. 
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Patients' RORC2 mRNA expression levels were therefore stratified by cagA 
and dupA status of their infecting strains. 
No significant difference was found in RORC2 mRNA expression between 
patients infected with Hp strains with or without the cagA or dupA virulence 
factor genes. Numbers in the some of the groups were low but these findings 
are consistent with the lack of difference detected in Il-17 levels in patients 
with and without these virulence factors in Chapter 5 (Figure 5.12A and data 
not shown). 
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6.3.5 Correlation of RORC2 Expression with Histopathology and 
Disease Status 
As Th17 cells are known to be important for recruitment of lymphocytes and 
neutrophils and IL-17 levels correlated with inflammation scores (measure of 
_ lymphocyte infiltration) and activity scores (measure of neutrophil infiltration) 
(section 5.3.6), RORC2 expression was also stratified by inflammation and 
B 
activity scores. 
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Figure 6.11 Association of RORC2 mRNA expression with inflammation and 
activity scores. RORC2 expression in biopsies from 40 Hp+ patients 
(normalized against GAPDH and expressed relative to a negative comparator 
reference sample) were stratified by A) Inflammation score (lymphocyte 
infiltration) and B) Activity score (neutrophil infiltration), scored by an 
experienced gastrointestinal histopathologist. 
A 
B 
No significant association between RORC2 expression and inflammation or 
activity scores was found (Figure 6.llA and B). 
Th17 cells are increased in a number of cancers (section 1.3.6) so next 
precancerous changes were correlated with RORC2 mRNA expression to help 
address the hypothesis that Th17 cells may contribute to the development of 
cancer in the inflamed stomach. 
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Figure 6.12 RORC2 mRNA expression stratified by A) Presence or absence of 
intestinal metaplasia and/or atrophy and B) Hp density score. RORC2 
expression in biopsies from 40/41 Hp+ patients (normalized against GAPDH 
and expressed relative to a negative comparator reference sample) were 
stratified for A} Atrophy and/or intestinal metaplasia and B} Hp density, 
scored by an experienced gastrointestinal histopathologist. ns= no significant 
difference (Mann-Whitney U-test). 
As for IL-17 (Chapter 5, Figure 5.14A), there was no association between 
RORC2 expression and the presence or absence of precancerous changes 
(Figure 6.12A). Median RORC2 expression levels increased with increasing Hp 
density score, but there was no statistically significant association between 
these parameters (Figure 6.12B). 
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Figure 6.13 RORe2 expression stratified by presence or absence of peptic 
ulcer disease. RORC2 expression in biopsies from 41 Hp+ patients (normalized 
against GAPDH and expressed relative to a negative comparator reference 
sample) was compared in patients with (n=21) and without (n=20) peptic 
ulcer disease (PUD). 
Despite finding no significant correlation between RORC2 mRNA expression 
and histopathological findings (Figures 6.11 and 6.12) or between IL-17 and 
peptic ulcer disease (Figure 5.15), peptic ulcer disease appeared to be 
associated with significantly higher levels of RORC2 expression. This finding 
needs to be taken with some caution as the difference in RORC2 expression 
between the peptic ulcer disease and ulcer-free groups was only l.4-fold. This 
may suggest that Th17 cytokines other than IL-17, or a combination of factors 
are required for the development of peptic ulceration (see discussion). 
6.4 DISCUSSION 
6.4.1 Frequencies of the Different T Cell Subtypes in the Hp-
Infected Gastric Mucosa and their Production of IL-17 upon 
Stimulation. 
Caruso et 01. reported that T cells are the main source of gastric IL-17 in Hp 
infection (Caruso et al., 2008). To assess which T cell subgroups may be 
significant contributors of IL-17, frequencies of the different T cell subtypes 
were first compared in unstimulated samples from Hp-infected and 
uninfected donors. Assessment of C04 status is easier in unstimulated 
samples than in samples stimulated with PMA/ionomycin, as PMA causes C04 
downregulation (Pelchen-Matthews et al., 1993). The C04:C08 ratio was 
significantly increased in the Hp-infected group, with a significant increase in 
absolute numbers of C04+ T cells but only a small, non-significant increase in 
absolute numbers of C08+ T cells (Figure 6.3 and Table 6.1), consistent with 
previously reported immunohistochemistry and flow cytometry findings 
(Bamford et aI., 1998, Wu et aI., 2007). However, COB+ T cell numbers were 
high in uninfected patients and the median C08+ T cell count remained higher 
that the median C04+ T cell count in the Hp-infected donors (Table 6.1). Some 
of the COB cells identified may be C08a:a T cells. "Unconventional" T cells 
that do not have an a:p TCR account for a significant proportion of mucosal T 
cells in the gastrointestinal tract (Janeway et al., 2005). 
A number of innate sources of IL-17 have recently been described, including 
C03+C04-COB- yeS T cells (section 1.3.9)(Sutton et aI., 2009). Frequencies of 
C03+C04-C08-T cells in Hp-infected and uninfected gastric biopsies were 
therefore compared. C03+C04-C08- T cell numbers were increased in the Hp-
infected group, though the increase in the proportion of T cells not expressing 
C04 or COB did not reach statistical significance (Figure 6.4A and B). The 
C03+C04-C08-T cells were a minority population (median B.O% ofT cells in the 
Hp+ group). Hatz et 01. previously found no significant increase in yeS T cells in 
Hp-infected lamina propria using immunohistochemistry (Hatz et al., 1996). 
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Futagami et 01. found increased yo T cells only in the Hp-infected group with 
the most severe gastritis (Futagami et al., 2006). They also noted significantly 
higher yo T cells in those with lymphoid follicles (Futagami et at, 2006). 
The method used in this study investigates epithelial lymphocytes as well as 
lamina propria lymphocytes, though in a number of flow cytometry studies, 
including the studies by Hatz et 01. and Futagami et 01. the epithelium has 
been removed in order to study lamina propria lymphocytes only (Hatz et at, 
1996, Bamford et at, 1998, Lundgren et at, 2005). The epithelium may be the 
source of many of the C03+C04-C08- T cells. Epithelial lymphocytes could be 
an important source of cytokines in vivo. However, Trejdosiewicz et 01. found 
no increase in intraepithelial yo T cells in Hp infection (Trejdosiewicz et al., 
1991). 
C04+,L-17+ Th17 and C08+IL-17+ Tc17 cells were both significantly increased in 
Hp infection (approximately 3-fold), with median Th17 numbers 1.6-fold 
higher than median Tc17 numbers. This suggests that Th17 cells are the 
conventional T cell population that contributes the most IL-17 during Hp 
infection, though the relative amounts of IL-17 produced by the different 
populations were not compared in this study. A lower proportion of the C08+ 
T cells present are IL-17-producers, but C08+ T cells are present at high 
frequencies in the gastric mucosa of many Hp-infected patients and are a 
significant source of IL-17. 
A relatively high proportion of C03+C04-C08-T cells produced IL-17, so this 
population made a significant IL-17 contribution despite being present in 
relatively low numbers (Table 6.1). It will be important to further characterize 
and positively identify these cells in future studies but they are likely to 
represent innate T lymphocytes, which could include yo T cells and NKT cells. 
Using flow cytometry O'Keefe et 01. found NKT cells accounted for <2% T cells 
in uninfected gastric mucosa, with no significant increase in Hp infection, 
suggesting that other innate T cells are involved (O'Keeffe et al., 2008). 
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These innate lymphocytes are likely to be important sources of cytokine early 
in the immune response, before conventional adaptive T cell responses have 
had time to develop. Hp can directly stimulate yo T cells to produce IFNy and 
TNF-a in the absence of antigen presenting cells (Romi et aL, 2011). Il-23 and 
Il-lp can stimulate yo T cells to produce Il-17 without a requirement for TCR 
engagement (Sutton et al., 2009). Mouse C04+ T cells express Il-17R and yo T 
cell-derived Il-17 can boost Il-17 production by C04+ T cells (Sutton et aL, 
2009). This suggests that the Il-17 produced by yo T cells and other innate T 
lymphocytes may have an important role in boosting conventional Th17 cell 
Il-17 production. 
6.4.2 Expression ofTh17 Transcription Factor RORC2 in Hp 
Infection and Correlation with IL-17 
RORC2 is generally accepted as the Th17 lineage transcription factor and one 
of the best Th17 markers. However expression of RORC2 or the mouse 
equivalent RORyt has been described in other Il-17-producing cells, including 
C08+ T cells, NKT cells, yo T cells, l Ti-like cells and other IlC3s (section 
1.3.9)(Takatori et aL, 2009, Burgler et al., 2009, Sutton et al., 2009, Buonocore 
et aL, 2010). This is the first study that I am aware of to investigate RORC2 
mRNA expression in the Hp-infected human gastric mucosa. As expected, in 
view of the marked increase in Il-17 during Hp infection, RORC2 expression 
was also significantly increased (Figure 6.8). 
There was a strong trend towards correlation between RORC2 and IL17 mRNA 
expression, but this did not reach statistical significance (Figure 6.9). RORC2-
expressing cells may represent a variety of types of Il-17-producing cells with 
heterogeneous Il-17 expression. 
Ideally RORC2 expression would have also been studied at the protein level 
but limited reagents were available. Flow cytometry was attempted with a 
RORC2-PE antibody but problems with non-specific staining made this 
uninformative, despite attempts at optimization with lower concentrations of 
antibody and FcR blocking. 
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6.4.3 Correlation of RORC2 mRNA Expression with Virulence 
Factor Status 
No correlation was found between RORC2 expression and cagA or dupA 
status of the infecting strains. However, numbers analyzed were small, so a 
link cannot be completely excluded. 
There was a weak trend for higher RORC2 mRNA expression in the biopsies 
infected with strains thought to have functional dupAl, forms of dupA, as 
described by Hussein et al. (Hussein et aI., 2010). The mode of action of dupA 
and the exact genes required for its function are not completely understood, 
though this virulence factor appears to have effects on immune cells including 
monocytes and dendritic cells (Hussein et aI., 2010){Figure 3.9). Il-17 levels 
were also higher, though not significantly so, in the dupA+ group (data not 
shown). It would be interesting to explore this further in a larger number of 
Hp-infected biopsies. 
6.4.4 Correlation of RORC2 mRNA Expression with 
Histopathology and Disease Status 
There were trends for correlations between RORC2 mRNA expression and 
inflammation and activity scores, but these did not reach statistical 
significance (Figure G.llA and B). These trends were not as strong as those 
between Il-17 protein levels and inflammation and activity scores shown in 
Chapter 5 (Figure 5.13A and B). RORC2 expression is perhaps a less direct 
measure, as it assumes that mRNA levels are reflected at the protein level and 
that RORC2 in turn reflects Th17 activity. 
Though Th17 levels are known to be increased in gastric cancer and a number 
of other malignancies, as discussed in the introduction, no difference in 
RORC2 expression was found between those with precancerous changes and 
those without (Figure G.12A). This is consistent with lack of difference in IL-17 
levels between these groups (Chapter 5). This does not support a critical role 
for Th17 cells in carcinogenesis in the Hp-infected stomach, but it is possible 
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that a small effect would be found in a larger study. IL-17/Th17 may have a 
role in progression of established gastric cancer. 
There was a trend for correlation of RORC2 expression with Hp density score 
{Figure 6.12B}. This is consistent with the increased Th17 response in Hp+ 
patients demonstrated with flow cytometry. The Sydney scoring system is 
category based rather than quantitative, which limits the statistical power for 
finding correlations. Quantitative scoring of inflammation, activity and Hp 
density may help confirm if IL-17 and RORC2 expression are indeed associated 
with these variables. 
Patients with peptic ulcer disease had significantly higher RORC2 expression 
than those without {Figure 6.13}. However no difference in IL-17 levels 
between the ulcer and ulcer-free groups was detected {Figure 5.15}. This 
finding needs to be taken with some caution as the difference in RORC21eveis 
was small and only just statistically significant. It is possible that small 
differences in IL-17 levels in patients with and without peptic ulcer disease 
may be detected in a larger study. However these findings raise the possibility 
that Th17 cells may have pathogenic effects in the stomach by a mechanism 
other than secretion of IL-17. 
GM-CSF is produced by some Th17 cells and was shown to be essential for 
pathogenicity in EAE {Codarri et aL, 2011, EI-Behi et aL, 2011}. However, GM-
CSF levels measured by Luminex did not differ between 32 Hp+ and 19 
un infected patients, or in the Hp+ patients with and without ulceration. 
Pro-inflammatory Th17 cells in inflamed tissue often produce IFNy in addition 
to IL-17. These "double-producers" were initially described in the inflamed 
bowel of patients with Crohn's disease but have since been described by 
many authors both in vivo and in vitro {section 1.3.3 and 4.4.2){Volpe et aL, 
2008, Annunziato et al., 2007, Abromson-Leeman et aL, 2009, Ghoreschi et 
aL, 2010, Kebir et aL, 2009}. Their differentiation seems to be favoured by a 
lack of TGF-p, which allows T-bet expression {Ghoreschi et aL, 2010}. Their 
phenotype is more similar to Th17 cells than Thl cells, even if they lose IL-17 
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expression (Boniface et aI., 2010). IFNy is strongly associated with gastric 
inflammation in human and animal studies, as discussed in Chapter 5. 
Patients with peptic ulcer disease tended to have more gastric C04+IFNy+ cells 
(Robinson et aL, 2008). IFNy is upregulated less than IL-17 during Hp infection 
(section 5.3.4), but may still have significant pathogenic effects. It may be 
partly produced by Th17 cells and may have potent effects, even at relatively 
low levels, in synergy with IL-17. 
The balance between Tregs and Th17 cells in the Hp-infected gastric mucosa 
is likely to influence risk of disease. These lineages are closely related (section 
1.3.2 and 1.3.3). IL-17-producing human FOXP3+ T regs have been described 
(Voo et aL, 2009). FOXP3+RORyt+IL-I0+ cells were found to be in equilibrium 
with RORyt+IL-17+ cells in mice, with FOXP3 and CCl20 favouring IL-I0 
production and IL-6 and IL-23 favouring IL-17 production (Lochner et aL, 
2008). Staphylococcus aureus-primed Th17 cells had the potential to produce 
IL-I0 and I L - l ~ ~ blockade led to increased IL-I0 production (Zielinski et al., 
2012). IL-27 promotes the development of IL-I0 secreting Trl Tregs, whilst 
inhibiting Th17 development, but has little effect on committed Th17 cells 
(Pot et aL, 2011, EI-behi et aL, 2009). 
Overall the gastric cytokine findings in Chapter 5 indicate that CCL20 and IL-27 
are significantly increased in the Hp-infected gastric mucosa (Figures 5.7A and 
5.9B), whereas I L - l ~ , , IL-6, and IL-23 are not. This might be expected to lead to 
predominance of regulatory IL-I0 (from Tregs and possibly also Th17 cells) 
over prO-inflammatory IL-17. This is consistent with the absence of clinical 
disease in the majority of Hp-infected patients. It is likely that the balance of 
cytokines is altered in those with Hp-induced pathology but the relative 
importance and potency of the various cytokines is not yet clear. 
In summary IL-17 in the Hp-infected gastric mucosa is produced mainly by 
Th17 cells, though Tc17 and C04-C08- T cells also make a significant 
contribution. Expression of the Th17 transcription factor RORC2 is also 
increased in Hp-infected gastric mucosa and high RORC2 mRNA expression is 
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associated with peptic ulcer disease, though IL-17 levels were not. IL-17 was 
associated with high activity and inflammation scores. No associations 
between RORC2 mRNA expression or IL-17 levels and cagA or dupA virulence 
factor status of the infecting strains or presence or absence of precancerous 
changes were detected. 
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7. DISCUSSION 
7.1 MAIN FINDINGS AND THEIR SIGNIFICANCE 
7.1.1 T Helper Cell Differentiation in Hp Infection 
7.1.1.1 Hp stimulation a/MoDes - relative IL-12p70 and IL-23 
secretion and effects a/mutating cagA and dupA virulence 
factors 
Most previous studies have used MoDCs to investigate DC responses to Hp 
(Guiney et aI., 2003, Kranzer et aI., 2004, Kranzer et aI., 2005, Hafsi et a/., 
2004, Mitchell et a/., 2007, Khamri et aI., 2010, Andres et aI., 2011). In this 
study relative Il-12p70 and Il-23 production by Hp-stimu/ated DCs were 
compared using two different DC models and the effects of mutating the cagA 
and dupA virulence factors were investigated (Chapter 3). 
Hp stimulation of MoDCs resulted in production of a broad range of 
inflammatory cytokines (ll-12p40, Il-12p70, Il-8, Il-6, Il-23 and Il-1P) and the 
anti-inflammatory Il-l0, strong upregulation of activation markers and high 
IFNy production when the Hp-stimu/ated MoDCs or their supernatants were 
cultured with naiVe T cells, consistent with previously published data 
(Bimczok et aI., 2010, Hafsi et a/., 2004, Guiney et a/., 2003, Kranzer et a/., 
2004, Khamri et aI., 2010). Relative Il-12p70 and Il-23 levels produced by Hp-
stimulated DCs have not been investigated previously. Il-12p70 levels 
produced by Hp-stimu/ated MoDCs were 12-fo/d and ls-fo/d higher than Il-23 
levels for the AB21 and AB31 Hp strains. This was reflected at the T cell level 
with high IFNy and little Il-17 production when Hp-stimu/ated MoDCs were 
cultured with naiVe T cells, suggesting a strong Thl bias. 
Stimulation with isogenic dupA and cagA AB21 Hp mutants led to lower Il-
12p70 and Il-23 responses than stimulation with the wild-type strains. The 
effect of dupA mutation on MoDC cytokine secretion was less marked than 
the effect found on monocytes, but monocytes are not present in the gastric 
mucosa (Hussein et aI., 2010). 
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7.1.1.2 Comparison of Hp stimulation of MoDCs and MyDCs 
Circulating CDlc+ MyDCs were also studied and found to produce lower IL-23 
concentrations than the MoDCs, and no detectable IFNy following Hp 
stimulation. NaiVe T cells cultured with Hp-stimulated MyDCs produced 
similar IL-17 levels to those cultured with Hp-stimulated MoDCs and secreted 
significant concentrations of IFNy despite the lack of IL-12p70. Bimczok et al. 
studied gastric DCs from patients having gastric resections for obesity. Similar 
to the current findings for Hp-stimulated MyDCs, they found that Hp-
stimulated gastric DCs did not produce any IL-12p70 at the mRNA or protein 
level, however T cells cultured with the Hp-stimulated gastric DCs did produce 
IFNy (Bimczok et aLi 2010). This suggests that MyDCs might be a better model 
for gastric DCs than the more widely used MoDCs. Further studies by Bimczok 
et al. showed that gastric stromal factors reduced IL-12 and Thl responses 
and inhibited upregulation of DC activation markers in response to Hp 
(Bimczok et aLi 2011). 
Luminex analysis of supernatants from homogenized snap frozen gastric 
biopsies showed much higher IL-23 than IL-12p70 levels, again more in 
keeping with the MyDC and gastric DC data than the MoDC data. This method 
measures cytokine content of the entire gastric biopsy and will therefore 
include cytokines produced by other cell types, but should give a good 
reflection of the cytokine milieu in the gastric mucosa. 
The site of T cell priming by antigen presenting cells in human Hp infection is 
uncertain. In mouse models Peyer's patches in the small intestine seem to 
play an important role, but lymphoid follicles can also form in Hp-infected 
human gastric mucosa, and may contribute (Nagai et aLi 2007, Kiriya et aLi 
2007). Regardless of the initial site of T cell priming, many CD4+ T cell 
populations are known to have a degree of plasticity (Rowell and Wilson, 
2009, Lee et aLi 2009), so the gastric cytokine environment could influence 
C04+ T cell phenotype. 
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7.1.2 The Cytokine Milieu in the Hp-Infected Gastric Mucosa 
7.1.2.1 Measurement 0/ cytokines in snap frozen gastric biopsies 
Luminex technology was used to measure relative levels of a broad panel of 
cytokines in supernatants from homogenized snap frozen gastric biopsies 
from Hp-infected and uninfected patients (Chapter 5). Endoscopic mucosal 
biopsies are small (typically approximately 5 mg) and levels of many of the 
cytokines of interest are low, so measuring multiple cytokines in a single 
sample represents a technical challenge. Other investigators have used semi-
quantitative methods including immunohistochemistry (Lehmann et aI., 2002, 
Lindholm et aI., 1998, Holck et aI., 2003) and western blotting (Luzza et al., 
2000, Tomita et aI., 2001), or PCR-based methods to quantitate cytokine 
mRNA, which mayor may not be reflected as the protein level (Yamaoka et 
aI., 2001, Luzza et aI., 2001, Yamaoka et aI., 1995, Serelli-Lee et aI., 2012, 
Yamauchi et aI., 2008). Cytokines have been measured in gastric biopsy 
homogenates using ELISA (Serelli-Lee et aI., 2012, Shimizu et aI., 2004, 
Yamaoka et aI., 1997, Yamaoka et aI., 2001, Yamauchi et aI., 2008, Caruso et 
aI., 2008), but additional volume (causing dilution) is required for each 
cytokine assayed, so the number of cytokines, particularly those present at 
low levels, that can be assayed using this method is limited. Another approach 
is to culture gastriC biopsies in vitro and measure cytokines in the 
supernatants (Bodger et aI., 1997, Mizuno et aI., 2005, Crabtree et al., 1991). 
Cytokines in the supernatants of cultured lamina propria mononuclear cells 
and T cell clones have also been measured and intracellular cytokine staining 
can be assessed by flow cytometry (Luzza et aI., 2000, Caruso et al., 2008, 
Lehmann et aI., 2002, D'Elios et aI., 1997, Bamford et aI., 1998, Robinson et 
al., 2008). However, all these methods require in vitro culture with or without 
stimulation which can alter the cytokine profile (Veldhoen et aI., 2009). The 
cytokine levels in homogenates of snap frozen gastric biopSies should more 
accurately reflect those found in the gastric mucosa in vivo. 
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7.1.2.2 Relative concentrations ofT helper subset effector 
cytokines in the Hp-infected gastric mucosa 
Levels of the Th17 cytokine IL-17 were significantly higher than the signature 
cytokines of the other main C04+ T cell subsets IFNy (Thl), IL-4 (Th2) and IL-I0 
(Treg) in gastric biopsies from Hp-infected patients and significantly higher 
than found in uninfected biopsies. In keeping with this, levels of IL-17F and 
chemokines CCL20 and IL-8, which are targeted by IL-17, were also increased. 
IL-21 and IL-22 can also be produced by Th17 cells, yet IL-21 levels were lower 
in Hp-infected gastric biopsies than those from un infected controls and there 
was no significant difference between IL-22 levels in biopsies from the Hp-
infected and uninfected groups. These IL-22 findings are consistent with ELISA 
and immunofluorescence microscopy published by Serelli-Lee et 01 (Serelli-
Lee et aL, 2012). IL-22 production by Th17 cells is dependent on availability of 
AhR ligands (Veldhoen et aL, 2009) and can be suppressed by high levels of 
TGF-f3 (Rutz et al., 2011). Thl and innate immune cells can also secrete IL-22, 
which could mask small changes in Th17-derived IL-22 in Hp-infected gastric 
mucosa. 
The IL-21 findings are unexpected, as Caruso et 01. found increased IL-21 in 
Hp-infected gastric biopsies at both protein and mRNA levels by western 
blotting and RT-qPCR (Caruso et aL, 2007a). Further studies are required to 
clarify these discrepancies. IL-21 promotes C08+ T cell expansion, so high IL-21 
levels in gastric biopsies from uninfected patients could be consistent with 
the higher proportion of C08+ cells found in these samples. 
7.1.2.3 Concentrations of cytokines involved in Th17 
differentiation In the Hp-Infected gastric mucosa 
IL-21 is also involved in early Th17 differentiation. No significant differences in 
levels of IL-lf3 and IL-6, also key in early Th17 differentiation, were found 
between the Hp-infected and uninfected groups. TGF-f3 levels were not 
measured in this study, but have been found to be increased in the Hp-
infected gastric mucosa at the mRNA level and by immunohistochemistry 
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(Lindholm et aI., 1998, Robinson et aI., 2008, Li and Li, 2006, Harris et aI., 
2008, Kandulski et aI., 2008). This suggests that gastric Th17 cells may be 
differentiated from naIve T cells at another site such as the Peyer's patches. 
Another alternative is that memory Th17 cells are recruited from the 
periphery. Consistent with this theory, high levels of CCL20 (chemokine ligand 
for CCR6+ Th17 cells) are present in the gastric mucosa, and are increased in 
Hp-infected compared to uninfected biopsies. 
IL-23 levels in the gastric mucosa are very high (though not found to be 
increased during Hp infection in this study). This cytokine is essential for 
terminal Th17 differentiation and effector function (McGeachy et aI., 2009). In 
combination with other pro-inflammatory cytokines it also promotes C04+IL-
17+IFNy+ pathogenic populations (Wilson et aI., 2007, Volpe et aI., 2008, 
Ghoreschi et al., 2010). It is therefore likely to be key to maintaining the 
phenotype and function of Th 17 cells in the gastric mucosa. 
7.1.2.4 Concentrations o/CCL20 and Tr1-dijferentiating lL-27 in 
the Hp-in/ected gastric mucosa 
CCL20 can be produced by Th17 cells, but also attracts them due to their 
expression of CCR6 (Wilson et al., 2007, Wu et aI., 2007). Tregs also express 
CCR6 and may be recruited to the gastric mucosa by the same mechanism. 
Levels of IL-27, which promotes IL-I0-producing Trl Tregs at the expense of 
Th17 cells (Pot et aI., 2011), are high within the gastric mucosa and increased 
in Hp infection. This raises the possibility that some de novo Treg 
differentiation may occur in the Hp infected stomach. IL-27 has little effect on 
mature Th17 cells (EI-behi et aI., 2009), in keeping with the strong Th17 
response and high IL-17 levels in the Hp-infected gastric mucosa. 
7.1.3 Peripheral Blood and Gastric Th17 Responses to Hp 
7.1.3.11L-17-producing cells in the Hp-in/ected gastric mucosa 
Having identified a dominant IL-17 response to Hp infection, flow cytometry 
studies were undertaken to identify which cells were the source ofthe IL-17 
(Chapter 6). In Hp infection the gastric C04+ T cell numbers increased, whilst 
there was no significant change in C08+ T cell numbers, but there were 
significant increases in both C04+,L-17+ Th17 cells and C08+IL-17+ Tc17 cells in 
the Hp-infected compared to uninfected gastric biopsies. There was also a 
significant increase in C04-C08- T cells, and numbers of these cells producing 
IL-17 during Hp infection. These are likely to be innate T cells, possiblyy8 T 
cells. Other unconventional T cells can also occur in the gut mucosa, including 
C08a:a cells which may express the ap or y8 TCR (Janeway et aL, 2005). In 
uninfected tissue y8 T cells are largely restricted to the gastric epithelium 
(Hatz et aL, 1996, Trejdosiewicz et aL, 1991, Futagami et aL, 2006), but y8 T 
cell infiltration of the lamina propria has been reported in Hp-associated 
gastritis (Futagami et aL, 2006). In the current study whole gastric biopsies, 
including epithelium and lamina propria, were homogenized, which may 
explain the relatively high numbers of C04-C08-T cells found. IL-17 produced 
by these cells may boost production from conventional aJ3 IL-17 producing 
cells such as Th17 cells (Sutton et aI., 2009). 
Expression of the Th17 transcription factor RORC2 was upregulated during Hp 
infection, consistent with the flow cytometry findings. However, RORC2 is not 
completely specific for Th17 cells, as it is also expressed by other IL-17 
producing cells including C08+ T cells and NKT cells and RORyt expression has 
been reported in a number of types of innate IL-17 producing cells, including 
y8 T cells and the recently designated ILC3s including LTi cells (Burgler et aL, 
2009, Sutton et al., 2009, Takatori et aL, 2009, Buonocore et aL, 2010, Spits et 
al., 2013). 
ILC3s are described in detail in section 1.3.9. These innate lymphoid cells 
express RORyt and produce IL-17 and/or IL-22 but are negative for the lineage 
markers C03 and C04 in humans (Spits et al., 2013). The flow cytometry 
analysis in this study was gated on C03 and would therefore have excluded 
these cells, but they may have contributed to the totallL-17 and/or IL-22 
measured in the gastric biopsies by RT-qPCR and Luminex. Caruso et 01. found 
that the vast majority of IL-17+ lamina propria mononuclear cells in the Hp-
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infected gastric mucosa were C03+ (Caruso et aI., 2008), but there may well 
be a higher proportion of C03-IL-17-producers in the gastric epithelium. 
PMA/ionomycin was used to stimulate the gastric biopsy cells prior to flow 
cytometry analysis, as the number of IL-17+ events from the numbers of 
gastric cells available using antigenic stimulation was too small for meaningful 
analysis. This approach has been used by a number of other groups 
investigating gastric T cell responses to Hp (Bamford et aI., 1998, Sommer et 
aI., 1998, Caruso et aI., 2008). 
7.1.3.2 Peripheral blood Th17 response to Hp 
In the peripheral blood there are many more T cells present which are likely 
to have a wider range of specificities than the gastric T cells. Use of the 
activation markers C069 and C0154 was initially investigated to see if they 
could help to identify antigen-specific C04+ T cell poulations, but the vast 
majority of C04+ cytokine + events were also activation marker positive so this 
approach did not seem to add much. There was a greater Th17 response to 
Hp antigen in PBMCs from Hp-infected patients than PBMCs from uninfected 
patients. When the PBMCs were cultured with medium only, or tetanus 
toxoid (control antigen), no difference in Th17 responses was seen between 
the Hp-infected and uninfected groups. This is good evidence that the 
response is indeed Hp-specific. The Hp-specific Th17 responses were of 
similar magnitude to Th17 responses to C. albicans, which is known to 
provoke a Th17 response and causes chronic infection in patients with defects 
in Th17 pathways. A C04+IFNy+ Th1 response to Hp was also detected in the 
peripheral blood, consistent with published findings (Kenefeck, 2008, 
Quiding-Jarbrink et aI., 2001b, Ren et aI., 2000). The magnitude of the Hp-
specific Th1 response was very similar to that of the Hp-specific Th17 
response. The proportion of C04+IL-17+ co-staining for IFNy was also 
investigated. The median %C04+IL-17+ also staining for was 33% in the Hp+ 
PBMCs, suggesting that this could be a significant population, though it is only 
a minority of Th17 cells in the peripheral blood of most Hp-infected patients. 
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7.1.3.3 Peripheral blood Trey responses to Hp and the balance of 
pro-inflammatory and anti-inflammatory responses 
Peripheral blood C04+C025high Tregs were increased in Hp infection but 
C04+C025highFOXP3+ and C04+C025highC012iow Tregs were not. This is 
consistent with published findings (Satoh et al.). There were approximately 
1000 times more C04+C025hlgh Tregs than Hp-stimulated Thl or Th17 cells. 
However, only approximately 1 in 300 C04+C025hlgh Tregs produce Il-l0 in 
response to Hp stimulation (Kenefeck, 2008). The data from this study does 
not allow direct comparison of cytokine secreting Treg with Thl and Th17 
levels, but the available evidence suggests a dominant Treg response. This is 
consistent with the lack of systemic inflammatory symptoms in Hp-infected 
patients and the possible protective effects of the Hp-induced Treg response 
against allergy and autoimmunity. 
Relative levels of pro-inflammatory Th17 and Thl cells and anti-inflammatory 
Tregs in the gastric mucosa are likely to influence Hp colonization density 
levels and disease. Gastric Thl and Treg levels were not measured in this 
study, therefore direct comparisons at the cellular level cannot be made. 
However, as Th17 cells can co-produce pro-inflammatory cytokines such as 
IFNy or anti-inflammatory Il-l0, and these key cytokines can also be produced 
by cells other than C04+ T cells, gastric mucosal levels of the relevant 
cytokines may be more informative than Th cell frequencies. Il-17 levels were 
significantly higher than Il-l0 levels in this study, but levels of anti-
inflammatory TGF-p and other pro-inflammatory cytokines may also be 
critical. Cytokines may differ in their potencies, so comparing absolute 
concentrations may not give an accurate picture of their relative biological 
importance. Novel findings regarding Il-17 and Th17 cells and their influence 
on histopathological findings and disease are discussed next. 
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7.1.4 Influence onL-17 and Th17 Cells on Histopathology and 
Disease 
7.1.4.1. Association o/Th17 markers with inflammation, activity 
and Hp density scores 
High gastric IL-17 levels were associated with high inflammation and activity 
scores upon grouped analysis by Mann-Whitney U-test, though the 
association did not quite reach significance when the data were analyzed 
using the Kruskal-Wallis test (section 5.3.6). This is consistent with the known 
role of IL-17 in neutrophils and lymphocyte recruitment. The Sydney scoring 
system used here is category based (Dixon et aI., 1996). It is possible that 
more statistically significant differences might be detected using a fully 
quantitative histopathology scoring system, which would provide greater 
statistical power. There were similar, but weaker trends for an association 
between RORe2 expression and inflammation and activity scores (section 
6.3.5). The group with the highest inflammation and activity scores was small 
(n=3). This group appeared to have lower RORe2 expression, perhaps due to 
the presence of relatively high numbers of other types of immune cells, such 
as neutrophils, but firm conclusions cannot be drawn from such a small 
subset of samples. 
There was a trend for higher RORe2 expression levels to be associated with 
higher Hp density scores, but this did not reach statistical Significance (Figure 
6.128). IL-17 levels were lower in those with high Hp density than those with 
intermediate scores. The same pattern was seen for IL-8 levels. This could 
reflect expansion of the infection in the face of a limited IL-17/IL-8 response. 
7.1.4.2 Association o/Th17 markers with clinical disease 
No significant difference was seen in IL-17 levels or RORe2 expression 
between Hp-infected patients with and without precancerous changes 
(atrophy and intestinal metaplasia). This argues against a key role for IL-
17ITh17 cells in early malignant transformation in the Hp-infected stomach 
which is consistent with previous findings (Mizuno et al., 2oo5). However, the 
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numbers of patients with precancerous changes were quite small and the 
changes were mostly of a low grade, so these findings need to be interpreted 
with a degree of caution. Th17 cells are known to be present in gastric cancer, 
and are found in increasing numbers with more advanced stage disease 
(Zhang et aI., 200Sa, lida et aI., 2011). The findings presented here suggest 
that these Th17 cells may be recruited or differentiated in the tumour 
microenvironment following carcinogenesis. 
Interestingly, although IL-17 levels did not correlate with peptic ulcer disease 
at the mRNA or protein level, there was an association between high RORC2 
expression and peptic ulcer disease (Figure 6.13). The increase in risk of peptic 
ulceration with high RORC2 levels was small, and only just statistically 
significant, so this needs to be interpreted with some caution. A link between 
IL-17 and peptic ulcer disease cannot completely be excluded. Gastric 
mucosallL-17 concentrations vary considerably between individuals and an 
association with peptic ulcer disease may be detected in larger studies or 
studies in different populations. However these findings make it unlikely that 
IL-17 has a very sizeable effect on peptic ulcer disease risk. The association 
between RORC2 mRNA expression and peptic ulcer disease but not IL-17 and 
peptic ulceration raises the possibility that a factor produced by Th17 cells 
other than IL-17, or a combination of factors, could contribute to this 
pathology. In the EAE autoimmune disease model Th17-derived GM-CSF is 
important for pathogenesis (Codarri et al., 2011, EI-Behi et al., 2011). 
However, only low levels of GM-CSF were detected in the gastric mucosa, 
which were not increased during Hp-infection. 
7.1.4.3 A role for IFNr-secreting Th17 cells In Hp-related disease? 
C04+IL-17+IFNy+ cells are well described and are pathogenic in the EAE mouse 
model and human juvenile idiopathic arthritis (Abromson-Leeman et al., 
2009, Cosmi et al., 2011). A proportion of Hp-specific Th17 cells were found to 
co-express IFNy in the peripheral blood. IL-17 and IFNy co-expression by 
gastric C04+ T cells was not investigated in this study but III 7 and IFNG mRNA 
showed a trend towards correlation (Spearman's p=0.4, p=0.05i). C04+,L-
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17+IFNy+ responses to other infectious agents including C. albicans and 
tuberculosis have been documented (Zielinski et al., 2012, Jurado et aI., 
2012). Indeed, in a fate mapping study nearly all ofthe IFNy response to C. 
albicans was Th17-derived (Hirota et al.). CD4+IL-17+IFNy+ cells co-express the 
Th17 and Thl transcription factors RORyt and T-bet and are derived from 
Th17 cells in the context of IL-lf3, IL-12, IL-23 and low TGF- f3 (Zielinski et aI., 
2012, Boniface et al., 2010, Abromson-Leeman et aI., 2009, Nistala et al., 
2010, Ghoreschi et al., 2010, Volpe et aI., 2008). In this study high levels of IL-
23 were detected in the gastric mucosa of both Hp-infected and uninfected 
patients, which could drive pathogenic Th17 populations following 
recruitment to the Hp-infected stomach. Only low levels of IFNy, IL-lf3 and IL-
12 were detected in gastric mucosal biopsies using Luminex, with no 
difference between the Hp-infected and uninfected, or Hp-infected with 
peptic ulcer and Hp-infected ulcer-free groups. It may not have been possible 
to detect differences between the groups due to the very low levels detected 
using this technology. Gastric stromal factors can reduce DC IL-12 production 
and Thl responses (Bimczok et aI., 2011). On the other hand numerous 
studies have found increased IFNy in the Hp-infected gastric mucosa using 
techniques including immunohistochemistry, ELISA, EIiSPOT, cytokine bead 
array and flow cytometry with Hp stimulation (lindholm et al., 1998, 
Lehmann et aI., 2002, Holck et aI., 2003, Bontems et al., 2003, Shimizu et al., 
2004, Robinson et aI., 2008). Pellicano et al. found increased IL-12, IFNy and t-
bet by ELISA and western blotting. Studies of Hp infection in Mongolian 
gerbils found high IFNy levels in those with ulcers (Yamaoka et aI., 2005). 
Taking the evidence as a whole, it still seems likely that IFNy (derived from t-
bet+rh17 and/or Thl cells) has a role in ulcer pathogenesis. 
TGF-f3 was not measured in this study, but is known to be increased in the Hp-
infected gastric mucosa and is produced by Tregs, which are associated with 
protection against peptic ulcer disease (Robinson et aI., 2008). It is possible 
that the association of high levels of Tregs with low risk of peptic ulceration is 
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partly due to their production of TGF-p inhibiting Th17 differentiation to an 
IFNy-producing phenotype. 
7.1.4.4 Relative gastric lL-17 and IFNyconcentrations 
The finding that IL-17 concentrations were 3.9-fold higher than IFNy 
concentrations in the Hp+ gastric biopsies was striking. Samples were spiked 
with known concentrations of IFNy and IL-12 to confirm that the Luminex 
assay was able to detect these cytokines satisfactorily. Few published studies 
have measured IFNy concentrations directly comparable with the results 
here. Shimizu et 01. measured IFNy in the supernatants of homogenized 
gastric biopsies from Hp-infected children by ELISA and found mean 
concentrations of approximately 30 pg/mg protein. In the current study mean 
concentration in the Hp+ biopsies was 9.1 pg/mg protein; a little lower but of 
the same order of magnitude. Serelli-Lee et 01. measured IL-17 and IFNy in 
supernatants from lamina propria mononuclear cells cultured with 
phytohaemagglutinin and IL-2 by ELISA, but used biopsy weight rather than 
total protein to adjust for biopsy size. In contrast to findings of the current 
study Serelli-Lee et 01. reported median IL-17 concentrations 89 pg/ml/g 
tissue (range 61-278) and IFNy concentrations 173 pg/ml/g tissue (range 56-
399) (Serelli-Lee et aI., 2012). The in vitro culture conditions could have 
altered the relative cytokine levels but it is possible that differences in the 
study populations and characteristics of the infecting Hp strains could account 
for some of the discrepancies as the study by Serelli-Lee et 01. was based in 
Singapore. 
The relative levels of cytokines might not necessarily reflect their relative 
biological activity, indeed the potency of a single cytokine for different 
functions may vary (Mire-Sluis et aI., 1998). Bioassays are required to assess 
cytokine function but are less well standardized than quantitative 
immunoassays. Both the Luminex and RT-qPCR methods used here assessed 
cytokine levels in whole gastric biopsies, so it is possible that high localized 
levels could occur at the site of disease, though no increase in total IL-17 or 
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IFNy levels was seen in those with peptic ulcer disease. Mizuno et 01. cultured 
gastric biopsies for 48 hours and measured Il-17 levels in the supernatants. In 
keeping with the results presented here they found no difference in Il-17 
levels between the gastric ulcer and non-ulcer patients. However, they found 
increased Il-17 levels at the ulcer site compared to normal antral tissue 
(Mizuno et aL, 2005). 
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Figure 7.1 Schematic diagram summarizing the main findings of the study with linking hypotheses. Findings from this study are 
shown in black, with previously published findings in dark blue and linking hypotheses in green. 
(1) IL-17 concentrations and expression of (7) The RORC2 transcription factor, are increased in the Hp-infected gastric mucosa. 
IL-17 is produced by (2) Th17, (3) Tc17, and (4) C04-C08- T cells. Frequencies of IL-17+ cells ofT cell subsets (2), (3) and (4) are all 
, 
increased in the Hp-infected gastric mucosa. IL-17 is associated with gastric inflammation which it may contribute to by 
increasing levels of the chemokines (5) CCL20 and (6) IL-8 which are known to attract CCR6+ lymphocytes (Th17s and Tregs) and 
neutrophils respectively. Il-17 may also upregulate G-CSF and GM-CSF (Gaffen, 2008). (8) Concentrations of the Th17 cytokine IL-
17F are also increased. (9) Concentrations of IL-10, which may be Treg-derived, were increased in the Hp-infected gastric 
mucosa. (10) Concentrations of IL-27, which favours differentiation of IL-10-producing Tr1 Tregs were also increased. (11) High 
concentrations of Il-23 were found in the gastric mucosa, regardless of Hp status. This may help to maintain the Th17 phenotype 
and/or favour the differentiation of pathogenic IF Ny-secreting Th17 cells. (14) Treg-derived TGF-\3 may inhibit the differentiation 
of C04+IL-17+IFNy+ cells. Inflammation may progress to PUO or precancer (atrophy and intestinal metaplasia), then cancer. (7) 
RORC2 mRNA expression was weakly associated with PUO. Neither IL-17 concentrations nor RORC2 mRNA expression were 
associated with precancerous changes, but Th17 cells may promote progression of established cancer. The Th17-differentiating 
cytokines IL-\3, IL-6 and IL-21 were not increased, suggesting that differentiation may occur at an extra-gastric site, such as (15) 
Peyer's patches, and/or Th17 cells may be recruited from the periphery via CCL20 (16). (12) Th17 and (13) C04+C02Shi Tregs are 
increased in the peripheral blood during Hp infection. 
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7.2 LIMITATIONS OF THE WORK 
7.2.1 Collection of samples from patients 
7.2.1.1 Patients, inclusion and exclusion criteria 
Samples were collected from adult patients attending the Queen's Medical 
Centre for upper gastrointestinal endoscopy. All of the patients were referred 
due to signs or symptoms suggestive of an abnormality in the upper 
gastrointestinal tract. The commonest indication was dyspepsia, but others 
included anaemia, acid reflux and weight loss. The patients were therefore 
not representative of the general population. Patients with a history of taking 
PPls in the preceding two weeks, antibiotics in the preceding 4 weeks or 
regular non-steroidal anti-inflammatory drugs or immunosuppressants were 
excluded from the study, though it is possible that not all aspirin and non-
steroidal anti-inflammatory use was disclosed. PPls and antibiotics can reduce 
the probability of detecting Hp and could therefore lead to patients being 
misclassified as Hp negative. Non-steroidal anti-inflammatory drugs are the 
other main cause of peptic ulceration, so patients taking these, with the 
exception of low dose aspirin for cardiovascular prophylaxis, were excluded 
so that Hp-induced peptic ulcer disease could be studied. The un infected 
patient group tested negative for Hp by multiple methods but did not 
necessarily have completely normal upper gastrointestinal tracts, as might be 
desired in negative controls. It is possible that some of the Hp- patients could 
have had previous Hp infection, but Hp serology is usually positive following 
recent infection. Hp is usually eradicated using triple or quadruple therapy 
with a PPI and multiple antibiotic agents, but the possibility that 
asymptomatic Hp infection could have been eradicated by antibiotics given 
for other infections in some cases cannot be excluded. 
7.2.1.2 Histopathological and c1inicaljlndings 
Clinical samples and endoscopy findings were taken at a single time point for 
each patient. Patients may have had previous ulcers that had healed. Many 
patients had stopped PPI treatment only two weeks prior to endoscopy. This 
may not have been sufficient time for detectable erosions or ulcers to recur. 
Numbers of patients with the precancerous changes of atrophy or intestinal 
metaplasia in the study were low, and when present the changes were of low 
grade. These changes develop following many decades of chronic Hp-induced 
gastritis and the time point when patients became symptomatic and are 
referred for investigation may precede this. Serelli-lee et 01. included a group 
of patients with previous Hp infection in their study and found a high 
prevalence of precancerous changes in this group (Serelli-lee et al., 2012). 
Hp-induced pathology may be patchy: ulcers and cancers usually develop at a 
single site with relatively normal surrounding mucosa. This raises the 
possibility of sampling errors. The biopsies sent for histopathological 
assessment would not have been taken from exactly the same site as the 
biopsies used for cytokine analysis by luminex or RT-qPCR. This may have 
reduced the probability of finding correlations between histopathological 
parameters and the cytokine and RORe2 expression data. Advanced 
endoscopy techniques are now available which can visualize areas of 
premalignant pathology. Future studies could use this technology to target 
precancerous tissue, to compare biopsies from damaged and undamaged 
sites and to assess patchiness of immune cell infiltration. 
7.2.1.3 Matching o/patient characteristics 
Due to the sample size it was not possible to strictly match Hp-infected and 
uninfected patients for age and gender, which may affect immune responses 
(Naylor et aI., 2005, Arnold et al., Karanfilov et aI., 1999, Hoffmann et al., 
2005, Afshan et al.). However, there was no significant difference in the ages 
or male:female ratio of the Hp-infected and un infected patients included in 
the study. 
Country of birth is another potentially important factor to consider, as 
infection often occurs early in life and more virulent strains are more 
common in certain geographical areas. For example East Asians strains 
frequently have a particularly virulent form of CagA (Atherton and Blaser, 
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2009). The questionnaire used to collect patient data could be amended to 
include detailed information on country of birth for future studies. 
As discussed in the Introduction, host genetic variations such as 
polymorphisms in cytokines including Il-17 can influence risk of Hp-related 
disease (EI-Omar et aI., 2000, Hou et al., 2007, Shibata et al., 2009). However 
the ethical approval for this study did not include permission for genotyping. 
An amendment to the current ethical approvals and consent form could be 
applied for to allow these factors to be investigated and controlled for in 
future studies. 
7.2.1.4 Subgrouping of Hp-infected patients 
This is the first study with high enough numbers of Hp+ patients to allow Th17 
markers to be stratified by histopathological and clinical findings, however 
some of the patient groups were disappointingly small, reducing the power of 
the study. The numbers of Hp-infected gastric biopsies analyzed by flow 
cytometry were relatively small, precluding subgrouping by histopathological 
findings or disease. It is particularly important to consider the size of the 
groups where there were negative findings. For example, as discussed above, 
the numbers of patients with precancerous changes were quite low and the 
precancerous changes tended to be low grade when they were found. This 
means that the finding that precancerous changes were not associated with 
Il-17 levels or RORe2 expression needs to be interpreted with some caution. 
Targeting premaligant gastric mucosa with advanced endoscopy techniques 
and/or including a group of patients with previous Hp infection are possible 
strategies that could be employed to increase numbers of biopsies/patients 
with precancerous findings. 
Similarly, though CD4+CD2Shigh Tregs were increased in the peripheral blood 
of Hp-infected compared to uninfected patients, no differences were found in 
CD4+CD2ShighCD12iow or CD4+CD2ShighFOXP3+ Tregs. These negative findings 
should ideally be confirmed on a larger set of samples, though they are 
consistent with others' findings (Greenaway et aI., 2011, Satoh et al.). The 
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number of samples studied for which virulence factor data was available was 
also low but could be expanded as additional strains are genotyped. 
This study has generated a number of hypotheses based on findings in clinical 
samples from patients, but was observational nature. Future work should 
include mechanistic studies where interventions can be made and conclusions 
can be drawn about causation {see below}. 
7.2.2 Methodology Employed 
7.2.2.1 In vitro DC work 
Preparing equal amounts of viable Hp of different strains for stimulation of 
DCs in vitro was technically difficult and DC responses showed wide inter-
donor variation, as noted by other authors {Kranzer et aL, 2004, Andres et aL, 
2011}. As relatively little is known about the phenotype of gastric DCs, 
responses of two different DC models to Hp were compared. Initially MoDCs 
were studied as they have been widely used in the study of DC responses to 
Hp and are relatively easy to work with. Subsequently MyDCs were used, 
which better reflected gastric DC responses and in vivo findings. The findings 
in the current study and by Bimczok et 01. {Bimczok et aL, 20l0} raise 
questions about the relevance of the MoDC model which has been widely 
used in Hp research. Ideally DCs extracted from gastric tissue would be used, 
but large amounts of gastric tissue would be required to obtain sufficient 
numbers of DCs. The commonest reason for surgical resection of the stomach 
locally is malignancy. DCs in these patients may not be typical and the vast 
majority of patients are treated with chemotherapy or immunosuppressants 
prior to surgery, so suitable samples were not available for this approach. 
Even with gastric DCs, simple in vitro models cannot reflect the complexity of 
gastric mucosa in vivo. In a recent publication Bimczok et 01. used "stroma-
conditioned media" to try to include the influence of stromal factors in their 
in vitro model and found that this reduced DC-stimulated Thl responses 
{Bimczok et al., 2011}. Other cell types present in the gastric mucosa in vivo 
but not in in vitro models may also have important effects on DCs and T cell 
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differentiation. In addition to DCs B cells and macrophages can also act as 
antigen presenting cells (Weaver et a/., 1988) (see section 7.3.1). 
7.2.2.2 RT-qPCR 
Real-time quantitative PCR is a sensitive method for evaluating gene 
eXpression, and was well suited to this study where the availability of clinical 
biopsy material from each patient was limited. Biopsies can be treated with 
RNA later, stored at -80°C, then processed and analyzed in batches. The 
exponential amplification that occurs during PCR means that a tiny amount of 
contamination may have a significant effect on the results obtained, so 
measures were taken to minimize the risk of this happening and controls 
were put in place to detect contamination if it occurred. 
As whole gastric biopsies were used for RT-qPCR analysis, the data obtained 
does not give any information on which cells expressed the genes studied. 
The mRNA level of gene expression may not be reflected at the protein level. 
RT-qPCR data should therefore be validated by protein data.fL17 RT-qPCR 
was validated by IL-17 protein data from Luminex, flow cytometry and ELISA 
in this study. Unfortunately RORC2 flow cytometry was not successful, so 
RORC2 protein expression was not measured. New RORC2 antibodies may 
become available for future studies or other techniques to quantify RORC2 
, protein such as immunohistochemistry or chip cytometry (see below) could 
be explored. Th17 cells by flow cytometry and RORC2 expression were both 
increased in Hp-infected compared to uninfected patients, but insufficient 
patients had both these variables measured to assess for correlations. 
The method of RT-qPCR analysis used was relative to a pooled control derived 
from uninfected donor material, rather than being fully quantitative. It is 
expressed relative to a housekeeping gene (GAPDH in this case) to normalize 
for the total amount of cDNA. The Pfaffl method was used for data analYSis, 
which takes account of the efficiencies of the PCR reactions (Pfaffl, 2001). This 
is in contrast to the MCT method, which can only be used when the 
efficiency of the PCR of the target gene approximates that of the 
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housekeeping gene (Giulietti et aL, 2001). Some authorities recommend 
including at least three biological replicates per sample (Taylor et aL, 2010), 
but the number of gastric biopsies per patient was limited by ethical 
approvals and other resources were also limited, so a single biopsy from each 
patient was used for RT-qPCR with three technical replicates. Analysis of 
multiple biopsies from each patient could have reduced the effect of 
patchiness of infection and inflammation. 
7.2.2.3 Luminex 
luminex is an attractive technique for maximizing the data obtained from 
small clinical samples. As multiple cytokines can be quantified in the same 
assay it can also give useful information about relative cytokine levels and 
cytokine profiles. Sample volume requirements are lower than for western 
blotting and ELISA. Sensitivity is similar to ELISA but the lower sample volume 
requirements avoid the need for dilution. Protein microarrays (also known as 
protein chips) are another technology that allows quantitation of multiple 
proteins in a small volume sample. Spots of capture antibody are bound to a 
support surface, such as a glass slide, to which the sample is added. This can 
then be probed with detection antibody, typically fluorescence-labelled. This 
approach can be expensive and a suitable scanner is required to analyze the 
. slides. luminex panels including our cytokines of interest allowed flexibility, 
Were commercially available and affordable and there was a Bio-Plex 200 
analyzer locally so luminex methodology was selected. Some data obtained 
Using a similar approach to investigate immune responses to Hp has been 
published previously (Serelli-lee et aL, 2012). 
luminex technology is rapidly gaining in popularity and is now in widespread 
Use for a number of clinical applications. However, the multiplex nature of 
this technique means that assays for different combinations of cytokines and 
for different types of samples need to be carefully validated and optimized. 
Some authors have suggested that luminex should only be used to select 
promiSing biomarkers to investigate further (Ojoba Siawaya et aI., 2008). It is 
good practice to confirm results by more than one technique, and further 
studies are needed to investigate the unexpectedly low Th1 cytokine results 
found by Luminex.ln vivo gastric IL-12 and IFNy levels may be low due to 
suppression by Tregs and other stromal factors (Bimczok et aI., 2011). Again, 
whole gastric biopsies were used so the Luminex data does not give 
information about the cellular sources of the cytokines measured. 
7.2.2.4 Flow cytometry 
Flow cytometry is a powerful technique for characterizing single cells and 
determining the cellular sources of cytokines. Four colour flow cytometry was 
used in this study, to ensure that there were no problems with compensation 
and we could be confident about the data obtained. Extracellular staining, 
intracellular staining and analysis were often done on separate days, so there 
would have been a risk of some of the less stable tandem dyes deconjugating 
prior to analysis. However, use of increasing numbers of colours is becoming 
more widespread with advances in flow cytometers and availability of 
fluorochromes with narrow emission spectra. C04+ T cells in the peripheral 
blood were co-stained for IL-17 and IFNy, but as more is now known about 
the range of phenotypes of Th 17 cells, it would be interesting to co-stain 
gastric Th17 for other cytokines and transcription factors (see future work). 
Attempts were made to investigate RORC2 by flow cytometry but limited 
reagents were available and problems with non-specific staining could not be 
overcome despite attempts at optimization with lower concentrations of 
RORC2 antibody and FcR blocking. As this is a relatively new target it is likely 
that improved reagents will become available, or alternatively RORC2 protein 
could be studied using other techniques, as discussed above. 
Short-term stimulation is used prior to flow cytometry analysis for cytokines. 
Antigenic stimulation may be more patho-physiological and was used for 
peripheral blood cells, but PMA/ionomycin stimulation was used for gastric 
cells in order to obtain sufficient numbers of the events of interest. There is a 
risk that in vitro stimulation could affect cytokine expression, but short-term 
stimulation should help keep this to a minimum. This can be borne in mind 
when interpreting the flow cytometry results in conjunction with results of 
the luminex assays, which were performed on snap frozen gastric biopsies 
and therefore should give a good reflection of in vivo cytokine levels. Despite 
using six gastric biopsies for flow cytometry there were usually only sufficient 
cells to set up a single stimulated tube and an unstimulated control tube. 
Ideally larger amounts of gastric tissue and hence larger numbers of gastric 
cells would be studied but the number of gastric biopsies that can be taken 
for research is limited by the ethical permission granted. Single biopsies were 
Used for RT-qPCR and luminex which yielded important data that helped to 
validate the flow cytometry data. 
It is Possible that short-term stimulation could skew towards cytokine 
production by innate immune cells, which are known to produce cytokine 
rapidly in response to infection in vivo. Hp present in biopsies from infected 
patients could act as an additional stimulus. Cells such as y8 T cells can secrete 
Il-17 in response to stimulation of pattern recognition receptions such as 
TlRs, without the need for TCR stimulation (Martin et aL, 2009, Sutton et aL, 
2009, Romi et aL, 2011). 
The relative amounts of Il-17 produced by its various cellular sources were 
not investigated. Median fluorescence intensities could give an indication of 
this, or the different T cell subsets could be isolated and the supernatants 
from short-term culture assayed for Il-17. 
Immunohistochemistry could have been used to study cell surface markers 
and transcription factors and can also be used for co-localization of cytokines. 
Advantages of immunohistochemistry are that it is performed on intact 
Sections of tissue, so cells can be localized. There would also be the potential 
for further analysis of historical samples, whereas flow cytometry is 
performed on cells isolated from fresh tissue. However, as detection of Il-17 
secreting cells was one of the main aims of this study flow cytometry was 
used. 
7.3 FUTURE WORK 
7.3.1 Antigen presenting cells in Hp infection 
like gastric DCs, MyDCs produced undetectable IL-12p70 in response to Hp 
stimulation (Bimczok et aL, 2010), in contrast to MoDCs which produced high 
concentrations of IL-12p70. The MoDC model has been widely used in 
published Hp research but the findings here indicate that different types of 
DC respond differently to Hp. There is no published data on IL-23 gastric DC 
responses to Hp. When planning future studies it needs to be borne in mind 
that models using DCs derived from circulating blood may not reflect gastric 
DC responses. 
The differences in cytokine secretion by MoDCs and MyDCs upon stimulation 
with wild-type Hp strains or dupA null mutants were surprisingly small 
compared to the differences previously observed with peripheral blood 
monocytes (Hussein et aL, 2010). However monocytes are not present in 
gastric tissue. Macrophages are present in gastric tissue and can act as 
antigen presenting cells (Fehlings et aL, 2012, Quiding-Jarbrink et aL, 2010). 
like gastric DCs and MyDCs, they produce little IL-12p70 upon Hp stimulation 
(Fehlings et aL, 2012). They may have a more similar TLR profile to monocytes 
than the MoDCs and MyDCs studied here. B cells are also present within the 
Hp-infected gastric mucosa and can act as antigen presenting cells. Work in 
the H. felis model s·uggests that B cells may have a regulatory role as B cells 
activated by Hp TLR2 induced IL-lO-secreting CD4+CD2S+Treg (Tr1) cells (Sayi 
et aL, 2011). IL-17 signalling may regulate B cell recruitment, as IL-17RA 
knockout mice had increased gastric B cells (Algood et aL, 2009). Interestingly 
Th17 cells were recently found to be crucial for B cell switching to IgA 
production in Peyer's patches in a fate mapping study (Hirota et aL, 2013). 
An interesting next step would be to look at the effect of Hp with and without 
active dupA on monocyte-derived macrophages. MoDCs could be included in 
the experiment for comparison. Ideally stroma-conditioned media and normal 
media would both be used to try to assess the effect of the gastric 
environment. It might be possible to set up a collaboration with the group 
that has access to large samples of surgically resected gastric mucosa and has 
published studies on gastric DCs and stroma-conditioned media (Bimczok et 
aI., 2010, Bimczok et aI., 2011). Large samples of human gastric tissue are not 
available locally at present other than from cancer patients, but would be 
very valuable for this research if opportunities arose to obtain them in the 
future. 
Some Hp strains with intact cagPAI that can colonize mice such as B128 and 
PMSSl are now available, but all the strains currently used for colonizing mice 
have disrupted dupA genes, making it difficult to investigate dupA effects in a 
mouse model. 
The role of MIF in Thl differentiation in Hp also requires further investigation. 
MIF has been shown to be increased during Hp infection and a role for it in 
carcinogenesis has also been postulated (Wong et aI., 2009, Xia et aI., 2004, 
He et aI., 200·6). It has been suggested that it could be the pro-Thl factor in 
the gastric mucosa in the absence of significant IL-12p70 levels (Bimczok et 
aI., 2010). However, Fehlings et al. reported that MIF secreted by DCs was 
reduced upon Hp stimulation (Fehlings et aI., 2012). Immunohistochemistry 
could be used to localize the MIF. We did not measure gastric MIF levels with 
Our Luminex analysis, but this could be included in future studies. MIF could 
be measured in addition to IL-12 family cytokines in the supernatants of Hp-
stimulated antigen presenting cells. 
7.3.2 Gastric cytokine milieu 
The finding of low IL-12 and IFNy in the study was striking. Both Luminex and 
RT-qPCR studies showed that significantly less IFNy than IL-17 is expressed in 
the gastric mucosa, and Tregs (known to be increased in the Hp-infected 
gastric mucosa) and other stromal factors are known to suppress Thl 
responses (Bimczok et aI., 2011). However, as discussed above, numerous 
previous studies have found increased IFNy in Hp infection and it has been 
linked to protection, inflammation, peptic ulcer disease and preneoplastic 
changes in animal models (Hitzler et aL, 2012b, Sawai et aL, 1999, Smythies et 
aL, 2000, Akhiani et aL, 2002, Obonyo et al., 2002, Cui et al., 2003, Sayi et aL, 
2009, Shi et aL, 2005), though other studies suggest that it is not essential for 
protection (Sawai et aL, 1999, Flach et aL, Garhart et aL, 2003). A next step 
might be to assay Il-17 and IFNy levels by ELISA in samples similar to those 
used for the luminex assays, if the sample volume for the EliSAs does not 
require so much dilution that the cytokine concentrations drop below 
detectable levels. 
Some cytokines not measured here could also have important roles in the 
gastric mucosa. T G F - ~ ~ is important for both Treg and Th17 differentiation and 
can SUppress Thl differentiation. It has been shown to be increased in Hp 
infection using immunohistochemistry and RT-qPCR and it is produced by 
gastric epithelial cells in response to Hp (li and li, 2006, lindholm et aL, 1998, 
Robinson et aL, 2008, Harris et al., 2008, Kandulski et aI., 2008, Beswick et aI., 
2007). T G F - ~ - i s s secreted and bound to the cell surface in an inactive form. For 
ELISA and luminex assays samples can be treated with acid prior to T G F - ~ ~
analysis to free the surface bound inactive form, but this may not reflect 
levels of biologically active T G F - ~ . . Acid-activation also precludes multiplex 
analysis. Il-18, traditionally thought of as a Thl cytokine, is known to be 
Upregulated in Hp infection and can be produced by gastric epithelial cells, 
and mononuclear cells including DCs (Tomita et aL, 2001, Shimada et aL, 
2008, Yamauchi et aL, 2008, Oertli et al., 2012). More recently DC-derived Il-
18 has been shown to drive Treg differentiation in a mouse model (Oertli et 
aI., 2012). As discussed above, MIF may be important for Thl differentiation. 
7.3.3 Further characterization of lL-17 producing cells in the Hp-
infected gastric mucosa 
It is now becoming clear that Th17 cells are not a single uniform population. 
There is a spectrum from pro-inflammatory to regulatory subtypes, with 
different cytokine profiles (Peters et aL, 2011). To further elucidate the role of 
Th17 cells in the Hp-infected gastric mucosa it would be helpful to check for T-
bet and FOXP3 co-expression with RORC2 and to see which cytokines in 
addition to Il-17 these cells are secreting. Cytokines of interest that Th17 cells 
can also produce include Il-17F, Il-21, Il-22, IFNy, GM-CSF, Il-26 and Il-10 
(Volpe et aL, 2008, Manel et aL, 2008, Wilson et aL, 2007, langrish et aL, 
2005). The cytokine profile of gastric Th17 cells could be characterized further 
using flow cytometry with more colours to allow more cytokines (and their 
co-expression) to be studied in a single sample. Chip cytometry is another 
approach to be explored. Immunohistochemistry could be used to co-localize 
cytokines with cell surface markers and transcription factors, as discussed 
above in section 7.2.2.4. 
Alternatively gastric Th17 populations could be isolated. larger amounts of 
gastric tissue would be required.for this technique. This could be done using 
capture technology where an antibody complex that can bind cell surface 
CD45 and secreted Il-17 is used. The surface bound Il-17 can then be labeled 
for sorting by flow cytometry or magnetic bead enrichment (Streeck et aL, 
2008). Commercial kits using this technology are now available for human 
Th17 cells (ll-17 Secretion Assay- Cell Enrichment and Detection Kit (PEl, 
human, Miltenyi Biotech). Brucklacher-Waldert et al. found that surface Il-17 
is expressed at low levels on stimulated Th17 cells and could be used to 
identify viable Il-17-secreting cells without the need for a capture antibody 
( B r u c k l a c h e r - W a l d . ~ r t t et aL, 2009a). This could potentially be applied to CD8+, 
yo T cell and other Il-17-secreting populations. RT-qPCR could be performed 
on mRNA extracted from the Il-17 secreting populations, and/or supernatants 
from short-term culture could be analyzed for the cytokines of interest. 
Amounts of Il-17 and other cytokines secreted by the different populations 
could be compared. 
Innate Il-17-secreting populations share many characteristics with Th17 cells 
but have been under-appreciated until recently. This study suggests that 
these populations are a significant source of gastric Il-17. It will be important 
to Positively identify and further characterize the CD4-CD8-ll-17+ 
population(s). It would be relatively straightforward to analyze Il-17+ yo T cell 
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frequencies by flow cytometry and NK cell markers, such as C056 could also 
be included. 
7.3.4 Relationship between gastric Th17 cells and other CD4+ T 
cells in the Hp-in/ected gastric mucosa 
Another important area for investigation is the relationship between Th17 
cells and other C04+ T cells present in the Hp-infected gastric mucosa. 
Understanding the plasticity of these cells and the influences they have on 
each other is key to understanding Hp-induced pathology and being able to 
develop appropriate prognostic tests and therapeutic interventions. 
The Th17 and Treg lineages are closely related. They both depend on TGF-B 
for differentiation (Bettelli et aL, 2006). A number of factors can influence the 
balance of Treg/Th17 differentia-tion, including the availability of AhR ligands 
(Quintana et aL, 2008, Veldhoen et aL, 2009). Retinoic acid, Il-35 and Il-27 
favour Treg differentiation (Mucida et aL, 2007, Niedbala et aL, 2007, Pot et 
aL, 2011). The balance is shifted in favour ofTh17 cells in the presence of pro-
inflammatory cytokines such as Il-6, low concentration TGF-B and pathogen 
PRRs (Torchinsky et aL, 2009, Nyirenda et aL, 2011, Bettelli et aL, 2006, 
Veldhoen et aL, 2006, Yang et aL, 2008b). 
Tregs may assist Th17 development by acting as a source ofTGF-B and an Il-2 
sink (Veldhoen et aL, 2006, Chen et aL, 2011), but FOXP3 can inhibit Th17 
differentiation by antagonizing RORyt (Zhou et aL, 2008a, Yang et aL, 2008b). 
Tregs can convert into Il-17-producing cells in pro-inflammatory 
environments and FOXP3+ll-17+cells, as well as Il-l0-producing Th17 cells 
have been described (Zielinski et aL, 2012, Voo et aL, 2009, Ghoreschi et aL, 
2010). Kao et 01. studied Th17/Treg balance in mouse Hp infection and found 
that Hp-stimulated OCs led to a lower Th17:Treg ratio than OCs stimulated 
With E. coli and A. Iwoffi (Kao et aL, 2010). Neutralizing Il-l0 and TGF-B or 
depleting Tregs with an anti-C025 antibody increased Th17 responses, and 
the enhanced Th17 responses were associated with reduced Hp colonization 
(Kao et aL, 2010). 
Th17 cells are also closely related to the Thl phenotype. Early studies 
establishing Th17 cells as a separate lineage found that IFNy suppressed Th17 
differentiation (Harrington et aL, 2005). Pathogenic CD4+IL-17+IFNy+ cells 
expressing both RORyt and T-bet are well recognized and seem to be derived 
from Th17 cells (Annunziato et aL, 2007, Zielinski et aL, 2012, Shi et aL, 2008, 
Lee et aL, 2009, Bending et aL, 2009, Hirota et aL, Boniface et aL, 2010, Cosmi 
et aL, 2011). T-bet can inhibit the Th17 phenotype by suppressing runxl-
mediated RORyt activation (Lazarevic et aL, 2011). Th17-derived CD4+IL-
17+IFNy+ cells can lose their IL-17-secreting capacity and differentiate into 
CD4+r-bet+IFNy+ cells, which retain some Th17-like characteristics such as 
CD161 expression and the ability to upregulate defensin genes (Nistala et aL, 
2010, Boniface et aL, 2010). Conversely Thl cells do not appear to be able to 
convert to a Th17 phenotype (Shi et aI., 2008). This raises questions as to 
Whether CD4+r-bet+IFNy+ cells identified in Hp infection are genuine Thl cells, 
or a Th17-derived population. Shi et 01. found that IL-17 rose before IFNy in 
murine Hp infection, and IL-17 knockout mice had reduced Thl responses (Shi 
et aL, 2010), which could fit with some "Thl"/IFNy responses being Th17-
derived. 
Th17 cells isolated from Hp-infected gastric mucosa could be cultured in 
gastric stroma-conditioned media and normal media to see if the gastric 
stromal factors influenced the numbers or phenotype of gastric Th17 cells. A 
similar experiment could be done with Tregs to see if there was any 
conversion of Tregs to Th17s when cultured with gastric stromal factors. 
Different ratios of Tregs and Th 17 cells could also be co-cultured. CD161 may 
be a useful additional marker for further studies of Thl cells. 
Animal studies could provide further information about the influence of 
different Th 17 populations on risk of disease. 
7.3.5 Bioassays and in vivo models 
Amajor limitation ofthis study is its observational nature. No interventions 
. Were made therefore only associations could be found. In vitro 
models/bioassays and animal models may help to elucidate the causes of Hp-
induced pathology. Gastric epithelial cell lines are widely used in vitro but are 
derived from gastric cancers rather than normal gastric epithelium. Mouse 
studies of Hp have been restricted by a lack of pathogenic Hp strains that 
successfully colonize the murine stomach. The related H. /elis has been used 
in a number of studies (Pritchard and Przemeck, 2004, Sayi et aL, 2009, Roth 
et aL, 1999, Hitzler et aL, 2012a). Mongolian gerbils have also been studied as 
they can be colonized by Hp and develop Hp-induced pathology, but the 
available reagents for these animals are limited. Recently a more virulent 
mouse-colonizing strain of Hp named PMSSl has become available, which is 
cagA+ and is able to transfer the CagA protein into host epithelial cells 
(Arnold et aL, 2011b, Hitzler et aL, 2012a). This could be an important tool for 
investigating Hp-related patho-physiology. Hitzler et al. studied the 
development of pre neoplastic p ~ t h o l o g y y in response to infection with this 
strain in af3 TCR-1-, p19-1- (lacking IL-23) and p3S-I- (lacking IL-12) mice. The af3 
TCR was required for control of Hp infection and development of 
preneoplastic pathology but neither p19 nor p3S seemed to affect Hp 
colonization densities (Hitzler et aL, 2012a). The p19 knockout mice had less 
gastritis and preneoplastic pathology (Hitzler et aL, 2012a). It would be 
informative to characterize IL-17-secreting cells and other C04+ cells in the 
stomachs of wild-type mice infected with the PMSSl strain. Possible 
pathogenic or anti-inflammatory populations could then be adoptively 
transferred to see "if this modulated disease. 
7.4 SUMMARY OF MAIN FINDINGS AND POSSIBLE CLINICAL 
IMPLICATIONS 
• IL-17 concentrations were significantly higher than IFNy, IL-4 or IL-
10 concentrations in the Hp-infected stomach. 
• C04+,L-17+ (Th17) cells were the main source of IL-17 in the Hp-
infected gastric mucosa but COS+IL-17+ (Tc17) and C03+C04-COS-IL-
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17+ cell frequencies were also increased. Innate T cell-derived IL-17 
could boost IL-17 production by conventional T cells. 
• Gastric CCL20 levels were high and markedly increased in Hp 
infection, but I L - 1 ~ , , IL-G and IL-21 levels were relatively low and 
not increased in Hp infection. This suggests that Hp-specific Th17 
cells differentiate at an extra-gastric site (perhaps Peyer's patches) 
and Th17 cells are recruited to the stomach by CCL20 due to their 
expression of CCRG. 
• High IL-23 levels in the gastric mucosa (though not increased in Hp 
infection) could help to maintain/expand Th17 populations and 
may promote their development into more 
inflammatory/pathogenic phenotypes e.g. with IFNy coexpression. 
• High RORC2 expression was associated with increased risk of 
peptic ulcer disease, though IL-17 levels were not, suggesting that 
other Th17 factors (perhaps IFNy) are involved in peptic ulceration. 
• ~ i t h e r r RORC2 expression nor IL-17 levels were correlated with 
risk of atrophy or intestinal metaplasia, suggesting that Th17 cells 
are not involved in carcinogenesis, although they may promote 
progression of established tumours. 
• Hp-specific Th17 cells were also increased in the blood of Hp-
infected patients. A proportion ofthe Hp-specific Th17 cells in the 
blood also expressed IFNy. 
• Different types of DC have different cytokine responses to Hp and 
it is not clear how well the MoDC or MyDC models reflect gastric 
DCs. 
• Mutation of the dupA virulence factor reduced cytokine secretion 
by Hp-stimulated DCs, though the effect was less marked than that 
reported for Hp-stimulated monocytes. 
This study has added substantially to the knowledge of IL-17/Th17 cells in 
human Hp infection. A range of techniques have been used to characterize IL-
17 /Th17 responses to Hp and compare their levels relative to Thl/IFNy 
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responses. A strong IL-17 response is a key part of the human immune 
response to this common pathogen, but may not be directly linked to disease. 
Data from murine models appears conflicting with reduced Hp colonization in 
IL-17 knockout mice, but increased colonization in IL-17RA knockout mice (Shi 
et aLI 2010, Shiomi et aLI 2008, OeLyria et aLI 2011, Algood et aLI 2009). It is 
now recognized that Th17 cells are heterogeneous, with some more 
regulatory Th17s co-expressing IL-10, and other pro-inflammatory Th17s 
expression IFNy and/or GM-CSF. This may account for some of the confusion 
about the role of Th17 cells in Hp infection. C08+ T cells and C04-C08- T cells 
are also important sources of IL-17, but little is known about these 
populations in the context of Hp infection. 
Further experiments including animal studies are needed to test the 
hypotheses generated by this study before IL-17/Th17 modulating therapies 
could be used in the management of patients with Hp. In symptomatic 
patients the first line treatment is usually to eradicate Hp. However antibiotic 
resistance i s ~ i n c r e a s i n g g and a persistent Th17 response may continue, even 
after successful eradication (Serelli-Lee et aLI 2012, Malfertheiner et aLI 
2012). IL-17/Th17 modulating treatments may become a reality for a high risk 
group of Hp-infected patients in the future. 
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